Uniprot-Accession,S9-Protein,0,3,5,7,9,11,13,15,E-value,Protein,Gene,Length,GO-BP,GO-IDs,Pathway,UniPathway,CDD,Pfam,GO-name
P79099,CHOYP_AQP4.3.3|m.44128,0,0,0,0,0,0,0,0,2.00E-70,Aquaporin-2 (AQP-2) (ADH water channel) (Aquaporin-CD) (AQP-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct),AQP2,271,cellular response to copper ion [GO:0071280]; cellular response to mercury ion [GO:0071288]; cellular response to water deprivation [GO:0042631]; ion transmembrane transport [GO:0034220]; metanephric collecting duct development [GO:0072205]; renal water transport [GO:0003097],GO:0003097; GO:0005794; GO:0005887; GO:0015168; GO:0015250; GO:0016323; GO:0016324; GO:0030659; GO:0034220; GO:0042631; GO:0055037; GO:0070062; GO:0071280; GO:0071288; GO:0072205,,,cd00333;,PF00230;,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; recycling endosome [GO:0055037]; glycerol transmembrane transporter activity [GO:0015168]; water channel activity [GO:0015250]; cellular response to copper ion [GO:0071280]; cellular response to mercury ion [GO:0071288]; cellular response to water deprivation [GO:0042631]; ion transmembrane transport [GO:0034220]; metanephric collecting duct development [GO:0072205]; renal water transport [GO:0003097]
Q920Q2,CHOYP_BRAFLDRAFT_213587.1.1|m.51383,0,0,0,0,0,0,0,0,4.00E-157,DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase),Rev1 Rev1l,1249,error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411],GO:0003684; GO:0005634; GO:0009411; GO:0017125; GO:0042276; GO:0046872,,,cd00027;,PF16589;PF14377;PF00817;PF11799;PF16727;,nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; metal ion binding [GO:0046872]; error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411]
O70352,CHOYP_CD82.2.3|m.17728,0,0,0,0,0,0,0,0,3.00E-36,CD82 antigen (Metastasis suppressor Kangai-1 homolog) (CD antigen CD82),Cd82 Kai1,266,cell surface receptor signaling pathway [GO:0007166],GO:0005887; GO:0007166,,,,PF00335;,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]
O16011,CHOYP_DYAK_GE11656.1.2|m.34706,0,0,0,0,0,0,0,0,3.00E-52,Protein muscleblind (Protein mindmelt),mbl mm CG33197,297,"apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; embryo development [GO:0009790]; eye development [GO:0001654]; imaginal disc-derived wing morphogenesis [GO:0007476]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; peripheral nervous system development [GO:0007422]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; somatic muscle development [GO:0007525]; visual perception [GO:0007601]",GO:0000381; GO:0001654; GO:0001751; GO:0003676; GO:0003677; GO:0005634; GO:0005737; GO:0006915; GO:0007422; GO:0007476; GO:0007517; GO:0007525; GO:0007601; GO:0009790; GO:0010468; GO:0030018; GO:0031673; GO:0042052; GO:0045924; GO:0046716; GO:0046872; GO:0048471; GO:0050896,,,,,"cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; embryo development [GO:0009790]; eye development [GO:0001654]; imaginal disc-derived wing morphogenesis [GO:0007476]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; peripheral nervous system development [GO:0007422]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; somatic muscle development [GO:0007525]; visual perception [GO:0007601]"
P48058,CHOYP_GLRK.1.3|m.29909,0,0,0,0,0,0,0,0,1.00E-69,"Glutamate receptor 4 (GluR-4) (GluR4) (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4) (GluA4)",GRIA4 GLUR4,902,glutamate receptor signaling pathway [GO:0007215]; transport [GO:0006810],GO:0004970; GO:0004971; GO:0005231; GO:0005234; GO:0005886; GO:0006810; GO:0007215; GO:0030054; GO:0030425; GO:0030666; GO:0032281; GO:0045211; GO:1903561,,,,PF01094;PF00060;PF10613;,AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; dendrite [GO:0030425]; endocytic vesicle membrane [GO:0030666]; extracellular vesicle [GO:1903561]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; AMPA glutamate receptor activity [GO:0004971]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellular-glutamate-gated ion channel activity [GO:0005234]; ionotropic glutamate receptor activity [GO:0004970]; glutamate receptor signaling pathway [GO:0007215]; transport [GO:0006810]
P33450,CHOYP_HGFAC.1.1|m.5902,0,0,0,0,0,0,0,0,0.000008,Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito],ft CG3352,5147,"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell morphogenesis involved in differentiation [GO:0000904]; cell proliferation [GO:0008283]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of Wnt signaling pathway [GO:0030178]; ommatidial rotation [GO:0016318]; peptide cross-linking [GO:0018149]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of organ growth [GO:0046620]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; single organismal cell-cell adhesion [GO:0016337]; tissue development [GO:0009888]; wing disc development [GO:0035220]",GO:0000904; GO:0001736; GO:0001737; GO:0004872; GO:0005509; GO:0005739; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008283; GO:0008285; GO:0009888; GO:0010629; GO:0016021; GO:0016318; GO:0016324; GO:0016336; GO:0016337; GO:0016339; GO:0018149; GO:0030178; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035329; GO:0040008; GO:0042067; GO:0044331; GO:0045198; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046620; GO:0048105; GO:0050839; GO:0090176,,,,PF00028;PF00008;PF00054;PF02210;,"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; receptor activity [GO:0004872]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis involved in differentiation [GO:0000904]; cell proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of Wnt signaling pathway [GO:0030178]; ommatidial rotation [GO:0016318]; peptide cross-linking [GO:0018149]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of organ growth [GO:0046620]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; single organismal cell-cell adhesion [GO:0016337]; tissue development [GO:0009888]; wing disc development [GO:0035220]"
Q9W6R5,CHOYP_HMCN2.11.12|m.51619,0,0,0,0,0,0,0,0,2.00E-21,Retinoschisin (X-linked juvenile retinoschisis protein homolog),xlrs1,280,cell adhesion [GO:0007155],GO:0005576; GO:0007155; GO:0070492,,,,PF00754;,extracellular region [GO:0005576]; oligosaccharide binding [GO:0070492]; cell adhesion [GO:0007155]
O74465,CHOYP_LOC100373100.4.4|m.65650,0,0,0,0,0,0,0,0,2.00E-61,Helicase required for RNAi-mediated heterochromatin assembly 1 (EC 3.6.4.13),hrr1 SPCC1739.03,999,cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]; chromosome segregation [GO:0007059],GO:0000775; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0006338; GO:0007049; GO:0007059; GO:0030702; GO:0031048; GO:0031379; GO:0031380,,,,,"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; RNA-directed RNA polymerase complex [GO:0031379]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]; chromosome segregation [GO:0007059]"
A0JPP8,CHOYP_LOC100373421.1.1|m.38932,1,0,0,0,0,0,0,0,2.00E-109,Coiled-coil domain-containing protein 61,Ccdc61,512,,GO:0005813,,,,,centrosome [GO:0005813]
B4KD90,CHOYP_LOC100533321.1.1|m.38814,0,0,0,0,0,0,0,0,0,Glutamate [NMDA] receptor subunit 1,Nmdar1 GI24494,980,behavioral response to ethanol [GO:0048149]; calcium ion homeostasis [GO:0055074]; chemical synaptic transmission [GO:0007268]; imaginal disc-derived wing morphogenesis [GO:0007476]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term memory [GO:0007616]; medium-term memory [GO:0072375]; olfactory learning [GO:0008355]; phototaxis [GO:0042331]; regulation of membrane potential [GO:0042391]; sensory perception of touch [GO:0050975],GO:0004970; GO:0004972; GO:0005234; GO:0007268; GO:0007476; GO:0007616; GO:0008355; GO:0014069; GO:0017146; GO:0030054; GO:0035235; GO:0042331; GO:0042391; GO:0045211; GO:0048149; GO:0050975; GO:0055074; GO:0072375,,,,PF01094;PF10562;PF00060;PF10613;,cell junction [GO:0030054]; NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; extracellular-glutamate-gated ion channel activity [GO:0005234]; ionotropic glutamate receptor activity [GO:0004970]; NMDA glutamate receptor activity [GO:0004972]; behavioral response to ethanol [GO:0048149]; calcium ion homeostasis [GO:0055074]; chemical synaptic transmission [GO:0007268]; imaginal disc-derived wing morphogenesis [GO:0007476]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term memory [GO:0007616]; medium-term memory [GO:0072375]; olfactory learning [GO:0008355]; phototaxis [GO:0042331]; regulation of membrane potential [GO:0042391]; sensory perception of touch [GO:0050975]
O01393,CHOYP_LOC100533356.6.6|m.63561,0,0,0,0,0,0,0,0,2.00E-94,Innexin unc-9 (Uncoordinated protein 9),unc-9 R12H7.1,386,ion transmembrane transport [GO:0034220],GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0034220; GO:0055077,,,,PF00876;,cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220]
Q5TFE4,CHOYP_LOC100556034.2.2|m.15378,0.5,0,0,0,0,0,0,0,1.00E-99,5'-nucleotidase domain-containing protein 1 (EC 3.1.3.-),NT5DC1 NT5C2L1 LP2642,455,,GO:0008253; GO:0046872,,,,PF05761;,5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]
P24540,CHOYP_LOC101065571.1.2|m.36430,0.5,0,0,0,0,0,0,0,1.00E-22,"Acylphosphatase-1 (EC 3.6.1.7) (Acylphosphatase, organ-common type isozyme) (Acylphosphate phosphohydrolase 1)",ACYP1 ACYPE,101,,GO:0003998,,,,PF00708;,acylphosphatase activity [GO:0003998]
Q9D0R4,CHOYP_LOC101168798.1.1|m.6128,0,0,0,0,0,0,0,0,0,Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 56),Ddx56 D11Ertd619e Noh61,546,positive regulation of neuron projection development [GO:0010976]; RNA secondary structure unwinding [GO:0010501]; rRNA processing [GO:0006364],GO:0003723; GO:0004004; GO:0005524; GO:0005730; GO:0006364; GO:0010501; GO:0010976; GO:0016020,,,,PF00270;PF00271;,membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; positive regulation of neuron projection development [GO:0010976]; RNA secondary structure unwinding [GO:0010501]; rRNA processing [GO:0006364]
P33450,CHOYP_NEMVEDRAFT_V1G122785.1.1|m.57840,0.5,0,0,0,0,0,0,0,3.00E-51,Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito],ft CG3352,5147,"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell morphogenesis involved in differentiation [GO:0000904]; cell proliferation [GO:0008283]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of Wnt signaling pathway [GO:0030178]; ommatidial rotation [GO:0016318]; peptide cross-linking [GO:0018149]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of organ growth [GO:0046620]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; single organismal cell-cell adhesion [GO:0016337]; tissue development [GO:0009888]; wing disc development [GO:0035220]",GO:0000904; GO:0001736; GO:0001737; GO:0004872; GO:0005509; GO:0005739; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008283; GO:0008285; GO:0009888; GO:0010629; GO:0016021; GO:0016318; GO:0016324; GO:0016336; GO:0016337; GO:0016339; GO:0018149; GO:0030178; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035329; GO:0040008; GO:0042067; GO:0044331; GO:0045198; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046620; GO:0048105; GO:0050839; GO:0090176,,,,PF00028;PF00008;PF00054;PF02210;,"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; receptor activity [GO:0004872]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis involved in differentiation [GO:0000904]; cell proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of Wnt signaling pathway [GO:0030178]; ommatidial rotation [GO:0016318]; peptide cross-linking [GO:0018149]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of organ growth [GO:0046620]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; single organismal cell-cell adhesion [GO:0016337]; tissue development [GO:0009888]; wing disc development [GO:0035220]"
P20163,CHOYP_NEMVEDRAFT_V1G212312.5.5|m.58424,0,0,0,0,0,0,0,0,0.000000005,Heat shock 70 kDa protein D,hsp-4 hsp70d F43E2.8,657,embryo development ending in birth or egg hatching [GO:0009792]; endoplasmic reticulum unfolded protein response [GO:0030968],GO:0001085; GO:0005524; GO:0005788; GO:0005791; GO:0009792; GO:0030968; GO:0034663,,,,PF00012;,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; RNA polymerase II transcription factor binding [GO:0001085]; embryo development ending in birth or egg hatching [GO:0009792]; endoplasmic reticulum unfolded protein response [GO:0030968]
A2ASS6,CHOYP_PHUM_PHUM226120.6.7|m.48915,0,0,0,0,0,0,0,0,0,Titin (EC 2.7.11.1) (Connectin),Ttn,35213,actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007015; GO:0007507; GO:0007512; GO:0008307; GO:0019899; GO:0019901; GO:0021591; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0070062; GO:0071688; GO:0097493; GO:1901897,,,cd00063;,PF00041;PF07679;PF00069;PF02818;PF09042;,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]
P34056,CHOYP_TCFAP2B.2.2|m.11727,0.5,0,0,0,0,0,0,0,2.00E-123,Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2),Tfap2a Ap2tf Tcfap2a,437,"anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; palate development [GO:0060021]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; trigeminal nerve development [GO:0021559]",GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000980; GO:0000981; GO:0000982; GO:0000987; GO:0001077; GO:0001078; GO:0001105; GO:0001106; GO:0001228; GO:0001822; GO:0001843; GO:0002089; GO:0003151; GO:0003334; GO:0003404; GO:0003409; GO:0003682; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005813; GO:0005829; GO:0006355; GO:0006357; GO:0007399; GO:0007423; GO:0007605; GO:0008285; GO:0009880; GO:0010172; GO:0010628; GO:0010944; GO:0014032; GO:0021506; GO:0021559; GO:0021623; GO:0021884; GO:0030335; GO:0030501; GO:0035115; GO:0035136; GO:0042059; GO:0042472; GO:0043066; GO:0043231; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0044212; GO:0045595; GO:0045664; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0048485; GO:0048596; GO:0048701; GO:0048705; GO:0048730; GO:0060021; GO:0060235; GO:0060325; GO:0060349; GO:0061029; GO:0061303; GO:0070172; GO:0071281; GO:0071711; GO:0072210; GO:2000378,,,,PF03299;,"centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; core promoter proximal region sequence-specific DNA binding [GO:0000987]; protein dimerization activity [GO:0046983]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription coactivator activity [GO:0001105]; RNA polymerase II transcription corepressor activity [GO:0001106]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0000982]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding [GO:0001228]; transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001078]; anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; palate development [GO:0060021]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell differentiation [GO:0045595]; regulation of neuron differentiation [GO:0045664]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; trigeminal nerve development [GO:0021559]"
Q6INX1,CHOYP_TMM98.1.1|m.51750,0,0,0,0,0,0,0,0,7.00E-68,Transmembrane protein 98,tmem98,226,,GO:0016021,,,,,integral component of membrane [GO:0016021]
P29590,CHOYP_TRIM56.2.2|m.59948,1,0,0,0,0,0,0,0,0.000008,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),PML MYL PP8675 RNF71 TRIM19,882,"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; defense response to virus [GO:0051607]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of viral release from host cell [GO:1902187]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein complex assembly [GO:0006461]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; SMAD protein import into nucleus [GO:0007184]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]",GO:0000784; GO:0001666; GO:0001932; GO:0002230; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006351; GO:0006355; GO:0006461; GO:0006605; GO:0006915; GO:0006919; GO:0006977; GO:0007050; GO:0007179; GO:0007182; GO:0007184; GO:0008270; GO:0008285; GO:0008630; GO:0008631; GO:0009411; GO:0010332; GO:0010522; GO:0010761; GO:0016032; GO:0016363; GO:0016525; GO:0016605; GO:0030099; GO:0030155; GO:0030308; GO:0030578; GO:0031065; GO:0031625; GO:0031901; GO:0031965; GO:0032183; GO:0032206; GO:0032211; GO:0032469; GO:0032922; GO:0032938; GO:0034097; GO:0042406; GO:0042752; GO:0042771; GO:0042803; GO:0043153; GO:0043161; GO:0045087; GO:0045165; GO:0045345; GO:0045892; GO:0045930; GO:0045944; GO:0046982; GO:0048146; GO:0048384; GO:0050713; GO:0050821; GO:0050897; GO:0051457; GO:0051607; GO:0051974; GO:0060058; GO:0060333; GO:0060444; GO:0070059; GO:0071353; GO:0090398; GO:0097191; GO:1901796; GO:1902187; GO:1904816; GO:2000059; GO:2000779; GO:2001238,,,,PF12126;PF00643;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SUMO binding [GO:0032183]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; defense response to virus [GO:0051607]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of viral release from host cell [GO:1902187]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein complex assembly [GO:0006461]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; SMAD protein import into nucleus [GO:0007184]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]"
P14248,CHOYP_BH13620.1.1|m.41020,1,0,0,0,0,0,0,0,6.00E-30,DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit),RPII,2452,transcription from RNA polymerase II promoter [GO:0006366],GO:0003677; GO:0003899; GO:0005665; GO:0006366; GO:0046872,,,,PF04997;PF00623;PF04983;PF05000;PF04998;PF04992;PF04990;PF05001;,"DNA-directed RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription from RNA polymerase II promoter [GO:0006366]"
A6NCI4,CHOYP_BRAFLDRAFT_117157.1.3|m.7944,1,0,0,0,0,0,0,0,4.00E-43,von Willebrand factor A domain-containing protein 3A,VWA3A,1184,,GO:0005576,,,,PF13768;,extracellular region [GO:0005576]
P51909,CHOYP_BRAFLDRAFT_125104.1.1|m.31139,0,0,0,0,0,0,0,0,2.00E-38,Apolipoprotein D (Apo-D) (ApoD),APOD,189,aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],GO:0000302; GO:0005215; GO:0005615; GO:0005783; GO:0006006; GO:0006629; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0070062; GO:0071638; GO:1900016; GO:2000098; GO:2000405,,,,PF08212;,cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; transporter activity [GO:0005215]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]
Q58EG3,CHOYP_CADM3.4.4|m.45272,0,0,0,0,0,0,0,0,0.00000004,Nectin-3-like protein (Nectin cell adhesion molecule 3) (Poliovirus receptor-related protein 3-like),nectin3 pvrl3l si:dkey-62a13.5 zgc:113035,574,cell recognition [GO:0008037]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; spermatid development [GO:0007286],GO:0004872; GO:0005102; GO:0005887; GO:0005913; GO:0007156; GO:0007157; GO:0007286; GO:0008037; GO:0042803; GO:0050839,,,,PF08205;PF07686;,cell-cell adherens junction [GO:0005913]; integral component of plasma membrane [GO:0005887]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; receptor activity [GO:0004872]; receptor binding [GO:0005102]; cell recognition [GO:0008037]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; spermatid development [GO:0007286]
O08893,CHOYP_CALCR.1.6|m.856,0.5,0,0,0,0,0,0,0,2.00E-74,Calcitonin receptor (CT-R),CALCR,478,cell surface receptor signaling pathway [GO:0007166],GO:0004948; GO:0005886; GO:0007166; GO:0016021,,,,PF00002;PF02793;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; cell surface receptor signaling pathway [GO:0007166]
Q5HZB6,CHOYP_CLASR.1.2|m.27688,0.5,0,0,0,0,0,0,0,4.00E-102,"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16)",Clasrp Sfrs16,668,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],GO:0005634; GO:0006397; GO:0008380,,,,PF09750;,nucleus [GO:0005634]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
A2BDA5,CHOYP_DCA15.1.1|m.11376,0,0,0,0,0,0,0,0,5.00E-41,DDB1- and CUL4-associated factor 15,dcaf15,600,protein ubiquitination [GO:0016567],GO:0016567,PATHWAY: Protein modification; protein ubiquitination.,,,PF14939;,protein ubiquitination [GO:0016567]
P0C7U4,CHOYP_DHR-1.1.1|m.43819,0,0,0,0,0,0,0,0,9.00E-20,C3a anaphylatoxin chemotactic receptor (C3AR) (C3a-R),c3ar1,361,cell chemotaxis [GO:0060326]; complement receptor mediated signaling pathway [GO:0002430]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204],GO:0002430; GO:0004875; GO:0004930; GO:0005887; GO:0006954; GO:0007200; GO:0007204; GO:0050900; GO:0060326,,,,PF00001;,integral component of plasma membrane [GO:0005887]; complement receptor activity [GO:0004875]; G-protein coupled receptor activity [GO:0004930]; cell chemotaxis [GO:0060326]; complement receptor mediated signaling pathway [GO:0002430]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
Q24157,CHOYP_DPSE_GA18536.2.2|m.47561,0,0,0,0,0,0,0,0,7.00E-43,"Beta-1,3-galactosyltransferase brn (EC 2.4.1.62) (Brainiac protein) (Neurogenic secreted-signaling protein brn)",brn CG4934,325,border follicle cell migration [GO:0007298]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; maintenance of polarity of follicular epithelium [GO:0042248]; morphogenesis of follicular epithelium [GO:0016333]; multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]; oogenesis [GO:0048477]; optic lobe placode formation [GO:0001744]; ovarian follicle cell-cell adhesion [GO:0007299]; ovarian follicle cell development [GO:0030707]; protein glycosylation [GO:0006486],GO:0000139; GO:0001744; GO:0005576; GO:0005795; GO:0006486; GO:0006688; GO:0007219; GO:0007275; GO:0007293; GO:0007298; GO:0007299; GO:0008375; GO:0016021; GO:0016333; GO:0030707; GO:0042248; GO:0046981; GO:0047915; GO:0048477,,,,PF01762;,"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity [GO:0046981]; ganglioside galactosyltransferase activity [GO:0047915]; border follicle cell migration [GO:0007298]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; maintenance of polarity of follicular epithelium [GO:0042248]; morphogenesis of follicular epithelium [GO:0016333]; multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]; oogenesis [GO:0048477]; optic lobe placode formation [GO:0001744]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell-cell adhesion [GO:0007299]; protein glycosylation [GO:0006486]"
Q6NZJ6,CHOYP_EIF4G1.1.2|m.33170,0,0,0,0,0,0,0,0,5.00E-164,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1),Eif4g1,1600,behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of energy homeostasis [GO:2000507]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; response to ethanol [GO:0045471]; translation [GO:0006412],GO:0001662; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005844; GO:0005913; GO:0006412; GO:0006446; GO:0007005; GO:0008135; GO:0008190; GO:0008284; GO:0010507; GO:0010801; GO:0016020; GO:0016281; GO:0030307; GO:0030324; GO:0032270; GO:0033138; GO:0034645; GO:0045471; GO:0045666; GO:0098641; GO:1900087; GO:1905537; GO:1905606; GO:1905612; GO:1905618; GO:1905696; GO:2000507,,,,PF02847;PF02854;PF02020;,"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; cadherin binding involved in cell-cell adhesion [GO:0098641]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of energy homeostasis [GO:2000507]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; response to ethanol [GO:0045471]; translation [GO:0006412]"
Q24798,CHOYP_HS12B.10.14|m.59859,0.5,0,0,0,0,0,0,0,4.00E-17,78 kDa glucose-regulated protein (GRP-78),GRP78,651,,GO:0005524; GO:0005788,,,,PF00012;,endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]
Q8SRR1,CHOYP_IRO.2.4|m.10201,0,0,0,0,0,0,0,0,1.00E-11,Homeobox protein HD-12 (EcHD-12),HD-12 ECU06_0740,193,"regulation of transcription, DNA-templated [GO:0006355]",GO:0003677; GO:0005634; GO:0006355,,,,PF05920;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]"
Q810N6,CHOYP_LOC100185472.1.1|m.66178,2.5,0,0,0,0,0,0,0,2.00E-47,Ankyrin repeat domain-containing protein 45,Ankrd45,248,,,,,,PF12796;,
Q9R0M3,CHOYP_LOC100367084.10.22|m.44502,0,0,0,0,0,0,0,0,7.00E-22,Sushi-repeat-containing protein SRPX (DRS protein),Srpx,464,autophagy [GO:0006914]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976],GO:0001845; GO:0005776; GO:0005783; GO:0006914; GO:0034976; GO:0060244; GO:2001241,,,cd00033;,PF13778;PF02494;PF00084;,autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; autophagy [GO:0006914]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976]
Q9R0M3,CHOYP_LOC100367084.2.22|m.27296,0,0,0,0,0,0,0,0,7.00E-26,Sushi-repeat-containing protein SRPX (DRS protein),Srpx,464,autophagy [GO:0006914]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976],GO:0001845; GO:0005776; GO:0005783; GO:0006914; GO:0034976; GO:0060244; GO:2001241,,,cd00033;,PF13778;PF02494;PF00084;,autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; autophagy [GO:0006914]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976]
C3YWU0,CHOYP_LOC100367436.1.1|m.20579,1,0,0,0,0,0,0,0,0,Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase),BRAFLDRAFT_56888,449,fucose metabolic process [GO:0006004],GO:0004560; GO:0005576; GO:0006004,,,,PF01120;PF16757;,extracellular region [GO:0005576]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]
B6SFA4,CHOYP_LOC100373100.3.4|m.51137,0,0,0,0,0,0,0,0,4.00E-22,Probable helicase MAGATAMA 3 (EC 3.6.4.-) (SEN1-like protein),MAA3 At4g15570 dl3825w,818,embryo sac development [GO:0009553]; pollen-pistil interaction [GO:0009875]; pollen tube guidance [GO:0010183],GO:0004386; GO:0005524; GO:0005634; GO:0009553; GO:0009875; GO:0010183,,,,,nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; embryo sac development [GO:0009553]; pollen tube guidance [GO:0010183]; pollen-pistil interaction [GO:0009875]
Q2NL11,CHOYP_LOC100378269.1.2|m.12226,2,0,0,0,0,0,0,0,2.00E-24,Uncharacterized protein C8orf74 homolog,,293,,,,,,PF14769;,
Q9HC84,CHOYP_LOC100497129.6.8|m.41866,77,0,0,0,0,0,0,0,2.00E-126,"Mucin-5B (MUC-5B) (Cervical mucin) (High molecular weight salivary mucin MG1) (Mucin-5 subtype B, tracheobronchial) (Sublingual gland mucin)",MUC5B MUC5,5762,defense response to bacterium [GO:0042742]; O-glycan processing [GO:0016266]; regulation of macrophage activation [GO:0043030]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],GO:0002223; GO:0005615; GO:0005796; GO:0005886; GO:0016266; GO:0042742; GO:0043030; GO:0043231; GO:0070062; GO:0070701,,,,PF08742;PF13330;PF01826;PF00093;PF00094;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; mucus layer [GO:0070701]; plasma membrane [GO:0005886]; defense response to bacterium [GO:0042742]; O-glycan processing [GO:0016266]; regulation of macrophage activation [GO:0043030]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]
Q01177,CHOYP_LOC100548534.1.1|m.26485,10.5,0,0,0,0,0,0,0,3.00E-80,"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]",Plg,812,blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; proteolysis involved in cellular protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trophoblast giant cell differentiation [GO:0060707],GO:0004175; GO:0004252; GO:0005576; GO:0005886; GO:0007596; GO:0019897; GO:0042246; GO:0042730; GO:0043231; GO:0045445; GO:0046716; GO:0048771; GO:0051603; GO:0060707; GO:0060716; GO:0071674,,,cd00190;,PF00051;PF00024;PF00089;,extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; proteolysis involved in cellular protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trophoblast giant cell differentiation [GO:0060707]
Q86V88,CHOYP_LOC100877618.1.1|m.39871,0.5,0,0,0,0,0,0,0,4.00E-48,Magnesium-dependent phosphatase 1 (MDP-1) (EC 3.1.3.-) (EC 3.1.3.48),MDP1,176,,GO:0004725; GO:0046872; GO:0070062,,,,PF12689;,extracellular exosome [GO:0070062]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]
Q8R151,CHOYP_LOC100891217.1.1|m.63544,0,0,0,0,0,0,0,0,7.00E-43,NFX1-type zinc finger-containing protein 1,Znfx1,1909,,GO:0003700; GO:0003723; GO:0005634; GO:0008270,,,,,"nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]"
P73795,CHOYP_NEMVEDRAFT_V1G240887.2.2|m.37649,0,0,0,0,0,0,0,0,0.00000005,Uncharacterized protein sll1147,sll1147,137,,GO:0004364; GO:0004602; GO:0005886; GO:0016021,,,,PF01124;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]
Q9VJ79,CHOYP_PDE11.1.3|m.8788,0,0,0,0,0,0,0,0,0,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11)",Pde11 CG34341,1451,cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; lateral inhibition [GO:0046331]; signal transduction [GO:0007165],GO:0004115; GO:0005829; GO:0007165; GO:0046058; GO:0046068; GO:0046331; GO:0046872; GO:0047555,,,,PF01590;PF00233;,"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; lateral inhibition [GO:0046331]; signal transduction [GO:0007165]"
Q9V6K3,CHOYP_PLMN.11.11|m.51036,0,0,0,0,0,0,0,0,1.00E-16,Tyrosine-protein kinase transmembrane receptor Ror2 (dRor2) (EC 2.7.10.1) (Neurospecific receptor tyrosine kinase),Nrk ROR2 CG4007,724,muscle cell cellular homeostasis [GO:0046716]; photoreceptor cell axon guidance [GO:0072499]; protein phosphorylation [GO:0006468]; rhabdomere development [GO:0042052]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0006468; GO:0007165; GO:0007169; GO:0016021; GO:0042052; GO:0046716; GO:0072499,,,,PF01392;PF00051;PF07714;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; muscle cell cellular homeostasis [GO:0046716]; photoreceptor cell axon guidance [GO:0072499]; protein phosphorylation [GO:0006468]; rhabdomere development [GO:0042052]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
O07552,CHOYP_SMP_001000.1.1|m.39561,1.5,0,0,0,0,0,0,0,3.00E-10,Stress response protein NhaX,nhaX yheK BSU09690,166,response to stress [GO:0006950],GO:0006950,,,,PF00582;,response to stress [GO:0006950]
A1L0T3,CHOYP_BRAFLDRAFT_120139.4.5|m.50713,0.5,0,0,0,0,0,0,0,3.00E-36,Scavenger receptor cysteine-rich domain-containing group B protein (Four scavenger receptor cysteine-rich domains-containing protein) (S4D-SRCRB),Ssc4d Srcrb4d,586,,GO:0005044; GO:0016020; GO:0070062,,,,PF00530;,extracellular exosome [GO:0070062]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]
Q9CQ46,CHOYP_BRAFLDRAFT_122339.1.1|m.58748,1.5,0,0,0,0,0,0,0,7.00E-73,EF-hand calcium-binding domain-containing protein 2,Efcab2,164,,GO:0005509,,,,,calcium ion binding [GO:0005509]
Q4R8M9,CHOYP_BRAFLDRAFT_124130.2.3|m.30247,0,0,0,0,0,0,0,0,2.00E-21,Gametocyte-specific factor 1 (Protein FAM112B),GTSF1 FAM112B QtsA-12026,167,cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],GO:0005737; GO:0007283; GO:0030154; GO:0046872,,,,PF05253;,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]
Q503Y4,CHOYP_BRAFLDRAFT_126058.1.1|m.1201,0.5,0,0,0,0,0,0,0,2.00E-72,Esterase OVCA2 (EC 3.1.2.-) (Ovarian cancer-associated gene 2 protein homolog),ovca2 zgc:110011,227,,GO:0016787,,,,PF03959;,hydrolase activity [GO:0016787]
Q569L8,CHOYP_CENPJ.1.1|m.49318,0,0,0,0,0,0,0,0,3.00E-84,Centromere protein J (CENP-J),Cenpj,1344,astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; microtubule polymerization [GO:0046785]; mitotic spindle pole body duplication [GO:1903087]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of centriole replication [GO:0046599]; smoothened signaling pathway [GO:0007224],GO:0003713; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005874; GO:0005886; GO:0007099; GO:0007224; GO:0015631; GO:0019901; GO:0019904; GO:0030954; GO:0036064; GO:0043015; GO:0044458; GO:0046427; GO:0046599; GO:0046785; GO:0051298; GO:0051301; GO:0061511; GO:0098534; GO:1902857; GO:1903087; GO:1905515,,,,PF07202;,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; gamma-tubulin binding [GO:0043015]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; microtubule polymerization [GO:0046785]; mitotic spindle pole body duplication [GO:1903087]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of centriole replication [GO:0046599]; smoothened signaling pathway [GO:0007224]
P54254,CHOYP_LOC100372922.1.1|m.12888,0,0,0,0,0,0,0,0,2.00E-48,Ataxin-1 (Spinocerebellar ataxia type 1 protein homolog),Atxn1 Sca1,791,"adult locomotory behavior [GO:0008344]; excitatory postsynaptic potential [GO:0060079]; lung alveolus development [GO:0048286]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; transcription, DNA-templated [GO:0006351]; visual learning [GO:0008542]",GO:0000122; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006351; GO:0008022; GO:0008266; GO:0008344; GO:0008542; GO:0016363; GO:0034046; GO:0042326; GO:0042405; GO:0042802; GO:0043234; GO:0043569; GO:0043621; GO:0045892; GO:0045944; GO:0048286; GO:0051168; GO:0060079; GO:0060252; GO:0098794,,,,PF12547;PF08517;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein complex [GO:0043234]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; excitatory postsynaptic potential [GO:0060079]; lung alveolus development [GO:0048286]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; transcription, DNA-templated [GO:0006351]; visual learning [GO:0008542]"
Q9U489,CHOYP_LOC100374741.83.83|m.66460,0,0,0,0,0,0,0,0,0.000000003,Protein lin-41 (Abnormal cell lineage protein 41),lin-41 C12C8.3,1147,"epidermal cell fate specification [GO:0009957]; gamete generation [GO:0007276]; multicellular organismal protein metabolic process [GO:0044268]; nematode male tail tip morphogenesis [GO:0045138]; positive regulation of gene expression [GO:0010628]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of development, heterochronic [GO:0040034]; regulation of epidermal cell differentiation [GO:0045604]",GO:0004842; GO:0005737; GO:0007276; GO:0008270; GO:0009957; GO:0010628; GO:0040034; GO:0042787; GO:0044268; GO:0045138; GO:0045604; GO:1990124,,,,PF00630;PF01436;,"cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; epidermal cell fate specification [GO:0009957]; gamete generation [GO:0007276]; multicellular organismal protein metabolic process [GO:0044268]; nematode male tail tip morphogenesis [GO:0045138]; positive regulation of gene expression [GO:0010628]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of development, heterochronic [GO:0040034]; regulation of epidermal cell differentiation [GO:0045604]"
Q2KI83,CHOYP_LOC100635352.1.1|m.9481,0,0,0,0,0,0,0,0,3.00E-84,DnaJ homolog subfamily C member 17,DNAJC17,304,"negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; toxin transport [GO:1901998]; transcription, DNA-templated [GO:0006351]",GO:0000122; GO:0000166; GO:0003723; GO:0005634; GO:0005737; GO:0006351; GO:1901998,,,cd06257;cd12429;,PF00226;PF00076;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; toxin transport [GO:1901998]; transcription, DNA-templated [GO:0006351]"
P50219,CHOYP_LOC100707249.1.1|m.15336,0,0,0,0,0,0,0,0,3.00E-43,Motor neuron and pancreas homeobox protein 1 (Homeobox protein HB9),MNX1 HLXB9,401,"anatomical structure morphogenesis [GO:0009653]; endocrine pancreas development [GO:0031018]; humoral immune response [GO:0006959]; neuron projection morphogenesis [GO:0048812]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; spinal cord motor neuron cell fate specification [GO:0021520]; transcription, DNA-templated [GO:0006351]",GO:0003700; GO:0005634; GO:0005730; GO:0005829; GO:0006351; GO:0006357; GO:0006959; GO:0009653; GO:0021520; GO:0031018; GO:0043565; GO:0048812,,,,PF00046;,"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; anatomical structure morphogenesis [GO:0009653]; endocrine pancreas development [GO:0031018]; humoral immune response [GO:0006959]; neuron projection morphogenesis [GO:0048812]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; spinal cord motor neuron cell fate specification [GO:0021520]; transcription, DNA-templated [GO:0006351]"
Q6NXH2,CHOYP_LOC100718937.1.1|m.13522,0,0,0,0,0,0,0,0,5.00E-153,"Glycoprotein endo-alpha-1,2-mannosidase (Endo-alpha mannosidase) (Endomannosidase) (mEndo) (EC 3.2.1.130)",Manea,462,,GO:0000139; GO:0004569; GO:0005794; GO:0016021,,,cd11574;,PF16317;,"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein endo-alpha-1,2-mannosidase activity [GO:0004569]"
O57460,CHOYP_LOC100898124.1.1|m.49610,0,0,0,0,0,0,0,0,0.00000003,Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein),tll1 mfn tld tolloid,1022,blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508],GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264,,,cd00041;cd04281;,PF01400;PF00431;,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508]
Q6Q4G4,CHOYP_LOC101076790.1.1|m.45316,0,0,0,0,0,0,0,0,0,Angiotensin-converting enzyme (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (TtACE),ACE,616,,GO:0004180; GO:0005615; GO:0008237; GO:0008241; GO:0016020; GO:0046872,,,cd06461;,PF01401;,extracellular space [GO:0005615]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]
Q96MB7,CHOYP_LOC101171725.3.3|m.62457,0,0,0,0,0,0,0,0,2.00E-61,Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease),HARBI1 C11orf77,349,,GO:0004518; GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0046872,,,,PF13359;,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
Q9NYQ7,CHOYP_MEGF6.53.59|m.55485,0,0,0,0,0,0,0,0,0.0000002,Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1) (EGF-like protein 1) (Flamingo homolog 1) (hFmi1) (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2),CELSR3 CDHF11 EGFL1 FMI1 KIAA0812 MEGF2,3312,"axonal fasciculation [GO:0007413]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; G-protein coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron migration [GO:0001764]; planar cell polarity pathway involved in axon guidance [GO:1904938]; regulation of protein localization [GO:0032880]; regulation of protein phosphorylation [GO:0001932]; serotonergic neuron axon guidance [GO:0036515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",GO:0001764; GO:0001932; GO:0004930; GO:0005509; GO:0005886; GO:0007156; GO:0007186; GO:0007413; GO:0016021; GO:0032880; GO:0036514; GO:0036515; GO:0060071; GO:0060271; GO:1904938,,,,PF00002;PF00028;PF00008;PF16489;PF01825;PF00053;PF02210;,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein coupled receptor activity [GO:0004930]; axonal fasciculation [GO:0007413]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; G-protein coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron migration [GO:0001764]; planar cell polarity pathway involved in axon guidance [GO:1904938]; regulation of protein localization [GO:0032880]; regulation of protein phosphorylation [GO:0001932]; serotonergic neuron axon guidance [GO:0036515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
Q5TUE9,CHOYP_RM23.1.1|m.173,0.5,0,0,0,0,0,0,0,6.00E-24,"Probable 39S ribosomal protein L23, mitochondrial (L23mt) (MRP-L23)",mRpL23 AGAP010338,151,DNA restriction-modification system [GO:0009307]; mitochondrial translation [GO:0032543],GO:0000166; GO:0003677; GO:0003723; GO:0003735; GO:0005762; GO:0009036; GO:0009307; GO:0032543,,,,PF00276;,mitochondrial large ribosomal subunit [GO:0005762]; DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; Type II site-specific deoxyribonuclease activity [GO:0009036]; DNA restriction-modification system [GO:0009307]; mitochondrial translation [GO:0032543]
P46545,CHOYP_XPP1.2.2|m.38696,0,0,0,0,0,0,0,0,2.00E-12,Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Proline dipeptidase) (Prolidase),pepQ,368,,GO:0005737; GO:0008237; GO:0046872; GO:0102009,,,,PF01321;PF00557;,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proline dipeptidase activity [GO:0102009]
Q8BYK8,CHOYP_ZC3H4.1.1|m.57516,0.5,0,0,0,0,0,0,0,3.00E-32,Zinc finger CCCH domain-containing protein 6,Zc3h6 Zc3hdc6,1177,,GO:0046872,,,,PF00642;,metal ion binding [GO:0046872]
Q20616,CHOYP_BRAFLDRAFT_125550.1.5|m.9080,1.5,0,0,0,0,0,0,0,4.00E-71,Peroxidase skpo-1 (EC 1.11.1.7) (ShKT and peroxidase domain-containing protein 1),skpo-1 F49E12.1,655,defense response to Gram-positive bacterium [GO:0050830]; determination of adult lifespan [GO:0008340]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; response to oxidative stress [GO:0006979],GO:0004601; GO:0005615; GO:0006979; GO:0008340; GO:0010629; GO:0020037; GO:0045087; GO:0046872; GO:0050830,,,,PF03098;PF01549;,extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; defense response to Gram-positive bacterium [GO:0050830]; determination of adult lifespan [GO:0008340]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; response to oxidative stress [GO:0006979]
P00920,CHOYP_BRAFLDRAFT_127510.1.1|m.48935,1.5,0,0,0,0,0,0,0,4.00E-55,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II),Ca2 Car2,260,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; one-carbon metabolic process [GO:0006730]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]",GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006730; GO:0006885; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0016323; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0070062; GO:0071498; GO:2001150; GO:2001225,,,,PF00194;,"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; one-carbon metabolic process [GO:0006730]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]"
Q8BZM1,CHOYP_GLMN.1.1|m.17085,0.5,0,0,0,0,0,0,0,4.00E-54,Glomulin (FK506-binding protein-associated protein) (FAP) (FKBP-associated protein),Glmn Fap48,596,"cell surface receptor signaling pathway [GO:0007166]; circulatory system development [GO:0072359]; muscle cell differentiation [GO:0042692]; negative regulation of cell proliferation [GO:0008285]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of phosphorylation [GO:0042327]; regulation of gene expression, epigenetic [GO:0040029]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vasculogenesis [GO:0001570]",GO:0001570; GO:0001843; GO:0005102; GO:0005171; GO:0005737; GO:0007166; GO:0008285; GO:0031461; GO:0031462; GO:0031463; GO:0031464; GO:0031625; GO:0032434; GO:0040029; GO:0042130; GO:0042327; GO:0042692; GO:0045086; GO:0050715; GO:0055105; GO:0072359,,,,PF08568;,"Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; hepatocyte growth factor receptor binding [GO:0005171]; receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105]; cell surface receptor signaling pathway [GO:0007166]; circulatory system development [GO:0072359]; muscle cell differentiation [GO:0042692]; negative regulation of cell proliferation [GO:0008285]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of phosphorylation [GO:0042327]; regulation of gene expression, epigenetic [GO:0040029]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vasculogenesis [GO:0001570]"
Q9HCM2,CHOYP_ISCW_ISCW007151.2.2|m.41979,0,0,0,0,0,0,0,0,0,Plexin-A4,PLXNA4 KIAA1550 PLXNA4A PLXNA4B UNQ2820/PRO34003,1894,anterior commissure morphogenesis [GO:0021960]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644],GO:0002116; GO:0005886; GO:0016021; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0048485; GO:0048841; GO:0050923; GO:0071526; GO:1902287,,,,PF08337;PF01437;PF01403;PF01833;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]
Q86YS6,CHOYP_LOC100366735.1.1|m.52023,0.5,0,0,0,0,0,0,0,2.00E-91,Ras-related protein Rab-43 (Ras-related protein Rab-41),RAB43 RAB41,212,"Golgi organization [GO:0007030]; phagosome maturation [GO:0090382]; retrograde transport, plasma membrane to Golgi [GO:0035526]; small GTPase mediated signal transduction [GO:0007264]; toxin transport [GO:1901998]; virion assembly [GO:0019068]",GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0007030; GO:0007264; GO:0019068; GO:0030670; GO:0032588; GO:0035526; GO:0045335; GO:0070062; GO:0090382; GO:1901998,,,,PF00071;,"endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Golgi organization [GO:0007030]; phagosome maturation [GO:0090382]; retrograde transport, plasma membrane to Golgi [GO:0035526]; small GTPase mediated signal transduction [GO:0007264]; toxin transport [GO:1901998]; virion assembly [GO:0019068]"
Q5XJ13,CHOYP_LOC100371435.1.1|m.6503,1,0,0,0,0,0,0,0,3.00E-11,Ankyrin repeat and SAM domain-containing protein 6 (Ankyrin repeat domain-containing protein 14) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6),anks6 samd6 zgc:85964,739,pronephros development [GO:0048793],GO:0005929; GO:0048793,,,,PF12796;PF00536;,cilium [GO:0005929]; pronephros development [GO:0048793]
Q62717,CHOYP_LOC100372028.1.1|m.22341,0.5,0,0,0,0,0,0,0,0,Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1) (CAPS-1) (rCAPS),Cadps Caps Caps1,1289,dense core granule exocytosis [GO:1990504]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; synaptic vesicle exocytosis [GO:0016079],GO:0005509; GO:0005546; GO:0015031; GO:0016079; GO:0030054; GO:0030659; GO:0031045; GO:0045055; GO:0045921; GO:0045956; GO:0098793; GO:1990504,,,,PF06292;PF00169;,"cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; dense core granule [GO:0031045]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; dense core granule exocytosis [GO:1990504]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; synaptic vesicle exocytosis [GO:0016079]"
Q09654,CHOYP_LOC100374741.13.83|m.17527,0,0,0,0,0,0,0,0,0.0000003,E3 ubiquitin-protein ligase arc-1 (EC 2.3.2.27) (Putative GTP-binding protein trim-23 homolog) (RING-type E3 ubiquitin transferase arc-1),arc-1 arl-4 ZK1320.6,539,protein ubiquitination [GO:0016567]; small GTPase mediated signal transduction [GO:0007264],GO:0005525; GO:0005622; GO:0007264; GO:0008270; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,PF00025;PF00643;PF13445;,intracellular [GO:0005622]; GTP binding [GO:0005525]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; small GTPase mediated signal transduction [GO:0007264]
O94759,CHOYP_LOC100704039.1.1|m.21695,0,0,0,0,0,0,0,0,3.00E-31,Transient receptor potential cation channel subfamily M member 2 (Estrogen-responsive element-associated gene 1 protein) (Long transient receptor potential channel 2) (LTrpC-2) (LTrpC2) (Transient receptor potential channel 7) (TrpC7) (Transient receptor potential melastatin 2),TRPM2 EREG1 KNP3 LTRPC2 TRPC7,1503,calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to purine-containing compound [GO:0071415]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; neutrophil degranulation [GO:0043312]; positive regulation of insulin secretion [GO:0032024]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to purine-containing compound [GO:0014074]; temperature homeostasis [GO:0001659]; zinc II ion transmembrane transport [GO:0071577],GO:0001659; GO:0002407; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005764; GO:0005765; GO:0005886; GO:0005887; GO:0006816; GO:0014074; GO:0015278; GO:0030659; GO:0032024; GO:0035579; GO:0035584; GO:0043005; GO:0043204; GO:0043312; GO:0044849; GO:0051209; GO:0051489; GO:0070301; GO:0070588; GO:0070821; GO:0071277; GO:0071415; GO:0071502; GO:0071577; GO:0097028; GO:0097553; GO:0098703; GO:0099604; GO:0101003; GO:1903223; GO:2000249,,,,PF00520;,cytoplasmic vesicle membrane [GO:0030659]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; cation channel activity [GO:0005261]; ligand-gated calcium channel activity [GO:0099604]; sodium channel activity [GO:0005272]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to purine-containing compound [GO:0071415]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; neutrophil degranulation [GO:0043312]; positive regulation of insulin secretion [GO:0032024]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to purine-containing compound [GO:0014074]; temperature homeostasis [GO:0001659]; zinc II ion transmembrane transport [GO:0071577]
Q86U38,CHOYP_LOC575478.1.1|m.6923,0,0,0,0,0,0,0,0,4.00E-54,Nucleolar protein 9,NOP9 C14orf21 KIAA2021,636,,GO:0003723,,,,,RNA binding [GO:0003723]
E9QBI7,CHOYP_LOC594646.2.2|m.38865,0,0,0,0,0,0,0,0,1.00E-80,"Metalloendopeptidase OMA1, mitochondrial (EC 3.4.24.-) (Overlapping with the m-AAA protease 1 homolog)",oma1 si:ch73-215a11.1,478,diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; misfolded or incompletely synthesized protein catabolic process [GO:0006515]; mitochondrial protein processing [GO:0034982]; negative regulation of mitochondrial fusion [GO:0010637]; response to stress [GO:0006950],GO:0002024; GO:0004222; GO:0005743; GO:0006006; GO:0006515; GO:0006629; GO:0006950; GO:0010637; GO:0016021; GO:0031966; GO:0034982; GO:0046872; GO:0097009,,,,PF01435;,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; misfolded or incompletely synthesized protein catabolic process [GO:0006515]; mitochondrial protein processing [GO:0034982]; negative regulation of mitochondrial fusion [GO:0010637]; response to stress [GO:0006950]
Q8NEZ4,CHOYP_MLL3.2.3|m.25295,1.5,0,0,0,0,0,0,0,2.00E-131,Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.43) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3),KMT2C HALR KIAA1506 MLL3,4911,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0008270; GO:0016746; GO:0018024; GO:0035097; GO:0042800; GO:0044666,,,,PF05965;PF05964;PF00628;PF00856;,"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA binding [GO:0003723]; transferase activity, transferring acyl groups [GO:0016746]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q9HCM2,CHOYP_PLXA2.1.3|m.17630,0,0,0,0,0,0,0,0,1.00E-157,Plexin-A4,PLXNA4 KIAA1550 PLXNA4A PLXNA4B UNQ2820/PRO34003,1894,anterior commissure morphogenesis [GO:0021960]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644],GO:0002116; GO:0005886; GO:0016021; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0048485; GO:0048841; GO:0050923; GO:0071526; GO:1902287,,,,PF08337;PF01437;PF01403;PF01833;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]
Q80U87,CHOYP_SELMODRAFT_2432.1.1|m.60719,0,0,0,0,0,0,0,0,1.00E-16,Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (mUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8),Usp8 Kiaa0055 Ubpy,1080,endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000281; GO:0004843; GO:0005622; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005913; GO:0006511; GO:0007032; GO:0007265; GO:0016579; GO:0019897; GO:0030496; GO:0031313; GO:0070536; GO:0071108; GO:0098641,,,,PF00581;PF00443;PF08969;,cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; intracellular [GO:0005622]; midbody [GO:0030496]; nucleus [GO:0005634]; cadherin binding involved in cell-cell adhesion [GO:0098641]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; ubiquitin-dependent protein catabolic process [GO:0006511]
Q09654,CHOYP_TIF1A.5.8|m.32570,1,0,0,0,0,0,0,0,0.000002,E3 ubiquitin-protein ligase arc-1 (EC 2.3.2.27) (Putative GTP-binding protein trim-23 homolog) (RING-type E3 ubiquitin transferase arc-1),arc-1 arl-4 ZK1320.6,539,protein ubiquitination [GO:0016567]; small GTPase mediated signal transduction [GO:0007264],GO:0005525; GO:0005622; GO:0007264; GO:0008270; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,PF00025;PF00643;PF13445;,intracellular [GO:0005622]; GTP binding [GO:0005525]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; small GTPase mediated signal transduction [GO:0007264]
Q9VR59,CHOYP_VIP2.1.1|m.54883,1.5,0,0,0,0,0,0,0,0,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase (EC 2.7.4.21) (EC 2.7.4.24) (InsP6 and PP-IP5 kinase),l(1)G0196 CG14616,1696,inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958],GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0052723; GO:0052724,,,cd07061;,PF00328;,"cytosol [GO:0005829]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]"
A5D7H5,CHOYP_YL58.1.1|m.35411,0,0,0,0,0,0,0,0,2.00E-28,Protein CASC3 (Cancer susceptibility candidate gene 3 protein) (Metastatic lymph node gene 51 protein homolog) (MLN 51 homolog) (Protein barentsz) (Btz),CASC3 MLN51,703,"intracellular mRNA localization [GO:0008298]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]",GO:0000184; GO:0003723; GO:0006397; GO:0006417; GO:0008298; GO:0008380; GO:0016607; GO:0030529; GO:0031965; GO:0035145; GO:0048471; GO:0051028,,,,PF09405;,"exon-exon junction complex [GO:0035145]; intracellular ribonucleoprotein complex [GO:0030529]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; intracellular mRNA localization [GO:0008298]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"
Q14686,CHOYP_contig_045662|m.53210,0.5,0,0,0,0,0,0,0,5.00E-19,"Nuclear receptor coactivator 6 (Activating signal cointegrator 2) (ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250) (NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein) (PPAR-interacting protein) (PRIP) (Thyroid hormone receptor-binding protein)",NCOA6 AIB3 KIAA0181 RAP250 TRBP,2063,"brain development [GO:0007420]; cellular lipid metabolic process [GO:0044255]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated transcription, initiation [GO:0006352]; glucocorticoid receptor signaling pathway [GO:0042921]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; response to hormone [GO:0009725]; transcription initiation from RNA polymerase II promoter [GO:0006367]",GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006260; GO:0006281; GO:0006310; GO:0006352; GO:0006367; GO:0006974; GO:0007420; GO:0007507; GO:0009725; GO:0019899; GO:0030099; GO:0030331; GO:0030374; GO:0030520; GO:0035097; GO:0042921; GO:0043231; GO:0044255; GO:0045893; GO:0045944; GO:0046965; GO:0046966,,,,PF13820;,"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; brain development [GO:0007420]; cellular lipid metabolic process [GO:0044255]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated transcription, initiation [GO:0006352]; glucocorticoid receptor signaling pathway [GO:0042921]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to hormone [GO:0009725]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
Q9BRS2,CHOYP_BRAFLDRAFT_124526.1.1|m.25228,0.5,0,0,0,0,0,0,0,0,Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.3.-) (RIO kinase 1),RIOK1,568,maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006364; GO:0016787; GO:0030490; GO:0030688; GO:0042274; GO:0046872; GO:2000234,,,,,"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]"
A0A0R4IBK5,CHOYP_BRAFLDRAFT_68766.4.4|m.38248,0,0,0,0,0,0,0,0,2.00E-48,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha),rnf213a,5209,sprouting angiogenesis [GO:0002040],GO:0002040; GO:0004842; GO:0005829; GO:0008270; GO:0016887,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.,,,,cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
P0DH96,CHOYP_CML1.1.1|m.30763,1,0,0,0,0,0,0,0,2.00E-22,Calmodulin-4 (CaM-4),CAM4 At1g66410 F28G11.13 T27F4.1,149,,GO:0005509,,,cd00051;,PF13499;,calcium ion binding [GO:0005509]
G5ED84,CHOYP_DGRI_GH14766.1.1|m.27098,0,0,0,0,0,0,0,0,4.00E-11,Kelch-like protein 8,kel-8 W02G9.2,690,protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787],GO:0014069; GO:0016567; GO:0030054; GO:0031463; GO:0042787; GO:0043005; GO:0043025,PATHWAY: Protein modification; protein ubiquitination.,,,PF07707;PF00651;PF01344;,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]
Q9UTF7,CHOYP_ELOV4.3.3|m.64203,0,0,0,0,0,0,0,0,1.00E-21,Putative elongation of fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase SPAC1B2.03c) (Very-long-chain 3-oxoacyl-CoA synthase 1),SPAC1B2.03c,334,"fatty acid elongation, unsaturated fatty acid [GO:0019368]; sphingolipid biosynthetic process [GO:0030148]",GO:0005783; GO:0005789; GO:0009922; GO:0019368; GO:0030148; GO:0030176; GO:0102336; GO:0102337; GO:0102338,,,,PF01151;,"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; fatty acid elongation, unsaturated fatty acid [GO:0019368]; sphingolipid biosynthetic process [GO:0030148]"
Q9JI19,CHOYP_FIBP.1.1|m.36402,0,0,0,0,0,0,0,0,3.00E-131,Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein),Fibp,357,platelet aggregation [GO:0070527],GO:0005634; GO:0012505; GO:0016020; GO:0016607; GO:0017134; GO:0070062; GO:0070527,,,,PF05427;,endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; platelet aggregation [GO:0070527]
Q9Y238,CHOYP_LOC100366606.1.2|m.47289,7.5,0,0,0,0,0,0,0,0,Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1) (DLC-1),DLEC1 DLC1,1755,negative regulation of cell proliferation [GO:0008285],GO:0005737; GO:0005829; GO:0008285,,,,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; negative regulation of cell proliferation [GO:0008285]
Q9BXW4,CHOYP_LOC100367880.1.1|m.12770,0,0,0,0,0,0,0,0,5.00E-57,Microtubule-associated proteins 1A/1B light chain 3C (Autophagy-related protein LC3 C) (Autophagy-related ubiquitin-like modifier LC3 C) (MAP1 light chain 3-like protein 3) (MAP1A/MAP1B light chain 3 C) (MAP1A/MAP1B LC3 C) (Microtubule-associated protein 1 light chain 3 gamma),MAP1LC3C,147,autophagosome maturation [GO:0097352]; macroautophagy [GO:0016236],GO:0000421; GO:0000932; GO:0005776; GO:0005829; GO:0005874; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0097352,,,cd01611;,PF02991;,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; P-body [GO:0000932]; ubiquitin protein ligase binding [GO:0031625]; autophagosome maturation [GO:0097352]; macroautophagy [GO:0016236]
Q9UPT6,CHOYP_LOC100374908.1.1|m.51418,0,0,0,0,0,0,0,0,3.00E-70,C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3) (Mitogen-activated protein kinase 8-interacting protein 3),MAPK8IP3 JIP3 KIAA1066,1336,activation of JUN kinase activity [GO:0007257]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; in utero embryonic development [GO:0001701]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; positive regulation of neuron differentiation [GO:0045666]; post-embryonic development [GO:0009791]; protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; regulation of JNK cascade [GO:0046328]; respiratory gaseous exchange [GO:0007585]; vesicle-mediated transport [GO:0016192],GO:0000139; GO:0001701; GO:0005078; GO:0005737; GO:0005790; GO:0007257; GO:0007411; GO:0007585; GO:0008104; GO:0008432; GO:0009791; GO:0010468; GO:0016192; GO:0019894; GO:0030159; GO:0030425; GO:0030673; GO:0030900; GO:0045666; GO:0046328; GO:0048286; GO:0060425,,,,PF16471;PF09744;,axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; smooth endoplasmic reticulum [GO:0005790]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; receptor signaling complex scaffold activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; in utero embryonic development [GO:0001701]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; positive regulation of neuron differentiation [GO:0045666]; post-embryonic development [GO:0009791]; protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; regulation of JNK cascade [GO:0046328]; respiratory gaseous exchange [GO:0007585]; vesicle-mediated transport [GO:0016192]
O02228,CHOYP_LOC100375425.1.1|m.7316,0,0,0,0,0,0,0,0,1.00E-61,High-affinity choline transporter 1,cho-1 C48D1.3,576,acetylcholine biosynthetic process [GO:0008292]; choline transport [GO:0015871],GO:0005307; GO:0005887; GO:0008021; GO:0008292; GO:0015220; GO:0015871; GO:0030424; GO:0033265; GO:0043005; GO:0043025; GO:0045202,,,,PF00474;,axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]; choline:sodium symporter activity [GO:0005307]; acetylcholine biosynthetic process [GO:0008292]; choline transport [GO:0015871]
Q8K4L0,CHOYP_LOC100375838.1.1|m.39473,0,0,0,0,0,0,0,0,0,ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (DEAD box protein 54),Ddx54,874,"regulation of transcription, DNA-templated [GO:0006355]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; RNA secondary structure unwinding [GO:0010501]; transcription, DNA-templated [GO:0006351]",GO:0003714; GO:0003723; GO:0004004; GO:0005102; GO:0005524; GO:0005634; GO:0005730; GO:0005794; GO:0006351; GO:0006355; GO:0006396; GO:0010501; GO:0016020; GO:0016070; GO:0030331,,,,PF08147;PF00270;PF00271;,"Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; estrogen receptor binding [GO:0030331]; receptor binding [GO:0005102]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; regulation of transcription, DNA-templated [GO:0006355]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; RNA secondary structure unwinding [GO:0010501]; transcription, DNA-templated [GO:0006351]"
Q8WXW3,CHOYP_LOC100377791.1.1|m.4144,0,0,0,0,0,0,0,0,0,Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90),PIBF1 C13orf24 PIBF,757,activation of JAK1 kinase activity [GO:0010531]; immune system process [GO:0002376]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of Stat4 protein [GO:0042521]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of Stat6 protein [GO:0042526]; protein localization to centrosome [GO:0071539],GO:0002376; GO:0005136; GO:0005615; GO:0005634; GO:0005654; GO:0005813; GO:0005815; GO:0005829; GO:0007080; GO:0010531; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0042521; GO:0042526; GO:0071539; GO:0090307; GO:1905515,,,,,centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; interleukin-4 receptor binding [GO:0005136]; activation of JAK1 kinase activity [GO:0010531]; immune system process [GO:0002376]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of Stat4 protein [GO:0042521]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of Stat6 protein [GO:0042526]; protein localization to centrosome [GO:0071539]
Q8IX29,CHOYP_LOC100486001.1.1|m.6209,1,0,0,0,0,0,0,0,2.00E-68,F-box only protein 16,FBXO16 FBX16,292,,,,,,PF12937;,
A0A0R4IBK5,CHOYP_LOC100537840.1.1|m.55651,0,0,0,0,0,0,0,0,6.00E-11,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha),rnf213a,5209,sprouting angiogenesis [GO:0002040],GO:0002040; GO:0004842; GO:0005829; GO:0008270; GO:0016887,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.,,,,cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
Q14517,CHOYP_LOC100640260.1.2|m.21931,1.5,0,0,0,0,0,0,0,2.00E-22,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]",FAT1 CDHF7 FAT,4588,actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; single organismal cell-cell adhesion [GO:0016337],GO:0005509; GO:0005634; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016337; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062,,,,PF00028;PF00008;PF02210;,cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; single organismal cell-cell adhesion [GO:0016337]
Q14517,CHOYP_LOC100740873.1.1|m.46472,0,0,0,0,0,0,0,0,0,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]",FAT1 CDHF7 FAT,4588,actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; single organismal cell-cell adhesion [GO:0016337],GO:0005509; GO:0005634; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016337; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062,,,,PF00028;PF00008;PF02210;,cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; single organismal cell-cell adhesion [GO:0016337]
O95428,CHOYP_LOC101162499.1.1|m.47400,0,0,0,0,0,0,0,0,2.00E-81,Papilin,PAPLN UNQ2420/PRO4977,1278,,GO:0004222; GO:0004867; GO:0005578; GO:0008270,,,,PF05986;PF07679;PF00014;PF08686;PF00090;,proteinaceous extracellular matrix [GO:0005578]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]; zinc ion binding [GO:0008270]
Q99572,CHOYP_LOC585718.2.2|m.40232,0,0,0,0,0,0,0,0,7.00E-17,P2X purinoceptor 7 (P2X7) (ATP receptor) (P2Z receptor) (Purinergic receptor),P2RX7,595,activation of MAPK activity [GO:0000187]; apoptotic signaling pathway [GO:0097190]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cellular response to dsRNA [GO:0071359]; cellular response to extracellular stimulus [GO:0031668]; ceramide biosynthetic process [GO:0046513]; collagen metabolic process [GO:0032963]; cytolysis [GO:0019835]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; membrane budding [GO:0006900]; membrane depolarization [GO:0051899]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion organization [GO:0007005]; multicellular organismal protein catabolic process [GO:0044254]; NAD transport [GO:0043132]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell volume [GO:0045794]; negative regulation of MAPK cascade [GO:0043409]; phagolysosome assembly [GO:0001845]; phospholipid scrambling [GO:0017121]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; pore complex assembly [GO:0046931]; positive regulation of bleb assembly [GO:1904172]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cytolysis [GO:0045919]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interleukin-1 alpha secretion [GO:0050717]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of lymphocyte apoptotic process [GO:0070230]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; purinergic nucleotide receptor signaling pathway [GO:0035590]; reactive oxygen species metabolic process [GO:0072593]; regulation of killing of cells of other organism [GO:0051709]; regulation of sodium ion transport [GO:0002028]; release of sequestered calcium ion into cytosol [GO:0051209]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to fluid shear stress [GO:0034405]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to zinc ion [GO:0010043]; sensory perception of pain [GO:0019233]; skeletal system morphogenesis [GO:0048705]; synaptic vesicle exocytosis [GO:0016079]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098],GO:0000187; GO:0000902; GO:0001530; GO:0001614; GO:0001845; GO:0001916; GO:0002028; GO:0004931; GO:0005102; GO:0005524; GO:0005639; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0006468; GO:0006509; GO:0006649; GO:0006900; GO:0006954; GO:0007005; GO:0007166; GO:0007596; GO:0009612; GO:0009897; GO:0010043; GO:0010524; GO:0010628; GO:0014049; GO:0014054; GO:0016020; GO:0016079; GO:0016485; GO:0017121; GO:0019233; GO:0019835; GO:0030501; GO:0031594; GO:0031668; GO:0032059; GO:0032060; GO:0032308; GO:0032496; GO:0032755; GO:0032963; GO:0033198; GO:0034405; GO:0034767; GO:0035590; GO:0042098; GO:0042493; GO:0042803; GO:0043025; GO:0043029; GO:0043132; GO:0043409; GO:0044254; GO:0045332; GO:0045779; GO:0045794; GO:0045821; GO:0045919; GO:0046513; GO:0046931; GO:0048705; GO:0048873; GO:0050717; GO:0050718; GO:0050830; GO:0051209; GO:0051259; GO:0051495; GO:0051592; GO:0051602; GO:0051709; GO:0051899; GO:0051901; GO:0070230; GO:0071359; GO:0072593; GO:0097190; GO:0097191; GO:0098793; GO:0098794; GO:1904172,,,,PF00864;,bleb [GO:0032059]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ATP binding [GO:0005524]; extracellular ATP-gated cation channel activity [GO:0004931]; lipopolysaccharide binding [GO:0001530]; protein homodimerization activity [GO:0042803]; purinergic nucleotide receptor activity [GO:0001614]; receptor binding [GO:0005102]; activation of MAPK activity [GO:0000187]; apoptotic signaling pathway [GO:0097190]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cellular response to dsRNA [GO:0071359]; cellular response to extracellular stimulus [GO:0031668]; ceramide biosynthetic process [GO:0046513]; collagen metabolic process [GO:0032963]; cytolysis [GO:0019835]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; membrane budding [GO:0006900]; membrane depolarization [GO:0051899]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion organization [GO:0007005]; multicellular organismal protein catabolic process [GO:0044254]; NAD transport [GO:0043132]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell volume [GO:0045794]; negative regulation of MAPK cascade [GO:0043409]; phagolysosome assembly [GO:0001845]; phospholipid scrambling [GO:0017121]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; pore complex assembly [GO:0046931]; positive regulation of bleb assembly [GO:1904172]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cytolysis [GO:0045919]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interleukin-1 alpha secretion [GO:0050717]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of lymphocyte apoptotic process [GO:0070230]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; purinergic nucleotide receptor signaling pathway [GO:0035590]; reactive oxygen species metabolic process [GO:0072593]; regulation of killing of cells of other organism [GO:0051709]; regulation of sodium ion transport [GO:0002028]; release of sequestered calcium ion into cytosol [GO:0051209]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to fluid shear stress [GO:0034405]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to zinc ion [GO:0010043]; sensory perception of pain [GO:0019233]; skeletal system morphogenesis [GO:0048705]; synaptic vesicle exocytosis [GO:0016079]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]
Q5XX13,CHOYP_LOC589839.1.1|m.29309,0,0,0,0,0,0,0,0,5.00E-143,F-box/WD repeat-containing protein 10 (F-box and WD-40 domain-containing protein 10) (Ubiquitin ligase-specificity factor),FBXW10,1052,protein polyubiquitination [GO:0000209],GO:0000209; GO:0004842; GO:0005829,,,,PF00400;,cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]
B7U179,CHOYP_NEMVEDRAFT_V1G221088.1.1|m.66380,0.5,0,0,0,0,0,0,0,1.00E-10,ARMADILLO BTB ARABIDOPSIS PROTEIN 1 (ABAP1),ABAP1 At5g13060 T19L5.20,737,DNA-dependent DNA replication [GO:0006261]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA-dependent DNA replication [GO:2000104]; protein ubiquitination [GO:0016567]; regulation of cell proliferation [GO:0042127],GO:0005634; GO:0005737; GO:0006261; GO:0008285; GO:0016567; GO:0031261; GO:0042127; GO:2000104,PATHWAY: Protein modification; protein ubiquitination.,,,PF00514;PF00651;,cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; nucleus [GO:0005634]; DNA-dependent DNA replication [GO:0006261]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA-dependent DNA replication [GO:2000104]; protein ubiquitination [GO:0016567]; regulation of cell proliferation [GO:0042127]
A0A0R4IBK5,CHOYP_NEMVEDRAFT_V1G244806.2.2|m.52012,0,0,0,0,0,0,0,0,1.00E-127,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha),rnf213a,5209,sprouting angiogenesis [GO:0002040],GO:0002040; GO:0004842; GO:0005829; GO:0008270; GO:0016887,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.,,,,cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
Q2QKL5,CHOYP_PCS-1.1.1|m.8305,0,0,0,0,0,0,0,0,2.00E-77,Glutathione gamma-glutamylcysteinyltransferase 3 (EC 2.3.2.15) (LjPCS3-7N) (Phytochelatin synthase 3),PCS3,479,phytochelatin biosynthetic process [GO:0046938]; response to metal ion [GO:0010038],GO:0010038; GO:0016756; GO:0046872; GO:0046938,,,,PF05023;PF09328;,glutathione gamma-glutamylcysteinyltransferase activity [GO:0016756]; metal ion binding [GO:0046872]; phytochelatin biosynthetic process [GO:0046938]; response to metal ion [GO:0010038]
Q99M80,CHOYP_PTPRA.9.22|m.46545,0,0,0,0,0,0,0,0,4.00E-83,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (RPTPmam4) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) (mRPTPrho),Ptprt,1454,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004725; GO:0005886; GO:0006470; GO:0007156; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0016790; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097,,,cd00063;cd06263;,PF00041;PF00629;PF00102;,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein tyrosine phosphatase activity [GO:0004725]; thiolester hydrolase activity [GO:0016790]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
Q99M80,CHOYP_PTPRT.6.45|m.24275,0.5,0,0,0,0,0,0,0,3.00E-81,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (RPTPmam4) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) (mRPTPrho),Ptprt,1454,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004725; GO:0005886; GO:0006470; GO:0007156; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0016790; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097,,,cd00063;cd06263;,PF00041;PF00629;PF00102;,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein tyrosine phosphatase activity [GO:0004725]; thiolester hydrolase activity [GO:0016790]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
A0A0R4IBK5,CHOYP_RN213.7.13|m.45975,0,0,0,0,0,0,0,0,0,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha),rnf213a,5209,sprouting angiogenesis [GO:0002040],GO:0002040; GO:0004842; GO:0005829; GO:0008270; GO:0016887,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.,,,,cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
A0A0R4IBK5,CHOYP_RNF213.1.4|m.3458,0.5,0,0,0,0,0,0,0,0,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha),rnf213a,5209,sprouting angiogenesis [GO:0002040],GO:0002040; GO:0004842; GO:0005829; GO:0008270; GO:0016887,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.,,,,cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
Q2TAK8,CHOYP_SALIVA_1456.1.1|m.19330,0,0,0,0,0,0,0,0,0.000000003,PWWP domain-containing protein MUM1 (Mutated melanoma-associated antigen 1) (MUM-1) (Protein expandere),MUM1 EXPAND1,710,chromatin organization [GO:0006325]; DNA repair [GO:0006281],GO:0005634; GO:0005829; GO:0006281; GO:0006325; GO:0031491,,,,,cytosol [GO:0005829]; nucleus [GO:0005634]; nucleosome binding [GO:0031491]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]
P18699,CHOYP_TBB2.2.2|m.53001,0,0,0,0,0,0,0,0,1.00E-70,Tubulin beta chain (Beta-tubulin) (Fragment),,111,microtubule-based process [GO:0007017],GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,,,,PF03953;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
Q6MG82,CHOYP_contig_047066|m.55375,0,0,0,0,0,0,0,0,2.00E-16,Proline-rich transmembrane protein 1 (Dispanin subfamily D member 1) (DSPD1),Prrt1 Ng5,306,response to biotic stimulus [GO:0009607],GO:0005886; GO:0009607; GO:0016021; GO:0030054; GO:0045202,,,,PF04505;,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; response to biotic stimulus [GO:0009607]
P06605,CHOYP_AAEL_AAEL013229.1.2|m.30359,4.5,0,0,0,0,0,0,0,1.00E-80,Tubulin alpha-3 chain,alphaTub84D TubA84D CG2512,450,microtubule-based process [GO:0007017]; mitotic cytokinesis [GO:0000281],GO:0000281; GO:0003924; GO:0005200; GO:0005525; GO:0005811; GO:0005874; GO:0007017; GO:0017022; GO:0048471,,,,PF00091;PF03953;,lipid particle [GO:0005811]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; mitotic cytokinesis [GO:0000281]
Q9DGG6,CHOYP_APLD.1.1|m.9873,0,0,0,0,0,0,0,0,0,Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9),ADCY9,1334,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165],GO:0004016; GO:0004383; GO:0005524; GO:0005886; GO:0005887; GO:0006171; GO:0006182; GO:0007165; GO:0007189; GO:0008074; GO:0016021; GO:0035556; GO:0046872; GO:0071880,,,,PF00211;,"guanylate cyclase complex, soluble [GO:0008074]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165]"
Q9CQY2,CHOYP_BRAFLDRAFT_221294.2.2|m.52722,2,0,0,0,0,0,0,0,0.000000006,RNMT-activating mini protein (RAM) (Protein FAM103A1),Fam103a1,119,7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259]; recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex [GO:0036031],GO:0003723; GO:0005634; GO:0005654; GO:0005845; GO:0006370; GO:0032259; GO:0036031,,,,PF15320;,mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259]; recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex [GO:0036031]
A6YIH8,CHOYP_BRAFLDRAFT_91870.3.3|m.62762,0,0,0,0,0,0,0,0,5.00E-31,Premnaspirodiene oxygenase (HPO) (EC 1.14.13.121) (Cytochrome P450 71D55),CYP71D55,502,,GO:0004497; GO:0005506; GO:0016021; GO:0016705; GO:0020037,,,,PF00067;,"integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
Q5ZI03,CHOYP_CIR1.1.2|m.16125,0,0,0,0,0,0,0,0,1.00E-87,Corepressor interacting with RBPJ 1 (CBF1-interacting corepressor),CIR1 CIR RCJMB04_31l21,460,"mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]",GO:0000118; GO:0006351; GO:0006397; GO:0008380; GO:0016607; GO:0045892,,,,PF10197;,"histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]"
Q9JLR1,CHOYP_COPA.1.1|m.31889,0,0,0,0,0,0,0,0,0,Protein transport protein Sec61 subunit alpha isoform 2 (Sec61 alpha-2),Sec61a2,476,protein transport [GO:0015031],GO:0005789; GO:0015031; GO:0016021; GO:0043022,,,,PF10559;PF00344;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ribosome binding [GO:0043022]; protein transport [GO:0015031]
Q28FE8,CHOYP_DSRAD.2.4|m.5410,2.5,0,0,0,0,0,0,0,1.00E-14,tRNA-specific adenosine deaminase 1 (EC 3.5.4.34) (tRNA-specific adenosine-37 deaminase),adat1 TEgg036c08.1,472,tRNA processing [GO:0008033],GO:0003723; GO:0008033; GO:0008251; GO:0046872,,,,PF02137;,metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; tRNA processing [GO:0008033]
Q6ZRF8,CHOYP_LOC100369929.1.5|m.32680,0,0,0,0,0,0,0,0,0.000000007,RING finger protein 207,RNF207 C1orf188,634,cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901207; GO:1902261; GO:1903762; GO:1903954,,,,PF00643;PF00097;,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]
P42674,CHOYP_LOC100371085.1.1|m.44789,0,0,0,0,0,0,0,0,1.00E-23,Blastula protease 10 (EC 3.4.24.-),BP10,597,,GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471,,,cd00041;cd04280;,PF01400;PF00431;,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
B0SJT4,CHOYP_LOC100371374.1.1|m.46502,0,0,0,0,0,0,0,0,5.00E-12,Nucleoside diphosphate kinase (NDK) (NDP kinase) (EC 2.7.4.6) (Nucleoside-2-P kinase),ndk LEPBI_I0084,137,CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228],GO:0004550; GO:0005524; GO:0005737; GO:0006183; GO:0006228; GO:0006241; GO:0046872,,,,PF00334;,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]
Q96MY1,CHOYP_LOC100376296.1.1|m.36837,0,0,0,0,0,0,0,0,7.00E-65,Nucleolar protein 4-like,NOL4L C20orf112 C20orf113,436,,GO:0005654; GO:0005829,,,,,cytosol [GO:0005829]; nucleoplasm [GO:0005654]
Q6ZRF8,CHOYP_LOC100376608.3.4|m.51379,0,0,0,0,0,0,0,0,2.00E-10,RING finger protein 207,RNF207 C1orf188,634,cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901207; GO:1902261; GO:1903762; GO:1903954,,,,PF00643;PF00097;,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]
P42674,CHOYP_LOC100548534.1.1|m.26484,22,0,0,0,0,0,0,0,8.00E-39,Blastula protease 10 (EC 3.4.24.-),BP10,597,,GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471,,,cd00041;cd04280;,PF01400;PF00431;,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
A9ULC7,CHOYP_LOC100888334.1.1|m.40374,0,0,0,0,0,0,0,0,7.00E-24,Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha),slc51a osta,339,bile acid and bile salt transport [GO:0015721]; transport [GO:0006810],GO:0005215; GO:0005789; GO:0005886; GO:0006810; GO:0015721; GO:0016021; GO:0042803; GO:0043234; GO:0046982,,,,PF03619;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transporter activity [GO:0005215]; bile acid and bile salt transport [GO:0015721]; transport [GO:0006810]
Q9Y7Y3,CHOYP_LOC580669.1.1|m.7758,0,0,0,0,0,0,0,0,2.00E-21,Uncharacterized RNA-binding protein C365.04c,SPBC365.04c,233,ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254],GO:0000166; GO:0003723; GO:0005634; GO:0005730; GO:0019843; GO:0030686; GO:0042254; GO:0042274,,,cd12400;,PF00076;,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]
Q9P2F6,CHOYP_LOC582570.1.1|m.65944,0,0,0,0,0,0,0,0,1.00E-98,Rho GTPase-activating protein 20 (Rho-type GTPase-activating protein 20),ARHGAP20 KIAA1391,1191,regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],GO:0005096; GO:0005829; GO:0007165; GO:0051056,,,,PF00788;PF00620;,cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]
P06280,CHOYP_LOC663249.1.1|m.25441,0,0,0,0,0,0,0,0,6.00E-135,Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Melibiase) (Agalsidase),GLA,429,glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide catabolic process [GO:0046477]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; neutrophil degranulation [GO:0043312]; oligosaccharide metabolic process [GO:0009311],GO:0003824; GO:0004557; GO:0005102; GO:0005576; GO:0005737; GO:0005764; GO:0005794; GO:0006687; GO:0009311; GO:0016139; GO:0016787; GO:0016936; GO:0035578; GO:0042803; GO:0043202; GO:0043312; GO:0045019; GO:0046477; GO:0046479; GO:0051001; GO:0052692; GO:0070062,,,cd14792;,PF16499;,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; catalytic activity [GO:0003824]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; raffinose alpha-galactosidase activity [GO:0052692]; receptor binding [GO:0005102]; glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide catabolic process [GO:0046477]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; neutrophil degranulation [GO:0043312]; oligosaccharide metabolic process [GO:0009311]
Q8N9B4,CHOYP_LOC755594.5.6|m.54446,0,0,0,0,0,0,0,0,5.00E-11,Ankyrin repeat domain-containing protein 42,ANKRD42,389,,,,,,PF12796;,
P42674,CHOYP_NAS13.1.1|m.30415,0,0,0,0,0,0,0,0,2.00E-52,Blastula protease 10 (EC 3.4.24.-),BP10,597,,GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471,,,cd00041;cd04280;,PF01400;PF00431;,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
Q17Q97,CHOYP_NEMVEDRAFT_V1G244077.1.1|m.14957,0,0,0,0,0,0,0,0,3.00E-19,Uncharacterized protein C19orf60 homolog,,180,,,,,,,
P42674,CHOYP_PLMN.4.11|m.29150,0.5,0,0,0,0,0,0,0,2.00E-41,Blastula protease 10 (EC 3.4.24.-),BP10,597,,GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471,,,cd00041;cd04280;,PF01400;PF00431;,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
A5B4K1,CHOYP_RS3A.14.15|m.57763,0,0,0,0,0,0,0,0,5.00E-112,40S ribosomal protein S3a-1,GSVIVT00020038001 LOC100249434 VITISV_020206,261,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412,,,,PF01015;,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
P83088,CHOYP_TRIADDRAFT_26518.1.1|m.16475,0,0,0,0,0,0,0,0,7.00E-28,"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)",FucTC CG40305,425,protein glycosylation [GO:0006486],GO:0000139; GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0046920,PATHWAY: Protein modification; protein glycosylation.,,,PF17039;PF00852;,Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; protein glycosylation [GO:0006486]
Q6PFX9,CHOYP_BRAFLDRAFT_126480.1.1|m.31307,0,0,0,0,0,0,0,0,0.000002,Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I),Tnks Tnks1,1320,"cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]",GO:0000139; GO:0000209; GO:0000775; GO:0000781; GO:0000784; GO:0000922; GO:0003950; GO:0005643; GO:0005654; GO:0005794; GO:0005829; GO:0006471; GO:0007067; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1904743; GO:1904908,,,,PF00023;PF12796;PF13606;PF00644;PF07647;,"chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"
Q6Q899,CHOYP_BRAFLDRAFT_249506.2.2|m.60314,2.5,0,0,0,0,0,0,0,1.00E-107,Probable ATP-dependent RNA helicase DDX58 (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I),Ddx58,926,detection of virus [GO:0009597]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],GO:0002230; GO:0003690; GO:0003725; GO:0003727; GO:0004386; GO:0005524; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010628; GO:0015629; GO:0030334; GO:0031625; GO:0032480; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0039529; GO:0042802; GO:0042993; GO:0043330; GO:0045087; GO:0045944,,,,PF16739;PF00271;PF04851;PF11648;,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]
Q5BIM1,CHOYP_BRAFLDRAFT_80577.2.6|m.24330,0,0,0,0,0,0,0,0,9.00E-15,Tripartite motif-containing protein 45,TRIM45,580,bone development [GO:0060348],GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348,,,,PF00630;PF00643;PF13445;,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
Q9P2E3,CHOYP_CED1.8.29|m.29029,0,0,0,0,0,0,0,0,0.0000002,NFX1-type zinc finger-containing protein 1,ZNFX1 KIAA1404,1918,,GO:0003700; GO:0003723; GO:0005634; GO:0008270,,,,,"nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]"
P17140,CHOYP_CPIPJ_CPIJ000723.1.1|m.7190,3.5,0,0,0,0,0,0,0,2.00E-19,Collagen alpha-2(IV) chain (Lethal protein 2),let-2 clb-1 F01G12.5,1758,cellular component organization [GO:0016043]; embryo development ending in birth or egg hatching [GO:0009792],GO:0005198; GO:0005587; GO:0005604; GO:0009792; GO:0016043; GO:0030020,,,,PF01413;PF01391;,basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; structural molecule activity [GO:0005198]; cellular component organization [GO:0016043]; embryo development ending in birth or egg hatching [GO:0009792]
P21180,CHOYP_CTRA.1.2|m.26705,4.5,0,0,0,0,0,0,0,9.00E-11,Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment],C2,760,"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; response to nutrient [GO:0007584]",GO:0004252; GO:0005615; GO:0006956; GO:0006958; GO:0007584; GO:0045087; GO:0046872; GO:0070062; GO:2000427,,,cd00033;cd00190;,PF00084;PF00089;PF00092;,"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; response to nutrient [GO:0007584]"
Q7KVW5,CHOYP_DGRI_GH24618.1.2|m.1995,0,0,0,0,0,0,0,0,0,Small conductance calcium-activated potassium channel protein (Protein SK) (dSK),SK CG10706,927,potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057],GO:0005516; GO:0005886; GO:0006813; GO:0009881; GO:0016021; GO:0016057; GO:0016286; GO:0043025,,,,PF02888;PF07885;PF03530;,integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; photoreceptor activity [GO:0009881]; small conductance calcium-activated potassium channel activity [GO:0016286]; potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057]
P50123,CHOYP_ENPEP.1.1|m.12765,0,0,0,0,0,0,0,0,0,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249),Enpep,945,angiotensin maturation [GO:0002003]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular aromatic compound metabolic process [GO:0006725]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],GO:0002003; GO:0003081; GO:0004177; GO:0005737; GO:0006508; GO:0006725; GO:0008217; GO:0008270; GO:0008283; GO:0012506; GO:0016021; GO:0016477; GO:0031983; GO:0042277; GO:0043171; GO:0070006,,,cd09601;,PF11838;PF01433;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; vesicle lumen [GO:0031983]; vesicle membrane [GO:0012506]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiotensin maturation [GO:0002003]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular aromatic compound metabolic process [GO:0006725]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]
Q9NRD1,CHOYP_FBX6.1.1|m.62308,0,0,0,0,0,0,0,0,9.00E-58,F-box only protein 6 (F-box protein that recognizes sugar chains 2) (F-box/G-domain protein 2),FBXO6 FBG2 FBS2 FBX6,293,DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glycoprotein catabolic process [GO:0006516]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to unfolded protein [GO:0006986]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],GO:0000077; GO:0000209; GO:0001948; GO:0004842; GO:0005737; GO:0005829; GO:0006281; GO:0006508; GO:0006516; GO:0006986; GO:0019005; GO:0030246; GO:0030433; GO:0031146; GO:0044322; GO:0061630,PATHWAY: Protein modification; protein ubiquitination.,,,PF12937;PF04300;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum quality control compartment [GO:0044322]; SCF ubiquitin ligase complex [GO:0019005]; carbohydrate binding [GO:0030246]; glycoprotein binding [GO:0001948]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glycoprotein catabolic process [GO:0006516]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to unfolded protein [GO:0006986]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
Q90W98,CHOYP_IVBI.2.2|m.67049,0.5,0,0,0,0,0,0,0,2.00E-13,Kunitz-type serine protease inhibitor textilinin-4 (Txln-4),,83,,GO:0004867; GO:0005576,,,,PF00014;,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]
Q5BIM1,CHOYP_LOC100157373.1.1|m.51867,0,0,0,0,0,0,0,0,0.000000005,Tripartite motif-containing protein 45,TRIM45,580,bone development [GO:0060348],GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348,,,,PF00630;PF00643;PF13445;,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
Q5BIM1,CHOYP_LOC100213744.7.19|m.33062,0,0,0,0,0,0,0,0,2.00E-16,Tripartite motif-containing protein 45,TRIM45,580,bone development [GO:0060348],GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348,,,,PF00630;PF00643;PF13445;,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
P20072,CHOYP_LOC100367736.2.2|m.66862,2,0,0,0,0,0,0,0,1.00E-127,Annexin A7 (Annexin VII) (Annexin-7) (Synexin),ANXA7 ANX7,463,autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176],GO:0003723; GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0048306; GO:0070062,,,,PF00191;,chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]
Q5REG4,CHOYP_LOC100368715.1.3|m.31823,0,0,0,0,0,0,0,0,2.00E-58,Probable E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING-type E3 ubiquitin transferase DTX3),DTX3,347,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],GO:0005737; GO:0007219; GO:0008270; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,,cytoplasm [GO:0005737]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
P35220,CHOYP_LOC100368833.1.1|m.52947,0,0,0,0,0,0,0,0,1.00E-40,Catenin alpha,alpha-Cat CG17947,917,adherens junction organization [GO:0034332]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelium development [GO:0060429]; establishment or maintenance of cell polarity [GO:0007163]; germarium-derived egg chamber formation [GO:0007293]; head morphogenesis [GO:0060323],GO:0003779; GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0005913; GO:0005914; GO:0005915; GO:0007016; GO:0007155; GO:0007163; GO:0007293; GO:0008092; GO:0015629; GO:0016342; GO:0034332; GO:0060323; GO:0060429,,,,PF01044;,actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; spot adherens junction [GO:0005914]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; structural molecule activity [GO:0005198]; adherens junction organization [GO:0034332]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelium development [GO:0060429]; establishment or maintenance of cell polarity [GO:0007163]; germarium-derived egg chamber formation [GO:0007293]; head morphogenesis [GO:0060323]
Q6NXP6,CHOYP_LOC100375012.1.1|m.11931,1,0,0,0,0,0,0,0,2.00E-56,NADP-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-) (Pyrroline-5-carboxylate reductase-like protein C14orf148),NOXRED1 C14orf148,359,proline biosynthetic process [GO:0006561],GO:0004735; GO:0006561,,,,PF03807;,pyrroline-5-carboxylate reductase activity [GO:0004735]; proline biosynthetic process [GO:0006561]
A9C3P0,CHOYP_LOC100740246.1.1|m.25108,0,0,0,0,0,0,0,0,2.00E-89,Malectin,mlec si:dkey-117k10.5,285,carbohydrate metabolic process [GO:0005975],GO:0005783; GO:0005789; GO:0005975; GO:0016021; GO:0030246,,,,PF11721;,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; carbohydrate metabolic process [GO:0005975]
P11147,CHOYP_LOC100899882.1.3|m.27725,1,0,0,0,0,0,0,0,8.00E-13,Heat shock 70 kDa protein cognate 4 (Heat shock 70 kDa protein 88E),Hsc70-4 Hsc4 CG4264,651,"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; cellular response to topologically incorrect protein [GO:0035967]; chaperone-mediated protein folding [GO:0061077]; embryonic development via the syncytial blastoderm [GO:0001700]; heterochromatin organization involved in chromatin silencing [GO:0070868]; late endosomal microautophagy [GO:0061738]; membrane organization [GO:0061024]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457]; RNA interference [GO:0016246]; vesicle-mediated transport [GO:0016192]",GO:0000398; GO:0001700; GO:0005524; GO:0005634; GO:0005726; GO:0005737; GO:0005739; GO:0005811; GO:0005875; GO:0006457; GO:0007269; GO:0007399; GO:0007411; GO:0007413; GO:0016192; GO:0016246; GO:0030707; GO:0035967; GO:0048471; GO:0051082; GO:0051087; GO:0061024; GO:0061077; GO:0061738; GO:0070868; GO:0071011; GO:0071013; GO:0098793,,,,PF00012;,"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; lipid particle [GO:0005811]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; perinuclear region of cytoplasm [GO:0048471]; precatalytic spliceosome [GO:0071011]; presynapse [GO:0098793]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cellular response to topologically incorrect protein [GO:0035967]; chaperone-mediated protein folding [GO:0061077]; embryonic development via the syncytial blastoderm [GO:0001700]; heterochromatin organization involved in chromatin silencing [GO:0070868]; late endosomal microautophagy [GO:0061738]; membrane organization [GO:0061024]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457]; RNA interference [GO:0016246]; vesicle-mediated transport [GO:0016192]"
Q96FN5,CHOYP_LOC100902075.1.1|m.10103,0,0,0,0,0,0,0,0,1.00E-113,Kinesin-like protein KIF12,KIF12,646,microtubule-based movement [GO:0007018],GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0016887; GO:0070062,,,,PF00225;,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
B3EWY8,CHOYP_LOC101238350.1.1|m.23002,1.5,0,0,0,0,0,0,0,2.00E-26,Skeletal aspartic acid-rich protein 2 (Fragment),,390,,GO:0016021,,,,,integral component of membrane [GO:0016021]
Q9NRF2,CHOYP_LOC552012.1.1|m.65224,0.5,0,0,0,0,0,0,0,1.00E-74,"SH2B adapter protein 1 (Pro-rich, PH and SH2 domain-containing signaling mediator) (PSM) (SH2 domain-containing protein 1B)",SH2B1 KIAA1299 SH2B,756,blood coagulation [GO:0007596]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of DNA biosynthetic process [GO:2000278],GO:0004871; GO:0005634; GO:0005829; GO:0007596; GO:0016020; GO:0030032; GO:0035556; GO:0035591; GO:0045840; GO:2000278,,,,PF00169;PF08916;PF00017;,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; signal transducer activity [GO:0004871]; signaling adaptor activity [GO:0035591]; blood coagulation [GO:0007596]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of DNA biosynthetic process [GO:2000278]
P46198,CHOYP_MTIF2.1.1|m.17935,0,0,0,0,0,0,0,0,2.00E-158,"Translation initiation factor IF-2, mitochondrial (IF-2(Mt)) (IF-2Mt) (IF2(mt))",MTIF2,727,mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790],GO:0003743; GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005759; GO:0008135; GO:0032790; GO:0043024; GO:0070124,,,,PF11987;,"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790]"
Q98943,CHOYP_TRIADDRAFT_62397.1.1|m.65618,0,0,0,0,0,0,0,0,0.0000004,Caspase-2 (CASP-2) (EC 3.4.22.55) (ICH-1L/1S) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12],CASP2 ICH1,424,execution phase of apoptosis [GO:0097194]; regulation of apoptotic process [GO:0042981],GO:0005737; GO:0042981; GO:0097194; GO:0097200,,,cd00032;,PF00619;,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; execution phase of apoptosis [GO:0097194]; regulation of apoptotic process [GO:0042981]
Q66KB0,CHOYP_UBE2Z.1.1|m.61760,0,0,0,0,0,0,0,0,9.00E-137,Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z),ube2z,313,apoptotic process [GO:0006915],GO:0005524; GO:0005634; GO:0005737; GO:0006915; GO:0031625; GO:0061630,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,,,PF00179;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]
Q9Y4B6,CHOYP_VPRBP.1.1|m.15849,0,0,0,0,0,0,0,0,0,Protein VPRBP (DDB1- and CUL4-associated factor 1) (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein),VPRBP DCAF1 KIAA0800 RIP,1507,"B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; protein ubiquitination [GO:0016567]; transcription, DNA-templated [GO:0006351]; V(D)J recombination [GO:0033151]; viral process [GO:0016032]",GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005737; GO:0006351; GO:0016032; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:1990244; GO:1990245,PATHWAY: Protein modification; protein ubiquitination.,,,,"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; histone kinase activity (H2A-T120 specific) [GO:1990244]; B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; protein ubiquitination [GO:0016567]; transcription, DNA-templated [GO:0006351]; V(D)J recombination [GO:0033151]; viral process [GO:0016032]"
Q9H2Y7,CHOYP_YTDC1.1.2|m.56405,0,0,0,0,0,0,0,0,2.00E-52,Zinc finger protein 106 (Zfp-106) (Zinc finger protein 474),ZNF106 SH3BP3 ZFP106 ZNF474,1883,insulin receptor signaling pathway [GO:0008286],GO:0003723; GO:0005730; GO:0005829; GO:0008286; GO:0016020; GO:0017124; GO:0046872,,,,PF00400;,cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; insulin receptor signaling pathway [GO:0008286]
Q08420,CHOYP_contig_050645|m.60289,1,0,0,0,0,0,0,0,0.000000002,Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B),Sod3 Sod-3,244,response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303],GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062,,,cd00305;,PF00080;,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
Q01650,CHOYP_BAT1.4.4|m.32273,0,0,0,0,0,0,0,0,2.00E-107,Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter),SLC7A5 CD98LC LAT1 MPE16,507,amino acid transport [GO:0006865]; cell differentiation [GO:0030154]; cellular amino acid metabolic process [GO:0006520]; leukocyte migration [GO:0050900]; nervous system development [GO:0007399]; neutral amino acid transport [GO:0015804]; transport [GO:0006810]; tryptophan catabolic process [GO:0006569],GO:0005829; GO:0005886; GO:0005887; GO:0006520; GO:0006569; GO:0006810; GO:0006865; GO:0007399; GO:0015171; GO:0015175; GO:0015179; GO:0015297; GO:0015804; GO:0016020; GO:0016324; GO:0030154; GO:0042605; GO:0043231; GO:0050900; GO:0070062,,,,PF13520;,apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; cell differentiation [GO:0030154]; cellular amino acid metabolic process [GO:0006520]; leukocyte migration [GO:0050900]; nervous system development [GO:0007399]; neutral amino acid transport [GO:0015804]; transport [GO:0006810]; tryptophan catabolic process [GO:0006569]
Q00808,CHOYP_BRAFLDRAFT_117940.1.1|m.59223,0.5,0,0,0,0,0,0,0,1.00E-12,Vegetative incompatibility protein HET-E-1,HET-E1,1356,,GO:0005525,,,,PF06985;PF00400;,GTP binding [GO:0005525]
A8DYE2,CHOYP_BRAFLDRAFT_118277.1.1|m.61321,0,0,0,0,0,0,0,0,3.00E-77,"Transient receptor potential cation channel trpm (Transient receptor potential cation channel, subfamily M ortholog)",Trpm CG44240,2023,cation transmembrane transport [GO:0098655]; cell growth [GO:0016049]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; mitochondrion organization [GO:0007005]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069],GO:0005261; GO:0007005; GO:0010960; GO:0016049; GO:0034703; GO:0046873; GO:0051262; GO:0055069; GO:0070838; GO:0097682; GO:0098655,,,,PF00520;PF16519;,"cation channel complex [GO:0034703]; cation channel activity [GO:0005261]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; metal ion transmembrane transporter activity [GO:0046873]; cation transmembrane transport [GO:0098655]; cell growth [GO:0016049]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; mitochondrion organization [GO:0007005]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]"
O75460,CHOYP_BRAFLDRAFT_118819.1.2|m.29565,0,0,0,0,0,0,0,0,0,Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (hIRE1p) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],ERN1 IRE1,977,"activation of JUN kinase activity [GO:0007257]; activation of signaling protein activity involved in unfolded protein response [GO:0006987]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA endonucleolytic cleavage involved in unfolded protein response [GO:0070055]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; transcription, DNA-templated [GO:0006351]",GO:0000287; GO:0001935; GO:0004521; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006351; GO:0006355; GO:0006379; GO:0006402; GO:0006468; GO:0006987; GO:0007050; GO:0007257; GO:0016241; GO:0019899; GO:0030176; GO:0030544; GO:0033120; GO:0034976; GO:0035924; GO:0036289; GO:0036498; GO:0042802; GO:0042803; GO:0043531; GO:0046777; GO:0051879; GO:0070054; GO:0070055; GO:0070059; GO:0071333; GO:1900103; GO:1901142; GO:1904707; GO:1990332; GO:1990579; GO:1990597; GO:1990604; GO:1990630,,,,PF00069;PF06479;,"AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; activation of signaling protein activity involved in unfolded protein response [GO:0006987]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA endonucleolytic cleavage involved in unfolded protein response [GO:0070055]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; transcription, DNA-templated [GO:0006351]"
Q5TZ24,CHOYP_BRAFLDRAFT_125270.1.1|m.2429,0,0,0,0,0,0,0,0,2.00E-117,DBH-like monooxygenase protein 1 homolog (EC 1.14.17.-),moxd1 si:ch211-193l17.1 si:dkey-266k12.5 si:dkeyp-119b4.5,614,dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0016021; GO:0030667; GO:0042420; GO:0042421,,,,PF03712;PF01082;PF03351;,endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]
O14618,CHOYP_BRAFLDRAFT_247007.1.1|m.15096,0,0,0,0,0,0,0,0,4.00E-71,Copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone),CCS,274,intracellular copper ion transport [GO:0015680]; positive regulation of oxidoreductase activity [GO:0051353]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; superoxide metabolic process [GO:0006801],GO:0000302; GO:0004784; GO:0005507; GO:0005634; GO:0005737; GO:0005829; GO:0006801; GO:0008270; GO:0015035; GO:0015680; GO:0019430; GO:0045296; GO:0051353,,,cd00305;cd00371;,PF00403;PF00080;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; protein disulfide oxidoreductase activity [GO:0015035]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; intracellular copper ion transport [GO:0015680]; positive regulation of oxidoreductase activity [GO:0051353]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; superoxide metabolic process [GO:0006801]
Q5UQ50,CHOYP_BRAFLDRAFT_276908.1.1|m.28794,0,0,0,0,0,0,0,0,6.00E-11,Collagen-like protein 6,MIMI_L668,1387,,GO:0019012,,,,PF01391;,virion [GO:0019012]
Q9ESN6,CHOYP_BRAFLDRAFT_82426.1.20|m.8067,0,0,0,0,0,0,0,0,0.000000002,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (Neural activity-related RING finger protein) (RING-type E3 ubiquitin transferase TRIM2),Trim2 Kiaa0517 Narf,744,regulation of neuron apoptotic process [GO:0043523],GO:0004842; GO:0005737; GO:0008270; GO:0017022; GO:0043523; GO:0061630,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
Q8VCY6,CHOYP_BRAFLDRAFT_92084.1.1|m.10643,1,0,0,0,0,0,0,0,7.00E-124,U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein),Utp6 Mhat,597,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]",GO:0000462; GO:0005730; GO:0030515; GO:0032040; GO:0034388,,,,PF08640;,"nucleolus [GO:0005730]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"
P20397,CHOYP_CALM.31.50|m.48469,0,0,0,0,0,0,0,0,2.00E-15,Nucleolin (Protein C23),ncl,651,,GO:0000166; GO:0003677; GO:0003723; GO:0005730,,,cd12403;cd12404;cd12405;cd12406;,PF00076;,nucleolus [GO:0005730]; DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]
O18783,CHOYP_CELA1.1.3|m.14531,0,0,0,0,0,0,0,0,2.00E-38,"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]",PLG,806,blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771],GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771,,,cd00190;,PF00051;PF00024;PF00089;,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
Q54H45,CHOYP_CTR1.2.4|m.39987,0,0,0,0,0,0,0,0,3.00E-33,Probable serine/threonine-protein kinase drkB (EC 2.7.11.1) (Receptor-like kinase 2) (Receptor-like kinase B) (Vesicle-associated receptor tyrosine kinase-like protein 2),drkB rk2 DDB_G0289709,690,intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468],GO:0004674; GO:0004871; GO:0005524; GO:0005622; GO:0006468; GO:0016021; GO:0035556,,,,PF07714;,integral component of membrane [GO:0016021]; intracellular [GO:0005622]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; signal transducer activity [GO:0004871]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]
Q5T2R2,CHOYP_DPS1.1.1|m.11868,0,0,0,0,0,0,0,0,1.00E-128,Decaprenyl-diphosphate synthase subunit 1 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 1) (Decaprenyl pyrophosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1),PDSS1 DPS1 TPRT,415,isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; ubiquinone biosynthetic process [GO:0006744],GO:0000010; GO:0005759; GO:0006744; GO:0008299; GO:0046872; GO:0046982; GO:0050347; GO:0051290; GO:1990234,PATHWAY: Cofactor biosynthesis; ubiquinone biosynthesis.,,,PF00348;,mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; ubiquinone biosynthetic process [GO:0006744]
P41095,CHOYP_ISCW_ISCW007303.1.1|m.42263,0,0,0,0,0,0,0,0,4.00E-21,60S acidic ribosomal protein P0,Os08g0130500 LOC_Os08g03640 P0582D05.130-1,319,ribosome biogenesis [GO:0042254],GO:0005840; GO:0042254,,,,PF00466;,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]
O73853,CHOYP_LOC100371830.5.6|m.55811,0,0,0,0,0,0,0,0,3.00E-90,"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)",cyp17a1 cyp17,514,sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],GO:0004508; GO:0005506; GO:0006694; GO:0007548; GO:0016020; GO:0020037; GO:0047442,PATHWAY: Lipid metabolism; steroid biosynthesis.,,,PF00067;,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]
O35600,CHOYP_LOC100373083.2.2|m.26841,0,0,0,0,0,0,0,0,4.00E-147,Retinal-specific ATP-binding cassette transporter (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP),Abca4 Abcr,2310,phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; visual perception [GO:0007601],GO:0001750; GO:0004012; GO:0005524; GO:0005548; GO:0005887; GO:0006649; GO:0007601; GO:0016887; GO:0042626; GO:0043231; GO:0045332; GO:0045494; GO:0050896; GO:0090555,,,,PF00005;,"integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; phosphatidylethanolamine-translocating ATPase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; phospholipid-translocating ATPase activity [GO:0004012]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; visual perception [GO:0007601]"
A7E3W5,CHOYP_LOC100373178.1.1|m.61012,0,0,0,0,0,0,0,0,3.00E-55,Synaptogyrin-2 (Cellugyrin),SYNGR2,224,,GO:0016021; GO:0030672; GO:0031594; GO:0070062,,,,PF01284;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]
P70227,CHOYP_LOC100375107.1.4|m.8458,0,0,0,0,0,0,0,0,3.00E-66,"Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor)",Itpr3,2670,calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; response to calcium ion [GO:0051592]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917],GO:0005220; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0006816; GO:0007613; GO:0015278; GO:0016020; GO:0035091; GO:0043235; GO:0050913; GO:0050916; GO:0050917; GO:0051592; GO:0060291; GO:0060402; GO:0070679,,,,PF08709;PF00520;PF02815;PF08454;PF01365;,"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; response to calcium ion [GO:0051592]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917]"
Q8NFH5,CHOYP_LOC101064384.1.1|m.19175,0,0,0,0,0,0,0,0,4.00E-68,Nucleoporin NUP53 (35 kDa nucleoporin) (Mitotic phosphoprotein 44) (MP-44) (Nuclear pore complex protein Nup53) (Nucleoporin Nup35),NUP35 MP44 NUP53,326,"gene silencing by RNA [GO:0031047]; intracellular transport of virus [GO:0075733]; mitotic nuclear envelope disassembly [GO:0007077]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of glucose transport [GO:0010827]; regulation of transcription, DNA-templated [GO:0006355]; transmembrane transport [GO:0055085]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]",GO:0003697; GO:0005487; GO:0005543; GO:0005635; GO:0005652; GO:0005654; GO:0005886; GO:0006355; GO:0006406; GO:0006409; GO:0006607; GO:0006999; GO:0007077; GO:0010827; GO:0016032; GO:0016925; GO:0019083; GO:0031047; GO:0031965; GO:0044613; GO:0044615; GO:0055085; GO:0075733; GO:1900034,,,,PF05172;,"nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; nucleocytoplasmic transporter activity [GO:0005487]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; gene silencing by RNA [GO:0031047]; intracellular transport of virus [GO:0075733]; mitotic nuclear envelope disassembly [GO:0007077]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of glucose transport [GO:0010827]; regulation of transcription, DNA-templated [GO:0006355]; transmembrane transport [GO:0055085]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]"
Q9DBF7,CHOYP_LOC577351.1.1|m.17664,1,0,0,0,0,0,0,0,4.00E-10,Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25),Cwc25 Ccdc49,416,,GO:0016607,,,,PF10197;PF12542;,nuclear speck [GO:0016607]
Q7PR68,CHOYP_MED7.1.1|m.48813,0,0,0,0,0,0,0,0,6.00E-87,Mediator of RNA polymerase II transcription subunit 7 (Mediator complex subunit 7),MED7 AGAP002823,219,"transcription, DNA-templated [GO:0006351]",GO:0001104; GO:0006351; GO:0016592; GO:0070847,,,,PF05983;,"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; RNA polymerase II transcription cofactor activity [GO:0001104]; transcription, DNA-templated [GO:0006351]"
Q80ZE5,CHOYP_PAQR8.1.2|m.7723,0,0,0,0,0,0,0,0,1.00E-56,Membrane progestin receptor beta (mPR beta) (Progestin and adipoQ receptor family member VIII),Paqr8 Mprb,354,multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; response to steroid hormone [GO:0048545],GO:0003707; GO:0005496; GO:0005794; GO:0005886; GO:0007275; GO:0016021; GO:0048477; GO:0048545,,,,PF03006;,Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; response to steroid hormone [GO:0048545]
Q9Y5B0,CHOYP_PHUM_PHUM378040.1.1|m.15341,0,0,0,0,0,0,0,0,2.00E-93,RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase),CTDP1 FCP1,961,cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation of viral transcription [GO:0050434]; protein dephosphorylation [GO:0006470]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription from RNA polymerase II promoter [GO:0006366],GO:0000922; GO:0004721; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0006366; GO:0006368; GO:0006470; GO:0008420; GO:0010458; GO:0015629; GO:0016591; GO:0016607; GO:0030496; GO:0050434; GO:0051233; GO:0051301; GO:0061052; GO:0070940,,,cd00027;,PF09309;PF03031;,"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; DNA-directed RNA polymerase II, holoenzyme [GO:0016591]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; CTD phosphatase activity [GO:0008420]; phosphoprotein phosphatase activity [GO:0004721]; cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation of viral transcription [GO:0050434]; protein dephosphorylation [GO:0006470]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription from RNA polymerase II promoter [GO:0006366]"
O17287,CHOYP_TOMM22.1.1|m.48750,0,0,0,0,0,0,0,0,1.00E-18,Mitochondrial import receptor subunit TOM22 homolog,tomm-22 W10D9.5,109,protein import into mitochondrial matrix [GO:0030150]; protein import into mitochondrial outer membrane [GO:0045040],GO:0005742; GO:0030150; GO:0031307; GO:0045040,,,,PF04281;,integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane translocase complex [GO:0005742]; protein import into mitochondrial matrix [GO:0030150]; protein import into mitochondrial outer membrane [GO:0045040]
Q6RFH5,CHOYP_WDR74.1.1|m.19017,0,0,0,0,0,0,0,0,4.00E-92,WD repeat-containing protein 74 (NOP seven-associated protein 1),WDR74 NSA1,385,ribosomal large subunit biogenesis [GO:0042273],GO:0005634; GO:0005730; GO:0030687; GO:0042273,,,,PF00400;,"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; ribosomal large subunit biogenesis [GO:0042273]"
P08953,CHOYP_AAEL_AAEL000057.1.1|m.36013,0,0,0,0,0,0,0,0,0.0000002,Protein toll,Tl CG5490,1097,antifungal humoral response [GO:0019732]; antimicrobial humoral response [GO:0019730]; cell adhesion [GO:0007155]; defense response [GO:0006952]; defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; hemocyte proliferation [GO:0035172]; hemopoiesis [GO:0030097]; immune response [GO:0006955]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; mitotic cytokinesis [GO:0000281]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; regulation of hemocyte differentiation [GO:0045610]; regulation of melanization defense response [GO:0035007]; response to bacterium [GO:0009617]; response to fungus [GO:0009620]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; zygotic specification of dorsal/ventral axis [GO:0007352],GO:0000281; GO:0002229; GO:0004888; GO:0005737; GO:0005769; GO:0005886; GO:0006952; GO:0006955; GO:0006963; GO:0006967; GO:0007155; GO:0007352; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009617; GO:0009620; GO:0009880; GO:0009897; GO:0009950; GO:0009986; GO:0016021; GO:0016201; GO:0019730; GO:0019732; GO:0019955; GO:0030097; GO:0032154; GO:0035007; GO:0035172; GO:0042802; GO:0043234; GO:0045087; GO:0045610; GO:0045944; GO:0050830; GO:0050832; GO:0070976; GO:1902875,,,,PF00560;PF13306;PF13855;PF01462;PF01582;,cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; cytokine binding [GO:0019955]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal humoral response [GO:0019732]; antimicrobial humoral response [GO:0019730]; cell adhesion [GO:0007155]; defense response [GO:0006952]; defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; hemocyte proliferation [GO:0035172]; hemopoiesis [GO:0030097]; immune response [GO:0006955]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; mitotic cytokinesis [GO:0000281]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; regulation of hemocyte differentiation [GO:0045610]; regulation of melanization defense response [GO:0035007]; response to bacterium [GO:0009617]; response to fungus [GO:0009620]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; zygotic specification of dorsal/ventral axis [GO:0007352]
Q5UPE3,CHOYP_AASI_1435.2.35|m.17918,0,0,0,0,0,0,0,0,4.00E-17,Putative ankyrin repeat protein L62,MIMI_L62,252,,,,,,PF12796;,
P09690,CHOYP_ACH91.1.1|m.48865,0,0,0,0,0,0,0,0,6.00E-59,Acetylcholine receptor subunit beta,Chrnb1 Acrb,501,"behavioral response to nicotine [GO:0035095]; cation transport [GO:0006812]; muscle contraction [GO:0006936]; muscle fiber development [GO:0048747]; neurological system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; postsynaptic membrane organization [GO:0001941]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; synaptic transmission, cholinergic [GO:0007271]",GO:0001941; GO:0003009; GO:0005886; GO:0005892; GO:0006812; GO:0006936; GO:0007165; GO:0007271; GO:0007274; GO:0015267; GO:0022848; GO:0030054; GO:0035094; GO:0035095; GO:0042166; GO:0042391; GO:0045202; GO:0045211; GO:0048747; GO:0050877,,,,PF02931;PF02932;,"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; channel activity [GO:0015267]; behavioral response to nicotine [GO:0035095]; cation transport [GO:0006812]; muscle contraction [GO:0006936]; muscle fiber development [GO:0048747]; neurological system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; postsynaptic membrane organization [GO:0001941]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; synaptic transmission, cholinergic [GO:0007271]"
Q7ZWB7,CHOYP_BBS5.1.1|m.56560,0.5,0,0,0,0,0,0,0,0,Bardet-Biedl syndrome 5 protein homolog,bbs5 zgc:56578,342,cilium assembly [GO:0060271]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116],GO:0001947; GO:0005737; GO:0007369; GO:0032266; GO:0032402; GO:0034464; GO:0036064; GO:0042051; GO:0046907; GO:0048749; GO:0051877; GO:0060170; GO:0060271; GO:0070121; GO:0072116,,,,PF07289;,BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; phosphatidylinositol-3-phosphate binding [GO:0032266]; cilium assembly [GO:0060271]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116]
Q95JT3,CHOYP_BRAFLDRAFT_125356.3.3|m.35009,0.5,0,0,0,0,0,0,0,2.00E-67,Leucine-rich repeat-containing protein 43,LRRC43 QtsA-13548,654,,,,,,PF13855;,
Q3V6T2,CHOYP_GRDN.1.5|m.12675,0,0,0,0,0,0,0,0,0,Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1),CCDC88A APE GRDN KIAA1212,1871,activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; DNA replication [GO:0006260]; lamellipodium assembly [GO:0030032]; membrane organization [GO:0061024]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of neuron projection development [GO:0010975]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929],GO:0001932; GO:0003779; GO:0005783; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0006260; GO:0006275; GO:0008017; GO:0010975; GO:0016020; GO:0016477; GO:0030027; GO:0030032; GO:0030705; GO:0031122; GO:0031410; GO:0031929; GO:0032148; GO:0032956; GO:0035091; GO:0036064; GO:0042127; GO:0042803; GO:0043422; GO:0045724; GO:0051959; GO:0061024; GO:1903566,,,,PF05622;,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; DNA replication [GO:0006260]; lamellipodium assembly [GO:0030032]; membrane organization [GO:0061024]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of neuron projection development [GO:0010975]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]
Q90871,CHOYP_IRF5.1.1|m.58123,0.5,0,0,0,0,0,0,0,4.00E-51,Interferon regulatory factor 8 (IRF-8) (Interferon consensus sequence-binding protein) (ICSBP),IRF8 ICSBP ICSBP1,425,"cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; myeloid cell differentiation [GO:0030099]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; phagocytosis [GO:0006909]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; transcription, DNA-templated [GO:0006351]",GO:0000122; GO:0000978; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006909; GO:0030099; GO:0032729; GO:0032735; GO:0042742; GO:0042832; GO:0044130; GO:0045944; GO:0060261; GO:0071222; GO:0071346,,,,PF00605;PF10401;,"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; myeloid cell differentiation [GO:0030099]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; phagocytosis [GO:0006909]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; transcription, DNA-templated [GO:0006351]"
Q5XKA2,CHOYP_LOC100186763.2.2|m.27544,0,0,0,0,0,0,0,0,8.00E-38,"Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)",timm21 tim21,232,protein import into mitochondrial matrix [GO:0030150],GO:0005744; GO:0016021; GO:0030150,,,,PF08294;,integral component of membrane [GO:0016021]; mitochondrial inner membrane presequence translocase complex [GO:0005744]; protein import into mitochondrial matrix [GO:0030150]
Q9R172,CHOYP_LOC100367084.12.22|m.48659,0.5,0,0,0,0,0,0,0,7.00E-17,Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain],Notch3,2319,"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]; regulation of transcription, DNA-templated [GO:0006355]; tissue regeneration [GO:0042246]; transcription, DNA-templated [GO:0006351]",GO:0004872; GO:0005509; GO:0005634; GO:0005886; GO:0006351; GO:0006355; GO:0007219; GO:0007275; GO:0016021; GO:0030154; GO:0042246,,,,PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;,"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; receptor activity [GO:0004872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]; regulation of transcription, DNA-templated [GO:0006355]; tissue regeneration [GO:0042246]; transcription, DNA-templated [GO:0006351]"
Q5R6Q2,CHOYP_LOC100367266.1.1|m.10803,0,0,0,0,0,0,0,0,1.00E-89,Syntaxin-6,STX6,255,Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025],GO:0000139; GO:0006886; GO:0016021; GO:0048193; GO:0061025,,,,PF05739;PF09177;,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]
Q3ZBY7,CHOYP_LOC100378209.1.2|m.7336,0,0,0,0,0,0,0,0,5.00E-152,Sphingolipid delta(4)-desaturase DES1 (EC 1.14.19.17) (Degenerative spermatocyte homolog 1),DEGS1 DES1,323,ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633],GO:0005739; GO:0005789; GO:0006633; GO:0016021; GO:0042284; GO:0046513,,,,PF00487;PF08557;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; sphingolipid delta-4 desaturase activity [GO:0042284]; ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]
P05140,CHOYP_LOC100378295.2.4|m.15030,0,0,0,0,0,0,0,0,2.00E-10,Type-2 ice-structuring protein (Type II antifreeze protein) (AFP),,163,,GO:0005576; GO:0030246,,,,PF00059;,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
Q5R8X6,CHOYP_LOC100465916.1.1|m.44328,0,0,0,0,0,0,0,0,2.00E-25,"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]",PLG,810,blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771],GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771,,,cd00190;,PF00051;PF00024;PF00089;,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
B8ARK7,CHOYP_LOC100632618.2.3|m.30752,0,0,0,0,0,0,0,0,3.00E-45,NAD-dependent protein deacetylase SRT1 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1),SRT1 OsI_15145,484,,GO:0005634; GO:0016787; GO:0046872; GO:0070403,,,,PF02146;,nucleus [GO:0005634]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]
C8V4D4,CHOYP_LOC100891447.1.1|m.18284,0,0,0,0,0,0,0,0,0.00000002,SCF E3 ubiquitin ligase complex F-box protein grrA (F-box and leucine-rich repeat protein grrA) (F-box/LRR-repeat protein grrA) (SCF substrate adapter protein grrA),grrA grr1 AN10516,585,ascospore formation [GO:0030437],GO:0005737; GO:0019005; GO:0030437,,,,PF12937;,cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; ascospore formation [GO:0030437]
O00566,CHOYP_LOC101169524.1.1|m.4630,0,0,0,0,0,0,0,0,1.00E-118,U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10),MPHOSPH10 MPP10,681,"maturation of SSU-rRNA [GO:0030490]; negative regulation of phosphatase activity [GO:0010923]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364]",GO:0000375; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005732; GO:0006364; GO:0006396; GO:0008380; GO:0010923; GO:0030490; GO:0032040; GO:0034457,,,,PF04006;,"chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; negative regulation of phosphatase activity [GO:0010923]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364]"
Q32KN8,CHOYP_LOC585338.2.2|m.40816,0,0,0,0,0,0,0,0,5.00E-170,Tubulin alpha-3 chain (Alpha-tubulin 3) [Cleaved into: Detyrosinated tubulin alpha-3 chain],TUBA3,450,microtubule-based process [GO:0007017],GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,,,,PF00091;PF03953;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
Q6GPD0,CHOYP_LOC656615.1.1|m.66274,0,0,0,0,0,0,0,0,0,Rho GTPase-activating protein 32 (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS),arhgap32 rics,1940,signal transduction [GO:0007165],GO:0005096; GO:0005737; GO:0005886; GO:0007165; GO:0035091,,,,PF00620;PF07653;,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; phosphatidylinositol binding [GO:0035091]; signal transduction [GO:0007165]
O75445,CHOYP_LRP6.1.6|m.878,0,0,0,0,0,0,0,0,0.0000002,Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein),USH2A,5202,establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],GO:0001917; GO:0002142; GO:0005518; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016021; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0045184; GO:0045494; GO:0048496; GO:0050896; GO:0050953; GO:0060113; GO:0060171; GO:1990075; GO:1990696,,,cd00063;,PF00041;PF00053;PF02210;PF00055;,apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696]; collagen binding [GO:0005518]; myosin binding [GO:0017022]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
Q8MIQ9,CHOYP_OCA2.1.1|m.46084,0,0,0,0,0,0,0,0,0,P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog),Oca2 P,845,transmembrane transport [GO:0055085],GO:0016021; GO:0033162; GO:0055085,,,,PF03600;,integral component of membrane [GO:0016021]; melanosome membrane [GO:0033162]; transmembrane transport [GO:0055085]
Q9NWU1,CHOYP_OXSM.1.1|m.30217,0,0,0,0,0,0,0,0,1.00E-154,"3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase)",OXSM,459,acyl-CoA metabolic process [GO:0006637]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790],GO:0004315; GO:0005739; GO:0005829; GO:0006637; GO:0051790; GO:0051792,PATHWAY: Lipid metabolism; fatty acid biosynthesis.,,,PF00109;PF02801;,cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; acyl-CoA metabolic process [GO:0006637]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790]
Q05209,CHOYP_PTPRT.38.45|m.60044,0,0,0,0,0,0,0,0,2.00E-49,Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1),PTPN12,780,cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB2 signaling pathway [GO:0038128]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246],GO:0002102; GO:0004721; GO:0004725; GO:0004726; GO:0005737; GO:0005829; GO:0005925; GO:0006470; GO:0017124; GO:0035335; GO:0038128; GO:0042058; GO:0042246; GO:0042995; GO:0071364; GO:1901185; GO:2000587,,,,PF00102;,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; podosome [GO:0002102]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB2 signaling pathway [GO:0038128]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246]
Q9JJ80,CHOYP_RPF2.2.2|m.27891,0,0,0,0,0,0,0,0,3.00E-140,Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog),Rpf2 Bxdc1 MNCb-4285,306,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit assembly [GO:0000027]",GO:0000027; GO:0000463; GO:0003723; GO:0005634; GO:0005730; GO:0019843,,,,PF04427;,"nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit assembly [GO:0000027]"
Q8INF0,CHOYP_SGCBETA-3.1.1|m.66126,0,0,0,0,0,0,0,0,0,Soluble guanylate cyclase 88E (EC 4.6.1.2),Gyc88E CG4154,947,cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]; signal transduction [GO:0007165],GO:0000302; GO:0001666; GO:0004383; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0008074; GO:0019825; GO:0019826; GO:0020037; GO:0035556; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026,,,,PF00211;PF07700;PF07701;,"guanylate cyclase complex, soluble [GO:0008074]; plasma membrane [GO:0005886]; carbon monoxide binding [GO:0070025]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]; signal transduction [GO:0007165]"
P91119,CHOYP_TRIADDRAFT_21752.1.1|m.62548,0,0,0,0,0,0,0,0,0,"Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17)",pde-5 C32E12.2,728,chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP biosynthetic process [GO:0030827]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542],GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0030827; GO:0032528; GO:0042542; GO:0046872; GO:0047555,,,,PF01590;PF00233;,"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP biosynthetic process [GO:0030827]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]"
Q9JMB1,CHOYP_BRAFLDRAFT_120588.1.1|m.22993,1.5,0,0,0,0,0,0,0,2.00E-12,Testicular haploid expressed gene protein,Theg,375,cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],GO:0005634; GO:0005737; GO:0007275; GO:0007283; GO:0030154,,,,PF14912;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
B4JG34,CHOYP_BRAFLDRAFT_124027.2.2|m.50286,0,0,0,0,0,0,0,0,9.00E-114,Transmembrane emp24 domain-containing protein eca,eca GH18190,216,dorsal/ventral pattern formation [GO:0009953]; regulation of post-mating oviposition [GO:0048042]; reproduction [GO:0000003]; transport [GO:0006810],GO:0000003; GO:0005789; GO:0006810; GO:0009953; GO:0016021; GO:0048042,,,,PF01105;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953]; regulation of post-mating oviposition [GO:0048042]; reproduction [GO:0000003]; transport [GO:0006810]
Q08295,CHOYP_BRAFLDRAFT_265208.7.7|m.62510,1.5,0,0,0,0,0,0,0,8.00E-34,"Oligo-1,6-glucosidase IMA2 (EC 3.2.1.10) (Alpha-glucosidase) (Isomaltase 2)",IMA2 YOL157C,589,disaccharide catabolic process [GO:0046352]; maltose metabolic process [GO:0000023],GO:0000023; GO:0004574; GO:0004575; GO:0046352,,,,PF00128;,"oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]; disaccharide catabolic process [GO:0046352]; maltose metabolic process [GO:0000023]"
P46874,CHOYP_BRAFLDRAFT_84054.1.2|m.8523,0,0,0,0,0,0,0,0,6.00E-41,Kinesin-like protein KLP2 (Fragment),,378,cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic nuclear division [GO:0007067],GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0007067; GO:0051301,,,,PF00225;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic nuclear division [GO:0007067]
Q9BG93,CHOYP_BRAFLDRAFT_87834.1.1|m.37325,0,0,0,0,0,0,0,0,8.00E-21,Nuclear receptor subfamily 0 group B member 1 (Nuclear receptor DAX-1),NR0B1 DAX1,470,"adrenal gland development [GO:0030325]; gonad development [GO:0008406]; male gonad development [GO:0008584]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of transcription, DNA-templated [GO:0045892]; protein localization [GO:0008104]; steroid biosynthetic process [GO:0006694]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003707; GO:0003723; GO:0004879; GO:0005634; GO:0005737; GO:0006351; GO:0006694; GO:0008104; GO:0008406; GO:0008584; GO:0016020; GO:0019904; GO:0030325; GO:0032448; GO:0033144; GO:0035258; GO:0042788; GO:0042803; GO:0043565; GO:0045892,,,,PF00104;PF14046;,"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; DNA binding [GO:0003677]; DNA hairpin binding [GO:0032448]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; steroid hormone receptor binding [GO:0035258]; adrenal gland development [GO:0030325]; gonad development [GO:0008406]; male gonad development [GO:0008584]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of transcription, DNA-templated [GO:0045892]; protein localization [GO:0008104]; steroid biosynthetic process [GO:0006694]; transcription, DNA-templated [GO:0006351]"
P51791,CHOYP_CLCN3.1.1|m.21245,0,0,0,0,0,0,0,0,0,H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3),Clcn3 Clc3,818,"adult locomotory behavior [GO:0008344]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; neuron cellular homeostasis [GO:0070050]; phagocytosis, engulfment [GO:0006911]; photoreceptor cell maintenance [GO:0045494]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle lumen acidification [GO:0097401]",GO:0005247; GO:0005254; GO:0005524; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0006911; GO:0008021; GO:0008344; GO:0009897; GO:0012506; GO:0015297; GO:0016020; GO:0030141; GO:0030165; GO:0030658; GO:0031410; GO:0031901; GO:0031902; GO:0034220; GO:0035249; GO:0042581; GO:0043679; GO:0045335; GO:0045494; GO:0045794; GO:0046982; GO:0051932; GO:0060077; GO:0070050; GO:0097401; GO:1902476; GO:1903428,,,,PF00571;PF00654;,"axon terminus [GO:0043679]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; specific granule [GO:0042581]; synaptic vesicle [GO:0008021]; transport vesicle membrane [GO:0030658]; vesicle membrane [GO:0012506]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; voltage-gated chloride channel activity [GO:0005247]; adult locomotory behavior [GO:0008344]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; neuron cellular homeostasis [GO:0070050]; phagocytosis, engulfment [GO:0006911]; photoreceptor cell maintenance [GO:0045494]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle lumen acidification [GO:0097401]"
Q5XQC7,CHOYP_CPNE8.2.2|m.58379,0,0,0,0,0,0,0,0,2.00E-133,Protein BONZAI 3,BON3 At1g08860 F7G19.25,584,defense response [GO:0006952]; negative regulation of cell death [GO:0060548]; stomatal closure [GO:0090332],GO:0005544; GO:0005886; GO:0006952; GO:0060548; GO:0090332,,,cd01459;,PF00168;PF07002;,plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; defense response [GO:0006952]; negative regulation of cell death [GO:0060548]; stomatal closure [GO:0090332]
Q5VY43,CHOYP_DVIR_GJ12529.1.1|m.21031,0,0,0,0,0,0,0,0,5.00E-39,Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12),PEAR1 MEGF12,1037,negative regulation of Notch signaling pathway [GO:0045746]; recognition of apoptotic cell [GO:0043654],GO:0001891; GO:0016021; GO:0043654; GO:0045746,,,,PF00053;,integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; negative regulation of Notch signaling pathway [GO:0045746]; recognition of apoptotic cell [GO:0043654]
Q9VCA9,CHOYP_FASN.3.4|m.60280,0,0,0,0,0,0,0,0,2.00E-79,Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22 kDa subunit) (SPC22) (SPase 22 kDa subunit),Spase22-23 CG5677,179,protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465],GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0031090; GO:0045047,,,,PF04573;,integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]
Q69Z37,CHOYP_LOC100367581.3.3|m.56472,4.5,0,0,0,0,0,0,0,1.00E-70,Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like),Samd9l Kiaa2005,1561,common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145],GO:0002244; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536,,,,,early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]
Q53GL7,CHOYP_LOC100368410.2.2|m.44510,0,0,0,0,0,0,0,0,0.0000003,Poly [ADP-ribose] polymerase 10 (PARP-10) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 10) (ARTD10),PARP10,1025,"NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein import into nucleus, translocation [GO:0033159]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of viral genome replication [GO:0045071]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]; regulation of chromatin assembly [GO:0010847]",GO:0003950; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006471; GO:0010629; GO:0010847; GO:0032088; GO:0033159; GO:0034356; GO:0043231; GO:0045071; GO:0048147; GO:0070212; GO:0070213; GO:0070530; GO:1900045,,,,PF00644;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; K63-linked polyubiquitin binding [GO:0070530]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein import into nucleus, translocation [GO:0033159]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of viral genome replication [GO:0045071]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]; regulation of chromatin assembly [GO:0010847]"
Q54RV9,CHOYP_LOC100370334.1.1|m.48934,0,0,0,0,0,0,0,0,7.00E-116,Sphingosine-1-phosphate lyase (S1P lyase) (S1PL) (SP-lyase) (SPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase),sglA DDB_G0282819,528,actin cytoskeleton organization [GO:0030036]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; cell death [GO:0008219]; cell motility [GO:0048870]; cellular calcium ion homeostasis [GO:0006874]; ceramide metabolic process [GO:0006672]; chemotaxis [GO:0006935]; locomotion [GO:0040011]; negative regulation of aggregate size involved in sorocarp development [GO:0031158]; negative regulation of lateral pseudopodium assembly [GO:0031276]; positive phototaxis [GO:0046956]; regulation of actin filament polymerization [GO:0030833]; sorocarp development [GO:0030587]; sphingolipid catabolic process [GO:0030149]; sporulation resulting in formation of a cellular spore [GO:0030435],GO:0001667; GO:0005789; GO:0006672; GO:0006874; GO:0006935; GO:0008117; GO:0008219; GO:0016021; GO:0016831; GO:0019752; GO:0030036; GO:0030149; GO:0030170; GO:0030435; GO:0030587; GO:0030833; GO:0031158; GO:0031276; GO:0040011; GO:0046956; GO:0048870,PATHWAY: Lipid metabolism; sphingolipid metabolism.,,,PF00282;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; actin cytoskeleton organization [GO:0030036]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; cell death [GO:0008219]; cell motility [GO:0048870]; cellular calcium ion homeostasis [GO:0006874]; ceramide metabolic process [GO:0006672]; chemotaxis [GO:0006935]; locomotion [GO:0040011]; negative regulation of aggregate size involved in sorocarp development [GO:0031158]; negative regulation of lateral pseudopodium assembly [GO:0031276]; positive phototaxis [GO:0046956]; regulation of actin filament polymerization [GO:0030833]; sorocarp development [GO:0030587]; sphingolipid catabolic process [GO:0030149]; sporulation resulting in formation of a cellular spore [GO:0030435]
A0JPI9,CHOYP_LOC100372392.4.8|m.31087,1,0,0,0,0,0,0,0,2.00E-90,Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74),Lrrc74a Lrrc74,479,,,,,,PF13516;,
Q61909,CHOYP_LOC100375491.1.1|m.11693,0,0,0,0,0,0,0,0,2.00E-157,Protein CBFA2T1 (Protein MTG8),Runx1t1 Cbfa2t1 Cbfa2t1h Mtg8,577,"fat cell differentiation [GO:0045444]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of DNA binding [GO:0051101]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0010977; GO:0016363; GO:0017053; GO:0042803; GO:0045444; GO:0045599; GO:0045892; GO:0046872; GO:0051101,,,,PF08788;PF07531;PF01753;,"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; fat cell differentiation [GO:0045444]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of DNA binding [GO:0051101]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q7LHG5,CHOYP_LOC100708199.6.6|m.57028,0,0,0,0,0,0,0,0,2.00E-104,Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)],TY3B-I YILWTy3-1 POL YIL082W-A,1498,"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]",GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197,,,,PF12384;PF00665;PF00078;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"
Q9VCA2,CHOYP_LOC100878786.1.1|m.55152,0,0,0,0,0,0,0,0,4.00E-111,Organic cation transporter protein,Orct CG6331,548,apoptotic process [GO:0006915],GO:0005887; GO:0006915; GO:0008514; GO:0016021,,,cd06174;,PF00083;,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; apoptotic process [GO:0006915]
A2RRH5,CHOYP_LOC100888253.1.1|m.18761,0.5,0,0,0,0,0,0,0,2.00E-133,WD repeat-containing protein 27,WDR27,827,,GO:0005654,,,,PF00400;,nucleoplasm [GO:0005654]
Q9VUL9,CHOYP_LOC663102.1.1|m.8869,0,0,0,0,0,0,0,0,4.00E-39,"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)",FucTA CG6869,503,nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486],GO:0000139; GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036071; GO:0046920,PATHWAY: Protein modification; protein glycosylation.,,,PF17039;PF00852;,"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]"
Q8R5M3,CHOYP_LRC15.2.3|m.43746,0,0,0,0,0,0,0,0,4.00E-44,Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by beta-amyloid) (rLib),Lrrc15 Lib,578,cell communication [GO:0007154]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of protein kinase activity [GO:0006469],GO:0004860; GO:0005622; GO:0005737; GO:0006469; GO:0007154; GO:0016021; GO:0019221; GO:0046426,,,,PF00560;PF13855;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; protein kinase inhibitor activity [GO:0004860]; cell communication [GO:0007154]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of protein kinase activity [GO:0006469]
Q8BLI0,CHOYP_MADD-4.1.1|m.33455,0,0,0,0,0,0,0,0,2.00E-39,ADAMTS-like protein 1 (ADAMTSL-1) (Punctin-1),Adamtsl1,1745,,GO:0005578; GO:0008237; GO:0008270,,,,PF07679;PF08686;PF00090;,proteinaceous extracellular matrix [GO:0005578]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]
Q29H55,CHOYP_MB21L.1.1|m.35723,0,0,0,0,0,0,0,0,0.000000004,Protein mab-21-like,GA18415,368,,,,,,PF03281;,
P50306,CHOYP_METK1.2.2|m.65101,0,0,0,0,0,0,0,0,0,Probable S-adenosylmethionine synthase 4 (AdoMet synthase 4) (EC 2.5.1.6) (Methionine adenosyltransferase 4) (MAT 4),sams-4 C06E7.3,404,one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0046872,PATHWAY: Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. {ECO:0000250|UniProtKB:Q00266}.,,,PF02773;PF02772;PF00438;,cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]
Q8BU85,CHOYP_MSRB3.2.4|m.17278,1,0,0,0,0,0,0,0,3.00E-61,"Methionine-R-sulfoxide reductase B3, mitochondrial (MsrB3) (EC 1.8.4.-)",Msrb3,253,protein repair [GO:0030091]; response to oxidative stress [GO:0006979],GO:0005739; GO:0005783; GO:0006979; GO:0008270; GO:0030091; GO:0033743,,,,PF01641;,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]
Q9NEN6,CHOYP_RS6.5.12|m.23146,0.5,0,0,0,0,0,0,0,4.00E-99,40S ribosomal protein S6,rps-6 Y71A12B.1,246,determination of adult lifespan [GO:0008340]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412],GO:0003735; GO:0006364; GO:0006412; GO:0008340; GO:0022627; GO:0042274,,,,PF01092;,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; determination of adult lifespan [GO:0008340]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]
Q969G6,CHOYP_RS7.5.9|m.38700,0,0,0,0,0,0,0,0,3.00E-65,Riboflavin kinase (EC 2.7.1.26) (ATP:riboflavin 5'-phosphotransferase) (Flavokinase),RFK,155,apoptotic process [GO:0006915]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771],GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006771; GO:0006915; GO:0008531; GO:0009231; GO:0009398; GO:0033864; GO:0046872; GO:0072593,PATHWAY: Cofactor biosynthesis; FMN biosynthesis; FMN from riboflavin (ATP route): step 1/1.,,,PF01687;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531]; apoptotic process [GO:0006915]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771]
Q3MHN8,CHOYP_TRM5.1.1|m.24347,0,0,0,0,0,0,0,0,5.00E-122,tRNA (guanine(37)-N1)-methyltransferase (EC 2.1.1.228) (M1G-methyltransferase) (tRNA [GM37] methyltransferase) (tRNA methyltransferase 5 homolog),TRMT5 TRM5,497,mitochondrial tRNA methylation [GO:0070901],GO:0005634; GO:0005759; GO:0052906; GO:0070901,,,,PF02475;,mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; mitochondrial tRNA methylation [GO:0070901]
O01761,CHOYP_UNC89.17.19|m.58312,0,0,0,0,0,0,0,0,5.00E-21,Muscle M-line assembly protein unc-89 (Obscurin) (Uncoordinated protein 89),unc-89 C09D1.1,8081,myosin filament assembly [GO:0031034]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; regulation of Rho protein signal transduction [GO:0035023]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688],GO:0004672; GO:0005089; GO:0005524; GO:0010628; GO:0017048; GO:0019902; GO:0030241; GO:0031034; GO:0031430; GO:0031672; GO:0035023; GO:0050850; GO:0060298; GO:0071688; GO:1905552,,,cd00063;,PF00041;PF07679;PF00069;PF05177;PF00621;,A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; myosin filament assembly [GO:0031034]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; regulation of Rho protein signal transduction [GO:0035023]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]
Q9D9G2,CHOYP_AAEL_AAEL007549.1.1|m.13827,0,0,0,0,0,0,0,0,2.00E-22,Phosphatidylethanolamine-binding protein 4 (PEBP-4),Pebp4,242,,GO:0005764; GO:0070062,,,,PF01161;,extracellular exosome [GO:0070062]; lysosome [GO:0005764]
Q3SWY8,CHOYP_AAEL_AAEL013635.1.1|m.54371,0,0,0,0,0,0,0,0,1.00E-92,Zinc finger with UFM1-specific peptidase domain protein,ZUFSP,579,,GO:0046872,,,,PF07910;,metal ion binding [GO:0046872]
P70705,CHOYP_ATP7A.1.1|m.23099,0,0,0,0,0,0,0,0,0,Copper-transporting ATPase 1 (EC 3.6.3.54) (Copper pump 1) (Menkes disease-associated protein homolog),Atp7a Mnk,1492,cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; copper ion export [GO:0060003]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; negative regulation of iron ion transmembrane transport [GO:0034760]; plasma membrane copper ion transport [GO:0015679]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; response to copper ion [GO:0046688]; response to iron(III) ion [GO:0010041]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043],GO:0001701; GO:0001889; GO:0005375; GO:0005507; GO:0005524; GO:0005634; GO:0005770; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006878; GO:0007595; GO:0010041; GO:0010042; GO:0010043; GO:0010288; GO:0010468; GO:0010592; GO:0015679; GO:0016021; GO:0016323; GO:0016324; GO:0019829; GO:0030140; GO:0030141; GO:0031252; GO:0031526; GO:0034760; GO:0036120; GO:0043204; GO:0045121; GO:0045793; GO:0046688; GO:0048365; GO:0048471; GO:0050679; GO:0051087; GO:0051353; GO:0060003; GO:0071230; GO:0071236; GO:0071276; GO:0071279; GO:0071280; GO:0071281; GO:0071284; GO:0071456; GO:1903036; GO:1904754; GO:1904959,,,cd00371;,PF00122;PF00403;,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane raft [GO:0045121]; microvillus [GO:0005902]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; Rac GTPase binding [GO:0048365]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; copper ion export [GO:0060003]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; negative regulation of iron ion transmembrane transport [GO:0034760]; plasma membrane copper ion transport [GO:0015679]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; response to copper ion [GO:0046688]; response to iron(III) ion [GO:0010041]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]
A0FKG7,CHOYP_CAN8.1.2|m.21091,0,0,0,0,0,0,0,0,3.00E-24,Calpain-7 (EC 3.4.22.-),CAPN7,813,proteolysis [GO:0006508],GO:0004198; GO:0005634; GO:0005737; GO:0006508,,,cd00044;,PF01067;PF04212;PF00648;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]
A3KN46,CHOYP_DMOJ_GI12418.1.1|m.49398,0.5,0,0,0,0,0,0,0,0.000000007,LETM1 domain-containing protein 1,LETMD1,360,cellular metal ion homeostasis [GO:0006875],GO:0005741; GO:0005743; GO:0006875; GO:0016021; GO:0043022,,,,PF07766;,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; ribosome binding [GO:0043022]; cellular metal ion homeostasis [GO:0006875]
Q2KIS9,CHOYP_DPSE_GA18582.1.1|m.58686,0,0,0,0,0,0,0,0,0.000002,Tetraspanin-8 (Tspan-8),TSPAN8,238,cell surface receptor signaling pathway [GO:0007166],GO:0005887; GO:0007166,,,,PF00335;,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]
Q460N5,CHOYP_DSPP.5.8|m.37255,0,0,0,0,0,0,0,0,3.00E-18,Poly [ADP-ribose] polymerase 14 (PARP-14) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2),PARP14 BAL2 KIAA1268,1801,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003950; GO:0005634; GO:0005829; GO:0006351; GO:0006355; GO:0016020,,,,PF01661;PF00644;,"cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q9HCC6,CHOYP_HES1.2.3|m.27001,0,0,0,0,0,0,0,0,6.00E-46,Transcription factor HES-4 (hHES4) (Class B basic helix-loop-helix protein 42) (bHLHb42) (Hairy and enhancer of split 4) (bHLH factor Hes4),HES4 BHLHB42,221,"cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0007399; GO:0008134; GO:0030154,,,,PF07527;PF00010;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
P45842,CHOYP_ISCW_ISCW001285.2.2|m.15985,0,0,0,0,0,0,0,0,1.00E-24,60S ribosomal protein L34 (L31),RpL34 RpL31,130,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412,,,,PF01199;,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
Q7T0M6,CHOYP_ISCW_ISCW013556.1.1|m.26406,0,0,0,0,0,0,0,0,6.00E-90,Histone chaperone asf1a-B (Anti-silencing function protein 1 homolog A-B),asf1ab asf1a,200,"chromatin assembly or disassembly [GO:0006333]; covalent chromatin modification [GO:0016569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0006333; GO:0006351; GO:0006355; GO:0016569,,,,PF04729;,"nucleus [GO:0005634]; chromatin assembly or disassembly [GO:0006333]; covalent chromatin modification [GO:0016569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q2M2Z5,CHOYP_KIZ.1.1|m.57618,0.5,0,0,0,0,0,0,0,2.00E-14,Centrosomal protein kizuna (Polo-like kinase 1 substrate 1),KIZ C20orf19 NCRNA00153 PLK1S1 HT013,673,spindle organization [GO:0007051],GO:0005737; GO:0005813; GO:0007051; GO:0019901; GO:0042995,,,,,cell projection [GO:0042995]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein kinase binding [GO:0019901]; spindle organization [GO:0007051]
Q9VYY9,CHOYP_LOC100378224.1.1|m.4326,0,0,0,0,0,0,0,0,0,Ecotropic viral integration site 5 ortholog,Evi5 CG11727,807,activation of GTPase activity [GO:0090630]; border follicle cell migration [GO:0007298]; intracellular protein transport [GO:0006886]; regulation of cell migration [GO:0030334]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]; regulation of vesicle fusion [GO:0031338],GO:0005096; GO:0005737; GO:0005768; GO:0005794; GO:0006886; GO:0007298; GO:0017137; GO:0030334; GO:0031338; GO:0031982; GO:0032880; GO:0043087; GO:0090630,,,,PF00566;,cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; border follicle cell migration [GO:0007298]; intracellular protein transport [GO:0006886]; regulation of cell migration [GO:0030334]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]; regulation of vesicle fusion [GO:0031338]
O35375,CHOYP_LOC100552730.1.1|m.18699,0,0,0,0,0,0,0,0,2.00E-20,Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2),Nrp2,931,angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; heart development [GO:0007507]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],GO:0001525; GO:0001755; GO:0001764; GO:0005021; GO:0005886; GO:0007411; GO:0007507; GO:0008201; GO:0016021; GO:0017154; GO:0021612; GO:0021649; GO:0021675; GO:0021828; GO:0030424; GO:0036486; GO:0046872; GO:0048846; GO:0050919; GO:0061549; GO:0061551; GO:0097374; GO:0097490; GO:0097491; GO:1901166; GO:1902285; GO:1903375; GO:1904835,,,cd00041;cd06263;,PF00431;PF11980;PF00754;PF00629;,axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; heart development [GO:0007507]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]
Q8WWT9,CHOYP_LOC100692894.1.1|m.10137,0,0,0,0,0,0,0,0,4.00E-144,Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3) (NaDC-3) (hNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2),SLC13A3 NADC3 SDCT2,602,citrate transport [GO:0015746],GO:0005886; GO:0005887; GO:0015137; GO:0015141; GO:0015362; GO:0015746; GO:0017153; GO:0070062,,,,PF00939;,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746]
A7X4K1,CHOYP_LOC100700188.1.1|m.30931,0,0,0,0,0,0,0,0,0.000000001,Waprin-Phi1,,134,defense response to bacterium [GO:0042742],GO:0005576; GO:0030414; GO:0042742,,,,PF00095;,extracellular region [GO:0005576]; peptidase inhibitor activity [GO:0030414]; defense response to bacterium [GO:0042742]
Q95JD5,CHOYP_LOC101169780.1.1|m.46531,0,0,0,0,0,0,0,0,2.00E-24,Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (cSULT1B1) (EC 2.8.2.-),SULT1B1 ST1B2,296,epithelial cell differentiation [GO:0030855]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],GO:0004062; GO:0005737; GO:0006805; GO:0008202; GO:0009812; GO:0030855; GO:0042403; GO:0051923,,,,PF00685;,cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; epithelial cell differentiation [GO:0030855]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
Q6R796,CHOYP_Y118.1.1|m.30002,0.5,0,0,0,0,0,0,0,4.00E-126,Putative RING finger protein ORF117,ORF117,371,,GO:0008270,,,,,zinc ion binding [GO:0008270]
Q8C8V1,CHOYP_ZN583.1.2|m.8418,0,0,0,0,0,0,0,0,4.00E-27,Zinc finger protein ZXDC,Zxdc,858,"positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]",GO:0003676; GO:0003700; GO:0005634; GO:0006351; GO:0030275; GO:0045893; GO:0046872; GO:0070742,,,,,"nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; LRR domain binding [GO:0030275]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]"
P86948,CHOYP_AAEL_AAEL007437.1.1|m.29443,0,0,0,0,0,0,0,0,2.00E-16,Mantle protein (MP),,260,,GO:0005576,,,,,extracellular region [GO:0005576]
Q68ER9,CHOYP_AGAP_AGAP006810.1.2|m.12514,0,0,0,0,0,0,0,0,4.00E-50,Chromatin modification-related protein MEAF6 (MYST/Esa1-associated factor 6) (Esa1-associated factor 6 homolog) (Protein EAF6 homolog),meaf6,191,"histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0000776; GO:0000777; GO:0005730; GO:0006351; GO:0006355; GO:0035267; GO:0043968; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0070776,,,,PF09340;,"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q921Q3,CHOYP_ALG1.1.1|m.40067,0,0,0,0,0,0,0,0,8.00E-158,"Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase)",Alg1,482,protein glycosylation [GO:0006486],GO:0000030; GO:0004578; GO:0005783; GO:0005789; GO:0006486; GO:0016020; GO:0016021,PATHWAY: Protein modification; protein glycosylation.,,,PF00534;,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]; mannosyltransferase activity [GO:0000030]; protein glycosylation [GO:0006486]
Q8CE72,CHOYP_BRAFLDRAFT_117629.2.2|m.31330,0.5,0,0,0,0,0,0,0,2.00E-130,Protein JBTS17 (Protein C5orf42 homolog),Jbts17,3214,cardiac septum development [GO:0003279]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; heart development [GO:0007507]; kidney development [GO:0001822]; palate development [GO:0060021]; protein localization to ciliary transition zone [GO:1904491]; ventricular septum development [GO:0003281],GO:0001736; GO:0001822; GO:0003279; GO:0003281; GO:0007507; GO:0016021; GO:0021549; GO:0035869; GO:0042733; GO:0060021; GO:0060271; GO:0060976; GO:1904491,,,,PF15392;,ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; cardiac septum development [GO:0003279]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; heart development [GO:0007507]; kidney development [GO:0001822]; palate development [GO:0060021]; protein localization to ciliary transition zone [GO:1904491]; ventricular septum development [GO:0003281]
Q99973,CHOYP_BRAFLDRAFT_128562.2.4|m.33663,0.5,0,0,0,0,0,0,0,6.00E-152,Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog),TEP1 TLP1 TP1,2627,RNA splicing [GO:0008380]; telomere maintenance via recombination [GO:0000722],GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005682; GO:0005697; GO:0005737; GO:0008380; GO:0016363; GO:0019899; GO:0030529; GO:0070034; GO:0071011; GO:0071013,,,,PF13271;PF05386;PF05731;PF00400;,"catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular ribonucleoprotein complex [GO:0030529]; nuclear matrix [GO:0016363]; precatalytic spliceosome [GO:0071011]; telomerase holoenzyme complex [GO:0005697]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; RNA splicing [GO:0008380]; telomere maintenance via recombination [GO:0000722]"
Q8WYH8,CHOYP_BRAFLDRAFT_133135.1.1|m.18788,1,0,0,0,0,0,0,0,1.00E-106,Inhibitor of growth protein 5 (p28ING5),ING5,240,"DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; negative regulation of cell proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription, DNA-templated [GO:0006351]",GO:0003682; GO:0005634; GO:0005654; GO:0006260; GO:0006351; GO:0006473; GO:0008270; GO:0008285; GO:0035064; GO:0043065; GO:0043966; GO:0045893; GO:0045926; GO:0070776; GO:1901796; GO:2001235,,,,PF12998;,"MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; negative regulation of cell proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription, DNA-templated [GO:0006351]"
B3DLA6,CHOYP_BRAFLDRAFT_202604.1.1|m.41616,0,0,0,0,0,0,0,0,6.00E-97,Endoribonuclease Dicer (EC 3.1.26.3),dicer1,1893,pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; targeting of mRNA for destruction involved in RNA interference [GO:0030423],GO:0003723; GO:0004386; GO:0004525; GO:0005524; GO:0005634; GO:0005737; GO:0016442; GO:0030422; GO:0030423; GO:0031054; GO:0046872; GO:0070578,,,cd00593;,PF00270;PF03368;PF00271;PF02170;PF00636;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]
P17978,CHOYP_BRAFLDRAFT_241726.4.22|m.3766,0,0,0,0,0,0,0,0,0.00000003,Virginiamycin B lyase (EC 4.2.99.-) (Streptogramin B lyase),vgb vgh,299,antibiotic catabolic process [GO:0017001]; response to antibiotic [GO:0046677],GO:0000287; GO:0016835; GO:0017001; GO:0046677,,,,,carbon-oxygen lyase activity [GO:0016835]; magnesium ion binding [GO:0000287]; antibiotic catabolic process [GO:0017001]; response to antibiotic [GO:0046677]
Q32LQ6,CHOYP_BRAFLDRAFT_277055.1.2|m.3095,0,0,0,0,0,0,0,0,0,Major facilitator superfamily domain-containing protein 1,mfsd1 zgc:123187,461,transmembrane transport [GO:0055085],GO:0016021; GO:0055085,,,cd06174;,PF07690;,integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
Q8VHE0,CHOYP_BRAFLDRAFT_284846.2.2|m.60100,0,0,0,0,0,0,0,0,0,Translocation protein SEC63 homolog,Sec63 Sec63l,760,"liver development [GO:0001889]; multicellular organism aging [GO:0010259]; nitrogen compound metabolic process [GO:0006807]; posttranslational protein targeting to membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]; renal system development [GO:0072001]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]",GO:0001889; GO:0003723; GO:0005783; GO:0005789; GO:0006614; GO:0006620; GO:0006807; GO:0008565; GO:0010259; GO:0016020; GO:0016021; GO:0031204; GO:0072001,,,cd06257;,PF00226;PF02889;,"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein transporter activity [GO:0008565]; RNA binding [GO:0003723]; liver development [GO:0001889]; multicellular organism aging [GO:0010259]; nitrogen compound metabolic process [GO:0006807]; posttranslational protein targeting to membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]; renal system development [GO:0072001]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]"
Q7ZXX1,CHOYP_CADM4.1.1|m.60661,0,0,0,0,0,0,0,0,4.00E-14,Cell adhesion molecule 3 (Immunoglobulin superfamily member 4B) (IgSF4B),cadm3 igsf4b,394,cell adhesion [GO:0007155],GO:0005886; GO:0007155; GO:0016021; GO:0030054,,,,PF08205;PF07679;,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
P97864,CHOYP_CASP7.11.23|m.26574,0.5,0,0,0,0,0,0,0,2.00E-87,Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (Cysteine protease LICE2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],Casp7 Lice2 Mch3,303,aging [GO:0007568]; apoptotic process [GO:0006915]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411],GO:0004190; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0007507; GO:0007568; GO:0008233; GO:0009411; GO:0016485; GO:0051402; GO:0097153; GO:0097194; GO:0097200,,,cd00032;,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]
Q8BGN2,CHOYP_CD033.1.1|m.25350,0,0,0,0,0,0,0,0,5.00E-65,UPF0462 protein C4orf33 homolog,D3Ertd751e,192,,,,,,,
Q9U4L6,CHOYP_DPSE_GA11443.1.1|m.19526,0,0,0,0,0,0,0,0,8.00E-103,Mitochondrial import receptor subunit TOM40 homolog 1 (dtom40) (Male sterile protein 15) (Translocase of outer membrane 40 kDa subunit homolog 1),Tom40 mit ms(1)15 CG12157,344,cellular response to hypoxia [GO:0071456]; ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626],GO:0005739; GO:0005742; GO:0006626; GO:0006811; GO:0015266; GO:0015288; GO:0015450; GO:0030150; GO:0046930; GO:0071456,,,,PF01459;,mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; pore complex [GO:0046930]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; porin activity [GO:0015288]; protein channel activity [GO:0015266]; cellular response to hypoxia [GO:0071456]; ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]
Q3UVX5,CHOYP_GRM1.1.2|m.48217,0,0,0,0,0,0,0,0,0,Metabotropic glutamate receptor 5 (mGluR5),Grm5 Gprc1e Mglur5,1203,"adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway [GO:0007196]; cognition [GO:0050890]; G-protein coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; locomotory behavior [GO:0007626]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic transmission, glutamatergic [GO:0051966]",GO:0001639; GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0007196; GO:0007216; GO:0007612; GO:0007626; GO:0008066; GO:0014069; GO:0042734; GO:0043005; GO:0048169; GO:0050890; GO:0051966; GO:0070062; GO:0099530; GO:0099583,,,,PF00003;PF01094;PF10606;PF07562;,"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; G-protein coupled receptor activity [GO:0004930]; G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PLC activating G-protein coupled glutamate receptor activity [GO:0001639]; adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway [GO:0007196]; cognition [GO:0050890]; G-protein coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; locomotory behavior [GO:0007626]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic transmission, glutamatergic [GO:0051966]"
Q9Y7M3,CHOYP_LOC100367312.7.13|m.37567,0,0,0,0,0,0,0,0,0.000000003,FYVE-type zinc finger-containing protein C9B6.03,SPBC9B6.03,293,"phosphatidylinositol phosphorylation [GO:0046854]; retrograde transport, endosome to Golgi [GO:0042147]",GO:0000285; GO:0000324; GO:0000329; GO:0005829; GO:0010008; GO:0035091; GO:0042147; GO:0046854; GO:0046872,,,,PF01363;,"cytosol [GO:0005829]; endosome membrane [GO:0010008]; fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol phosphorylation [GO:0046854]; retrograde transport, endosome to Golgi [GO:0042147]"
Q5U3T0,CHOYP_LOC100372236.3.4|m.54964,0,0,0,0,0,0,0,0,2.00E-68,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)",mgat4c zgc:101663,454,carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486],GO:0000139; GO:0005975; GO:0006486; GO:0008454; GO:0016021; GO:0046872,PATHWAY: Protein modification; protein glycosylation.,,,PF04666;,"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]"
Q6DBY9,CHOYP_LOC100372809.1.1|m.39753,0,0,0,0,0,0,0,0,1.00E-14,Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST),chst1 zgc:100904,420,carbohydrate metabolic process [GO:0005975]; sulfur compound metabolic process [GO:0006790],GO:0000139; GO:0001517; GO:0005975; GO:0006790; GO:0016021; GO:0045130,,,,PF00685;,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; sulfur compound metabolic process [GO:0006790]
Q6YHK3,CHOYP_LOC100647494.1.1|m.55801,0,0,0,0,0,0,0,0,1.00E-102,CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109),CD109 CPAMD7,1445,C-terminal protein lipidation [GO:0006501]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005886; GO:0006501; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675,,,,PF00207;PF07678;PF01835;PF07703;PF07677;PF10569;,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; C-terminal protein lipidation [GO:0006501]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
Q6VMQ6,CHOYP_LOC100881659.1.1|m.14698,0,0,0,0,0,0,0,0,2.00E-29,Activating transcription factor 7-interacting protein 1 (ATF-interacting protein) (ATF-IP) (ATF7-interacting protein) (ATFa-associated modulator) (hAM) (MBD1-containing chromatin-associated factor 1) (P621),ATF7IP MCAF MCAF1,1270,"DNA methylation [GO:0006306]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]",GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006306; GO:0006351; GO:0016032; GO:0016604; GO:0016887; GO:0045892; GO:0045893; GO:0045898,,,,PF16788;PF16794;,"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]"
Q5T5Y3,CHOYP_LOC100932567.1.1|m.26590,0,0,0,0,0,0,0,0,5.00E-61,Calmodulin-regulated spectrin-associated protein 1,CAMSAP1,1602,cytoskeleton organization [GO:0007010]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604],GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0008017; GO:0022604; GO:0030507; GO:0031175,,,,PF17095;PF11971;PF08683;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; spectrin binding [GO:0030507]; cytoskeleton organization [GO:0007010]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]
Q5BKR2,CHOYP_LOC594676.1.1|m.8936,0,0,0,0,0,0,0,0,4.00E-131,Mitochondrial sodium/hydrogen exchanger 9B2 (Mitochondrial Na(+)/H(+) exchanger NHA2) (NHA-oc) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),Slc9b2 Nha2 Nhedc2,547,positive regulation of osteoclast development [GO:2001206]; sodium ion transport [GO:0006814],GO:0006814; GO:0015299; GO:0016021; GO:0031966; GO:2001206,,,,PF00999;,integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; solute:proton antiporter activity [GO:0015299]; positive regulation of osteoclast development [GO:2001206]; sodium ion transport [GO:0006814]
O75954,CHOYP_LOC751836.5.6|m.43257,0,0,0,0,0,0,0,0,2.00E-13,Tetraspanin-9 (Tspan-9) (Tetraspan NET-5),TSPAN9 NET5,239,cell surface receptor signaling pathway [GO:0007166],GO:0005886; GO:0005887; GO:0005925; GO:0007166; GO:0097197,,,,PF00335;,focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197]; cell surface receptor signaling pathway [GO:0007166]
Q9VXT2,CHOYP_LOC755300.1.1|m.8324,0,0,0,0,0,0,0,0,3.00E-94,DnaJ homolog subfamily C member 25 homolog,CG7872,333,,GO:0012505; GO:0016021,,,cd06257;,PF00226;,endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]
Q9H9L4,CHOYP_MGC154513.1.1|m.20908,0,0,0,0,0,0,0,0,2.00E-93,KAT8 regulatory NSL complex subunit 2 (NSL complex protein NSL2) (Non-specific lethal 2 homolog),KANSL2 C12orf41 NSL2,492,histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],GO:0000123; GO:0005654; GO:0005829; GO:0005886; GO:0015629; GO:0043981; GO:0043982; GO:0043984,,,,PF13891;,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]
Q4VBI7,CHOYP_STX18.2.2|m.51179,0,0,0,0,0,0,0,0,1.00E-106,Syntaxin-18,stx18 zgc:112326,314,"ER to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]",GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0006890; GO:0016021; GO:0031201; GO:0061025,,,,PF10496;,"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; ER to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]"
Q89YT0,CHOYP_TRIADDRAFT_21078.2.2|m.64279,0,0,0,0,0,0,0,0,7.00E-101,Probable endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV),nfo BT_4651,277,base-excision repair [GO:0006284],GO:0003677; GO:0003906; GO:0006284; GO:0008081; GO:0008270; GO:0008833,,,,PF01261;,deoxyribonuclease IV (phage-T4-induced) activity [GO:0008833]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) lyase activity [GO:0003906]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]
P24043,CHOYP_TVAG_012450.7.8|m.63509,0.5,0,0,0,0,0,0,0,0.000000002,Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain),LAMA2 LAMM,3122,"axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; muscle organ development [GO:0007517]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]",GO:0005198; GO:0005576; GO:0005604; GO:0005605; GO:0005615; GO:0007155; GO:0007411; GO:0007517; GO:0014037; GO:0030155; GO:0030198; GO:0030334; GO:0032224; GO:0042383; GO:0043197; GO:0045995; GO:0070062,,,,PF00052;PF00053;PF00054;PF02210;PF06008;PF06009;PF00055;,"basal lamina [GO:0005605]; basement membrane [GO:0005604]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcolemma [GO:0042383]; structural molecule activity [GO:0005198]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; muscle organ development [GO:0007517]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]"
P15145,CHOYP_AMPN.1.1|m.28244,0,0,0,0,0,0,0,0,3.00E-28,Aminopeptidase N (AP-N) (pAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (gp130) (CD antigen CD13),ANPEP,963,angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165],GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0007267; GO:0008217; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006,,,cd09601;,PF11838;PF01433;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]
Q6CEJ6,CHOYP_BRAFLDRAFT_109077.1.1|m.7494,0.5,0,0,0,0,0,0,0,2.00E-36,Glucose-repressible alcohol dehydrogenase transcriptional effector (EC 3.1.13.4) (Carbon catabolite repressor protein 4) (Cytoplasmic deadenylase),CCR4 YALI0B15147g,705,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0006351; GO:0006355; GO:0046872,,,,PF03372;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q29496,CHOYP_CYP3A89.1.1|m.53245,0,0,0,0,0,0,0,0,1.00E-100,Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24),CYP3A24,503,,GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0031090; GO:0070330,,,,PF00067;,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]
Q2FVD5,CHOYP_DHR11.2.2|m.36445,1.5,0,0,0,0,0,0,0,7.00E-42,Uncharacterized oxidoreductase SAOUHSC_02778 (EC 1.-.-.-),SAOUHSC_02778,231,,GO:0016491,,,,PF00106;,oxidoreductase activity [GO:0016491]
P78417,CHOYP_GSTO1.1.2|m.14745,0.5,0,0,0,0,0,0,0,6.00E-61,Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R),GSTO1 GSTTLP28,241,cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178],GO:0004364; GO:0005737; GO:0005829; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0032259; GO:0042178; GO:0045174; GO:0050610; GO:0060315; GO:0060316; GO:0070062; GO:0071243; GO:1901687,,,,PF14497;PF13417;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178]
Q15751,CHOYP_HERC1.2.2|m.51367,0,0,0,0,0,0,0,0,0,Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619),HERC1,4861,cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; transport [GO:0006810],GO:0004842; GO:0005086; GO:0005737; GO:0005794; GO:0005829; GO:0006810; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885,PATHWAY: Protein modification; protein ubiquitination.,,cd00078;,PF00632;PF00415;PF00622;PF00400;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; transport [GO:0006810]
Q24372,CHOYP_HMCN2.10.12|m.49343,1.5,0,0,0,0,0,0,0,8.00E-32,Lachesin,Lac CG12369,359,"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]",GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0061343,,,,PF07679;,"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]"
Q6IQ55,CHOYP_KC1A.1.2|m.14719,0.5,0,0,0,0,0,0,0,4.00E-45,Tau-tubulin kinase 2 (EC 2.7.11.1),TTBK2 KIAA0847,1244,ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224],GO:0004674; GO:0005524; GO:0005615; GO:0005634; GO:0005814; GO:0005829; GO:0007224; GO:0008360; GO:0018105; GO:0035869; GO:0036064; GO:0060271; GO:0097711,,,,PF00069;,centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224]
Q6V0I7,CHOYP_LOC100366518.4.6|m.40074,0,0,0,0,0,0,0,0,1.00E-34,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),FAT4 CDHF14 FATJ Nbla00548,4981,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],GO:0001658; GO:0003007; GO:0005509; GO:0005622; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072137; GO:0072307,,,,PF00028;PF07645;PF12661;PF02210;,apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
Q6P0I8,CHOYP_LOC100369488.1.1|m.10559,0.5,0,0,0,0,0,0,0,5.00E-81,Exosome complex component MTR3 (Exosome component 6) (mRNA transport regulator 3 homolog),exosc6 mtr3,271,"nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA 3'-end processing [GO:0031125]; rRNA catabolic process [GO:0016075]; U4 snRNA 3'-end processing [GO:0034475]",GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005730; GO:0016075; GO:0031125; GO:0034427; GO:0034475; GO:0071028; GO:0071051,,,,PF01138;,"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA 3'-end processing [GO:0031125]; rRNA catabolic process [GO:0016075]; U4 snRNA 3'-end processing [GO:0034475]"
Q9CQ90,CHOYP_LOC100650709.1.1|m.12958,0,0,0,0,0,0,0,0,6.00E-35,Uncharacterized protein C9orf85 homolog,,155,,,,,,PF10217;,
Q60738,CHOYP_LOC100677972.1.1|m.12181,0.5,0,0,0,0,0,0,0,4.00E-97,Zinc transporter 1 (ZnT-1) (Solute carrier family 30 member 1),Slc30a1 Znt1,503,cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc II ion transport [GO:0006829],GO:0001701; GO:0005385; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0006829; GO:0006874; GO:0006882; GO:0010043; GO:0016021; GO:0019855; GO:0030315; GO:0031965; GO:0046929; GO:0061088; GO:0070509; GO:0070574; GO:0071584; GO:0071585; GO:0090281,,,,PF01545;,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]; cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc II ion transport [GO:0006829]
P20273,CHOYP_LOC100880815.3.7|m.45911,0,0,0,0,0,0,0,0,3.00E-24,B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22),CD22 SIGLEC2,847,cell adhesion [GO:0007155],GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0070062,,,,PF08205;PF13895;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155]
Q6P2D8,CHOYP_LOC584905.1.1|m.51595,1.5,0,0,0,0,0,0,0,2.00E-56,X-ray radiation resistance-associated protein 1,XRRA1,792,response to X-ray [GO:0010165],GO:0005634; GO:0005654; GO:0005737; GO:0010165; GO:0016604,,,,,cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; response to X-ray [GO:0010165]
Q6V0I7,CHOYP_MEGF6.44.59|m.47511,0.5,0,0,0,0,0,0,0,0.00000002,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),FAT4 CDHF14 FATJ Nbla00548,4981,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],GO:0001658; GO:0003007; GO:0005509; GO:0005622; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072137; GO:0072307,,,,PF00028;PF07645;PF12661;PF02210;,apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
Q9D787,CHOYP_PPIL2.1.1|m.55184,0,0,0,0,0,0,0,0,0,Peptidyl-prolyl cis-trans isomerase-like 2 (PPIase) (EC 2.3.2.27) (EC 5.2.1.8) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (RING-type E3 ubiquitin transferase isomerase-like 2) (Rotamase PPIL2),Ppil2,521,protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209],GO:0000209; GO:0003755; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006457; GO:0034450; GO:0061630; GO:0072659,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q13356}.,,,PF00160;,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]
Q7SYJ9,CHOYP_SPAG7.1.1|m.66661,0,0,0,0,0,0,0,0,4.00E-68,Sperm-associated antigen 7 homolog,spag7,230,,GO:0003676,,,cd02636;,PF01424;,nucleic acid binding [GO:0003676]
Q9VN03,CHOYP_SUV3.1.1|m.14574,0,0,0,0,0,0,0,0,0,"ATP-dependent RNA helicase SUV3 homolog, mitochondrial (EC 3.6.4.13)",CG9791,763,DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; oxidative phosphorylation [GO:0006119]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; respiratory electron transport chain [GO:0022904]; RNA catabolic process [GO:0006401],GO:0000963; GO:0003677; GO:0003678; GO:0004004; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006119; GO:0006401; GO:0022904; GO:0032508; GO:0044528; GO:0045025; GO:0070131; GO:0090646; GO:0097222,,,,PF00271;PF12513;,mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; oxidative phosphorylation [GO:0006119]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; respiratory electron transport chain [GO:0022904]; RNA catabolic process [GO:0006401]
P58727,CHOYP_TLR6.1.2|m.24581,0,0,0,0,0,0,0,0,5.00E-30,Toll-like receptor 4 (CD antigen CD284),TLR4,833,defense response to Gram-negative bacterium [GO:0050829]; detection of lipopolysaccharide [GO:0032497]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224],GO:0001530; GO:0001875; GO:0002224; GO:0002755; GO:0004888; GO:0005887; GO:0006954; GO:0032497; GO:0034142; GO:0042116; GO:0045087; GO:0046696; GO:0050702; GO:0050707; GO:0050829; GO:1900227,,,,PF00560;PF13855;PF01582;,integral component of plasma membrane [GO:0005887]; lipopolysaccharide receptor complex [GO:0046696]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide receptor activity [GO:0001875]; transmembrane signaling receptor activity [GO:0004888]; defense response to Gram-negative bacterium [GO:0050829]; detection of lipopolysaccharide [GO:0032497]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]
Q9P3U8,CHOYP_TVAG_199400.1.1|m.52426,0.5,0,0,0,0,0,0,0,0.0000002,Uncharacterized RING finger protein C548.05c,SPCC548.05c,468,CENP-A containing nucleosome assembly [GO:0034080]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368],GO:0005634; GO:0006368; GO:0008270; GO:0016567; GO:0034080; GO:0035861; GO:0043161; GO:0044732; GO:0061630,,,,,mitotic spindle pole body [GO:0044732]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; CENP-A containing nucleosome assembly [GO:0034080]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368]
Q9VCA8,CHOYP_TVAG_313830.1.4|m.32667,0,0,0,0,0,0,0,0,2.00E-49,Ankyrin repeat and KH domain-containing protein mask (Multiple ankyrin repeat single KH domain-containing protein),mask CG33106,4001,antimicrobial humoral response [GO:0019730]; centrosome duplication [GO:0051298]; compound eye photoreceptor cell differentiation [GO:0001751]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitophagy [GO:1903147]; positive regulation of JAK-STAT cascade [GO:0046427]; sarcomere organization [GO:0045214]; sensory perception of pain [GO:0019233]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0001751; GO:0003723; GO:0005737; GO:0005811; GO:0005829; GO:0007005; GO:0007169; GO:0019233; GO:0019730; GO:0030018; GO:0031430; GO:0043066; GO:0045214; GO:0046427; GO:0051298; GO:1903147,,,,PF12796;PF00013;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid particle [GO:0005811]; M band [GO:0031430]; Z disc [GO:0030018]; RNA binding [GO:0003723]; antimicrobial humoral response [GO:0019730]; centrosome duplication [GO:0051298]; compound eye photoreceptor cell differentiation [GO:0001751]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitophagy [GO:1903147]; positive regulation of JAK-STAT cascade [GO:0046427]; sarcomere organization [GO:0045214]; sensory perception of pain [GO:0019233]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
P31843,CHOYP_contig_040048|m.45313,0.5,0,0,0,0,0,0,0,7.00E-21,RNA-directed DNA polymerase homolog (EC 2.7.7.48) (Reverse transcriptase homolog),,142,,GO:0003964; GO:0003968; GO:0005739,,,,PF00078;,mitochondrion [GO:0005739]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; RNA-directed DNA polymerase activity [GO:0003964]
B5X2S3,CHOYP_ACT6.1.2|m.20329,0,0,0,0,0,0,0,0,2.00E-11,Actin-related protein 8,actr8,632,"cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitotic nuclear division [GO:0007067]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005524; GO:0006281; GO:0006310; GO:0006338; GO:0006351; GO:0006355; GO:0007067; GO:0031011; GO:0051301,,,,PF00022;,"Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitotic nuclear division [GO:0007067]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q62283,CHOYP_BRAFLDRAFT_265104.1.1|m.4645,0,0,0,0,0,0,0,0,6.00E-63,Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (PE31) (TALLA homolog) (Transmembrane 4 superfamily member 2) (CD antigen CD231),Tspan7 Mxs1 Tm4sf2,249,cell surface receptor signaling pathway [GO:0007166],GO:0005887; GO:0007166,,,,PF00335;,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]
Q6P3R8,CHOYP_BRAFLDRAFT_63676.1.1|m.37146,0.5,0,0,0,0,0,0,0,1.00E-79,Serine/threonine-protein kinase Nek5 (EC 2.7.11.1) (Never in mitosis A-related kinase 5) (NimA-related protein kinase 5),NEK5,708,positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of striated muscle cell differentiation [GO:0051155],GO:0004674; GO:0005524; GO:0046872; GO:0051155; GO:2001056,,,,PF00069;,ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of striated muscle cell differentiation [GO:0051155]
Q0MQD8,CHOYP_DGRI_GH15309.1.1|m.15570,0,0,0,0,0,0,0,0,2.00E-15,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH) (CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit)",NDUFB5,189,oxidation-reduction process [GO:0055114],GO:0005654; GO:0005747; GO:0016021; GO:0055114,,,,PF09781;,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; nucleoplasm [GO:0005654]; oxidation-reduction process [GO:0055114]
Q8C0D5,CHOYP_EFTUD1.1.1|m.10474,0,0,0,0,0,0,0,0,0,Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A),Efl1 Eftud1,1127,mature ribosome assembly [GO:0042256],GO:0003746; GO:0003924; GO:0005525; GO:0042256; GO:0043022,,,,PF00679;PF14492;,GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mature ribosome assembly [GO:0042256]
Q5ZK62,CHOYP_ENO.1.2|m.7680,0.5,0,0,0,0,0,0,0,0,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)",ACAP2 CENTB2 RCJMB04_12p24,781,cellular response to nerve growth factor stimulus [GO:1990090]; protein localization to endosome [GO:0036010],GO:0005096; GO:0010008; GO:0036010; GO:0046872; GO:1990090,,,,PF12796;PF01412;PF00169;,endosome membrane [GO:0010008]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cellular response to nerve growth factor stimulus [GO:1990090]; protein localization to endosome [GO:0036010]
Q5R6J7,CHOYP_GPAT4.1.1|m.56178,0.5,0,0,0,0,0,0,0,2.00E-156,Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta),GPAT4 AGPAT6,456,acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432],GO:0002071; GO:0004366; GO:0005783; GO:0005789; GO:0006631; GO:0006637; GO:0006656; GO:0007595; GO:0008610; GO:0016021; GO:0016024; GO:0019432; GO:0040014; GO:0046339,PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-diacylglycerol from sn-glycerol 3-phosphate: step 1/3.,,,PF01553;,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]
P22063,CHOYP_HMCN1.39.44|m.61047,0,0,0,0,0,0,0,0,3.00E-31,Contactin-2 (Axonal glycoprotein TAG-1) (Axonin-1) (Transient axonal glycoprotein 1) (TAX-1),Cntn2 Tax1,1040,axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; presynaptic membrane organization [GO:0097090],GO:0005886; GO:0007160; GO:0007409; GO:0009986; GO:0031225; GO:0045202; GO:0097090,,,cd00063;,PF00041;PF07679;,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; plasma membrane [GO:0005886]; synapse [GO:0045202]; axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; presynaptic membrane organization [GO:0097090]
Q505D1,CHOYP_ISCW_ISCW019933.1.1|m.884,0,0,0,0,0,0,0,0,0.00000002,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK),Ankrd28,1053,,GO:0005654,,,,PF00023;PF12796;,nucleoplasm [GO:0005654]
O54890,CHOYP_ITB1.2.4|m.24270,0,0,0,0,0,0,0,0,1.00E-152,Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61),Itgb3,787,activation of protein kinase activity [GO:0032147]; angiogenesis involved in wound healing [GO:0060055]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; cell adhesion mediated by integrin [GO:0033627]; cell growth [GO:0016049]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell projection morphogenesis [GO:0048858]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045715]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of extracellular matrix organization [GO:1903053]; regulation of protein tyrosine kinase activity [GO:0061097]; smooth muscle cell migration [GO:0014909]; substrate adhesion-dependent cell spreading [GO:0034446]; viral entry into host cell [GO:0046718],GO:0001938; GO:0001954; GO:0001968; GO:0002020; GO:0003756; GO:0004872; GO:0005178; GO:0005634; GO:0005886; GO:0005925; GO:0007044; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009986; GO:0010595; GO:0010628; GO:0010745; GO:0010763; GO:0010888; GO:0014909; GO:0016049; GO:0016324; GO:0016477; GO:0019899; GO:0030168; GO:0030334; GO:0030335; GO:0031258; GO:0031527; GO:0031528; GO:0031589; GO:0032147; GO:0032369; GO:0032587; GO:0032956; GO:0033627; GO:0033690; GO:0034113; GO:0034446; GO:0034679; GO:0034683; GO:0035867; GO:0036120; GO:0038027; GO:0042470; GO:0042802; GO:0043184; GO:0043235; GO:0045672; GO:0045715; GO:0045780; GO:0046718; GO:0048008; GO:0048146; GO:0048858; GO:0050731; GO:0050748; GO:0050839; GO:0050840; GO:0050919; GO:0060055; GO:0061097; GO:0070062; GO:0070527; GO:0071133; GO:1900026; GO:1903053; GO:2000406,,,,PF07974;PF08725;PF07965;PF00362;PF17205;,alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integrin alpha9-beta1 complex [GO:0034679]; integrin alphav-beta3 complex [GO:0034683]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; melanosome [GO:0042470]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; cell adhesion molecule binding [GO:0050839]; enzyme binding [GO:0019899]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein disulfide isomerase activity [GO:0003756]; receptor activity [GO:0004872]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; activation of protein kinase activity [GO:0032147]; angiogenesis involved in wound healing [GO:0060055]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; cell adhesion mediated by integrin [GO:0033627]; cell growth [GO:0016049]; cell migration [GO:0016477]; cell projection morphogenesis [GO:0048858]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045715]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of extracellular matrix organization [GO:1903053]; regulation of protein tyrosine kinase activity [GO:0061097]; smooth muscle cell migration [GO:0014909]; substrate adhesion-dependent cell spreading [GO:0034446]; viral entry into host cell [GO:0046718]
Q10741,CHOYP_LOC100117425.1.1|m.1256,0.5,0,0,0,0,0,0,0,3.00E-177,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (Myelin-associated metalloproteinase) (CD antigen CD156c),ADAM10 MADM,748,constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; response to tumor necrosis factor [GO:0034612],GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005615; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005925; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0008284; GO:0009986; GO:0010820; GO:0014069; GO:0016021; GO:0016485; GO:0019901; GO:0030307; GO:0034612; GO:0042117; GO:0042803; GO:0046872; GO:0051088; GO:0051089; GO:0070062; GO:0097038; GO:0097197,,,cd04270;,PF00200;PF01562;,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; postsynaptic density [GO:0014069]; tetraspanin-enriched microdomain [GO:0097197]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; response to tumor necrosis factor [GO:0034612]
Q15070,CHOYP_LOC100117732.1.1|m.18587,0,0,0,0,0,0,0,0,4.00E-52,Mitochondrial inner membrane protein OXA1L (Hsa) (OXA1Hs) (Oxidase assembly 1-like protein) (OXA1-like protein),OXA1L,435,aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex I biogenesis [GO:0097031]; negative regulation of ATPase activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; oxidation-reduction process [GO:0055114]; protein complex assembly [GO:0006461]; protein insertion into membrane [GO:0051205]; protein tetramerization [GO:0051262],GO:0005739; GO:0005746; GO:0006461; GO:0009060; GO:0031966; GO:0032592; GO:0032780; GO:0032981; GO:0033615; GO:0042803; GO:0043234; GO:0051205; GO:0051262; GO:0051354; GO:0055114; GO:0097031; GO:0097177,,,,PF02096;,integral component of mitochondrial membrane [GO:0032592]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain [GO:0005746]; mitochondrion [GO:0005739]; protein complex [GO:0043234]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex I biogenesis [GO:0097031]; negative regulation of ATPase activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; oxidation-reduction process [GO:0055114]; protein complex assembly [GO:0006461]; protein insertion into membrane [GO:0051205]; protein tetramerization [GO:0051262]
Q5U4F6,CHOYP_LOC100373578.1.1|m.478,0.5,0,0,0,0,0,0,0,2.00E-118,WD repeat-containing protein 34,Wdr34,535,,GO:0005814; GO:0005829; GO:0005868; GO:0005930; GO:0036064,,,,PF00400;,axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]
Q9D882,CHOYP_LOC100374742.1.2|m.209,0.5,0,0,0,0,0,0,0,3.00E-10,Uncharacterized protein C10orf35 homolog,,120,,GO:0016021,,,,PF15378;,integral component of membrane [GO:0016021]
O75592,CHOYP_LOC100560904.1.1|m.37479,0,0,0,0,0,0,0,0,3.00E-70,E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.27) (Myc-binding protein 2) (Pam/highwire/rpm-1 protein) (Protein associated with Myc) (RING-type E3 ubiquitin transferase MYCBP2),MYCBP2 KIAA0916 PAM,4640,"protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0006351; GO:0006355; GO:0008270; GO:0016020; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,PF03256;PF00630;PF08005;PF00415;PF08239;PF13639;,"membrane [GO:0016020]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
P27401,CHOYP_LOC100679608.3.3|m.55829,0,0,0,0,0,0,0,0,9.00E-14,Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)],pol,1143,DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732],GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0019012; GO:0030430; GO:0042025; GO:0046718; GO:0046872; GO:0075713; GO:0075732,,,,PF00075;PF00665;PF00078;PF03539;,host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732]
Q8R087,CHOYP_LOC100693702.1.1|m.8794,0,0,0,0,0,0,0,0,9.00E-103,"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) [Includes: Xylosylprotein 4-beta-galactosyltransferase (EC 2.4.1.133) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein beta-1,4-galactosyltransferase)]",B4galt7 Xgalt1,327,carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435],GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0032580; GO:0046525; GO:0048147; GO:0097435,PATHWAY: Protein modification; protein glycosylation.,,,PF02709;PF13733;,"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]"
Q5ZQU0,CHOYP_LOC580675.1.1|m.44042,0,0,0,0,0,0,0,0,3.00E-17,"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1)",Sned1,1403,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005576; GO:0007160,,,cd00033;cd00063;,PF00008;PF00041;PF12661;PF06119;,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
Q00725,CHOYP_LOC689840.1.1|m.6512,2.5,0,0,0,0,0,0,0,0.00000002,Salivary glue protein Sgs-4,Sgs4 Sgs-4 CG12181,297,,GO:0005576,,,,,extracellular region [GO:0005576]
O75095,CHOYP_MEGF6.48.59|m.51016,0.5,0,0,0,0,0,0,0,1.00E-103,Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3),MEGF6 EGFL3 KIAA0815,1541,,GO:0005509; GO:0005576,,,,PF07645;PF12661;PF00053;,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
Q2KIR0,CHOYP_NEMVEDRAFT_V1G208725.1.1|m.36498,1,0,0,0,0,0,0,0,8.00E-12,Uncharacterized protein C4orf45 homolog,,197,,,,,,PF15123;,
Q14684,CHOYP_RRP1B.1.1|m.21811,0,0,0,0,0,0,0,0,1.00E-63,Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B),RRP1B KIAA0179,758,negative regulation of phosphatase activity [GO:0010923]; rRNA processing [GO:0006364],GO:0000791; GO:0000792; GO:0003723; GO:0005634; GO:0005730; GO:0005829; GO:0006364; GO:0010923; GO:0030687; GO:0030688,,,,PF05997;,"cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; negative regulation of phosphatase activity [GO:0010923]; rRNA processing [GO:0006364]"
Q14151,CHOYP_SAFB2.3.3|m.33384,2,0,0,0,0,0,0,0,8.00E-22,Scaffold attachment factor B2 (SAF-B2),SAFB2 KIAA0138,953,"regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; Sertoli cell differentiation [GO:0060008]; transcription, DNA-templated [GO:0006351]",GO:0000166; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006357; GO:0016604; GO:0042802; GO:0043231; GO:0043565; GO:0050684; GO:0060008; GO:0060765; GO:0070062,,,,PF00076;PF02037;,"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; Sertoli cell differentiation [GO:0060008]; transcription, DNA-templated [GO:0006351]"
P44963,CHOYP_SC5A9.3.5|m.27017,0,0,0,0,0,0,0,0,6.00E-11,Sodium/pantothenate symporter (Pantothenate permease),panF HI_0975,484,sodium ion export [GO:0071436],GO:0005886; GO:0015081; GO:0015233; GO:0015293; GO:0016021; GO:0031402; GO:0071436,,,cd10327;,PF00474;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pantothenate transmembrane transporter activity [GO:0015233]; sodium ion binding [GO:0031402]; sodium ion transmembrane transporter activity [GO:0015081]; symporter activity [GO:0015293]; sodium ion export [GO:0071436]
Q95ZJ1,CHOYP_SMP_005500.1.1|m.34627,0,0,0,0,0,0,0,0,0,Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5),gly-5 Y39E4B.12,626,protein O-linked glycosylation via threonine [GO:0018243],GO:0000139; GO:0004653; GO:0016021; GO:0018243; GO:0030246; GO:0046872,PATHWAY: Protein modification; protein glycosylation.,,,PF00535;PF00652;,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]
Q8TCJ2,CHOYP_STT3B.1.1|m.58945,0,0,0,0,0,0,0,0,0,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog),STT3B SIMP,826,co-translational protein modification [GO:0043686]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986],GO:0004579; GO:0005783; GO:0006516; GO:0006986; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0030433; GO:0043686; GO:0043687,PATHWAY: Protein modification; protein glycosylation.,,,PF02516;,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; co-translational protein modification [GO:0043686]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]
Q18206,CHOYP_TSP_10831.1.1|m.47028,3.5,0,0,0,0,0,0,0,2.00E-26,Zinc metalloproteinase nas-36 (EC 3.4.24.21) (Nematode astacin 36),nas-36 C26C6.3,617,"molting cycle, collagen and cuticulin-based cuticle [GO:0018996]; multicellular organism development [GO:0007275]",GO:0004222; GO:0005576; GO:0007275; GO:0008270; GO:0018996,,,cd00041;cd04280;,PF01400;PF00431;PF00090;,"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]; multicellular organism development [GO:0007275]"
P45962,CHOYP_BRAFLDRAFT_118210.1.1|m.51280,0,0,0,0,0,0,0,0,6.00E-90,Kinesin-like protein klp-3,klp-3 T09A5.2,598,microtubule-based movement [GO:0007018],GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0016887,,,,PF00225;,cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
Q5ZM73,CHOYP_BRAFLDRAFT_93126.2.3|m.15451,0,0,0,0,0,0,0,0,0,Mitochondrial Rho GTPase 1 (MIRO-1) (EC 3.6.5.-) (Ras homolog gene family member T1),RHOT1 RCJMB04_2p2,619,cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion transport along microtubule [GO:0047497]; small GTPase mediated signal transduction [GO:0007264],GO:0003924; GO:0005509; GO:0005525; GO:0007264; GO:0019725; GO:0031307; GO:0047497; GO:0097345,,,,PF08355;PF08356;PF00071;,integral component of mitochondrial outer membrane [GO:0031307]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion transport along microtubule [GO:0047497]; small GTPase mediated signal transduction [GO:0007264]
Q717B4,CHOYP_CAOG_01182.1.1|m.8019,1,0,0,0,0,0,0,0,7.00E-18,TD and POZ domain-containing protein 3,Tdpoz3,365,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of proteolysis [GO:0030162],GO:0005634; GO:0005737; GO:0019005; GO:0030162; GO:0031625; GO:0042787; GO:0043161,,,cd14734;,PF00651;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of proteolysis [GO:0030162]
Q70E20,CHOYP_DLLC.2.2|m.27073,0,0,0,0,0,0,0,0,4.00E-28,"Sushi, nidogen and EGF-like domain-containing protein 1 (Secreted protein SST-3) (Stromal nidogen extracellular matrix protein)",Sned1 Snep,1403,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0007160; GO:0070062,,,cd00033;cd00063;,PF00008;PF00041;PF12661;PF06119;,extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
P54099,CHOYP_DPOG1.1.1|m.35597,0,0,0,0,0,0,0,0,0,DNA polymerase subunit gamma-1 (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha),Polg Polg1,1218,aging [GO:0007568]; mitochondrial DNA replication [GO:0006264],GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0004527; GO:0005739; GO:0005743; GO:0005760; GO:0006264; GO:0007568; GO:0008408; GO:0042645; GO:0043234; GO:0070062,,,,PF00476;,extracellular exosome [GO:0070062]; gamma DNA polymerase complex [GO:0005760]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein complex [GO:0043234]; 3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exonuclease activity [GO:0004527]; protease binding [GO:0002020]; aging [GO:0007568]; mitochondrial DNA replication [GO:0006264]
Q868Z9,CHOYP_DSEC_GM16292.1.1|m.12184,15.5,0,0,0,0,0,0,0,2.00E-96,Papilin,Ppn CG33103,2898,extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],GO:0004222; GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008270; GO:0030198,,,,PF05986;PF07679;PF00014;PF08686;PF00090;,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]
Q05695,CHOYP_ISCW_ISCW020054.1.1|m.58472,0,0,0,0,0,0,0,0,2.00E-25,Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (Nerve-growth factor-inducible large external glycoprotein) (NILE) (CD antigen CD171),L1cam Caml1,1259,axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066],GO:0005768; GO:0005886; GO:0007155; GO:0007413; GO:0009986; GO:0010811; GO:0014823; GO:0016021; GO:0030165; GO:0030182; GO:0030424; GO:0030425; GO:0043025; GO:0044294; GO:0044295; GO:0045121; GO:0045773; GO:0070372; GO:0071361; GO:0071542; GO:0071549; GO:0071560; GO:0097066; GO:0097069; GO:1990090,,,cd00063;,PF13882;PF00041;PF07679;,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]
Q17RP2,CHOYP_LOC100162439.1.1|m.19182,0.5,0,0,0,0,0,0,0,3.00E-66,Tigger transposable element-derived protein 6,TIGD6,521,,GO:0003677; GO:0005634,,,,PF04218;PF03184;PF03221;,nucleus [GO:0005634]; DNA binding [GO:0003677]
Q8WZ42,CHOYP_LOC100536583.1.1|m.58016,0,0,0,0,0,0,0,0,1.00E-38,Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14),TTN,34350,cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941],GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493,,,cd00063;,PF00041;PF07679;PF00069;PF02818;PF09042;,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]
Q9QXW9,CHOYP_LOC100904518.1.1|m.53104,0,0,0,0,0,0,0,0,4.00E-172,Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8),Slc7a8 Lat2,531,amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; neutral amino acid transport [GO:0015804],GO:0005275; GO:0005737; GO:0005886; GO:0005887; GO:0006865; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015297; GO:0015804; GO:0015807; GO:0016323; GO:0019534; GO:0070062,,,,PF13520;,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amine transmembrane transporter activity [GO:0005275]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; toxin transporter activity [GO:0019534]; amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; neutral amino acid transport [GO:0015804]
A4IHD9,CHOYP_MED25.2.2|m.42845,0.5,0,0,0,0,0,0,0,1.00E-64,Mediator of RNA polymerase II transcription subunit 25 (Mediator complex subunit 25),med25,805,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0006351; GO:0006355,,,,PF11232;PF11244;PF11235;PF11265;,"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q6IE52,CHOYP_MUG2.1.1|m.55656,0,0,0,0,0,0,0,0,4.00E-113,Murinoglobulin-2,Mug2,1448,,GO:0004867; GO:0005615,,,,PF00207;PF07678;PF01835;PF07703;PF07677;PF10569;,extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]
Q80VI1,CHOYP_NEMVEDRAFT_V1G193373.1.2|m.19292,0,0,0,0,0,0,0,0,2.00E-15,E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56),Trim56,734,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],GO:0003723; GO:0004842; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0045087; GO:0046597; GO:0051607; GO:0061630; GO:0070534; GO:1902187,,,,PF00643;PF13445;,cytoplasm [GO:0005737]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]
Q8CI17,CHOYP_NEMVEDRAFT_V1G206032.1.1|m.58857,0,0,0,0,0,0,0,0,0.000000009,Protein mab-21-like 3,Mab21L3,429,,,,,,PF03281;,
P22105,CHOYP_PAT3.4.4|m.54228,0,0,0,0,0,0,0,0,1.00E-18,Tenascin-X (TN-X) (Hexabrachion-like protein),TNXB HXBL TNX TNXB1 TNXB2 XB,4242,actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],GO:0005178; GO:0005578; GO:0005615; GO:0005622; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0032963; GO:0048251; GO:0070062,,,cd00063;cd00087;,PF07974;PF00147;PF00041;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
Q868Z9,CHOYP_PHUM_PHUM547410.1.1|m.10964,5.5,0,0,0,0,0,0,0,7.00E-54,Papilin,Ppn CG33103,2898,extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],GO:0004222; GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008270; GO:0030198,,,,PF05986;PF07679;PF00014;PF08686;PF00090;,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]
Q01196,CHOYP_RUNX1.1.1|m.49526,0,0,0,0,0,0,0,0,5.00E-60,Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit),RUNX1 AML1 CBFA2,453,"chondrocyte differentiation [GO:0002062]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; negative regulation of granulocyte differentiation [GO:0030853]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]",GO:0000975; GO:0000977; GO:0001047; GO:0001228; GO:0001503; GO:0002062; GO:0003677; GO:0003700; GO:0005509; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0008134; GO:0030097; GO:0030099; GO:0030853; GO:0030854; GO:0032743; GO:0042803; GO:0043231; GO:0045766; GO:0045893; GO:0045944; GO:0046982; GO:0048935; GO:0071425,,,,PF00853;PF08504;,"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; regulatory region DNA binding [GO:0000975]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription factor binding [GO:0008134]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding [GO:0001228]; chondrocyte differentiation [GO:0002062]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; negative regulation of granulocyte differentiation [GO:0030853]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"
Q08628,CHOYP_TBA1A.2.4|m.19573,0,0,0,0,0,0,0,0,6.00E-16,Tubulin alpha chain (Fragment),,50,microtubule-based process [GO:0007017],GO:0005525; GO:0005737; GO:0005874; GO:0007017,,,,,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; microtubule-based process [GO:0007017]
Q96GQ7,CHOYP_VP13D.2.3|m.58593,0,0,0,0,0,0,0,0,0,Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27),DDX27 cPERP-F RHLP HSPC259 PP3241,796,RNA secondary structure unwinding [GO:0010501]; rRNA processing [GO:0006364],GO:0003723; GO:0004004; GO:0005524; GO:0005694; GO:0005730; GO:0006364; GO:0010501,,,,PF00270;PF00271;,chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; RNA secondary structure unwinding [GO:0010501]; rRNA processing [GO:0006364]
Q5ZIM6,CHOYP_AATF.1.1|m.34004,0,0,0,0,0,0,0,0,2.00E-113,Protein AATF (Apoptosis-antagonizing transcription factor),AATF RCJMB04_24o4,574,cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; ribosome biogenesis [GO:0042254],GO:0003723; GO:0005730; GO:0005737; GO:0006357; GO:0006974; GO:0007155; GO:0007346; GO:0032929; GO:0040016; GO:0042254; GO:0042985; GO:0043066; GO:0045944,,,,PF13339;PF08164;,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; ribosome biogenesis [GO:0042254]
Q7Z0T3,CHOYP_ACDOPBH.8.9|m.52946,0,0,0,0,0,0,0,0,6.00E-30,Temptin,,125,,GO:0005576,,,,,extracellular region [GO:0005576]
Q9JJL8,CHOYP_AGAP_AGAP000991.1.1|m.5123,0,0,0,0,0,0,0,0,2.00E-103,"Serine--tRNA ligase, mitochondrial (EC 6.1.1.11) (SerRSmt) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)",Sars2 Sarsm,518,selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434],GO:0003723; GO:0004828; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006434; GO:0097056,PATHWAY: Aminoacyl-tRNA biosynthesis; selenocysteinyl-tRNA(Sec) biosynthesis; L-seryl-tRNA(Sec) from L-serine and tRNA(Sec): step 1/1.,,cd00770;,PF02403;PF00587;,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]
P82251,CHOYP_BAT1.1.4|m.3906,0,0,0,0,0,0,0,0,7.00E-175,"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,487,amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein complex assembly [GO:0006461],GO:0005886; GO:0005887; GO:0006461; GO:0006865; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0050900,,,,PF13520;,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein complex assembly [GO:0006461]
Q6PGL7,CHOYP_BRAFLDRAFT_118099.1.6|m.1356,0,0,0,0,0,0,0,0,1.00E-90,WASH complex subunit 2,Washc2 D6Wsu116e Fam21 Kiaa0592,1334,"protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]",GO:0005546; GO:0005547; GO:0005730; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0010314; GO:0015031; GO:0031901; GO:0032266; GO:0042147; GO:0043231; GO:0043325; GO:0070273; GO:0071203; GO:0080025; GO:1905394,,,,PF15255;,"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"
Q4QR86,CHOYP_BRAFLDRAFT_214790.1.1|m.15955,0,0,0,0,0,0,0,0,6.00E-57,DEP domain-containing protein 7,Depdc7,511,intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165],GO:0005622; GO:0007165; GO:0035556,,,,PF00610;,intracellular [GO:0005622]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165]
Q6X862,CHOYP_CAD1.2.2|m.61448,0.5,0,0,0,0,0,0,0,3.00E-116,Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome),PCDH11X PCDH11 PCDHX,1347,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],GO:0005509; GO:0005886; GO:0007156; GO:0010923; GO:0016021,,,,PF00028;PF08266;PF08374;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923]
Q9CQV4,CHOYP_F134C.1.1|m.51074,0,0,0,0,0,0,0,0,7.00E-51,Protein FAM134C,Fam134c,466,positive regulation of neuron projection development [GO:0010976],GO:0010976; GO:0016021,,,,,integral component of membrane [GO:0016021]; positive regulation of neuron projection development [GO:0010976]
O13412,CHOYP_GATA1.1.2|m.16576,0,0,0,0,0,0,0,0,4.00E-15,Nitrogen regulatory protein areA,areA,882,"nitrate assimilation [GO:0042128]; transcription, DNA-templated [GO:0006351]",GO:0003700; GO:0005634; GO:0006351; GO:0008270; GO:0042128; GO:0043565,,,,PF07573;PF08550;PF00320;,"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]; nitrate assimilation [GO:0042128]; transcription, DNA-templated [GO:0006351]"
Q8N801,CHOYP_ITIH3.1.3|m.21736,1.5,0,0,0,0,0,0,0,3.00E-38,Uncharacterized protein C2orf61,C2orf61,248,C-5 methylation of cytosine [GO:0090116],GO:0001939; GO:0001940; GO:0005737; GO:0042585; GO:0090116,,,,PF07004;,cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; germinal vesicle [GO:0042585]; male pronucleus [GO:0001940]; C-5 methylation of cytosine [GO:0090116]
P15253,CHOYP_LOC100083524.1.1|m.50023,0,0,0,0,0,0,0,0,0,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP),CALR,418,protein folding [GO:0006457]; protein stabilization [GO:0050821],GO:0005509; GO:0006457; GO:0030246; GO:0033018; GO:0050821,,,,PF00262;,sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; protein folding [GO:0006457]; protein stabilization [GO:0050821]
Q66IH2,CHOYP_LOC100708602.1.1|m.65805,0.5,0,0,0,0,0,0,0,1.00E-67,Transforming growth factor beta regulator 1,tbrg1 TEgg020g14.1,409,cell cycle [GO:0007049],GO:0005634; GO:0007049,,,,PF05965;PF05964;,nucleus [GO:0005634]; cell cycle [GO:0007049]
Q9VMY1,CHOYP_LOC100879807.1.1|m.14598,0,0,0,0,0,0,0,0,3.00E-34,"Probable 39S ribosomal protein L24, mitochondrial (L24mt) (MRP-L24)",mRpL24 CG8849,247,mitochondrial translation [GO:0032543]; sensory perception of pain [GO:0019233]; translation [GO:0006412],GO:0003735; GO:0005762; GO:0006412; GO:0019233; GO:0032543,,,,PF00467;PF17136;,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; sensory perception of pain [GO:0019233]; translation [GO:0006412]
A9CPT4,CHOYP_LOC100892150.1.1|m.10319,0,0,0,0,0,0,0,0,1.00E-15,Tudor domain-containing protein 1,tdrd1,1133,DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],GO:0007275; GO:0007281; GO:0007283; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546,,,,PF00567;PF01753;,P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]
O54926,CHOYP_LOC100892743.1.1|m.55850,0.5,0,0,0,0,0,0,0,3.00E-21,Apoptosis regulatory protein Siva (CD27-binding protein) (CD27BP),Siva1 Siva,175,activation-induced cell death of T cells [GO:0006924]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030],GO:0001618; GO:0005164; GO:0005175; GO:0005654; GO:0005737; GO:0005739; GO:0006924; GO:0008270; GO:0032088; GO:0097191; GO:1901030,,,,PF05458;,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; CD27 receptor binding [GO:0005175]; tumor necrosis factor receptor binding [GO:0005164]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; activation-induced cell death of T cells [GO:0006924]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]
P59222,CHOYP_LOC101077597.2.3|m.25843,0,0,0,0,0,0,0,0,0.00000005,Scavenger receptor class F member 2 (Scavenger receptor expressed by endothelial cells 2 protein) (SREC-II),Scarf2 Srec2,833,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157],GO:0005044; GO:0005925; GO:0007157; GO:0016021,,,,PF00053;,focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]
F4JS25,CHOYP_LOC587791.2.3|m.33887,0.5,0,0,0,0,0,0,0,3.00E-10,"Suppressor of RPS4-RLD 1 (Protein SUPPRESSOR OF npr1-1, CONSTITUTIVE 5) (AtSNC5)",SRFR1 SNC5 At4g37460 F6G17.110,1052,"defense response to bacterium [GO:0042742]; defense response to bacterium, incompatible interaction [GO:0009816]; negative regulation of defense response [GO:0031348]; negative regulation of transcription, DNA-templated [GO:0045892]",GO:0005634; GO:0005737; GO:0005783; GO:0009816; GO:0016021; GO:0031348; GO:0032947; GO:0042742; GO:0043231; GO:0045892; GO:0048471,,,,PF13181;,"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex scaffold [GO:0032947]; defense response to bacterium [GO:0042742]; defense response to bacterium, incompatible interaction [GO:0009816]; negative regulation of defense response [GO:0031348]; negative regulation of transcription, DNA-templated [GO:0045892]"
Q14919,CHOYP_NC2A.1.1|m.22786,0.5,0,0,0,0,0,0,0,4.00E-47,Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha) (NC2-alpha),DRAP1,205,"negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; transcription, DNA-templated [GO:0006351]",GO:0000122; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0006351; GO:0042802,,,,PF00808;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; transcription, DNA-templated [GO:0006351]"
Q9DCL2,CHOYP_NEMVEDRAFT_V1G246622.1.1|m.24513,0,0,0,0,0,0,0,0,5.00E-49,MIP18 family protein FAM96A,Fam96a,160,chromosome segregation [GO:0007059],GO:0005634; GO:0005654; GO:0005829; GO:0007059; GO:0046872,,,,PF01883;,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; chromosome segregation [GO:0007059]
P15253,CHOYP_NEMVEDRAFT_V1G61368.1.1|m.42775,0,0,0,0,0,0,0,0,2.00E-49,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP),CALR,418,protein folding [GO:0006457]; protein stabilization [GO:0050821],GO:0005509; GO:0006457; GO:0030246; GO:0033018; GO:0050821,,,,PF00262;,sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; protein folding [GO:0006457]; protein stabilization [GO:0050821]
Q9Y236,CHOYP_OSGI2.1.1|m.11055,0,0,0,0,0,0,0,0,9.00E-134,Oxidative stress-induced growth inhibitor 2 (hT41),OSGIN2 C8orf1,505,meiotic cell cycle [GO:0051321]; negative regulation of cell growth [GO:0030308],GO:0008083; GO:0016491; GO:0030308; GO:0051321,,,,,growth factor activity [GO:0008083]; oxidoreductase activity [GO:0016491]; meiotic cell cycle [GO:0051321]; negative regulation of cell growth [GO:0030308]
O60344,CHOYP_PHUM_PHUM135440.1.1|m.40573,0,0,0,0,0,0,0,0,0,Endothelin-converting enzyme 2 (ECE-2) [Includes: Methyltransferase-like region (EC 2.1.1.-); Endothelin-converting enzyme 2 region (EC 3.4.24.71)],ECE2 KIAA0604 UNQ403/PRO740,883,brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; cell-cell signaling [GO:0007267]; heart development [GO:0007507]; peptide hormone processing [GO:0016486],GO:0000139; GO:0004222; GO:0007267; GO:0007420; GO:0007507; GO:0008168; GO:0010002; GO:0016021; GO:0016486; GO:0030658; GO:0030659; GO:0046872,,,cd08662;,PF01431;PF05649;,cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; methyltransferase activity [GO:0008168]; brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; cell-cell signaling [GO:0007267]; heart development [GO:0007507]; peptide hormone processing [GO:0016486]
B2CAZ2,CHOYP_RS3A.2.15|m.2682,0,0,0,0,0,0,0,0,6.00E-87,40S ribosomal protein S3a (Ts6 protein),,257,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412,,,,PF01015;,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
Q8TKI9,CHOYP_RS3A.7.15|m.20182,0,0,0,0,0,0,0,0,3.00E-19,30S ribosomal protein S3Ae (Ribosomal protein S1e),rps3ae MA_3416,203,translation [GO:0006412],GO:0003735; GO:0005829; GO:0005840; GO:0006412,,,,PF01015;,cytosol [GO:0005829]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
Q29RU1,CHOYP_AGAP_AGAP013102.1.1|m.50186,0,0,0,0,0,0,0,0,9.00E-40,"28S ribosomal protein S12, mitochondrial (MRP-S12) (S12mt)",MRPS12,139,mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124],GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0032543; GO:0070124; GO:0070125,,,cd03368;,PF00164;,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124]
Q96SB8,CHOYP_BRAFLDRAFT_131216.1.1|m.8822,0,0,0,0,0,0,0,0,0,Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (hSMC6),SMC6 SMC6L1,1091,cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; telomere maintenance via recombination [GO:0000722],GO:0000722; GO:0000724; GO:0000781; GO:0000803; GO:0005524; GO:0005622; GO:0005634; GO:0005654; GO:0006974; GO:0016605; GO:0016607; GO:0030915; GO:0031625; GO:0035061; GO:0035861; GO:0051984; GO:0090398,,,,PF02463;,"chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; intracellular [GO:0005622]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; telomere maintenance via recombination [GO:0000722]"
Q9I931,CHOYP_BRAFLDRAFT_189049.2.2|m.59154,0,0,0,0,0,0,0,0,3.00E-14,Fucolectin-1,,178,"regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]",GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088,,,,PF00754;,"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
Q0UI56,CHOYP_BRAFLDRAFT_215208.1.1|m.40012,0,0,0,0,0,0,0,0,7.00E-88,Cytosolic Fe-S cluster assembly factor NBP35 (Nucleotide-binding protein 35),NBP35 SNOG_08558,340,iron-sulfur cluster assembly [GO:0016226],GO:0005524; GO:0005737; GO:0016226; GO:0046872; GO:0051539,,,cd02037;,PF10609;,"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"
Q9VIU7,CHOYP_BRAFLDRAFT_276832.1.2|m.7666,0,0,0,0,0,0,0,0,0.00000003,Probable dolichol-phosphate mannosyltransferase (DPM synthase) (Dolichol-phosphate mannose synthase) (EC 2.4.1.83) (Dolichyl-phosphate beta-D-mannosyltransferase) (Mannose-P-dolichol synthase) (MPD synthase),CG10166,241,protein glycosylation [GO:0006486],GO:0004582; GO:0005783; GO:0006486,PATHWAY: Protein modification; protein glycosylation.,,,PF00535;,endoplasmic reticulum [GO:0005783]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; protein glycosylation [GO:0006486]
Q05932,CHOYP_BRAFLDRAFT_284412.1.1|m.37396,1,0,0,0,0,0,0,0,3.00E-158,"Folylpolyglutamate synthase, mitochondrial (EC 6.3.2.17) (Folylpoly-gamma-glutamate synthetase) (FPGS) (Tetrahydrofolylpolyglutamate synthase) (Tetrahydrofolate synthase)",FPGS,587,animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell proliferation [GO:0008283]; folic acid-containing compound metabolic process [GO:0006760]; folic acid metabolic process [GO:0046655]; glutamate metabolic process [GO:0006536]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901],GO:0001889; GO:0004326; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006139; GO:0006536; GO:0006730; GO:0006760; GO:0007420; GO:0008283; GO:0031100; GO:0046655; GO:0046872; GO:0046901,PATHWAY: Cofactor biosynthesis; tetrahydrofolylpolyglutamate biosynthesis.,,,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell proliferation [GO:0008283]; folic acid metabolic process [GO:0046655]; folic acid-containing compound metabolic process [GO:0006760]; glutamate metabolic process [GO:0006536]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901]
Q9VCU9,CHOYP_DICER.1.3|m.9936,0,0,0,0,0,0,0,0,2.00E-160,Endoribonuclease Dcr-1 (Protein dicer-1) (EC 3.1.26.-),Dcr-1 CG4792,2249,"dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line stem cell division [GO:0042078]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]",GO:0003725; GO:0003727; GO:0004386; GO:0004525; GO:0005524; GO:0005737; GO:0007279; GO:0007294; GO:0007367; GO:0016246; GO:0016442; GO:0016443; GO:0030422; GO:0030727; GO:0031054; GO:0033227; GO:0035087; GO:0035196; GO:0042078; GO:0042594; GO:0045448; GO:0046872; GO:0048813; GO:0070883,,,cd00593;,PF03368;PF00271;PF02170;PF00636;,"cytoplasm [GO:0005737]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; single-stranded RNA binding [GO:0003727]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germ-line stem cell division [GO:0042078]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]"
Q86YH6,CHOYP_DLP1.1.1|m.40279,0,0,0,0,0,0,0,0,9.00E-103,Decaprenyl-diphosphate synthase subunit 2 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 2) (Candidate tumor suppressor protein) (Decaprenyl pyrophosphate synthase subunit 2),PDSS2 C6orf210 DLP1,399,isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744],GO:0000010; GO:0005759; GO:0005829; GO:0006744; GO:0008299; GO:0046982; GO:0050347; GO:0050878; GO:0051290; GO:1990234,PATHWAY: Cofactor biosynthesis; ubiquinone biosynthesis.,,,PF00348;,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744]
P51892,CHOYP_DNLI1.1.2|m.19123,0.5,0,0,0,0,0,0,0,0,DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1),lig1,1070,cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260],GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0006260; GO:0006310; GO:0007049; GO:0046872; GO:0051103; GO:0051301; GO:0071897,,,,PF04679;PF01068;PF04675;,nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]
Q9JK41,CHOYP_DPSE_GA20368.1.1|m.6272,0,0,0,0,0,0,0,0,4.00E-13,High affinity copper uptake protein 1 (Copper transporter 1) (rCTR1) (Liver regeneration-related protein LRRGT00200) (Solute carrier family 31 member 1),Slc31a1 Copt1 Ctr1,187,cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import [GO:0015677]; copper ion import into cell [GO:1902861]; drug transmembrane transport [GO:0006855],GO:0005375; GO:0005737; GO:0005770; GO:0005886; GO:0006855; GO:0006878; GO:0015088; GO:0015677; GO:0016021; GO:0043025; GO:0055037; GO:0072719; GO:1902861,,,,PF04145;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; copper ion transmembrane transporter activity [GO:0005375]; copper uptake transmembrane transporter activity [GO:0015088]; cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import [GO:0015677]; copper ion import into cell [GO:1902861]; drug transmembrane transport [GO:0006855]
Q9H9B1,CHOYP_EHMT2.1.1|m.263,0,0,0,0,0,0,0,0,0,Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D),EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D,1298,"chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; embryo development [GO:0009790]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to fungicide [GO:0060992]",GO:0000122; GO:0002039; GO:0005634; GO:0005654; GO:0005694; GO:0006306; GO:0006325; GO:0008168; GO:0008270; GO:0009790; GO:0016279; GO:0016571; GO:0016604; GO:0018024; GO:0018026; GO:0018027; GO:0045892; GO:0046974; GO:0046976; GO:0060992; GO:1901796,,,,PF12796;PF05033;PF00856;,"chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; embryo development [GO:0009790]; histone methylation [GO:0016571]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to fungicide [GO:0060992]"
Q1RMT1,CHOYP_ERCC3.1.1|m.34841,0,0,0,0,0,0,0,0,0,TFIIH basal transcription factor complex helicase XPB subunit (EC 3.6.4.12) (DNA excision repair protein ERCC-3),ERCC3,782,"apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription from RNA polymerase II promoter [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; UV protection [GO:0009650]",GO:0000717; GO:0003677; GO:0004003; GO:0005524; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0008353; GO:0009411; GO:0009650; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0045944; GO:0047485; GO:1901990,,,,PF16203;PF13625;PF04851;,"holo TFIIH complex [GO:0005675]; transcription factor TFIID complex [GO:0005669]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II carboxy-terminal domain kinase activity [GO:0008353]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription from RNA polymerase II promoter [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"
Q9I931,CHOYP_FUCL1.1.1|m.28893,11.5,0,0,0,0,0,0,0,1.00E-14,Fucolectin-1,,178,"regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]",GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088,,,,PF00754;,"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
Q640B4,CHOYP_LOC100180920.1.1|m.17133,0,0,0,0,0,0,0,0,1.00E-89,Crossover junction endonuclease MUS81 (EC 3.1.22.-),mus81,612,double-strand break repair via break-induced replication [GO:0000727]; intra-S DNA damage checkpoint [GO:0031573]; mitotic G2 DNA damage checkpoint [GO:0007095]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712],GO:0000712; GO:0000727; GO:0003677; GO:0005634; GO:0007095; GO:0031297; GO:0031573; GO:0046872; GO:0048257; GO:0048476,,,,PF02732;,Holliday junction resolvase complex [GO:0048476]; nucleus [GO:0005634]; 3'-flap endonuclease activity [GO:0048257]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; double-strand break repair via break-induced replication [GO:0000727]; intra-S DNA damage checkpoint [GO:0031573]; mitotic G2 DNA damage checkpoint [GO:0007095]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]
Q8N2E2,CHOYP_LOC100199379.1.2|m.59875,0.5,0,0,0,0,0,0,0,3.00E-27,von Willebrand factor D and EGF domain-containing protein,VWDE,1590,,GO:0005576,,,,PF00094;,extracellular region [GO:0005576]
P61315,CHOYP_LOC100206557.1.1|m.11857,0.5,0,0,0,0,0,0,0,7.00E-37,"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)",Gal3st3,431,glycolipid biosynthetic process [GO:0009247],GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694,PATHWAY: Protein modification; carbohydrate sulfation.,,,PF06990;,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
Q9I931,CHOYP_LOC100373240.1.1|m.28382,7,0,0,0,0,0,0,0,7.00E-14,Fucolectin-1,,178,"regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]",GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088,,,,PF00754;,"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
Q923L3,CHOYP_LOC100906063.1.3|m.20630,0,0,0,0,0,0,0,0,7.00E-13,CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1),Csmd1,3564,glucose homeostasis [GO:0042593]; startle response [GO:0001964],GO:0001964; GO:0016021; GO:0042593,,,cd00033;cd00041;,PF00431;PF00084;,integral component of membrane [GO:0016021]; glucose homeostasis [GO:0042593]; startle response [GO:0001964]
Q9NR21,CHOYP_LOC101161108.1.1|m.52561,0,0,0,0,0,0,0,0,7.00E-20,Poly [ADP-ribose] polymerase 11 (PARP-11) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 11) (ARTD11),PARP11 C12orf6,331,cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein transport [GO:0015031]; spermatogenesis [GO:0007283],GO:0003950; GO:0005635; GO:0005643; GO:0006998; GO:0007283; GO:0015031; GO:0030154; GO:0051028,,,,PF00644;PF02825;,nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]
P07314,CHOYP_LOC580355.1.1|m.29389,0,0,0,0,0,0,0,0,8.00E-108,Gamma-glutamyltranspeptidase 1 (GGT 1) (EC 2.3.2.2) (Gamma-glutamyltransferase 1) (Glutathione hydrolase 1) (EC 3.4.19.13) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Gamma-glutamyltranspeptidase 1 heavy chain; Gamma-glutamyltranspeptidase 1 light chain],Ggt1 Ggt,568,aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; peptide modification [GO:0031179]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; zymogen activation [GO:0031638],GO:0003840; GO:0005615; GO:0005886; GO:0005887; GO:0006536; GO:0006750; GO:0006751; GO:0007568; GO:0016755; GO:0031179; GO:0031638; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374,PATHWAY: Sulfur metabolism; glutathione metabolism.,,,PF01019;,"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; gamma-glutamyltransferase activity [GO:0003840]; glutathione hydrolase activity [GO:0036374]; transferase activity, transferring amino-acyl groups [GO:0016755]; aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; peptide modification [GO:0031179]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; zymogen activation [GO:0031638]"
P53563,CHOYP_LOC585734.1.1|m.36212,0,0,0,0,0,0,0,0,0.000004,Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X),Bcl2l1 Bclx Blc2l,233,aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to astaxanthin [GO:1905218]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to erythropoietin [GO:0036018]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prolactin [GO:1990646]; cellular response to thapsigargin [GO:1904579]; cellular response to tumor necrosis factor [GO:0071356]; cerebral cortex development [GO:0021987]; cytokinesis [GO:0000910]; endocytosis [GO:0006897]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of apoptotic process [GO:0043066]; negative regulation of execution phase of apoptosis [GO:1900118]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to erythropoietin [GO:0036017]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to ischemia [GO:0002931]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434],GO:0000910; GO:0001541; GO:0001666; GO:0002931; GO:0005739; GO:0005740; GO:0005741; GO:0005743; GO:0005759; GO:0005813; GO:0005829; GO:0006897; GO:0006915; GO:0006979; GO:0007093; GO:0007568; GO:0008134; GO:0010035; GO:0010243; GO:0010288; GO:0014070; GO:0016021; GO:0021987; GO:0030054; GO:0030672; GO:0031965; GO:0032496; GO:0035690; GO:0036017; GO:0036018; GO:0042493; GO:0042542; GO:0042981; GO:0043027; GO:0043065; GO:0043066; GO:0043434; GO:0046982; GO:0051400; GO:0051602; GO:0071320; GO:0071347; GO:0071356; GO:0071456; GO:0071549; GO:0097371; GO:1900118; GO:1904579; GO:1905218; GO:1990646,,,,PF00452;PF02180;,cell junction [GO:0030054]; centrosome [GO:0005813]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; synaptic vesicle membrane [GO:0030672]; BH domain binding [GO:0051400]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; MDM2/MDM4 family protein binding [GO:0097371]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to astaxanthin [GO:1905218]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to erythropoietin [GO:0036018]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prolactin [GO:1990646]; cellular response to thapsigargin [GO:1904579]; cellular response to tumor necrosis factor [GO:0071356]; cerebral cortex development [GO:0021987]; cytokinesis [GO:0000910]; endocytosis [GO:0006897]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of apoptotic process [GO:0043066]; negative regulation of execution phase of apoptosis [GO:1900118]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to erythropoietin [GO:0036017]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to ischemia [GO:0002931]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]
Q5XIJ8,CHOYP_LOC585839.1.1|m.51865,2,0,0,0,0,0,0,0,9.00E-147,Coiled-coil domain-containing protein 65,Ccdc65,502,,,,,,,
Q08D57,CHOYP_LOC657811.1.1|m.29214,0,0,0,0,0,0,0,0,2.00E-104,Histone-lysine N-methyltransferase SETD1B (EC 2.1.1.43) (SET domain-containing protein 1B),setd1b,1956,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0000166; GO:0003723; GO:0005694; GO:0006351; GO:0006355; GO:0016607; GO:0018024,,,,PF11764;PF00076;PF00856;,"chromosome [GO:0005694]; nuclear speck [GO:0016607]; histone-lysine N-methyltransferase activity [GO:0018024]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
P79110,CHOYP_LOC660776.1.1|m.53402,0,0,0,0,0,0,0,0,5.00E-142,"Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein)",SLC25A1 SLC20A3,311,mitochondrial citrate transport [GO:0006843],GO:0005743; GO:0006843; GO:0015137; GO:0016021,,,,PF00153;,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; citrate transmembrane transporter activity [GO:0015137]; mitochondrial citrate transport [GO:0006843]
Q5ZHY5,CHOYP_PHUM_PHUM234540.1.1|m.9211,0,0,0,0,0,0,0,0,1.00E-116,STIP1 homology and U box-containing protein 1 (EC 2.3.2.27) (E3 ubiquitin-protein ligase CHIP) (RING-type E3 ubiquitin transferase CHIP),STUB1 RCJMB04_32b21,314,cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; misfolded or incompletely synthesized protein catabolic process [GO:0006515]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579],GO:0000151; GO:0000209; GO:0004842; GO:0005654; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006515; GO:0030018; GO:0030512; GO:0030579; GO:0030968; GO:0031647; GO:0031943; GO:0032091; GO:0032436; GO:0034450; GO:0042405; GO:0042787; GO:0042803; GO:0043161; GO:0051443; GO:0051865; GO:0070062; GO:0070534; GO:0071218; GO:0090035; GO:1904264,,,,PF04564;,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity involved in ERAD pathway [GO:1904264]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; misfolded or incompletely synthesized protein catabolic process [GO:0006515]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]
Q9JK66,CHOYP_PRKN2.1.1|m.54903,0,0,0,0,0,0,0,0,1.00E-111,E3 ubiquitin-protein ligase parkin (EC 2.3.2.-),Park2 Prkn,465,"adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; cellular protein modification process [GO:0006464]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; mitochondrial fission [GO:0000266]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000422]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron cellular homeostasis [GO:0070050]; neuron maturation [GO:0042551]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of DNA binding [GO:0043388]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein K6-linked ubiquitination [GO:0085020]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of autophagy [GO:0010506]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of mitochondrion organization [GO:0010821]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; response to unfolded protein [GO:0006986]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]",GO:0000139; GO:0000151; GO:0000209; GO:0000266; GO:0000422; GO:0000976; GO:0001664; GO:0001933; GO:0004842; GO:0005622; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0006351; GO:0006464; GO:0006511; GO:0006513; GO:0006979; GO:0006986; GO:0007005; GO:0008021; GO:0008344; GO:0010506; GO:0010636; GO:0010637; GO:0010821; GO:0010918; GO:0014069; GO:0016235; GO:0016567; GO:0019901; GO:0030054; GO:0030165; GO:0030425; GO:0030672; GO:0031410; GO:0031624; GO:0032403; GO:0032436; GO:0033132; GO:0034976; GO:0035774; GO:0042493; GO:0042551; GO:0042787; GO:0042802; GO:0043005; GO:0043123; GO:0043130; GO:0043161; GO:0043195; GO:0043388; GO:0043524; GO:0045121; GO:0045202; GO:0045211; GO:0045944; GO:0046329; GO:0046676; GO:0046872; GO:0048471; GO:0051412; GO:0051646; GO:0051865; GO:0051967; GO:0055069; GO:0061630; GO:0070050; GO:0070534; GO:0070585; GO:0070842; GO:0070936; GO:0070979; GO:0071287; GO:0085020; GO:0090141; GO:0090201; GO:0090258; GO:0090394; GO:0097237; GO:0097602; GO:1900407; GO:1901215; GO:1902236; GO:1903204; GO:1903265; GO:1903377; GO:1903427; GO:1990444; GO:1990452; GO:2000378; GO:2001171,PATHWAY: Protein modification; protein ubiquitination.,,,PF01485;PF00240;,"aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intracellular [GO:0005622]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; G-protein coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein complex binding [GO:0032403]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; cellular protein modification process [GO:0006464]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; mitochondrial fission [GO:0000266]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000422]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron cellular homeostasis [GO:0070050]; neuron maturation [GO:0042551]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of DNA binding [GO:0043388]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of autophagy [GO:0010506]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of mitochondrion organization [GO:0010821]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; response to unfolded protein [GO:0006986]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]"
P0AGF9,CHOYP_TSIB_0893.1.1|m.10314,0.5,0,0,0,0,0,0,0,3.00E-41,L-threonine dehydratase catabolic TdcB (EC 4.3.1.19) (L-serine dehydratase) (EC 4.3.1.17) (Threonine deaminase),tdcB SF3157 S3369,329,L-threonine catabolic process to propionate [GO:0070689],GO:0000166; GO:0003941; GO:0004794; GO:0030170; GO:0070689,PATHWAY: Amino-acid degradation; L-threonine degradation via propanoate pathway; propanoate from L-threonine: step 1/4.,,,PF00291;,L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; L-threonine catabolic process to propionate [GO:0070689]
Q5BLE8,CHOYP_BRAFLDRAFT_119025.1.3|m.7630,0,0,0,0,0,0,0,0,2.00E-168,"Putative all-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase) (RetSat)",retsat zgc:113107,607,,GO:0016020; GO:0051786,,,,PF01593;,"membrane [GO:0016020]; all-trans-retinol 13,14-reductase activity [GO:0051786]"
Q9VQG2,CHOYP_BRAFLDRAFT_123275.1.1|m.4993,0,0,0,0,0,0,0,0,9.00E-85,Gamma-secretase subunit Aph-1 (Presenilin-stabilization factor),aph-1 PSF CG2855,238,Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; regulation of Notch signaling pathway [GO:0008593],GO:0004175; GO:0005770; GO:0005783; GO:0005887; GO:0007219; GO:0007220; GO:0008593; GO:0016485; GO:0043085; GO:0055037; GO:0070765,,,,PF06105;,endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; endopeptidase activity [GO:0004175]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; regulation of Notch signaling pathway [GO:0008593]
O54750,CHOYP_BRAFLDRAFT_278496.1.1|m.17793,0,0,0,0,0,0,0,0,5.00E-90,Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6),Cyp2j6,501,epoxygenase P450 pathway [GO:0019373]; female pregnancy [GO:0007565]; linoleic acid metabolic process [GO:0043651]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523],GO:0001523; GO:0003958; GO:0005506; GO:0005783; GO:0005789; GO:0007565; GO:0008392; GO:0008404; GO:0008405; GO:0014070; GO:0019373; GO:0020037; GO:0031090; GO:0043651; GO:0070062; GO:0070330; GO:0071614,,,,PF00067;,"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; organelle membrane [GO:0031090]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; epoxygenase P450 pathway [GO:0019373]; female pregnancy [GO:0007565]; linoleic acid metabolic process [GO:0043651]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]"
Q14DK5,CHOYP_BRAFLDRAFT_68917.2.3|m.28554,0.5,0,0,0,0,0,0,0,9.00E-19,HHIP-like protein 1,Hhipl1 Hhip2 Kiaa1822,791,carbohydrate metabolic process [GO:0005975],GO:0005044; GO:0005576; GO:0005975; GO:0016020; GO:0016901; GO:0048038,,,,PF03024;PF07995;PF00530;,"extracellular region [GO:0005576]; membrane [GO:0016020]; oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor [GO:0016901]; quinone binding [GO:0048038]; scavenger receptor activity [GO:0005044]; carbohydrate metabolic process [GO:0005975]"
Q91VR8,CHOYP_BRK1.1.3|m.12345,0,0,0,0,0,0,0,0,7.00E-31,Protein BRICK1 (BRK1),Brk1,75,actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; in utero embryonic development [GO:0001701]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of cell proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; protein homotrimerization [GO:0070207]; Rac protein signal transduction [GO:0016601]; regulation of actin polymerization or depolymerization [GO:0008064],GO:0001701; GO:0005856; GO:0007015; GO:0008064; GO:0008284; GO:0010592; GO:0016601; GO:0030027; GO:0030036; GO:0031209; GO:0032403; GO:0048870; GO:0070062; GO:0070207; GO:2000601,,,,,cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; SCAR complex [GO:0031209]; protein complex binding [GO:0032403]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; in utero embryonic development [GO:0001701]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of cell proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; protein homotrimerization [GO:0070207]; Rac protein signal transduction [GO:0016601]; regulation of actin polymerization or depolymerization [GO:0008064]
Q801S8,CHOYP_COHA1.1.1|m.60326,0,0,0,0,0,0,0,0,2.00E-27,Collagen alpha-1(VI) chain,col6a1,1045,cell adhesion [GO:0007155],GO:0005578; GO:0005581; GO:0007155,,,,PF01391;PF00092;,collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
Q5U3G1,CHOYP_COL4A4.1.1|m.30919,1.5,0,0,0,0,0,0,0,0.000000001,Collectin-11,colec11 zgc:103572,271,developmental process [GO:0032502]; neural crest cell migration [GO:0001755],GO:0001755; GO:0005537; GO:0005576; GO:0005581; GO:0032502,,,cd03591;,PF01391;PF00059;,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; mannose binding [GO:0005537]; developmental process [GO:0032502]; neural crest cell migration [GO:0001755]
P10632,CHOYP_CP2CN.1.1|m.20209,0,0,0,0,0,0,0,0,6.00E-123,Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase),CYP2C8,490,drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; lipid hydroxylation [GO:0002933]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805],GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008392; GO:0017144; GO:0019373; GO:0019825; GO:0020037; GO:0031090; GO:0034875; GO:0042738; GO:0055114; GO:0070330; GO:0070989; GO:0097267; GO:0101020,,,,PF00067;,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; lipid hydroxylation [GO:0002933]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]
Q9DBX3,CHOYP_CPIPJ_CPIJ017084.1.1|m.51185,0,0,0,0,0,0,0,0,2.00E-66,Sushi domain-containing protein 2,Susd2,820,immune response [GO:0006955]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782],GO:0005044; GO:0005886; GO:0006955; GO:0016021; GO:0030247; GO:0051782; GO:0070062; GO:1902807,,,cd00033;,PF03782;PF01033;PF00084;PF00094;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782]
Q16760,CHOYP_DGKD.2.2|m.9520,0,0,0,0,0,0,0,0,0,Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) (130 kDa diacylglycerol kinase) (Diglyceride kinase delta) (DGK-delta),DGKD KIAA0145,1214,cell growth [GO:0016049]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; lipid phosphorylation [GO:0046834]; multicellular organism development [GO:0007275]; platelet activation [GO:0030168]; protein homooligomerization [GO:0051260]; protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; second-messenger-mediated signaling [GO:0019932]; signal transduction [GO:0007165],GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0007173; GO:0007205; GO:0007275; GO:0010033; GO:0015031; GO:0016049; GO:0019932; GO:0019992; GO:0030168; GO:0031410; GO:0042803; GO:0046339; GO:0046834; GO:0046872; GO:0046982; GO:0051260,,,cd00029;,PF00130;PF00609;PF00781;PF00169;PF07647;,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell growth [GO:0016049]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; lipid phosphorylation [GO:0046834]; multicellular organism development [GO:0007275]; platelet activation [GO:0030168]; protein homooligomerization [GO:0051260]; protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; second-messenger-mediated signaling [GO:0019932]; signal transduction [GO:0007165]
P46023,CHOYP_GR101.3.3|m.43507,0,0,0,0,0,0,0,0,0,G-protein coupled receptor GRL101,,1115,,GO:0004930; GO:0005886; GO:0016021,,,,PF00001;PF00057;PF12799;PF13855;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G-protein coupled receptor activity [GO:0004930]
Q9CAG8,CHOYP_KLHL7.1.1|m.9444,0,0,0,0,0,0,0,0,9.00E-14,F-box/kelch-repeat protein At1g67480,At1g67480 F12B7.3 T1F15.5,376,protein ubiquitination [GO:0016567],GO:0016567; GO:0031463,,,,PF01344;,Cul3-RING ubiquitin ligase complex [GO:0031463]; protein ubiquitination [GO:0016567]
Q07553,CHOYP_LOC100370187.1.1|m.8872,0,0,0,0,0,0,0,0,6.00E-73,Guanylate cyclase 32E (EC 4.6.1.2),Gyc32E GC CG33114,1163,cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; signal transduction [GO:0007165],GO:0004383; GO:0004872; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0008074; GO:0019934,,,,PF01094;PF00211;PF07714;,"guanylate cyclase complex, soluble [GO:0008074]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; receptor activity [GO:0004872]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; signal transduction [GO:0007165]"
Q5UQ35,CHOYP_LOC100372473.4.5|m.48798,0.5,0,0,0,0,0,0,0,1.00E-11,Putative ariadne-like RING finger protein R811,MIMI_R811,990,,GO:0008270,,,,PF01485;,zinc ion binding [GO:0008270]
Q9BZ19,CHOYP_LOC100374676.1.1|m.61638,1,0,0,0,0,0,0,0,4.00E-43,Ankyrin repeat domain-containing protein 60,ANKRD60 C20orf86,345,,,,,,PF12796;,
Q9QXE5,CHOYP_LOC100377982.1.1|m.43510,0.5,0,0,0,0,0,0,0,6.00E-110,Thymus-specific serine protease (EC 3.4.-.-) (Serine protease 16),Prss16 Tssp,509,,GO:0005764; GO:0005768; GO:0008236,,,,PF05577;,endosome [GO:0005768]; lysosome [GO:0005764]; serine-type peptidase activity [GO:0008236]
P11031,CHOYP_LOC100900939.1.1|m.15284,2,0,0,0,0,0,0,0,2.00E-23,Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (Single-stranded DNA-binding protein p9) (p14),Sub1 Pc4 Rpo2tc1,127,positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; SMAD protein signal transduction [GO:0060395],GO:0001205; GO:0003697; GO:0003713; GO:0003723; GO:0005634; GO:0005667; GO:0005730; GO:0006357; GO:0060261; GO:0060395; GO:0070062,,,,PF02229;,"extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding [GO:0001205]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; SMAD protein signal transduction [GO:0060395]"
C6KFA3,CHOYP_LOC577191.1.1|m.25751,0,0,0,0,0,0,0,0,6.00E-60,Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)],adgrg6 gpr126,1185,cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G-protein coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879],GO:0001503; GO:0004930; GO:0005518; GO:0005622; GO:0005886; GO:0007005; GO:0007166; GO:0007186; GO:0007507; GO:0014037; GO:0016021; GO:0019933; GO:0022011; GO:0032290; GO:0042552; GO:0043236; GO:0043583; GO:0048932; GO:0050840; GO:0060347; GO:0060879; GO:1903670,,,cd00041;,PF00002;PF00431;PF01825;PF00354;,integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G-protein coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G-protein coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879]
Q28FY0,CHOYP_LOC586953.1.1|m.19600,0,0,0,0,0,0,0,0,2.00E-158,Protein tilB homolog (Leucine-rich repeat-containing protein 6),lrrc6 TGas012h22.1,470,cilium movement [GO:0003341],GO:0003341; GO:0005737; GO:0005929,,,,,cilium [GO:0005929]; cytoplasm [GO:0005737]; cilium movement [GO:0003341]
Q5T0B9,CHOYP_LOC660560.4.4|m.54542,0.5,0,0,0,0,0,0,0,3.00E-32,Zinc finger protein 362,ZNF362 PP6997,420,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872,,,,PF00096;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
O15439,CHOYP_MRP4.1.3|m.6939,0,0,0,0,0,0,0,0,0,Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B),ABCC4 MRP4,1325,cilium assembly [GO:0060271]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085],GO:0002576; GO:0005524; GO:0005886; GO:0005887; GO:0010243; GO:0014070; GO:0015662; GO:0016020; GO:0016323; GO:0016404; GO:0031088; GO:0032310; GO:0042493; GO:0042626; GO:0043225; GO:0048661; GO:0055085; GO:0060271,,,,PF00664;PF00005;,"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism [GO:0015662]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATPase-coupled anion transmembrane transporter activity [GO:0043225]; cilium assembly [GO:0060271]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]"
Q0IHH1,CHOYP_NAA30.1.1|m.50680,0,0,0,0,0,0,0,0,6.00E-88,N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit),naa30 mak3 nat12,273,,GO:0004596; GO:0005634; GO:0005737; GO:0031417,,,,PF00583;,cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]
Q9PT61,CHOYP_OTX5B.1.1|m.10054,0.5,0,0,0,0,0,0,0,3.00E-68,Homeobox protein otx5-B (Orthodenticle homolog 5-B) (XOtx5b),otx5-b otx5b,290,"anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; transcription, DNA-templated [GO:0006351]",GO:0003700; GO:0005634; GO:0006351; GO:0009952; GO:0042706; GO:0043565; GO:0045872; GO:0045893; GO:0045944,,,,PF00046;PF03529;,"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]"
Q8C033,CHOYP_PHUM_PHUM169900.2.2|m.61606,0,0,0,0,0,0,0,0,7.00E-120,Rho guanine nucleotide exchange factor 10,Arhgef10 Kiaa0294,1345,activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023],GO:0005089; GO:0005813; GO:0005829; GO:0019894; GO:0022011; GO:0035023; GO:0051298; GO:0051496; GO:0090307; GO:0090630,,,,PF00621;,centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]
Q80XC3,CHOYP_PHUM_PHUM537100.1.1|m.62217,1,0,0,0,0,0,0,0,4.00E-150,USP6 N-terminal-like protein,Usp6nl Kiaa0019,819,"activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of Golgi organization [GO:1903358]; regulation of vesicle fusion [GO:0031338]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]",GO:0005096; GO:0005794; GO:0005886; GO:0006886; GO:0007030; GO:0012505; GO:0017137; GO:0019068; GO:0031338; GO:0031410; GO:0035526; GO:0048227; GO:0090630; GO:1903358,,,,PF00566;,"cytoplasmic vesicle [GO:0031410]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of Golgi organization [GO:1903358]; regulation of vesicle fusion [GO:0031338]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"
Q9Z1G4,CHOYP_VPP1.1.2|m.2769,0,0,0,0,0,0,0,0,0,V-type proton ATPase 116 kDa subunit a isoform 1 (V-ATPase 116 kDa isoform a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1),Atp6v0a1 Atp6n1,839,ATP hydrolysis coupled proton transport [GO:0015991]; ATP synthesis coupled proton transport [GO:0015986]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0015986; GO:0015991; GO:0016021; GO:0016241; GO:0016471; GO:0016607; GO:0030659; GO:0042470; GO:0043231; GO:0046961; GO:0051117; GO:0070062; GO:0070072; GO:1901998,,,,PF01496;,"cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP synthesis coupled proton transport [GO:0015986]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]"
Q8N7Z5,CHOYP_WRI_006090.1.1|m.34650,9,0,0,0,0,0,0,0,1.00E-14,Putative ankyrin repeat domain-containing protein 31,ANKRD31,1873,,,,,,PF00023;PF12796;,
Q0P4F7,CHOYP_ACSF2.2.4|m.30204,4.5,0,0,0,0,0,0,0,8.00E-46,"Acyl-CoA synthetase family member 2, mitochondrial (EC 6.2.1.-)",acsf2 zgc:152887,606,fatty acid metabolic process [GO:0006631],GO:0005524; GO:0005739; GO:0006631; GO:0016874,,,,PF00501;PF13193;,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631]
Q7TPQ3,CHOYP_BRAFLDRAFT_125252.1.1|m.14950,0,0,0,0,0,0,0,0,3.00E-24,"E3 ubiquitin-protein ligase SHPRH (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase)",Shprh,1674,cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209],GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006334; GO:0006974; GO:0008270; GO:0031625,PATHWAY: Protein modification; protein ubiquitination.,,,PF00271;PF00538;PF00176;,nucleosome [GO:0000786]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]
Q9D2L1,CHOYP_BRAFLDRAFT_206907.11.11|m.60959,0,0,0,0,0,0,0,0,0.00000003,Arylsulfatase K (ASK) (EC 3.1.6.-),Arsk,553,metabolic process [GO:0008152],GO:0005576; GO:0008152; GO:0008484; GO:0046872,,,,PF00884;,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]; metabolic process [GO:0008152]
O70277,CHOYP_BRAFLDRAFT_232970.5.5|m.53358,0,0,0,0,0,0,0,0,0.0000001,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22),Trim3 Berp Rnf22,744,protein transport [GO:0015031],GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0030425,,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; zinc ion binding [GO:0008270]; protein transport [GO:0015031]
Q86VX9,CHOYP_BRAFLDRAFT_234513.1.1|m.9581,0.5,0,0,0,0,0,0,0,4.00E-160,Vacuolar fusion protein MON1 homolog A,MON1A SAND1,555,membrane organization [GO:0061024]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192],GO:0005085; GO:0005829; GO:0009306; GO:0012505; GO:0016192; GO:0061024,,,,PF03164;,cytosol [GO:0005829]; endomembrane system [GO:0012505]; guanyl-nucleotide exchange factor activity [GO:0005085]; membrane organization [GO:0061024]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]
P31944,CHOYP_BRAFLDRAFT_66705.1.1|m.47148,2.5,0,0,0,0,0,0,0,5.00E-20,"Caspase-14 (CASP-14) (EC 3.4.22.-) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form]",CASP14,242,cornification [GO:0070268]; epidermis development [GO:0008544]; execution phase of apoptosis [GO:0097194]; keratinization [GO:0031424],GO:0004175; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0008544; GO:0031012; GO:0031424; GO:0045095; GO:0070062; GO:0070268; GO:0097194; GO:0097200,,,cd00032;,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; keratin filament [GO:0045095]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; cornification [GO:0070268]; epidermis development [GO:0008544]; execution phase of apoptosis [GO:0097194]; keratinization [GO:0031424]
Q10Q46,CHOYP_CYT5.1.1|m.29960,0,0,0,0,0,0,0,0,0.00000001,Cysteine proteinase inhibitor 6 (Oryzacystatin VI) (OC-VI) (Oryzacystatin-6),Os03g0210200 LOC_Os03g11180,113,defense response [GO:0006952],GO:0004869; GO:0005576; GO:0006952,,,cd00042;,PF16845;,extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; defense response [GO:0006952]
A4IFJ6,CHOYP_IKZF.1.1|m.55498,0,0,0,0,0,0,0,0,9.00E-12,Zinc finger protein Pegasus (Ikaros family zinc finger protein 5),IKZF5,419,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872,,,,,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
P54267,CHOYP_LOC100212386.1.2|m.33906,0,0,0,0,0,0,0,0,1.00E-19,Chitin synthase G (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase G) (Class-III chitin synthase G),chsG AFUA_3G14420,911,cell wall organization [GO:0071555]; chitin biosynthetic process [GO:0006031]; conidium formation [GO:0048315]; hyphal growth [GO:0030448],GO:0004100; GO:0005886; GO:0006031; GO:0016021; GO:0030448; GO:0048315; GO:0071555,,,,PF01644;PF08407;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; cell wall organization [GO:0071555]; chitin biosynthetic process [GO:0006031]; conidium formation [GO:0048315]; hyphal growth [GO:0030448]
Q32LJ3,CHOYP_LOC100373454.1.1|m.59681,2.5,0,0,0,0,0,0,0,9.00E-12,Uncharacterized protein CXorf65 homolog,,174,,,,,,,
O60231,CHOYP_LOC100375367.1.1|m.10761,0,0,0,0,0,0,0,0,0,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16),DHX16 DBP2 DDX16 KIAA0577,1041,"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",GO:0000398; GO:0003723; GO:0003724; GO:0004004; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0008380; GO:0016887,,,,PF00270;PF04408;PF00271;PF07717;,"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"
Q40588,CHOYP_LOC100376272.3.4|m.30521,1,0,0,0,0,0,0,0,4.00E-59,L-ascorbate oxidase (ASO) (Ascorbase) (EC 1.10.3.3),AAO,578,,GO:0005507; GO:0005576; GO:0008447,,,cd13845;cd13893;,PF00394;PF07731;PF07732;,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447]
Q6AX59,CHOYP_LOC100377220.1.1|m.36306,0,0,0,0,0,0,0,0,1.00E-68,Protein ABHD8 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 8) (Abhydrolase domain-containing protein 8),abhd8,424,,GO:0016787,,,,PF00561;,hydrolase activity [GO:0016787]
Q5VZQ5,CHOYP_LOC100377647.1.2|m.10110,3,0,0,0,0,0,0,0,2.00E-13,Testis-expressed protein 36,TEX36 C10orf122,186,,,,,,PF15115;,
A1L2I9,CHOYP_LOC100559294.1.1|m.8325,0,0,0,0,0,0,0,0,1.00E-96,Transmembrane protein 214-B,tmem214-b,679,apoptotic process [GO:0006915],GO:0005789; GO:0006915; GO:0016021,,,,PF10151;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]
Q5BK09,CHOYP_LOC100576447.2.2|m.55515,0.5,0,0,0,0,0,0,0,1.00E-38,DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77),Dram2 Tmem77,267,apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601],GO:0001917; GO:0005764; GO:0005765; GO:0006914; GO:0006915; GO:0007601; GO:0010506; GO:0016021; GO:0016324; GO:0045494,,,,PF10277;,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601]
O70277,CHOYP_LOC101169131.2.2|m.32499,0,0,0,0,0,0,0,0,3.00E-11,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22),Trim3 Berp Rnf22,744,protein transport [GO:0015031],GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0030425,,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; zinc ion binding [GO:0008270]; protein transport [GO:0015031]
Q13569,CHOYP_LOC586471.1.1|m.8913,0,0,0,0,0,0,0,0,9.00E-81,G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (Thymine-DNA glycosylase) (hTDG),TDG,410,"base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; covalent chromatin modification [GO:0016569]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; embryo development [GO:0009790]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of gene expression, epigenetic [GO:0040029]; transcription, DNA-templated [GO:0006351]",GO:0000122; GO:0001104; GO:0003677; GO:0003684; GO:0003690; GO:0004844; GO:0005634; GO:0005654; GO:0005886; GO:0006284; GO:0006285; GO:0006298; GO:0006351; GO:0008263; GO:0009790; GO:0016569; GO:0016605; GO:0019104; GO:0030983; GO:0032091; GO:0035511; GO:0035562; GO:0040029; GO:0042803; GO:0045008; GO:0080111,,,cd10028;,PF03167;,"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; mismatched DNA binding [GO:0030983]; protein homodimerization activity [GO:0042803]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; RNA polymerase II transcription cofactor activity [GO:0001104]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; covalent chromatin modification [GO:0016569]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; embryo development [GO:0009790]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of gene expression, epigenetic [GO:0040029]; transcription, DNA-templated [GO:0006351]"
P23606,CHOYP_NEMVEDRAFT_V1G194582.2.2|m.40726,0,0,0,0,0,0,0,0,3.00E-99,Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1),Tgm1,824,keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838],GO:0003810; GO:0010838; GO:0018149; GO:0031224; GO:0031424; GO:0045787; GO:0046872; GO:0070062,,,,PF00927;PF01841;PF00868;,extracellular exosome [GO:0070062]; intrinsic component of membrane [GO:0031224]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]
Q8N884,CHOYP_NEMVEDRAFT_V1G218264.11.14|m.51529,0,0,0,0,0,0,0,0,0.0000002,Cyclic GMP-AMP synthase (cGAMP synthase) (cGAS) (h-cGAS) (EC 2.7.7.86) (2'3'-cGAMP synthase) (Mab-21 domain-containing protein 1),MB21D1 C6orf150,522,activation of innate immune response [GO:0002218]; cellular response to exogenous dsRNA [GO:0071360]; cyclic nucleotide biosynthetic process [GO:0009190]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481],GO:0002218; GO:0002230; GO:0003677; GO:0005524; GO:0005525; GO:0005829; GO:0009190; GO:0032481; GO:0045087; GO:0046872; GO:0051607; GO:0061501; GO:0071360,,,,PF03281;,cytosol [GO:0005829]; ATP binding [GO:0005524]; cyclic-GMP-AMP synthase activity [GO:0061501]; DNA binding [GO:0003677]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; activation of innate immune response [GO:0002218]; cellular response to exogenous dsRNA [GO:0071360]; cyclic nucleotide biosynthetic process [GO:0009190]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]
A7SLZ2,CHOYP_NEMVEDRAFT_V1G246111.1.2|m.45249,0,0,0,0,0,0,0,0,4.00E-14,Stimulator of interferon genes protein (STING),v1g246111,377,activation of innate immune response [GO:0002218]; positive regulation of type I interferon production [GO:0032481],GO:0002218; GO:0005789; GO:0016021; GO:0032481; GO:0035438; GO:0061507,,,cd12146;,PF15009;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]; activation of innate immune response [GO:0002218]; positive regulation of type I interferon production [GO:0032481]
Q6ZHE5,CHOYP_NEMVEDRAFT_V1G92762.1.1|m.1253,0,0,0,0,0,0,0,0,2.00E-87,"Putative D-cysteine desulfhydrase 1, mitochondrial (EC 4.4.1.15) (OsD-CDes1) (D-CDes1)",Os02g0773300 LOC_Os02g53330 OJ1611_C08.26 OsJ_08555,426,,GO:0005739; GO:0019148,,,,PF00291;,mitochondrion [GO:0005739]; D-cysteine desulfhydrase activity [GO:0019148]
P41885,CHOYP_PCLO.1.2|m.27122,0,0,0,0,0,0,0,0,9.00E-19,Rabphilin-1,rbf-1 F37A4.7,1106,calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; dense core granule exocytosis [GO:1990504]; intracellular protein transport [GO:0006886]; positive regulation of locomotion [GO:0040017]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle fusion [GO:0006906],GO:0005509; GO:0005544; GO:0005886; GO:0006886; GO:0006906; GO:0008021; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0040017; GO:0048791; GO:1990504,,,,PF00168;PF02318;,cell junction [GO:0030054]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; dense core granule exocytosis [GO:1990504]; intracellular protein transport [GO:0006886]; positive regulation of locomotion [GO:0040017]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle fusion [GO:0006906]
O95822,CHOYP_PHUM_PHUM479110.1.1|m.54103,0.5,0,0,0,0,0,0,0,1.00E-133,"Malonyl-CoA decarboxylase, mitochondrial (MCD) (EC 4.1.1.9)",MLYCD,493,acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931],GO:0002931; GO:0005102; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0006085; GO:0006633; GO:0006637; GO:0010906; GO:0046321; GO:0050080; GO:2001294,PATHWAY: Metabolic intermediate biosynthesis; acetyl-CoA biosynthesis; acetyl-CoA from malonyl-CoA: step 1/1.,,,PF05292;,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; malonyl-CoA decarboxylase activity [GO:0050080]; receptor binding [GO:0005102]; acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931]
Q7ZUC7,CHOYP_PHUM_PHUM580720.1.1|m.14624,0,0,0,0,0,0,0,0,5.00E-77,Prostaglandin E synthase 2 (EC 5.3.99.3) (Microsomal prostaglandin E synthase 2) (mPGES-2),ptges2 pges2 ptgesl,377,cell redox homeostasis [GO:0045454]; prostaglandin biosynthetic process [GO:0001516],GO:0000139; GO:0001516; GO:0009055; GO:0015035; GO:0016021; GO:0016829; GO:0020037; GO:0043295; GO:0045454; GO:0050220,PATHWAY: Lipid metabolism; prostaglandin biosynthesis. {ECO:0000250|UniProtKB:Q66LN0}.,,cd03197;,PF00462;PF00043;,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; electron carrier activity [GO:0009055]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; prostaglandin biosynthetic process [GO:0001516]
Q8BWF0,CHOYP_POPTRDRAFT_1091519.1.1|m.56854,0,0,0,0,0,0,0,0,0,"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)",Aldh5a1,523,acetate metabolic process [GO:0006083]; central nervous system development [GO:0007417]; galactosylceramide metabolic process [GO:0006681]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glucose metabolic process [GO:0006006]; glucosylceramide metabolic process [GO:0006678]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glutathione metabolic process [GO:0006749]; glycerophospholipid metabolic process [GO:0006650]; neurotransmitter catabolic process [GO:0042135]; oxidation-reduction process [GO:0055114]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; respiratory electron transport chain [GO:0022904]; short-chain fatty acid metabolic process [GO:0046459]; succinate metabolic process [GO:0006105],GO:0004777; GO:0005739; GO:0006006; GO:0006083; GO:0006105; GO:0006536; GO:0006541; GO:0006650; GO:0006678; GO:0006681; GO:0006749; GO:0007417; GO:0009013; GO:0009448; GO:0009450; GO:0009791; GO:0022904; GO:0042135; GO:0046459; GO:0051289; GO:0055114,PATHWAY: Amino-acid degradation; 4-aminobutanoate degradation.,,,PF00171;,mitochondrion [GO:0005739]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; acetate metabolic process [GO:0006083]; central nervous system development [GO:0007417]; galactosylceramide metabolic process [GO:0006681]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glucose metabolic process [GO:0006006]; glucosylceramide metabolic process [GO:0006678]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glutathione metabolic process [GO:0006749]; glycerophospholipid metabolic process [GO:0006650]; neurotransmitter catabolic process [GO:0042135]; oxidation-reduction process [GO:0055114]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; respiratory electron transport chain [GO:0022904]; short-chain fatty acid metabolic process [GO:0046459]; succinate metabolic process [GO:0006105]
Q60857,CHOYP_SC6A7.1.1|m.64266,0,0,0,0,0,0,0,0,4.00E-139,Sodium-dependent serotonin transporter (SERT) (5HT transporter) (5HTT) (Solute carrier family 6 member 4),Slc6a4 Htt Sert,630,"brain morphogenesis [GO:0048854]; cellular response to cGMP [GO:0071321]; cellular response to organic substance [GO:0071310]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; dopamine uptake involved in synaptic transmission [GO:0051583]; memory [GO:0007613]; monoamine transport [GO:0015844]; negative regulation of cerebellar granule cell precursor proliferation [GO:0021941]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of organ growth [GO:0046621]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of serotonin secretion [GO:0014064]; protein homooligomerization [GO:0051260]; protein oligomerization [GO:0051259]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to toxic substance [GO:0009636]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; thalamus development [GO:0021794]; vasoconstriction [GO:0042310]",GO:0001666; GO:0005330; GO:0005335; GO:0005829; GO:0005886; GO:0005887; GO:0006837; GO:0007584; GO:0007613; GO:0007623; GO:0008504; GO:0009636; GO:0010008; GO:0010628; GO:0012505; GO:0014064; GO:0015222; GO:0015844; GO:0017137; GO:0019811; GO:0021794; GO:0021941; GO:0032227; GO:0032355; GO:0035176; GO:0042310; GO:0042493; GO:0042713; GO:0043005; GO:0045121; GO:0045665; GO:0045787; GO:0046621; GO:0046872; GO:0048854; GO:0050998; GO:0051015; GO:0051259; GO:0051260; GO:0051583; GO:0051610; GO:0071300; GO:0071310; GO:0071321; GO:0098793,,,,PF03491;PF00209;,"cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; cocaine binding [GO:0019811]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; nitric-oxide synthase binding [GO:0050998]; Rab GTPase binding [GO:0017137]; serotonin transmembrane transporter activity [GO:0015222]; serotonin:sodium symporter activity [GO:0005335]; brain morphogenesis [GO:0048854]; cellular response to cGMP [GO:0071321]; cellular response to organic substance [GO:0071310]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; dopamine uptake involved in synaptic transmission [GO:0051583]; memory [GO:0007613]; monoamine transport [GO:0015844]; negative regulation of cerebellar granule cell precursor proliferation [GO:0021941]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of organ growth [GO:0046621]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of serotonin secretion [GO:0014064]; protein homooligomerization [GO:0051260]; protein oligomerization [GO:0051259]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to toxic substance [GO:0009636]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; thalamus development [GO:0021794]; vasoconstriction [GO:0042310]"
Q8K078,CHOYP_SO4A1.1.1|m.46501,0,0,0,0,0,0,0,0,0,Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12),Slco4a1 Oatp4a1 Oatpe Slc21a12,723,organic anion transport [GO:0015711],GO:0005887; GO:0008514; GO:0015711,,,cd06174;,PF07648;PF03137;,integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; organic anion transport [GO:0015711]
Q60542,CHOYP_ZEB2.1.1|m.29733,0.5,0,0,0,0,0,0,0,0.000000002,Zinc finger E-box-binding homeobox 1 (Transcription factor 8) (TCF-8) (Zinc finger protein BZP),ZEB1 BZP TCF8,1043,"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0006351; GO:0045666; GO:0045892; GO:0046872; GO:0070888,,,,PF00046;PF05605;,"nucleus [GO:0005634]; E-box binding [GO:0070888]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; transcription, DNA-templated [GO:0006351]"
Q96EY1,CHOYP_contig_006299|m.7138,0,0,0,0,0,0,0,0,6.00E-15,"DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog)",DNAJA3 HCA57 TID1,480,activation-induced cell death of T cells [GO:0006924]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006264; GO:0006457; GO:0006469; GO:0006919; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0007569; GO:0008134; GO:0008285; GO:0009408; GO:0019897; GO:0019901; GO:0030054; GO:0030695; GO:0031398; GO:0031594; GO:0032088; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043154; GO:0043231; GO:0045211; GO:0046872; GO:0050821; GO:0051059; GO:0060336; GO:0071340,,,cd06257;,PF00226;PF01556;PF00684;,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]
Q5UNS9,CHOYP_contig_025639|m.29255,0,0,0,0,0,0,0,0,7.00E-54,Collagen-like protein 7,MIMI_L669,1937,,GO:0019012,,,,PF01391;,virion [GO:0019012]
P36956,CHOYP_BRAFLDRAFT_117231.1.1|m.4966,0,0,0,0,0,0,0,0,0,Sterol regulatory element-binding protein 1 (SREBP-1) (Class D basic helix-loop-helix protein 1) (bHLHd1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1],SREBF1 BHLHD1 SREBP1,1147,aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription from RNA polymerase II promoter [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of mitophagy [GO:1903146]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526],GO:0000122; GO:0000139; GO:0000977; GO:0000978; GO:0001077; GO:0003062; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006357; GO:0006629; GO:0007568; GO:0007623; GO:0008203; GO:0008286; GO:0008610; GO:0009267; GO:0009749; GO:0010867; GO:0012507; GO:0016021; GO:0019217; GO:0030324; GO:0031065; GO:0031647; GO:0032094; GO:0032526; GO:0032570; GO:0032810; GO:0033762; GO:0042493; GO:0042789; GO:0043234; GO:0045444; GO:0045542; GO:0045944; GO:0046676; GO:0051591; GO:0071398; GO:1903146; GO:1903214,,,,PF00010;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein complex [GO:0043234]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding [GO:0004879]; sterol response element binding [GO:0032810]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription from RNA polymerase II promoter [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of mitophagy [GO:1903146]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]"
Q9NZJ4,CHOYP_BRAFLDRAFT_118535.8.8|m.61819,1,0,0,0,0,0,0,0,0,Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29),SACS KIAA0730,4579,negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084,,,,PF05168;PF00240;,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]
O43736,CHOYP_BRAFLDRAFT_120146.1.1|m.26173,0,0,0,0,0,0,0,0,2.00E-14,Integral membrane protein 2A (Protein E25),ITM2A UNQ603/PRO1189,263,immunoglobulin production [GO:0002377]; plasma cell differentiation [GO:0002317],GO:0002317; GO:0002377; GO:0016021,,,,PF04089;,integral component of membrane [GO:0016021]; immunoglobulin production [GO:0002377]; plasma cell differentiation [GO:0002317]
A0JNH9,CHOYP_BRAFLDRAFT_122376.1.1|m.49446,0,0,0,0,0,0,0,0,0.000000008,Aprataxin and PNK-like factor (EC 4.2.99.18) (Apurinic-apyrimidinic endonuclease APLF),APLF,485,cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012],GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005829; GO:0006302; GO:0006974; GO:0008408; GO:0046872,,,,PF10283;,cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; DNA-(apurinic or apyrimidinic site) lyase activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]
P32187,CHOYP_BRAFLDRAFT_129108.1.2|m.2456,0,0,0,0,0,0,0,0,0.000002,Ependymin (EPD),epd,212,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005576; GO:0007160,,,,PF00811;,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
B3EWY9,CHOYP_BRAFLDRAFT_129967.1.4|m.4020,0,0,0,0,0,0,0,0,2.00E-104,Mucin-like protein (Fragment),,1594,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0007160; GO:0016021,,,,PF12662;PF06119;PF00090;PF00094;,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
Q9TUQ3,CHOYP_BRAFLDRAFT_85664.2.10|m.9436,0,0,0,0,0,0,0,0,0.000000004,Complement component C7,C7,843,"complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]",GO:0005576; GO:0005579; GO:0006957; GO:0006958; GO:0019835,,,cd00033;,PF00057;PF01823;PF00084;PF00090;,"extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]"
Q9D3P8,CHOYP_BRAFLDRAFT_88556.1.1|m.50506,0,0,0,0,0,0,0,0,9.00E-37,Plasminogen receptor (KT) (Plg-R(KT)),Plgrkt,147,chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; positive regulation of plasminogen activation [GO:0010756],GO:0005739; GO:0005887; GO:0006935; GO:0006954; GO:0010756,,,,PF10166;,integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; positive regulation of plasminogen activation [GO:0010756]
A9JRL3,CHOYP_CBPC1.1.1|m.30712,0,0,0,0,0,0,0,0,0,Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (ATP/GTP-binding protein 1),agtpbp1 ccp1,1226,cerebellar Purkinje cell differentiation [GO:0021702]; chordate embryonic development [GO:0043009]; C-terminal protein deglutamylation [GO:0035609]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]; T cell differentiation in thymus [GO:0033077],GO:0001754; GO:0004181; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0007005; GO:0008270; GO:0015631; GO:0021702; GO:0021772; GO:0033077; GO:0035609; GO:0035610; GO:0043009; GO:0050905,,,cd06906;,PF00246;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; cerebellar Purkinje cell differentiation [GO:0021702]; chordate embryonic development [GO:0043009]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]; T cell differentiation in thymus [GO:0033077]
A1A4R8,CHOYP_CDC23.1.1|m.6463,0,0,0,0,0,0,0,0,0,Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8),CDC23 ANAPC8,597,cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic metaphase/anaphase transition [GO:0030071],GO:0005680; GO:0007080; GO:0030071; GO:0051301; GO:0070979,PATHWAY: Protein modification; protein ubiquitination.,,,PF04049;PF13414;PF13181;,anaphase-promoting complex [GO:0005680]; cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic metaphase/anaphase transition [GO:0030071]
A2AJ76,CHOYP_CNTN6.1.2|m.781,0,0,0,0,0,0,0,0,1.00E-23,Hemicentin-2,Hmcn2,5100,positive regulation of cell migration [GO:0030335]; response to stimulus [GO:0050896]; smooth muscle contraction [GO:0006939],GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0006939; GO:0030054; GO:0030335; GO:0032154; GO:0050896,,,,PF12662;PF07645;PF07474;PF07679;,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; positive regulation of cell migration [GO:0030335]; response to stimulus [GO:0050896]; smooth muscle contraction [GO:0006939]
A2AJ76,CHOYP_CRE-UNC-89.3.3|m.61234,0,0,0,0,0,0,0,0,0.0000002,Hemicentin-2,Hmcn2,5100,positive regulation of cell migration [GO:0030335]; response to stimulus [GO:0050896]; smooth muscle contraction [GO:0006939],GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0006939; GO:0030054; GO:0030335; GO:0032154; GO:0050896,,,,PF12662;PF07645;PF07474;PF07679;,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; positive regulation of cell migration [GO:0030335]; response to stimulus [GO:0050896]; smooth muscle contraction [GO:0006939]
O17482,CHOYP_DGRI_GH13197.1.1|m.35578,0,0,0,0,0,0,0,0,3.00E-67,Protein timeless,tim,1343,rhythmic process [GO:0048511],GO:0005634; GO:0048471; GO:0048511,,,,PF04821;,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; rhythmic process [GO:0048511]
Q8C088,CHOYP_DRPR.1.2|m.58255,0,0,0,0,0,0,0,0,7.00E-16,EGF-like and EMI domain-containing protein 1,Egfem1,590,,GO:0005509,,,,PF07645;PF07546;,calcium ion binding [GO:0005509]
Q68FD7,CHOYP_FNIP1.1.1|m.23640,0,0,0,0,0,0,0,0,4.00E-97,Folliculin-interacting protein 1,Fnip1 Kiaa1961,1165,cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein phosphorylation [GO:0001934]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929],GO:0000122; GO:0001932; GO:0001934; GO:0002327; GO:0002904; GO:0005085; GO:0005737; GO:0009267; GO:0031334; GO:0031929; GO:0032007; GO:0033138; GO:0042030; GO:0043154; GO:0051087; GO:2000973,,,,PF14638;PF14637;PF14636;,cytoplasm [GO:0005737]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein phosphorylation [GO:0001934]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]
Q0UI93,CHOYP_IFIH1.4.14|m.40815,0,0,0,0,0,0,0,0,2.00E-14,Dicer-like protein 1 [Includes: Endoribonuclease DCL1 (EC 3.1.26.-); ATP-dependent helicase DCL1 (EC 3.6.4.-)],DCL1 SNOG_08521,1522,defense response to virus [GO:0051607]; production of siRNA involved in RNA interference [GO:0030422]; regulation of defense response to virus [GO:0050688],GO:0003677; GO:0003723; GO:0004386; GO:0004525; GO:0005524; GO:0005634; GO:0005737; GO:0016442; GO:0030422; GO:0046872; GO:0050688; GO:0051607,,,cd00593;,PF03368;PF00271;PF04851;PF00636;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; production of siRNA involved in RNA interference [GO:0030422]; regulation of defense response to virus [GO:0050688]
Q8TB96,CHOYP_ITFG1.1.1|m.51655,0,0,0,0,0,0,0,0,2.00E-140,T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin),ITFG1 LNKN-1 TIP CDA08,612,,GO:0016021; GO:0070062,,,,,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]
P55214,CHOYP_LOC100068258.1.1|m.37406,0,0,0,0,0,0,0,0,5.00E-69,Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (ICE-like apoptotic protease 3) (ICE-LAP3) (SREBP cleavage activity 2) (SCA-2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],CASP7 MCH3,303,apoptotic process [GO:0006915],GO:0004197; GO:0005737; GO:0006915,,,cd00032;,,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]
P97376,CHOYP_LOC100123667.1.1|m.22353,0.5,0,0,0,0,0,0,0,2.00E-78,Protein FRG1 (FSHD region gene 1 protein),Frg1,258,mRNA processing [GO:0006397]; muscle organ development [GO:0007517]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],GO:0003723; GO:0005730; GO:0006364; GO:0006397; GO:0007517; GO:0008380; GO:0015030; GO:0030018; GO:0051015; GO:0055120; GO:0071013,,,,PF06229;,Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; muscle organ development [GO:0007517]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]
Q4L208,CHOYP_LOC100159032.1.1|m.14934,0,0,0,0,0,0,0,0,3.00E-175,Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8),Slc9a8 Nhe8,575,potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453],GO:0000139; GO:0005794; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805,,,,PF00999;,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]
P18293,CHOYP_LOC100197876.1.1|m.45271,0.5,0,0,0,0,0,0,0,3.00E-153,Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A),Npr1 Npra,1057,cGMP biosynthetic process [GO:0006182]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP biosynthetic process [GO:0030828]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood vessel size [GO:0050880],GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0008074; GO:0016021; GO:0016941; GO:0017046; GO:0030828; GO:0035556; GO:0042417; GO:0042562; GO:0043235; GO:0048662; GO:0050880,,,,PF01094;PF00211;PF07714;,"guanylate cyclase complex, soluble [GO:0008074]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP biosynthetic process [GO:0030828]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood vessel size [GO:0050880]"
Q9JM83,CHOYP_LOC100261610.1.1|m.6374,1.5,0,0,0,0,0,0,0,1.00E-15,Calmodulin-4 (Calcium-binding protein Dd112),Calm4 Dd112,148,,GO:0005509; GO:0070062,,,cd00051;,PF13499;,extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]
Q9ULL1,CHOYP_LOC100367084.6.22|m.31842,0,0,0,0,0,0,0,0,1.00E-101,Pleckstrin homology domain-containing family G member 1,PLEKHG1 KIAA1209,1385,regulation of Rho protein signal transduction [GO:0035023],GO:0005089; GO:0005634; GO:0005654; GO:0035023,,,,PF00621;,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023]
Q502L2,CHOYP_LOC100367769.1.2|m.27169,0,0,0,0,0,0,0,0,2.00E-93,"Serine/threonine-protein phosphatase PGAM5, mitochondrial (EC 3.1.3.16) (Phosphoglycerate mutase family member 5)",pgam5 si:dkey-69p22.1 zgc:92057,289,programmed cell death [GO:0012501],GO:0004721; GO:0005741; GO:0012501; GO:0016021,,,cd07067;,PF00300;,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; phosphoprotein phosphatase activity [GO:0004721]; programmed cell death [GO:0012501]
P46555,CHOYP_LOC100370244.1.4|m.24792,0,0,0,0,0,0,0,0,8.00E-97,D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase),hse-5 B0285.5,616,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparin biosynthetic process [GO:0030210]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]",GO:0005604; GO:0005886; GO:0015015; GO:0016021; GO:0030210; GO:0030334; GO:0040018; GO:0047464,PATHWAY: Glycan metabolism; heparan sulfate biosynthesis.; PATHWAY: Glycan metabolism; heparin biosynthesis.,,,PF06662;,"basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparin biosynthetic process [GO:0030210]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]"
Q8BTK5,CHOYP_LOC100372698.1.1|m.18674,0,0,0,0,0,0,0,0,2.00E-51,SET and MYND domain-containing protein 4 (EC 2.1.1.-),Smyd4 Kiaa1936,799,,GO:0008168; GO:0046872,,,,PF00856;PF01753;,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]
Q22549,CHOYP_LOC100533355.1.2|m.6485,0,0,0,0,0,0,0,0,5.00E-79,Innexin-10 (Protein opu-10),inx-10 opu-10 T18H9.5,559,ion transport [GO:0006811],GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021; GO:0055077,,,,PF00876;,gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transport [GO:0006811]
Q5M9G3,CHOYP_LOC100565981.1.1|m.29912,0,0,0,0,0,0,0,0,7.00E-55,Caprin-1 (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (RNA granule protein 105),Caprin1 Gpiap1 Rng105,707,negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003],GO:0000932; GO:0003723; GO:0005829; GO:0010494; GO:0017148; GO:0030425; GO:0050775; GO:0061003,,,,PF12287;,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; P-body [GO:0000932]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]
P23469,CHOYP_LOC100890753.2.3|m.53551,0,0,0,0,0,0,0,0,7.00E-74,Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48),PTPRE,700,negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185],GO:0005001; GO:0005634; GO:0005737; GO:0005886; GO:0006470; GO:0007185; GO:0016021; GO:0033003; GO:0046627,,,,PF00102;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]
P61805,CHOYP_LOC578220.1.2|m.16983,0,0,0,0,0,0,0,0,3.00E-56,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (Oligosaccharyl transferase subunit DAD1) (EC 2.4.99.18) (Defender against cell death 1) (DAD-1),Dad1,113,apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of apoptotic process [GO:0043066]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; response to drug [GO:0042493]; response to nutrient [GO:0007584],GO:0001824; GO:0004579; GO:0006486; GO:0006487; GO:0006915; GO:0007584; GO:0008250; GO:0016021; GO:0042493; GO:0043066; GO:0070062,PATHWAY: Protein modification; protein glycosylation.,,,PF02109;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of apoptotic process [GO:0043066]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; response to drug [GO:0042493]; response to nutrient [GO:0007584]
P14133,CHOYP_LOC584333.1.1|m.42540,0,0,0,0,0,0,0,0,3.00E-29,L-ascorbate oxidase (ASO) (Ascorbase) (EC 1.10.3.3),,587,,GO:0005507; GO:0005576; GO:0008447,,,cd13845;cd13893;,PF00394;PF07731;PF07732;,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447]
B3EWY9,CHOYP_LOC590125.6.7|m.53735,0,0,0,0,0,0,0,0,4.00E-112,Mucin-like protein (Fragment),,1594,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0007160; GO:0016021,,,,PF12662;PF06119;PF00090;PF00094;,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
Q62925,CHOYP_M3K1.1.1|m.7202,0,0,0,0,0,0,0,0,8.00E-119,Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1),Map3k1 Mekk Mekk1,1493,activation of JNKK activity [GO:0007256]; activation of MAPKK activity [GO:0000186]; MAPK cascade [GO:0000165]; negative regulation of actin filament bundle assembly [GO:0032232]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein autophosphorylation [GO:0046777]; protein oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; response to osmotic stress [GO:0006970],GO:0000165; GO:0000186; GO:0000209; GO:0004706; GO:0004709; GO:0004842; GO:0005524; GO:0005737; GO:0006468; GO:0006970; GO:0007256; GO:0008270; GO:0008432; GO:0016020; GO:0018105; GO:0031434; GO:0032232; GO:0042787; GO:0043065; GO:0043406; GO:0043507; GO:0045944; GO:0046625; GO:0046777; GO:0050434; GO:0051019; GO:0051259,,,,PF00069;,cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; JUN kinase binding [GO:0008432]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; sphingolipid binding [GO:0046625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of JNKK activity [GO:0007256]; activation of MAPKK activity [GO:0000186]; MAPK cascade [GO:0000165]; negative regulation of actin filament bundle assembly [GO:0032232]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein autophosphorylation [GO:0046777]; protein oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; response to osmotic stress [GO:0006970]
B3EWY7,CHOYP_NEMVEDRAFT_V1G246686.1.1|m.53126,0.5,0,0,0,0,0,0,0,2.00E-29,Acidic skeletal organic matrix protein (Acidic SOMP),,359,,GO:0005576,,,,,extracellular region [GO:0005576]
Q6AY62,CHOYP_NEUFC.1.1|m.44515,0,0,0,0,0,0,0,0,6.00E-69,Neuferricin (Cytochrome b5 domain-containing protein 2),Cyb5d2,263,positive regulation of neuron differentiation [GO:0045666],GO:0005576; GO:0012505; GO:0016020; GO:0020037; GO:0045666,,,,PF00173;,endomembrane system [GO:0012505]; extracellular region [GO:0005576]; membrane [GO:0016020]; heme binding [GO:0020037]; positive regulation of neuron differentiation [GO:0045666]
A2AJ76,CHOYP_PEAR1.10.16|m.42850,0,0,0,0,0,0,0,0,0.000004,Hemicentin-2,Hmcn2,5100,positive regulation of cell migration [GO:0030335]; response to stimulus [GO:0050896]; smooth muscle contraction [GO:0006939],GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0006939; GO:0030054; GO:0030335; GO:0032154; GO:0050896,,,,PF12662;PF07645;PF07474;PF07679;,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; positive regulation of cell migration [GO:0030335]; response to stimulus [GO:0050896]; smooth muscle contraction [GO:0006939]
Q9NZJ4,CHOYP_SACS.14.17|m.61817,0,0,0,0,0,0,0,0,0,Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29),SACS KIAA0730,4579,negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084,,,,PF05168;PF00240;,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]
Q80VJ2,CHOYP_SRA1.1.1|m.56432,0,0,0,0,0,0,0,0,4.00E-14,Steroid receptor RNA activator 1 (Steroid receptor RNA activator protein) (SRAP),Sra1,232,"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0005831; GO:0005886; GO:0006351; GO:0006357; GO:0006915; GO:0008283; GO:0010861; GO:0015630; GO:0030154; GO:0030374; GO:0030529; GO:0031252; GO:0042981; GO:0045171; GO:0045944,,,,PF07304;,"cell leading edge [GO:0031252]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular ribonucleoprotein complex [GO:0030529]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; steroid hormone aporeceptor complex [GO:0005831]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor activator activity [GO:0010861]; transcription coactivator activity [GO:0003713]; transcription cofactor activity [GO:0003712]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]"
B3EWY9,CHOYP_contig_050919|m.60703,0,0,0,0,0,0,0,0,3.00E-95,Mucin-like protein (Fragment),,1594,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0007160; GO:0016021,,,,PF12662;PF06119;PF00090;PF00094;,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
P55096,CHOYP_ABCD3.1.1|m.14559,0,0,0,0,0,0,0,0,0,ATP-binding cassette sub-family D member 3 (68 kDa peroxisomal membrane protein) (PMP68) (70 kDa peroxisomal membrane protein) (PMP70),Abcd3 Pmp70 Pxmp1,659,fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; peroxisomal long-chain fatty acid import [GO:0015910]; peroxisome organization [GO:0007031]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; very long-chain fatty acid catabolic process [GO:0042760],GO:0005324; GO:0005524; GO:0005739; GO:0005743; GO:0005777; GO:0005778; GO:0005782; GO:0006633; GO:0006635; GO:0007031; GO:0014070; GO:0015910; GO:0016020; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0042760; GO:0042803; GO:0043231,,,,PF06472;PF00005;,"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; peroxisomal long-chain fatty acid import [GO:0015910]; peroxisome organization [GO:0007031]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; very long-chain fatty acid catabolic process [GO:0042760]"
P91620,CHOYP_AGAP_AGAP006590.1.1|m.42108,0,0,0,0,0,0,0,0,0,"Protein still life, isoforms C/SIF type 2",sif CG34418,2061,actin cytoskeleton organization [GO:0030036]; intracellular signal transduction [GO:0035556]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synapse structure or activity [GO:0050803],GO:0005057; GO:0005622; GO:0030036; GO:0030054; GO:0030676; GO:0035023; GO:0035556; GO:0043087; GO:0045202; GO:0050770; GO:0050803; GO:0051491,,,,PF00169;PF02196;PF00621;,"cell junction [GO:0030054]; intracellular [GO:0005622]; synapse [GO:0045202]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; signal transducer activity, downstream of receptor [GO:0005057]; actin cytoskeleton organization [GO:0030036]; intracellular signal transduction [GO:0035556]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synapse structure or activity [GO:0050803]"
Q54SW1,CHOYP_BRAFLDRAFT_120431.1.1|m.49038,0.5,0,0,0,0,0,0,0,0.00000005,Putative phosphatidylglycerol/phosphatidylinositol transfer protein DDB_G0282179,DDB_G0282179,145,lipid transport [GO:0006869],GO:0006869,,,,PF02221;,lipid transport [GO:0006869]
A5IXT5,CHOYP_BRAFLDRAFT_208197.18.21|m.59194,0,0,0,0,0,0,0,0,3.00E-11,Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70),dnaK MAG1460,598,protein folding [GO:0006457],GO:0005524; GO:0006457,,,,PF00012;,ATP binding [GO:0005524]; protein folding [GO:0006457]
Q1ZXD6,CHOYP_BRAFLDRAFT_208436.11.32|m.42955,0,0,0,0,0,0,0,0,0.000000009,Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5),roco5 DDB_G0294533,2800,intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]; sorocarp development [GO:0030587],GO:0004672; GO:0004674; GO:0004871; GO:0005089; GO:0005524; GO:0005525; GO:0005737; GO:0006468; GO:0007264; GO:0030587; GO:0035023; GO:0035556,,,,PF16095;PF13516;PF13855;PF07714;PF00621;PF08477;,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; signal transducer activity [GO:0004871]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]; sorocarp development [GO:0030587]
Q9HCS2,CHOYP_BRAFLDRAFT_61250.13.14|m.57254,0,0,0,0,0,0,0,0,4.00E-117,Cytochrome P450 4F12 (EC 1.14.14.1) (CYPIVF12),CYP4F12 UNQ568/PRO1129,524,arachidonic acid metabolic process [GO:0019369]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; leukotriene B4 catabolic process [GO:0036101]; long-chain fatty acid metabolic process [GO:0001676]; oxidation-reduction process [GO:0055114]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360],GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0005506; GO:0005737; GO:0005789; GO:0008392; GO:0016021; GO:0016324; GO:0017144; GO:0018685; GO:0019369; GO:0019373; GO:0019825; GO:0020037; GO:0031090; GO:0036101; GO:0042360; GO:0043231; GO:0050051; GO:0055078; GO:0055114; GO:0070330,,,,PF00067;,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; oxygen binding [GO:0019825]; arachidonic acid metabolic process [GO:0019369]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; leukotriene B4 catabolic process [GO:0036101]; long-chain fatty acid metabolic process [GO:0001676]; oxidation-reduction process [GO:0055114]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]
E1BD59,CHOYP_BRAFLDRAFT_88223.9.22|m.34933,0,0,0,0,0,0,0,0,1.00E-33,E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56),TRIM56,732,defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],GO:0004842; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0051607; GO:0070534,,,,PF00643;PF13445;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]
Q5F4C0,CHOYP_HVCN1.1.4|m.8888,0,0,0,0,0,0,0,0,1.00E-13,Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1),HVCN1 RCJMB04_1c7,235,cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transport [GO:0015992]; response to pH [GO:0009268]; response to zinc ion [GO:0010043],GO:0005887; GO:0009268; GO:0010043; GO:0015992; GO:0016021; GO:0030171; GO:0071294; GO:0071467,,,,PF00520;PF16799;,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; voltage-gated proton channel activity [GO:0030171]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transport [GO:0015992]; response to pH [GO:0009268]; response to zinc ion [GO:0010043]
Q99JY4,CHOYP_ISCW_ISCW013325.1.2|m.5734,0,0,0,0,0,0,0,0,4.00E-87,TraB domain-containing protein,Trabd,376,,,,,,PF01963;,
A0JMK9,CHOYP_LOC100120677.1.1|m.16799,0,0,0,0,0,0,0,0,2.00E-38,Chromatin assembly factor 1 subunit A (CAF-1 subunit A) (Chromatin assembly factor I p150 subunit) (CAF-I 150 kDa subunit) (CAF-I p150),chaf1a caip150 ch211-129c21.3 zgc:153930,863,cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334],GO:0005634; GO:0006260; GO:0006281; GO:0006334; GO:0007049; GO:0031497; GO:0033186,,,,PF15539;PF15557;PF12253;,CAF-1 complex [GO:0033186]; nucleus [GO:0005634]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]
Q1RMG8,CHOYP_LOC100200424.1.1|m.16669,0,0,0,0,0,0,0,0,3.00E-39,DNA-directed RNA polymerases I and III subunit RPAC2 (RNA polymerases I and III subunit AC2) (DNA-directed RNA polymerase I subunit D),POLR1D,133,transcription from RNA polymerase III promoter [GO:0006383]; transcription from RNA polymerase I promoter [GO:0006360],GO:0003677; GO:0003899; GO:0005666; GO:0005736; GO:0006360; GO:0006383,,,cd07029;,PF13656;,DNA-directed RNA polymerase I complex [GO:0005736]; DNA-directed RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription from RNA polymerase I promoter [GO:0006360]; transcription from RNA polymerase III promoter [GO:0006383]
A8K8P3,CHOYP_LOC574744.1.1|m.26506,0,0,0,0,0,0,0,0,6.00E-106,Protein SFI1 homolog (hSFI1),SFI1 KIAA0542,1242,ciliary basal body docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of phosphatase activity [GO:0010923],GO:0000086; GO:0005814; GO:0005829; GO:0010923; GO:0019902; GO:0097711,,,,,centriole [GO:0005814]; cytosol [GO:0005829]; phosphatase binding [GO:0019902]; ciliary basal body docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of phosphatase activity [GO:0010923]
Q99LG0,CHOYP_LOC585494.1.1|m.64158,0.5,0,0,0,0,0,0,0,4.00E-86,Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-specific-processing protease 16),Usp16,825,"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic nuclear division [GO:0007067]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0003713; GO:0004197; GO:0004843; GO:0005634; GO:0006351; GO:0006357; GO:0006511; GO:0006974; GO:0007067; GO:0008270; GO:0016578; GO:0035522; GO:0042393; GO:0043130; GO:0045893; GO:0045901; GO:0045944; GO:0051289; GO:0051301; GO:0051726; GO:0070537,,,,PF00443;PF02148;,"nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic nuclear division [GO:0007067]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]"
Q59641,CHOYP_PPIB.2.4|m.40019,2,0,0,0,0,0,0,0,0.000000004,Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Rotamase A),ppiA cypH PA3227,187,protein folding [GO:0006457],GO:0003755; GO:0006457; GO:0042597,,,,PF00160;,periplasmic space [GO:0042597]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]
Q22813,CHOYP_TBX20.3.4|m.49132,0,0,0,0,0,0,0,0,0.000000003,Putative T-box protein 41,tbx-41 T26C11.1,233,"transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003700; GO:0005634; GO:0006351,,,,PF00907;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription, DNA-templated [GO:0006351]"
Q66J74,CHOYP_TFP11.1.1|m.65838,0.5,0,0,0,0,0,0,0,0,Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1),tfip11 stip,824,"mRNA processing [GO:0006397]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]",GO:0003677; GO:0005681; GO:0006355; GO:0006397; GO:0008380,,,,PF01585;PF07842;PF12457;,"spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA processing [GO:0006397]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]"
Q9R182,CHOYP_TL5A.3.3|m.59951,0,0,0,0,0,0,0,0,8.00E-36,Angiopoietin-related protein 3 (Angiopoietin-like protein 3) [Cleaved into: ANGPTL3(17-224)],Angptl3,455,acylglycerol homeostasis [GO:0055090]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell-matrix adhesion [GO:0007160]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; fatty acid metabolic process [GO:0006631]; glycerol metabolic process [GO:0006071]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of lipoprotein lipase activity [GO:0051005]; negative regulation of phospholipase activity [GO:0010519]; phospholipid catabolic process [GO:0009395]; phospholipid homeostasis [GO:0055091]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of lipid metabolic process [GO:0045834]; response to hormone [GO:0009725]; signal transduction [GO:0007165]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641],GO:0001525; GO:0004857; GO:0004859; GO:0005178; GO:0005576; GO:0005615; GO:0005769; GO:0005794; GO:0006071; GO:0006631; GO:0006641; GO:0006644; GO:0007160; GO:0007165; GO:0008083; GO:0008201; GO:0008203; GO:0009395; GO:0009725; GO:0009986; GO:0010519; GO:0019915; GO:0030027; GO:0030335; GO:0042632; GO:0045766; GO:0045834; GO:0048844; GO:0050996; GO:0051005; GO:0055088; GO:0055090; GO:0055091; GO:0070328,,,cd00087;,PF00147;,cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; enzyme inhibitor activity [GO:0004857]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; phospholipase inhibitor activity [GO:0004859]; acylglycerol homeostasis [GO:0055090]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell-matrix adhesion [GO:0007160]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; fatty acid metabolic process [GO:0006631]; glycerol metabolic process [GO:0006071]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of lipoprotein lipase activity [GO:0051005]; negative regulation of phospholipase activity [GO:0010519]; phospholipid catabolic process [GO:0009395]; phospholipid homeostasis [GO:0055091]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of lipid metabolic process [GO:0045834]; response to hormone [GO:0009725]; signal transduction [GO:0007165]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]
Q1ZXD6,CHOYP_TRIADDRAFT_61416.1.1|m.26099,0,0,0,0,0,0,0,0,0.00000001,Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5),roco5 DDB_G0294533,2800,intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]; sorocarp development [GO:0030587],GO:0004672; GO:0004674; GO:0004871; GO:0005089; GO:0005524; GO:0005525; GO:0005737; GO:0006468; GO:0007264; GO:0030587; GO:0035023; GO:0035556,,,,PF16095;PF13516;PF13855;PF07714;PF00621;PF08477;,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; signal transducer activity [GO:0004871]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]; sorocarp development [GO:0030587]
Q3TX08,CHOYP_TRMT1.1.1|m.48190,0,0,0,0,0,0,0,0,0,"tRNA (guanine(26)-N(2))-dimethyltransferase (EC 2.1.1.216) (tRNA 2,2-dimethylguanosine-26 methyltransferase) (tRNA(guanine-26,N(2)-N(2)) methyltransferase) (tRNA(m(2,2)G26)dimethyltransferase)",Trmt1 D8Ertd812e,663,tRNA N2-guanine methylation [GO:0002940],GO:0000049; GO:0002940; GO:0003723; GO:0004809; GO:0005634; GO:0005739; GO:0046872,,,,PF02005;PF00642;,mitochondrion [GO:0005739]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]; tRNA N2-guanine methylation [GO:0002940]
Q6MFY5,CHOYP_ZNRD1.1.2|m.7107,0,0,0,0,0,0,0,0,1.00E-42,DNA-directed RNA polymerase I subunit RPA12 (Zinc ribbon domain-containing protein 1),Znrd1,123,"mRNA cleavage [GO:0006379]; transcription, DNA-templated [GO:0006351]",GO:0003676; GO:0003899; GO:0005730; GO:0006351; GO:0006379; GO:0008270,,,cd10507;,PF01096;,"nucleolus [GO:0005730]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA cleavage [GO:0006379]; transcription, DNA-templated [GO:0006351]"
Q5REW9,CHOYP_ANKRD27.1.1|m.12550,0,0,0,0,0,0,0,0,1.00E-155,Ankyrin repeat domain-containing protein 27,ANKRD27,1050,protein transport [GO:0015031],GO:0005764; GO:0005769; GO:0005770; GO:0005886; GO:0015031; GO:0030659; GO:0042470,,,,PF12796;PF02204;,cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; protein transport [GO:0015031]
Q5VVH5,CHOYP_BRAFLDRAFT_122970.1.1|m.52022,0,0,0,0,0,0,0,0,4.00E-57,Interleukin-1 receptor-associated kinase 1-binding protein 1 (IRAK1-binding protein 1),IRAK1BP1,260,"I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0005737; GO:0006351; GO:0006355; GO:0006955; GO:0007249,,,,PF04402;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q6DGP2,CHOYP_BRAFLDRAFT_238139.1.1|m.12224,0.5,0,0,0,0,0,0,0,1.00E-92,Pre-mRNA-splicing factor syf2,syf2 zgc:92835,238,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],GO:0000974; GO:0006397; GO:0008380; GO:0071013; GO:0071014,,,,PF08231;,catalytic step 2 spliceosome [GO:0071013]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
Q9JJH7,CHOYP_BRAFLDRAFT_70987.2.2|m.58284,1,0,0,0,0,0,0,0,1.00E-52,Transient receptor potential cation channel subfamily M member 5 (Long transient receptor potential channel 5) (LTrpC-5) (LTrpC5) (MLSN1- and TRP-related gene 1 protein),Trpm5 Ltrpc5 Mtr1,1158,ion transmembrane transport [GO:0034220]; sensory perception of taste [GO:0050909],GO:0005227; GO:0005244; GO:0005267; GO:0005272; GO:0005886; GO:0016021; GO:0030425; GO:0034220; GO:0043025; GO:0050909,,,,PF00520;,dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; ion transmembrane transport [GO:0034220]; sensory perception of taste [GO:0050909]
Q8EYT0,CHOYP_BRAFLDRAFT_84838.6.6|m.66693,0,0,0,0,0,0,0,0,3.00E-27,Macro domain-containing protein LA_4133,LA_4133,175,,,,,,PF01661;,
Q8IYE0,CHOYP_CCDC146.1.1|m.11347,1.5,0,0,0,0,0,0,0,0,Coiled-coil domain-containing protein 146,CCDC146 KIAA1505,955,,GO:0005814,,,,,centriole [GO:0005814]
Q5F339,CHOYP_CCHL.2.2|m.66608,0,0,0,0,0,0,0,0,1.00E-108,Cytochrome c-type heme lyase (CCHL) (EC 4.4.1.17) (Holocytochrome c-type synthase),HCCS RCJMB04_37l21,273,cytochrome c-heme linkage [GO:0018063],GO:0004408; GO:0005739; GO:0005743; GO:0018063; GO:0046872,,,,PF01265;,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063]
O14578,CHOYP_CIT.1.2|m.47708,0,0,0,0,0,0,0,0,8.00E-161,Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21),CIT CRIK KIAA0949 STK21,2027,cytokinesis [GO:0000910]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; mitotic nuclear division [GO:0007067]; neuron apoptotic process [GO:0051402]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064],GO:0000086; GO:0000281; GO:0000910; GO:0004674; GO:0005524; GO:0005829; GO:0005886; GO:0007030; GO:0007067; GO:0008064; GO:0016020; GO:0030165; GO:0031985; GO:0032467; GO:0035556; GO:0043025; GO:0046872; GO:0048699; GO:0051402; GO:0097110,,,cd00029;,PF00780;PF00169;PF00069;,cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; cytokinesis [GO:0000910]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; mitotic nuclear division [GO:0007067]; neuron apoptotic process [GO:0051402]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064]
Q8MRC9,CHOYP_DPSE_GA25136.1.1|m.66680,0.5,0,0,0,0,0,0,0,2.00E-35,Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9),pgant9 CG30463,650,multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493],GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872,PATHWAY: Protein modification; protein glycosylation.,,,PF00535;PF00652;,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]
Q5XIS2,CHOYP_DSIM_GD25210.1.1|m.29275,0.5,0,0,0,0,0,0,0,4.00E-42,Ceramide-1-phosphate transfer protein (Glycolipid transfer protein domain-containing protein 1) (CPTP),Cptp Gltpd1,216,ceramide 1-phosphate transport [GO:1902389],GO:0005543; GO:0005548; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0010008; GO:0017089; GO:0051861; GO:1902387; GO:1902388; GO:1902389,,,,PF08718;,cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; glycolipid binding [GO:0051861]; glycolipid transporter activity [GO:0017089]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; ceramide 1-phosphate transport [GO:1902389]
Q8SWR3,CHOYP_DVIR_GJ18645.1.1|m.55503,0,0,0,0,0,0,0,0,2.00E-41,Sex peptide receptor,SPR CG16752,435,"G-protein coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]",GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042,,,,PF10324;,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G-protein coupled peptide receptor activity [GO:0008528]; G-protein coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
Q01780,CHOYP_EXOSC10.1.1|m.39774,0.5,0,0,0,0,0,0,0,0,Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2),EXOSC10 PMSCL PMSCL2 RRP6,885,"CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]",GO:0000166; GO:0000175; GO:0000176; GO:0000178; GO:0000184; GO:0000460; GO:0000956; GO:0003723; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0009048; GO:0016020; GO:0035327; GO:0071028; GO:0071034; GO:0071035; GO:0071044; GO:0071048,,,,PF01612;PF00570;PF08066;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"
P48566,CHOYP_GRT1A.1.2|m.29772,0,0,0,0,0,0,0,0,4.00E-24,GTPase-activating protein GYP3 (Multicopy suppressor of bud emergence 3) (Protein MSB3),MSB3 GYP3 YNL293W N0470,633,activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; formin-nucleated actin cable assembly [GO:0070649]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880],GO:0000131; GO:0000133; GO:0000329; GO:0005096; GO:0005770; GO:0005829; GO:0005886; GO:0005934; GO:0005935; GO:0006887; GO:0006897; GO:0032880; GO:0043087; GO:0070649; GO:0090630,,,,PF00566;,cellular bud neck [GO:0005935]; cellular bud tip [GO:0005934]; cytosol [GO:0005829]; fungal-type vacuole membrane [GO:0000329]; incipient cellular bud site [GO:0000131]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; polarisome [GO:0000133]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; formin-nucleated actin cable assembly [GO:0070649]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]
Q99315,CHOYP_LOC100121360.1.1|m.56328,0,0,0,0,0,0,0,0,1.00E-14,Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)],TY3B-G YGRWTy3-1 POL YGR109W-B G5984,1547,"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]",GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197,,,,PF12384;PF00665;PF00078;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"
Q8N7X2,CHOYP_LOC100175702.1.1|m.56240,1.5,0,0,0,0,0,0,0,0.0000006,Protein STPG3 (Sperm-tail PG-rich repeat-containing protein 3),STPG3 C9orf173,389,,,,,,,
Q8N2S1,CHOYP_LOC100182237.2.2|m.33734,0,0,0,0,0,0,0,0,2.00E-62,Latent-transforming growth factor beta-binding protein 4 (LTBP-4),LTBP4,1624,growth hormone secretion [GO:0030252]; multicellular organism development [GO:0007275]; protein folding [GO:0006457]; regulation of cell differentiation [GO:0045595]; regulation of cell growth [GO:0001558]; regulation of proteolysis [GO:0030162]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0001558; GO:0005024; GO:0005178; GO:0005509; GO:0005539; GO:0005576; GO:0005578; GO:0005615; GO:0006457; GO:0007179; GO:0007275; GO:0017015; GO:0030162; GO:0030252; GO:0031012; GO:0045595; GO:0050431; GO:0070062,,,,PF07645;PF00683;,extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; integrin binding [GO:0005178]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]; growth hormone secretion [GO:0030252]; multicellular organism development [GO:0007275]; protein folding [GO:0006457]; regulation of cell differentiation [GO:0045595]; regulation of cell growth [GO:0001558]; regulation of proteolysis [GO:0030162]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; transforming growth factor beta receptor signaling pathway [GO:0007179]
Q8BYU6,CHOYP_LOC100185473.1.1|m.5316,0,0,0,0,0,0,0,0,0.000002,Torsin-1A-interacting protein 2,Tor1aip2 Ifrg15 Lull1,502,endoplasmic reticulum organization [GO:0007029]; positive regulation of ATPase activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435],GO:0001671; GO:0005635; GO:0005783; GO:0005789; GO:0007029; GO:0016021; GO:0032781; GO:0051117; GO:0090435,,,,PF05609;,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; endoplasmic reticulum organization [GO:0007029]; positive regulation of ATPase activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435]
Q6P2C0,CHOYP_LOC100370122.2.2|m.59310,2.5,0,0,0,0,0,0,0,4.00E-68,WD repeat-containing protein 93,WDR93,686,electron transport chain [GO:0022900],GO:0016651; GO:0022900,,,,,"oxidoreductase activity, acting on NAD(P)H [GO:0016651]; electron transport chain [GO:0022900]"
Q14159,CHOYP_LOC100374845.1.1|m.49323,0.5,0,0,0,0,0,0,0,0.00000001,DNA repair-scaffolding protein (Scaffolding protein involved in DNA repair),SPIDR KIAA0146,915,cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of protein complex assembly [GO:0031334]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of establishment of protein localization to chromosome [GO:0070202],GO:0000228; GO:0000724; GO:0005654; GO:0006974; GO:0010569; GO:0031334; GO:0070202; GO:0071479; GO:0072711; GO:0072757; GO:2000781,,,,PF14950;PF14951;,nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of protein complex assembly [GO:0031334]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of establishment of protein localization to chromosome [GO:0070202]
Q3T0Z5,CHOYP_LOC100375896.1.2|m.23761,0,0,0,0,0,0,0,0,3.00E-32,Leukocyte receptor cluster member 1 homolog,LENG1,263,,,,,,PF10197;,
Q14624,CHOYP_LOC100692402.2.2|m.49856,0,0,0,0,0,0,0,0,7.00E-123,Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4],ITIH4 IHRP ITIHL1 PK120 PRO1851,930,acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097],GO:0002576; GO:0004866; GO:0004867; GO:0005576; GO:0005886; GO:0006953; GO:0030212; GO:0031089; GO:0034097; GO:0070062; GO:0072562,,,,PF06668;PF08487;PF00092;,blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]
Q8CDF7,CHOYP_LOC100875978.1.1|m.34640,5.5,0,0,0,0,0,0,0,0.0000003,piRNA biogenesis protein EXD1 (Exonuclease 3'-5' domain-containing protein 1) (Exonuclease 3'-5' domain-like-containing protein 1) (Inactive exonuclease EXD1) (mExd1),Exd1 Exdl1,570,gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587],GO:0003723; GO:0031047; GO:0034587; GO:0042803; GO:0043186; GO:0051321; GO:1990923,,,,PF01612;,P granule [GO:0043186]; PET complex [GO:1990923]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]
Q5HY98,CHOYP_LOC100888889.1.1|m.14397,0,0,0,0,0,0,0,0,3.00E-22,Zinc finger protein 766,ZNF766,468,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872,,,cd07765;,PF01352;PF00096;PF13912;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q1RJN6,CHOYP_LOC583072.4.25|m.20255,0,0,0,0,0,0,0,0,0.00000006,Putative ankyrin repeat protein RBE_0347,RBE_0347,334,,,,,,PF12796;,
Q2KJC3,CHOYP_MPEG1.4.5|m.49975,0,0,0,0,0,0,0,0,6.00E-157,Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1),MPEG1,717,,GO:0016021,,,,PF01823;,integral component of membrane [GO:0016021]
Q9JLC8,CHOYP_NEMVEDRAFT_V1G247395.1.8|m.5020,0.5,0,0,0,0,0,0,0,2.00E-44,Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29),Sacs Kiaa0730,4582,,GO:0005737; GO:0050750,,,,PF05168;,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750]
Q5R995,CHOYP_PABP4.5.6|m.38922,0,0,0,0,0,0,0,0,0.000000001,CUGBP Elav-like family member 1 (CELF-1) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (RNA-binding protein BRUNOL-2),CELF1 CUGBP1,513,mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],GO:0000166; GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0008380; GO:0043484,,,cd12631;cd12634;cd12638;,PF00076;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]
A4IFW2,CHOYP_PTPRA.19.22|m.59233,0,0,0,0,0,0,0,0,6.00E-72,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48),ptprf si:dkey-21k10.1,1909,cell adhesion [GO:0007155]; sensory neuron axon guidance [GO:0097374],GO:0004725; GO:0007155; GO:0008201; GO:0016021; GO:0097374,,,cd00063;,PF00041;PF07679;PF00102;,integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; sensory neuron axon guidance [GO:0097374]
Q46AN4,CHOYP_RS3A.10.15|m.40676,0,0,0,0,0,0,0,0,6.00E-21,30S ribosomal protein S3Ae (Ribosomal protein S1e),rps3ae Mbar_A2127,207,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412,,,,PF01015;,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
P08842,CHOYP_STS.1.1|m.35785,0,0,0,0,0,0,0,0,8.00E-158,Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase),STS ARSC1,583,epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]; steroid catabolic process [GO:0006706],GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006687; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0016021; GO:0043231; GO:0043687; GO:0046872,,,,PF00884;,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]; epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]; steroid catabolic process [GO:0006706]
A0JMD4,CHOYP_TPC2.1.2|m.19378,0,0,0,0,0,0,0,0,0,Two pore calcium channel protein 2 (Voltage-dependent calcium channel protein TPC2),tpcn2 tpc2 zgc:152898,774,membrane depolarization during action potential [GO:0086010]; smooth muscle contraction [GO:0006939],GO:0005245; GO:0005764; GO:0005765; GO:0005886; GO:0006939; GO:0016021; GO:0072345; GO:0086010,,,,PF00520;,integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; membrane depolarization during action potential [GO:0086010]; smooth muscle contraction [GO:0006939]
O23300,CHOYP_TRIADDRAFT_52755.1.1|m.64495,0,0,0,0,0,0,0,0,1.00E-25,"Enoyl-CoA delta isomerase 3 (EC 5.3.3.8) (3-hydroxyacyl-CoA dehydratase 1) (Delta(3),Delta(2)-enoyl CoA isomerase 3) (AtECI3)",ECI3 HCD1 At4g14440 dl3260c,238,fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; response to karrikin [GO:0080167],GO:0004165; GO:0005634; GO:0005829; GO:0006635; GO:0009062; GO:0080167,PATHWAY: Lipid metabolism; fatty acid beta-oxidation. {ECO:0000305}.,,,PF00378;,cytosol [GO:0005829]; nucleus [GO:0005634]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; response to karrikin [GO:0080167]
Q9JJH7,CHOYP_TRPM3.3.7|m.16169,0,0,0,0,0,0,0,0,6.00E-119,Transient receptor potential cation channel subfamily M member 5 (Long transient receptor potential channel 5) (LTrpC-5) (LTrpC5) (MLSN1- and TRP-related gene 1 protein),Trpm5 Ltrpc5 Mtr1,1158,ion transmembrane transport [GO:0034220]; sensory perception of taste [GO:0050909],GO:0005227; GO:0005244; GO:0005267; GO:0005272; GO:0005886; GO:0016021; GO:0030425; GO:0034220; GO:0043025; GO:0050909,,,,PF00520;,dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; ion transmembrane transport [GO:0034220]; sensory perception of taste [GO:0050909]
Q5UPV1,CHOYP_TVAG_291510.9.9|m.53036,0,0,0,0,0,0,0,0,0.000000007,Putative ankyrin repeat protein L271,MIMI_L271,728,,,,,,PF12796;,
P10394,CHOYP_YG31B.1.3|m.6174,0.5,0,0,0,0,0,0,0,1.00E-93,Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease],POL ORF3,1237,DNA integration [GO:0015074],GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074,,,cd06095;,PF00665;PF00077;PF00078;PF09337;,aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]
Q8R205,CHOYP_ZC3HA.1.1|m.27569,1,0,0,0,0,0,0,0,3.00E-76,Zinc finger CCCH domain-containing protein 10,Zc3h10,435,,GO:0003723; GO:0046872,,,,PF00642;,metal ion binding [GO:0046872]; RNA binding [GO:0003723]
P48445,CHOYP_BPL1.1.1|m.15002,0,0,0,0,0,0,0,0,1.00E-21,Biotin--protein ligase (EC 6.3.4.-) (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase (EC 6.3.4.9); Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase (EC 6.3.4.10) (Holocarboxylase synthetase) (HCS); Biotin--[methylcrotonoyl-CoA-carboxylase] ligase (EC 6.3.4.11); Biotin--[acetyl-CoA-carboxylase] ligase (EC 6.3.4.15)],BPL1 ACC2 YDL141W D2140,690,protein biotinylation [GO:0009305],GO:0004077; GO:0004078; GO:0004079; GO:0004080; GO:0005524; GO:0005737; GO:0009305; GO:0071734,,,,PF02237;PF03099;PF09825;,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-[pyruvate-carboxylase] ligase activity [GO:0071734]; protein biotinylation [GO:0009305]
P58340,CHOYP_BRAFLDRAFT_127486.1.1|m.57687,0.5,0,0,0,0,0,0,0,4.00E-39,Myeloid leukemia factor 1 (Myelodysplasia-myeloid leukemia factor 1),MLF1,268,"cell cycle arrest [GO:0007050]; myeloid progenitor cell differentiation [GO:0002318]; transcription, DNA-templated [GO:0006351]",GO:0002318; GO:0003677; GO:0005634; GO:0005737; GO:0006351; GO:0007050; GO:0019904,,,,PF10248;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; cell cycle arrest [GO:0007050]; myeloid progenitor cell differentiation [GO:0002318]; transcription, DNA-templated [GO:0006351]"
Q91WV0,CHOYP_BRAFLDRAFT_68934.1.2|m.57609,0.5,0,0,0,0,0,0,0,2.00E-66,Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein),Dr1,176,"histone H3 acetylation [GO:0043966]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0005671; GO:0006351; GO:0006355; GO:0017025; GO:0043966,,,,PF00808;,"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleus [GO:0005634]; DNA binding [GO:0003677]; TBP-class protein binding [GO:0017025]; histone H3 acetylation [GO:0043966]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q98949,CHOYP_BRAFLDRAFT_99630.5.9|m.36500,0,0,0,0,0,0,0,0,1.00E-32,Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Retina-expressed kinase) (Rek),TYRO3 REK,873,cell adhesion [GO:0007155],GO:0004714; GO:0005524; GO:0005886; GO:0007155; GO:0016021,,,cd00063;,PF00041;PF07679;PF07714;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell adhesion [GO:0007155]
Q8AY75,CHOYP_CALM.37.50|m.52385,0,0,0,0,0,0,0,0,1.00E-37,Calglandulin,,156,,GO:0005509; GO:0005737,,,cd00051;,PF13499;PF13833;,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]
Q9NRH2,CHOYP_CPIPJ_CPIJ003599.1.1|m.61267,0,0,0,0,0,0,0,0,0,SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase),SNRK KIAA0096 SNFRK,765,intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468],GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0030099; GO:0035556,,,,PF00069;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468]
Q9TUP7,CHOYP_LOC100120994.1.1|m.54109,0,0,0,0,0,0,0,0,4.00E-91,Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2),HCRTR2,444,"cellular response to hormone stimulus [GO:0032870]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to peptide [GO:1901652]",GO:0005887; GO:0007200; GO:0007218; GO:0007631; GO:0010840; GO:0016499; GO:0022410; GO:0032870; GO:0042277; GO:0045187; GO:0051480; GO:1901652,,,,PF00001;PF03827;,"integral component of plasma membrane [GO:0005887]; orexin receptor activity [GO:0016499]; peptide binding [GO:0042277]; cellular response to hormone stimulus [GO:0032870]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to peptide [GO:1901652]"
P19208,CHOYP_LOC100200137.1.1|m.23041,0,0,0,0,0,0,0,0,0,Heat shock 70 kDa protein C,hsp-3 CBG14829,661,endoplasmic reticulum unfolded protein response [GO:0030968],GO:0005524; GO:0005788; GO:0030968,,,,PF00012;,endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; endoplasmic reticulum unfolded protein response [GO:0030968]
Q5EB30,CHOYP_LOC100207216.2.2|m.28185,2,0,0,0,0,0,0,0,6.00E-45,Outer dense fiber protein 3 (Outer dense fiber of sperm tails protein 3),odf3 TTpA001k06.1,256,,GO:0005737,,,,PF07004;,cytoplasm [GO:0005737]
Q9R1R2,CHOYP_LOC100213744.9.19|m.37687,0,0,0,0,0,0,0,0,0.0000006,Tripartite motif-containing protein 3 (RING finger protein 22) (RING finger protein HAC1),Trim3 Hac1 Rnf22,744,protein transport [GO:0015031]; protein ubiquitination [GO:0016567],GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0061630,,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]
Q66IC8,CHOYP_LOC100371143.1.1|m.27046,1.5,0,0,0,0,0,0,0,2.00E-26,Tctex1 domain-containing protein 1,tctex1d1 zgc:101774,173,,,,,,PF03645;,
Q9R0M5,CHOYP_LOC100371654.1.1|m.14188,0.5,0,0,0,0,0,0,0,8.00E-75,Thiamin pyrophosphokinase 1 (mTPK1) (EC 2.7.6.2) (Thiamine pyrophosphokinase 1),Tpk1,243,thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772],GO:0004788; GO:0005524; GO:0006772; GO:0009229; GO:0016301; GO:0030975,PATHWAY: Cofactor biosynthesis; thiamine diphosphate biosynthesis; thiamine diphosphate from thiamine: step 1/1.,,cd07995;,PF04265;PF04263;,ATP binding [GO:0005524]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772]
Q9R1R2,CHOYP_LOC100374741.55.83|m.53276,0,0,0,0,0,0,0,0,2.00E-12,Tripartite motif-containing protein 3 (RING finger protein 22) (RING finger protein HAC1),Trim3 Hac1 Rnf22,744,protein transport [GO:0015031]; protein ubiquitination [GO:0016567],GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0061630,,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]
Q9VCX1,CHOYP_LOC100889318.1.1|m.61506,0,0,0,0,0,0,0,0,9.00E-72,Regulator of G-protein signaling loco (RGS) (Locomotion defects protein) (Loco),loco CG5248,1541,"adult chitin-containing cuticle pigmentation [GO:0048085]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization [GO:0008105]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; glial cell differentiation [GO:0010001]; G-protein coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G-protein coupled receptor protein signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]",GO:0000578; GO:0001965; GO:0003015; GO:0005057; GO:0005092; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0006979; GO:0007049; GO:0007186; GO:0007303; GO:0007310; GO:0007419; GO:0008069; GO:0008105; GO:0008277; GO:0009408; GO:0009786; GO:0010001; GO:0014045; GO:0016324; GO:0019991; GO:0030866; GO:0032291; GO:0042594; GO:0045179; GO:0048085; GO:0050832; GO:0055059; GO:0060857,,,,PF00595;PF02196;PF00615;,"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; signal transducer activity, downstream of receptor [GO:0005057]; adult chitin-containing cuticle pigmentation [GO:0048085]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization [GO:0008105]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; G-protein coupled receptor signaling pathway [GO:0007186]; glial cell differentiation [GO:0010001]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G-protein coupled receptor protein signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]"
A1A4J8,CHOYP_LOC657827.1.1|m.26986,0,0,0,0,0,0,0,0,2.00E-71,"Protein SCO1 homolog, mitochondrial",SCO1 SCOD1,305,cellular copper ion homeostasis [GO:0006878]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of proteasomal protein catabolic process [GO:1901799],GO:0005739; GO:0006878; GO:0030016; GO:0033617; GO:0046872; GO:0072492; GO:1901799,,,cd02968;,PF02630;,host cell mitochondrial intermembrane space [GO:0072492]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; metal ion binding [GO:0046872]; cellular copper ion homeostasis [GO:0006878]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of proteasomal protein catabolic process [GO:1901799]
Q9Y2H2,CHOYP_LOC663138.1.1|m.7661,0,0,0,0,0,0,0,0,1.00E-109,Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2),INPP5F KIAA0966 SAC2 MSTP007 MSTP047,1132,adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of Stat3 protein [GO:0042518]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896],GO:0001921; GO:0005769; GO:0005905; GO:0006661; GO:0008344; GO:0008934; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0031901; GO:0033137; GO:0034595; GO:0034596; GO:0042518; GO:0042803; GO:0043025; GO:0045334; GO:0046856; GO:0048015; GO:0048681; GO:0051896; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135,,,,PF12456;PF02383;,axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; protein homodimerization activity [GO:0042803]; adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of Stat3 protein [GO:0042518]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896]
Q6P423,CHOYP_MED23.1.1|m.13417,0,0,0,0,0,0,0,0,0,Mediator of RNA polymerase II transcription subunit 23 (Mediator complex subunit 23),med23,1369,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0006351; GO:0006355,,,,PF11573;,"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q9D9R9,CHOYP_NEMVEDRAFT_V1G214844.22.34|m.54623,1.5,0,0,0,0,0,0,0,3.00E-25,Protein FAM186A,FAM186A Gm920,1790,,,,,,,
P23665,CHOYP_NEMVEDRAFT_V1G83869.3.3|m.30283,2,0,0,0,0,0,0,0,1.00E-11,"Endoglucanase A (EC 3.2.1.4) (Cellulase) (Endo-1,4-beta-glucanase)",endA,453,cellulose catabolic process [GO:0030245],GO:0008810; GO:0030245; GO:0042597,,,,PF00759;,periplasmic space [GO:0042597]; cellulase activity [GO:0008810]; cellulose catabolic process [GO:0030245]
Q8N584,CHOYP_TT39C.1.1|m.6317,0,0,0,0,0,0,0,0,3.00E-178,Tetratricopeptide repeat protein 39C (TPR repeat protein 39C),TTC39C C18orf17,583,,,,,,PF10300;,
P13635,CHOYP_BRAFLDRAFT_74383.1.1|m.14279,0,0,0,0,0,0,0,0,1.00E-88,Ceruloplasmin (EC 1.16.3.1) (Ferroxidase),Cp,1059,aging [GO:0007568]; cellular iron ion homeostasis [GO:0006879]; liver development [GO:0001889]; lung development [GO:0030324]; plasma membrane copper ion transport [GO:0015679]; response to copper ion [GO:0046688]; response to nutrient [GO:0007584],GO:0001889; GO:0004322; GO:0005507; GO:0005615; GO:0006879; GO:0007568; GO:0007584; GO:0015679; GO:0030324; GO:0046658; GO:0046688,,,,PF00394;PF07731;PF07732;,anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; aging [GO:0007568]; cellular iron ion homeostasis [GO:0006879]; liver development [GO:0001889]; lung development [GO:0030324]; plasma membrane copper ion transport [GO:0015679]; response to copper ion [GO:0046688]; response to nutrient [GO:0007584]
O14815,CHOYP_CAPN9.1.1|m.9975,0,0,0,0,0,0,0,0,6.00E-143,Calpain-9 (EC 3.4.22.-) (Digestive tract-specific calpain) (New calpain 4) (nCL-4) (Protein CG36),CAPN9 NCL4,690,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007586,,,cd00214;cd00044;cd00051;,PF01067;PF13833;PF00648;,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508]
Q8VHK2,CHOYP_CSKI2.1.1|m.29327,0,0,0,0,0,0,0,0,4.00E-114,Caskin-1 (CASK-interacting protein 1),Caskin1,1430,signal transduction [GO:0007165],GO:0005737; GO:0007165; GO:0016020; GO:0019904,,,,PF12796;PF16632;PF16600;PF00536;PF07653;,cytoplasm [GO:0005737]; membrane [GO:0016020]; protein domain specific binding [GO:0019904]; signal transduction [GO:0007165]
Q761V0,CHOYP_DGRI_GH22876.2.3|m.54068,0.5,0,0,0,0,0,0,0,1.00E-180,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),Slc6a5 Glyt2,799,"glycine import [GO:0036233]; synaptic transmission, glycinergic [GO:0060012]",GO:0005328; GO:0005886; GO:0005887; GO:0015375; GO:0036233; GO:0046872; GO:0060012,,,,PF00209;,"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; glycine import [GO:0036233]; synaptic transmission, glycinergic [GO:0060012]"
Q9JLY7,CHOYP_LOAG_05814.1.1|m.56611,0,0,0,0,0,0,0,0,2.00E-58,Dual specificity protein phosphatase 14 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 6) (MAP kinase phosphatase 6) (MKP-6),Dusp14 Mkp6,198,peptidyl-tyrosine dephosphorylation [GO:0035335],GO:0003723; GO:0004725; GO:0005634; GO:0005737; GO:0017017; GO:0035335,,,cd00127;,PF00782;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]; peptidyl-tyrosine dephosphorylation [GO:0035335]
O75319,CHOYP_LOC100179134.1.1|m.23870,0,0,0,0,0,0,0,0,3.00E-47,RNA/RNP complex-1-interacting phosphatase (EC 3.1.3.-) (Dual specificity protein phosphatase 11) (Phosphatase that interacts with RNA/RNP complex 1),DUSP11 PIR1,330,polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396],GO:0001650; GO:0003723; GO:0004651; GO:0004725; GO:0005634; GO:0006396; GO:0006470; GO:0008138; GO:0016070; GO:0016607; GO:0016791; GO:0045171; GO:0098507; GO:0098519,,,,PF00782;,"fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA binding [GO:0003723]; polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"
Q4R6F0,CHOYP_LOC100187348.1.1|m.29904,1,0,0,0,0,0,0,0,5.00E-54,Leucine-rich repeat and death domain-containing protein 1,LRRD1 QtsA-18164,863,signal transduction [GO:0007165],GO:0007165,,,,PF13855;,signal transduction [GO:0007165]
P32018,CHOYP_LOC100369879.3.3|m.59095,0,0,0,0,0,0,0,0,3.00E-21,Collagen alpha-1(XIV) chain (Undulin),COL14A1,1888,cell adhesion [GO:0007155],GO:0005578; GO:0005581; GO:0007155,,,cd00063;,PF01391;PF00041;PF00092;,collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
P24045,CHOYP_LOC100533289.6.6|m.59221,0,0,0,0,0,0,0,0,4.00E-82,Gamma-aminobutyric acid receptor subunit beta-4 (GABA(A) receptor subunit beta-4),GABRB4,488,,GO:0004890; GO:0005230; GO:0005254; GO:0030054; GO:0034707; GO:0045211; GO:1902711,,,,PF02931;PF02932;,cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]
A9JS71,CHOYP_LOC100695307.1.1|m.51209,0.5,0,0,0,0,0,0,0,1.00E-115,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",echdc3,294,metabolic process [GO:0008152],GO:0003824; GO:0005739; GO:0008152,,,,PF00378;,mitochondrion [GO:0005739]; catalytic activity [GO:0003824]; metabolic process [GO:0008152]
Q68LP1,CHOYP_LOC100865663.1.1|m.9283,0,0,0,0,0,0,0,0,8.00E-23,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RBSC-skeletrophin/dystrophin-like polypeptide) (RING-type E3 ubiquitin transferase MIB2),Mib2,971,Notch signaling pathway [GO:0007219],GO:0004842; GO:0005737; GO:0005768; GO:0007219; GO:0008270,PATHWAY: Protein modification; protein ubiquitination.,,,PF12796;PF06701;PF00569;,cytoplasm [GO:0005737]; endosome [GO:0005768]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]
Q8K1S3,CHOYP_LOC101236385.3.6|m.4348,0,0,0,0,0,0,0,0,2.00E-25,Netrin receptor UNC5B (Protein unc-5 homolog 2) (Protein unc-5 homolog B),Unc5b Unc5h2,945,angiogenesis [GO:0001525]; anterior/posterior axon guidance [GO:0033564]; axon guidance [GO:0007411]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068],GO:0001525; GO:0005829; GO:0005886; GO:0007411; GO:0014068; GO:0016021; GO:0033564; GO:0043524; GO:0045121; GO:0097192; GO:2001240,,,,PF00531;PF07679;PF00090;PF17217;PF00791;,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; anterior/posterior axon guidance [GO:0033564]; axon guidance [GO:0007411]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]
Q25379,CHOYP_LOC101470738.2.2|m.26124,0,0,0,0,0,0,0,0,4.00E-41,"Actin, cytoskeletal 3 (LPC3) (Fragment)",,172,,GO:0005524; GO:0005737; GO:0005856,,,,PF00022;,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
Q8BUG5,CHOYP_LOC579381.1.1|m.10900,0,0,0,0,0,0,0,0,8.00E-95,Calcyphosin-2 (Calcyphosine-2),Caps2,550,calcium ion homeostasis [GO:0055074],GO:0005432; GO:0005509; GO:0055074,,,,,calcium ion binding [GO:0005509]; calcium:sodium antiporter activity [GO:0005432]; calcium ion homeostasis [GO:0055074]
P55265,CHOYP_LOC584058.1.1|m.59244,0.5,0,0,0,0,0,0,0,1.00E-142,Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP),ADAR ADAR1 DSRAD G1P1 IFI4,1226,adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; innate immune response [GO:0045087]; in utero embryonic development [GO:0001701]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of RNA interference [GO:1900369]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; somatic diversification of immune receptors via somatic mutation [GO:0002566]; type I interferon signaling pathway [GO:0060337],GO:0001649; GO:0001701; GO:0002244; GO:0002566; GO:0003677; GO:0003723; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006397; GO:0006606; GO:0006611; GO:0009615; GO:0016020; GO:0016553; GO:0030218; GO:0031054; GO:0035280; GO:0035455; GO:0043066; GO:0044387; GO:0044530; GO:0045070; GO:0045071; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060337; GO:0060339; GO:0061484; GO:0098586; GO:1900369,,,,PF02137;PF00035;PF02295;,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of RNA interference [GO:1900369]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; somatic diversification of immune receptors via somatic mutation [GO:0002566]; type I interferon signaling pathway [GO:0060337]
A4IF87,CHOYP_LOC590838.1.1|m.24953,0,0,0,0,0,0,0,0,6.00E-167,Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase),GNPAT,680,ether lipid biosynthetic process [GO:0008611]; glycerophospholipid metabolic process [GO:0006650],GO:0005778; GO:0006650; GO:0008611; GO:0016287,PATHWAY: Membrane lipid metabolism; glycerophospholipid metabolism.,,,PF01553;,peroxisomal membrane [GO:0005778]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid metabolic process [GO:0006650]
Q9HB75,CHOYP_PIDD.1.1|m.54294,9.5,0,0,0,0,0,0,0,0.00000001,p53-induced death domain-containing protein 1 (Leucine-rich repeat and death domain-containing protein),PIDD1 LRDD PIDD,910,"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]",GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0006977; GO:0007165; GO:0042981; GO:0043065; GO:0043066; GO:0051092; GO:1902043,,,,PF00531;PF13855;PF10461;PF00791;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; death receptor binding [GO:0005123]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]"
Q2PZL6,CHOYP_RB886.1.1|m.36185,0,0,0,0,0,0,0,0,1.00E-23,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Fat4 Fatj,4981,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005622; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072006; GO:0072137; GO:0072307,,,,PF00028;PF00008;PF07645;PF12661;PF02210;,apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
Q9JJT0,CHOYP_RCL1.1.1|m.7474,0,0,0,0,0,0,0,0,2.00E-170,RNA 3'-terminal phosphate cyclase-like protein,Rcl1 Rnac,373,"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; rRNA processing [GO:0006364]",GO:0000447; GO:0000480; GO:0003824; GO:0005730; GO:0006364,,,cd00875;,PF01137;PF05189;,"nucleolus [GO:0005730]; catalytic activity [GO:0003824]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; rRNA processing [GO:0006364]"
Q761V0,CHOYP_SC6A9.5.6|m.26569,0,0,0,0,0,0,0,0,0,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),Slc6a5 Glyt2,799,"glycine import [GO:0036233]; synaptic transmission, glycinergic [GO:0060012]",GO:0005328; GO:0005886; GO:0005887; GO:0015375; GO:0036233; GO:0046872; GO:0060012,,,,PF00209;,"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; glycine import [GO:0036233]; synaptic transmission, glycinergic [GO:0060012]"
Q9H9B4,CHOYP_SFXN1.1.1|m.27758,0,0,0,0,0,0,0,0,9.00E-158,Sideroflexin-1 (Tricarboxylate carrier protein) (TCC),SFXN1,322,erythrocyte differentiation [GO:0030218]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826],GO:0005739; GO:0005743; GO:0006826; GO:0015075; GO:0016021; GO:0030218; GO:0055072,,,,PF03820;,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ion transmembrane transporter activity [GO:0015075]; erythrocyte differentiation [GO:0030218]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]
Q9VF08,CHOYP_SMP_168770.1.1|m.18618,1.5,0,0,0,0,0,0,0,4.00E-42,Mitochondrial import inner membrane translocase subunit Tim16 (Protein black pearl),blp CG5268,141,embryonic development via the syncytial blastoderm [GO:0001700]; instar larval development [GO:0002168]; neurogenesis [GO:0022008]; protein import into mitochondrial matrix [GO:0030150],GO:0001700; GO:0002168; GO:0005744; GO:0022008; GO:0030150,,,,,mitochondrial inner membrane presequence translocase complex [GO:0005744]; embryonic development via the syncytial blastoderm [GO:0001700]; instar larval development [GO:0002168]; neurogenesis [GO:0022008]; protein import into mitochondrial matrix [GO:0030150]
Q01841,CHOYP_TGM1.2.2|m.59718,0,0,0,0,0,0,0,0,2.00E-117,Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (Tissue transglutaminase) (Transglutaminase C) (TG(C)) (TGC) (TGase C) (Transglutaminase-2) (TGase-2),TGL2,689,peptide cross-linking [GO:0018149],GO:0003810; GO:0018149; GO:0046872,,,,PF00927;PF01841;PF00868;,metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]
Q24K03,CHOYP_THUM1.1.1|m.47876,0.5,0,0,0,0,0,0,0,8.00E-67,THUMP domain-containing protein 1,THUMPD1,357,tRNA modification [GO:0006400],GO:0003723; GO:0006400,,,,PF02926;,RNA binding [GO:0003723]; tRNA modification [GO:0006400]
Q8IUH5,CHOYP_ZDHHC17.1.1|m.29726,0.5,0,0,0,0,0,0,0,0,Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17) (DHHC-17),ZDHHC17 HIP14 HIP3 HYPH KIAA0946 HSPC294,632,lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345],GO:0000139; GO:0004871; GO:0005794; GO:0005829; GO:0015095; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0030054; GO:0030659; GO:0030660; GO:0042734; GO:0042802; GO:0042953; GO:0043123; GO:0043231,,,,PF12796;PF01529;,cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; signal transducer activity [GO:0004871]; lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345]
Q96RW7,CHOYP_AGAP_AGAP010186.1.1|m.62503,0,0,0,0,0,0,0,0,2.00E-19,Hemicentin-1 (Fibulin-6) (FIBL-6),HMCN1 FIBL6,5635,cell cycle [GO:0007049]; cell division [GO:0051301]; response to stimulus [GO:0050896]; visual perception [GO:0007601],GO:0005509; GO:0005604; GO:0005938; GO:0007049; GO:0007601; GO:0030054; GO:0032154; GO:0050896; GO:0051301; GO:0070062,,,cd00255;,PF12662;PF07645;PF07474;PF07679;PF00090;,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
Q8QGW7,CHOYP_BCL3.2.2|m.57487,0,0,0,0,0,0,0,0,7.00E-24,Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog) (Small integral membrane protein of lysosome/late endosome),LITAF SIMPLE,148,"cytokine production [GO:0001816]; regulation of transcription, DNA-templated [GO:0006355]; sexual reproduction [GO:0019953]; transcription, DNA-templated [GO:0006351]",GO:0001816; GO:0005125; GO:0005765; GO:0006351; GO:0006355; GO:0019953,,,,PF10601;,"lysosomal membrane [GO:0005765]; cytokine activity [GO:0005125]; cytokine production [GO:0001816]; regulation of transcription, DNA-templated [GO:0006355]; sexual reproduction [GO:0019953]; transcription, DNA-templated [GO:0006351]"
Q9X6U2,CHOYP_BN6_64710.1.1|m.52168,0.5,0,0,0,0,0,0,0,2.00E-11,D-beta-hydroxybutyrate dehydrogenase (BDH) (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (3-HBDH),hbdH1 H16_A1334,258,,GO:0003858,,,,PF00106;,3-hydroxybutyrate dehydrogenase activity [GO:0003858]
Q5BK43,CHOYP_BRAFLDRAFT_119549.1.1|m.56597,1,0,0,0,0,0,0,0,5.00E-12,Epithelial-stromal interaction protein 1,Epsti1,314,,,,,,,
Q8NDA2,CHOYP_BRAFLDRAFT_205939.3.3|m.64021,0,0,0,0,0,0,0,0,3.00E-23,Hemicentin-2,HMCN2,5059,positive regulation of cell migration [GO:0030335]; response to stimulus [GO:0050896]; smooth muscle contraction [GO:0006939],GO:0005509; GO:0005604; GO:0005938; GO:0006939; GO:0030054; GO:0030335; GO:0032154; GO:0050896,,,,PF12662;PF07645;PF07474;PF07679;,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; calcium ion binding [GO:0005509]; positive regulation of cell migration [GO:0030335]; response to stimulus [GO:0050896]; smooth muscle contraction [GO:0006939]
O18404,CHOYP_BRAFLDRAFT_291364.1.1|m.47990,0.5,0,0,0,0,0,0,0,2.00E-54,3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Scully protein) (Type II HADH),scu CG7113,255,acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ATP metabolic process [GO:0046034]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; mitochondrion morphogenesis [GO:0070584]; steroid metabolic process [GO:0008202],GO:0003857; GO:0004303; GO:0005739; GO:0005811; GO:0005829; GO:0005875; GO:0006631; GO:0006637; GO:0008202; GO:0008205; GO:0008209; GO:0008210; GO:0016229; GO:0018454; GO:0030283; GO:0046034; GO:0047015; GO:0047022; GO:0047035; GO:0070584; GO:0090646,,,,PF00106;,cytosol [GO:0005829]; lipid particle [GO:0005811]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ATP metabolic process [GO:0046034]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; mitochondrion morphogenesis [GO:0070584]; steroid metabolic process [GO:0008202]
Q9JHA8,CHOYP_BRAFLDRAFT_63397.6.8|m.48804,0,0,0,0,0,0,0,0,2.00E-53,von Willebrand factor A domain-containing protein 7 (Protein G7c),Vwa7 D17h6s56e-3 G7c,891,,GO:0005576,,,,,extracellular region [GO:0005576]
Q5XIK8,CHOYP_CCNB.2.2|m.16936,0.5,0,0,0,0,0,0,0,1.00E-127,CTD small phosphatase-like protein 2 (CTDSP-like 2) (EC 3.1.3.-),Ctdspl2,465,,GO:0004721,,,,PF03031;,phosphoprotein phosphatase activity [GO:0004721]
Q8CB62,CHOYP_CNTROB.1.1|m.11584,0,0,0,0,0,0,0,0,9.00E-62,Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8),Cntrob Lip8,887,centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410],GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0019904; GO:0051299; GO:1902410,,,,,centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein domain specific binding [GO:0019904]; centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]
Q9VZW5,CHOYP_CRE_21950.1.1|m.55,0,0,0,0,0,0,0,0,7.00E-24,FMRFamide receptor (DFR) (DrmFMRFa-R) (Larval opioid receptor),FR FMRFaR CG2114,549,adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G-protein coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204],GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021,,,,PF10324;,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G-protein coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G-protein coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
P80416,CHOYP_CSTA.1.3|m.6422,1,0,0,0,0,0,0,0,2.00E-16,"Cystatin-A (Cystatin-AS) (Stefin-A) [Cleaved into: Cystatin-A, N-terminally processed]",CSTA STF1,98,,GO:0004869; GO:0005737,,,cd00042;,PF00031;,cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity [GO:0004869]
Q28I29,CHOYP_DTWD1.1.1|m.49358,0,0,0,0,0,0,0,0,3.00E-68,DTW domain-containing protein 1,dtwd1 TEgg073n17.1,294,,,,,,PF03942;,
Q6GQ69,CHOYP_FAF2A.1.1|m.27947,0,0,0,0,0,0,0,0,8.00E-169,FAS-associated factor 2-B (UBX domain-containing protein 8-B),faf2-b ubxd8-b,445,,GO:0005783; GO:0005811,,,,PF00789;,endoplasmic reticulum [GO:0005783]; lipid particle [GO:0005811]
Q9ESL4,CHOYP_FGFR2.2.3|m.53947,0.5,0,0,0,0,0,0,0,3.00E-25,Mitogen-activated protein kinase kinase kinase MLT (EC 2.7.11.25) (Leucine zipper- and sterile alpha motif kinase ZAK) (MLK-like mitogen-activated protein triple kinase) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK),Zak Mltk,802,activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cell cycle checkpoint [GO:0000075]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; intracellular signal transduction [GO:0035556]; limb development [GO:0060173]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]; response to radiation [GO:0009314],GO:0000075; GO:0000077; GO:0000287; GO:0003723; GO:0004674; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007010; GO:0007050; GO:0007257; GO:0009314; GO:0035556; GO:0042733; GO:0043065; GO:0060173,,,,PF07714;PF00536;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cell cycle checkpoint [GO:0000075]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; intracellular signal transduction [GO:0035556]; limb development [GO:0060173]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]; response to radiation [GO:0009314]
Q8QGW7,CHOYP_GLRA3.1.2|m.53462,0,0,0,0,0,0,0,0,4.00E-22,Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog) (Small integral membrane protein of lysosome/late endosome),LITAF SIMPLE,148,"cytokine production [GO:0001816]; regulation of transcription, DNA-templated [GO:0006355]; sexual reproduction [GO:0019953]; transcription, DNA-templated [GO:0006351]",GO:0001816; GO:0005125; GO:0005765; GO:0006351; GO:0006355; GO:0019953,,,,PF10601;,"lysosomal membrane [GO:0005765]; cytokine activity [GO:0005125]; cytokine production [GO:0001816]; regulation of transcription, DNA-templated [GO:0006355]; sexual reproduction [GO:0019953]; transcription, DNA-templated [GO:0006351]"
Q3EBC8,CHOYP_IFIH1.3.14|m.24387,0,0,0,0,0,0,0,0,4.00E-16,Endoribonuclease Dicer homolog 2 (EC 3.1.26.-) (Dicer-like protein 2) (AtDCL2),At3g03300 T17B22.1,1388,maintenance of DNA methylation [GO:0010216]; production of siRNA involved in RNA interference [GO:0030422]; production of ta-siRNAs involved in RNA interference [GO:0010267]; RNA virus induced gene silencing [GO:0051214],GO:0003723; GO:0004386; GO:0004525; GO:0005524; GO:0005634; GO:0005737; GO:0010216; GO:0010267; GO:0016442; GO:0030422; GO:0046872; GO:0051214,,,cd00593;,PF00270;PF03368;PF00271;PF02170;PF00636;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; maintenance of DNA methylation [GO:0010216]; production of siRNA involved in RNA interference [GO:0030422]; production of ta-siRNAs involved in RNA interference [GO:0010267]; RNA virus induced gene silencing [GO:0051214]
P23229,CHOYP_ITA7.1.1|m.1060,0.5,0,0,0,0,0,0,0,2.00E-127,Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)],ITGA6,1130,amelogenesis [GO:0097186]; brown fat cell differentiation [GO:0050873]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to extracellular stimulus [GO:0031668]; cellular response to organic cyclic compound [GO:0071407]; digestive tract development [GO:0048565]; ectodermal cell differentiation [GO:0010668]; extracellular matrix organization [GO:0030198]; filopodium assembly [GO:0046847]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; renal system development [GO:0072001]; single organismal cell-cell adhesion [GO:0016337]; skin development [GO:0043588],GO:0005604; GO:0005886; GO:0005913; GO:0005925; GO:0007044; GO:0007160; GO:0007229; GO:0009897; GO:0009925; GO:0009986; GO:0010668; GO:0010811; GO:0016337; GO:0022409; GO:0030056; GO:0030175; GO:0030198; GO:0030335; GO:0031581; GO:0031589; GO:0031668; GO:0033627; GO:0034676; GO:0035878; GO:0042327; GO:0043065; GO:0043547; GO:0043588; GO:0045296; GO:0045944; GO:0046847; GO:0046872; GO:0048565; GO:0050873; GO:0050900; GO:0071407; GO:0072001; GO:0097186; GO:2001237,,,,PF01839;PF08441;,basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; external side of plasma membrane [GO:0009897]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; integrin alpha6-beta4 complex [GO:0034676]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; amelogenesis [GO:0097186]; brown fat cell differentiation [GO:0050873]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to extracellular stimulus [GO:0031668]; cellular response to organic cyclic compound [GO:0071407]; digestive tract development [GO:0048565]; ectodermal cell differentiation [GO:0010668]; extracellular matrix organization [GO:0030198]; filopodium assembly [GO:0046847]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; renal system development [GO:0072001]; single organismal cell-cell adhesion [GO:0016337]; skin development [GO:0043588]
O14513,CHOYP_LOC100372012.1.1|m.36569,0,0,0,0,0,0,0,0,3.00E-47,Nck-associated protein 5 (NAP-5) (Peripheral clock protein),NCKAP5 ERIH NAP5,1909,,,,,,PF15246;,
Q65YR7,CHOYP_LOC100899149.1.2|m.6146,0.5,0,0,0,0,0,0,0,1.00E-12,Cystatin-A2,cpiB DDB_G0280439,95,proteolysis [GO:0006508],GO:0004869; GO:0005829; GO:0006508,,,,PF00031;,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508]
Q9JHA8,CHOYP_LOC565211.1.2|m.34982,0,0,0,0,0,0,0,0,1.00E-39,von Willebrand factor A domain-containing protein 7 (Protein G7c),Vwa7 D17h6s56e-3 G7c,891,,GO:0005576,,,,,extracellular region [GO:0005576]
Q54BT3,CHOYP_MDR1.1.2|m.22971,0,0,0,0,0,0,0,0,0,ABC transporter B family member 2 (ABC transporter ABCB.2),abcB2 DDB_G0293438,1397,,GO:0005215; GO:0005524; GO:0016021; GO:0042626,,,,PF00664;PF00005;,"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; transporter activity [GO:0005215]"
H2A0L6,CHOYP_NEMVEDRAFT_V1G201552.4.6|m.22239,0,0,0,0,0,0,0,0,4.00E-42,Putative beta-hexosaminidase (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Chitobiase) (N-acetyl-beta-glucosaminidase),,1135,carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032],GO:0004563; GO:0005576; GO:0005975; GO:0006032; GO:0030247,PATHWAY: Glycan degradation; chitin degradation. {ECO:0000250|UniProtKB:Q04786}.,,,PF03173;PF00728;,extracellular region [GO:0005576]; beta-N-acetylhexosaminidase activity [GO:0004563]; polysaccharide binding [GO:0030247]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032]
Q6R7L5,CHOYP_OSHV1_GP010.1.2|m.28854,0,0,0,0,0,0,0,0,0,Uncharacterized protein ORF8,ORF8,319,,,,,,,
Q9H5P4,CHOYP_PDZD7B.1.1|m.64961,0,0,0,0,0,0,0,0,2.00E-48,PDZ domain-containing protein 7,PDZD7 PDZK7,517,auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184],GO:0002141; GO:0005615; GO:0005634; GO:0005929; GO:0045184; GO:0050910; GO:0060088; GO:1990696,,,,PF00595;,cilium [GO:0005929]; extracellular space [GO:0005615]; nucleus [GO:0005634]; stereocilia ankle link [GO:0002141]; USH2 complex [GO:1990696]; auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]
Q3ZBG9,CHOYP_PLS2.1.1|m.25963,0,0,0,0,0,0,0,0,4.00E-62,Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2),PLSCR2,293,,GO:0005886; GO:0016021; GO:0017128; GO:0046872,,,,PF03803;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]
Q6P1M0,CHOYP_S27A4.2.2|m.14401,0,0,0,0,0,0,0,0,0,Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (EC 6.2.1.-) (Solute carrier family 27 member 4),SLC27A4 ACSVL4 FATP4,643,fatty acid transport [GO:0015908]; lipid metabolic process [GO:0006629]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; response to nutrient [GO:0007584]; skin development [GO:0043588]; transport [GO:0006810]; very long-chain fatty acid catabolic process [GO:0042760],GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005789; GO:0005886; GO:0005902; GO:0006629; GO:0006810; GO:0007584; GO:0015245; GO:0015908; GO:0015909; GO:0016020; GO:0016021; GO:0031526; GO:0031957; GO:0042760; GO:0043588; GO:0044539,,,,PF00501;PF13193;,brush border membrane [GO:0031526]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; fatty acid transporter activity [GO:0015245]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid transport [GO:0015908]; lipid metabolic process [GO:0006629]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; response to nutrient [GO:0007584]; skin development [GO:0043588]; transport [GO:0006810]; very long-chain fatty acid catabolic process [GO:0042760]
Q6P3W7,CHOYP_SCYL2.1.1|m.6216,0,0,0,0,0,0,0,0,0,SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa),SCYL2 CVAK104 KIAA1360,929,endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286],GO:0002092; GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0008333; GO:0010008; GO:0030136; GO:0048471; GO:0090090; GO:2000286; GO:2000370,,,,PF00069;,clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; receptor binding [GO:0005102]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]
B5X165,CHOYP_SMG9.1.1|m.2906,0,0,0,0,0,0,0,0,2.00E-126,Protein SMG9 (Protein smg-9 homolog),smg9,505,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]",GO:0000184,,,,PF10220;,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"
Q9BVM4,CHOYP_A2LDB.1.1|m.29880,0,0,0,0,0,0,0,0,1.00E-32,Gamma-glutamylaminecyclotransferase (GGACT) (EC 2.3.2.4) (AIG2-like domain-containing protein 1) (Gamma-glutamylamine cyclotransferase),GGACT A2LD1,153,cellular modified amino acid catabolic process [GO:0042219],GO:0003839; GO:0042219; GO:0070062,,,cd06661;,PF06094;,extracellular exosome [GO:0070062]; gamma-glutamylcyclotransferase activity [GO:0003839]; cellular modified amino acid catabolic process [GO:0042219]
O15484,CHOYP_CAN5.1.1|m.42242,0,0,0,0,0,0,0,0,0,Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3),CAPN5 NCL3,640,proteolysis [GO:0006508]; signal transduction [GO:0007165],GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0070062,,,cd04046;cd00214;cd00044;,PF01067;PF00648;,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165]
Q8R242,CHOYP_CTBS.1.1|m.54468,0,0,0,0,0,0,0,0,9.00E-25,Di-N-acetylchitobiase (EC 3.2.1.-),Ctbs,366,chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313],GO:0004568; GO:0005615; GO:0005764; GO:0006032; GO:0009313; GO:0070062,,,,PF00704;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313]
Q90705,CHOYP_EEF2.2.2|m.54908,0,0,0,0,0,0,0,0,8.00E-160,Elongation factor 2 (EF-2),EEF2,858,,GO:0003746; GO:0003924; GO:0005525; GO:0005737,,,,PF00679;PF14492;PF03764;PF03144;,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]
P86939,CHOYP_EF-1A.5.9|m.37988,0,0,0,0,0,0,0,0,4.00E-120,Elongation factor 1-alpha 2 (EF-1-alpha 2),Tb10.70.5670,449,calcium-mediated signaling [GO:0019722]; microtubule-based process [GO:0007017],GO:0003746; GO:0003924; GO:0005516; GO:0005525; GO:0005622; GO:0005737; GO:0007017; GO:0019722,,,,PF03144;PF03143;,cytoplasm [GO:0005737]; intracellular [GO:0005622]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; calcium-mediated signaling [GO:0019722]; microtubule-based process [GO:0007017]
Q61080,CHOYP_FOXF1.1.1|m.4194,0,0,0,0,0,0,0,0,2.00E-62,Forkhead box protein F1 (Forkhead-related protein FKHL5) (Forkhead-related transcription factor 1) (FREAC-1) (Hepatocyte nuclear factor 3 forkhead homolog 8) (HFH-8),Foxf1 Fkhl5 Foxf1a Freac1 Hfh8,378,"animal organ morphogenesis [GO:0009887]; blood vessel development [GO:0001568]; branching involved in open tracheal system development [GO:0060446]; cardiac left ventricle morphogenesis [GO:0003214]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; mesoderm development [GO:0007498]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system development [GO:0072001]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; single organismal cell-cell adhesion [GO:0016337]; smoothened signaling pathway [GO:0007224]; smooth muscle cell differentiation [GO:0051145]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]",GO:0000122; GO:0000977; GO:0001228; GO:0001568; GO:0001570; GO:0001701; GO:0001756; GO:0001763; GO:0002053; GO:0003197; GO:0003214; GO:0003677; GO:0003705; GO:0005634; GO:0007224; GO:0007368; GO:0007494; GO:0007498; GO:0007507; GO:0009887; GO:0010811; GO:0014822; GO:0016337; GO:0030198; GO:0030323; GO:0030324; GO:0030335; GO:0031016; GO:0043305; GO:0044212; GO:0045198; GO:0045893; GO:0045944; GO:0048286; GO:0048371; GO:0048557; GO:0048565; GO:0048566; GO:0048613; GO:0048617; GO:0050728; GO:0051145; GO:0051150; GO:0060425; GO:0060426; GO:0060438; GO:0060441; GO:0060446; GO:0060461; GO:0060463; GO:0060841; GO:0061030; GO:0071345; GO:0071407; GO:0072001; GO:0072189; GO:0090131; GO:0097070,,,,PF00250;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding [GO:0003705]; transcription regulatory region DNA binding [GO:0044212]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding [GO:0001228]; animal organ morphogenesis [GO:0009887]; blood vessel development [GO:0001568]; branching involved in open tracheal system development [GO:0060446]; cardiac left ventricle morphogenesis [GO:0003214]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; mesoderm development [GO:0007498]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system development [GO:0072001]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; single organismal cell-cell adhesion [GO:0016337]; smooth muscle cell differentiation [GO:0051145]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]"
Q8BZ21,CHOYP_KAT6B.1.2|m.10955,0.5,0,0,0,0,0,0,0,0,"Histone acetyltransferase KAT6A (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3) (MYST-3) (Monocytic leukemia zinc finger homolog) (Monocytic leukemia zinc finger protein)",Kat6a Moz Myst3,2003,"aorta morphogenesis [GO:0035909]; cellular senescence [GO:0090398]; embryonic hemopoiesis [GO:0035162]; face morphogenesis [GO:0060325]; heart morphogenesis [GO:0003007]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]",GO:0000786; GO:0003007; GO:0003677; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005730; GO:0005829; GO:0006334; GO:0006351; GO:0006473; GO:0008134; GO:0008270; GO:0016407; GO:0016573; GO:0016605; GO:0016607; GO:0030099; GO:0035019; GO:0035162; GO:0035909; GO:0043433; GO:0043966; GO:0045892; GO:0045893; GO:0060325; GO:0070776; GO:0090398,,,,PF01853;PF00628;,"cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; cellular senescence [GO:0090398]; embryonic hemopoiesis [GO:0035162]; face morphogenesis [GO:0060325]; heart morphogenesis [GO:0003007]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]"
Q28298,CHOYP_LOC100369294.2.6|m.22959,0,0,0,0,0,0,0,0,8.00E-32,Ribosome-binding protein 1 (180 kDa ribosome receptor) (RRp),RRBP1 P180,1534,protein transport [GO:0015031]; signal transduction [GO:0007165]; translation [GO:0006412],GO:0004872; GO:0005840; GO:0006412; GO:0007165; GO:0015031; GO:0030176,,,,PF05104;,integral component of endoplasmic reticulum membrane [GO:0030176]; ribosome [GO:0005840]; receptor activity [GO:0004872]; protein transport [GO:0015031]; signal transduction [GO:0007165]; translation [GO:0006412]
Q9UF56,CHOYP_LOC100369625.1.1|m.56695,0,0,0,0,0,0,0,0,5.00E-70,F-box/LRR-repeat protein 17 (F-box and leucine-rich repeat protein 17) (F-box only protein 13),FBXL17 FBL17 FBX13 FBXO13,701,,,,,,PF12937;PF13516;,
A6NJI9,CHOYP_LOC100370463.1.1|m.30276,1,0,0,0,0,0,0,0,3.00E-43,Leucine-rich repeat-containing protein 72,LRRC72,287,,,,,,,
O67118,CHOYP_LOC100374651.3.4|m.52010,0,0,0,0,0,0,0,0,1.00E-15,Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70),dnaK aq_996,632,protein folding [GO:0006457],GO:0005524; GO:0006457,,,,PF00012;,ATP binding [GO:0005524]; protein folding [GO:0006457]
Q6FRC1,CHOYP_LOC100377001.2.2|m.52324,0,0,0,0,0,0,0,0,3.00E-22,"Protein FMP52, mitochondrial",FMP52 CAGL0H09768g,233,,GO:0005741,,,,PF08732;,mitochondrial outer membrane [GO:0005741]
O15484,CHOYP_LOC100554578.1.2|m.7421,1,0,0,0,0,0,0,0,0,Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3),CAPN5 NCL3,640,proteolysis [GO:0006508]; signal transduction [GO:0007165],GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0070062,,,cd04046;cd00214;cd00044;,PF01067;PF00648;,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165]
Q9H3K2,CHOYP_LOC100693508.1.1|m.16381,0,0,0,0,0,0,0,0,4.00E-116,Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5),GHITM DERP2 MICS1 TMBIM5 My021 UNQ244/PRO281,345,apoptotic process [GO:0006915],GO:0005739; GO:0005743; GO:0006915; GO:0016021; GO:0070062,,,,PF01027;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]
Q13310,CHOYP_LOC100741783.1.1|m.10158,0,0,0,0,0,0,0,0,3.00E-122,Polyadenylate-binding protein 4 (PABP-4) (Poly(A)-binding protein 4) (Activated-platelet protein 1) (APP-1) (Inducible poly(A)-binding protein) (iPABP),PABPC4 APP1 PABP4,644,blood coagulation [GO:0007596]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412],GO:0000166; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0006412; GO:0007596; GO:0008143; GO:0008266; GO:0010494; GO:0030529,,,,PF00658;PF00076;,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; intracellular ribonucleoprotein complex [GO:0030529]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412]
P10447,CHOYP_LOC100841619.1.1|m.40382,0,0,0,0,0,0,0,0,4.00E-14,Tyrosine-protein kinase transforming protein Abl (EC 2.7.10.2) (V-abl),ABL,439,,GO:0004715; GO:0005524,,,,PF07714;PF00017;PF00018;,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]
Q9ULB1,CHOYP_LOC100856796.2.3|m.36646,0,0,0,0,0,0,0,0,0,Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha),NRXN1 KIAA0578,1477,"adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; prepulse inhibition [GO:0060134]; regulation of grooming behavior [GO:2000821]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]; vocal learning [GO:0042297]",GO:0004872; GO:0005246; GO:0005509; GO:0005783; GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007269; GO:0007411; GO:0007416; GO:0007612; GO:0009986; GO:0030054; GO:0030534; GO:0031965; GO:0031982; GO:0033130; GO:0035176; GO:0042297; GO:0042734; GO:0043025; GO:0043234; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0060134; GO:0061178; GO:0071625; GO:0090129; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:2000463; GO:2000821,,,,PF00008;PF02210;PF01034;,"cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein complex [GO:0043234]; vesicle [GO:0031982]; acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; prepulse inhibition [GO:0060134]; regulation of grooming behavior [GO:2000821]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]"
Q4AC94,CHOYP_LOC576341.1.2|m.9414,0,0,0,0,0,0,0,0,0,C2 domain-containing protein 3,C2CD3,2353,brain development [GO:0007420]; centriole elongation [GO:0061511]; ciliary basal body docking [GO:0097711]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589],GO:0001701; GO:0001947; GO:0005813; GO:0005814; GO:0005829; GO:0007420; GO:0008589; GO:0016485; GO:0021915; GO:0021997; GO:0030162; GO:0034451; GO:0036064; GO:0042733; GO:0061511; GO:0071539; GO:0097711; GO:1905515,,,,PF00168;,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; brain development [GO:0007420]; centriole elongation [GO:0061511]; ciliary basal body docking [GO:0097711]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589]
Q16649,CHOYP_NFIL3.1.1|m.26076,0.5,0,0,0,0,0,0,0,7.00E-21,Nuclear factor interleukin-3-regulated protein (E4 promoter-binding protein 4) (Interleukin-3 promoter transcriptional activator) (Interleukin-3-binding protein 1) (Transcriptional activator NF-IL3A),NFIL3 E4BP4 IL3BP1,462,cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of gene expression [GO:0010628]; transcription from RNA polymerase II promoter [GO:0006366],GO:0000122; GO:0000977; GO:0000979; GO:0001078; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0006366; GO:0006955; GO:0007623; GO:0010628; GO:0071353,,,,PF07716;PF06529;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001078]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of gene expression [GO:0010628]; transcription from RNA polymerase II promoter [GO:0006366]"
Q8VID6,CHOYP_PDE11.3.3|m.51375,0,0,0,0,0,0,0,0,0,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)",Pde11a,935,cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; signal transduction [GO:0007165],GO:0004112; GO:0004118; GO:0005829; GO:0006198; GO:0007165; GO:0030552; GO:0030553; GO:0043204; GO:0046069; GO:0046872; GO:0047555,,,,PF01590;PF00233;,"cytosol [GO:0005829]; perikaryon [GO:0043204]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; signal transduction [GO:0007165]"
A4IIY1,CHOYP_RN19A.1.1|m.35894,1.5,0,0,0,0,0,0,0,0.000000001,Probable E3 ubiquitin-protein ligase RNF144A (EC 2.3.2.-) (RING finger protein 144A),rnf144a,292,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787],GO:0000151; GO:0000209; GO:0005794; GO:0008270; GO:0016021; GO:0031624; GO:0032436; GO:0042787; GO:0061630,PATHWAY: Protein modification; protein ubiquitination.,,,PF01485;,Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]
O61231,CHOYP_RPL10.1.2|m.4994,0,0,0,0,0,0,0,0,1.00E-68,60S ribosomal protein L10 (QM protein homolog) (dQM),RpL10 Qm CG17521,218,centrosome duplication [GO:0051298]; centrosome organization [GO:0051297]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; sensory perception of pain [GO:0019233],GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0005840; GO:0019233; GO:0022625; GO:0022626; GO:0043025; GO:0051297; GO:0051298,,,cd01433;,PF00252;,cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; centrosome duplication [GO:0051298]; centrosome organization [GO:0051297]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; sensory perception of pain [GO:0019233]
Q66PY1,CHOYP_RS3A.9.15|m.36330,0,0,0,0,0,0,0,0,0.0000006,"Signal peptide, CUB and EGF-like domain-containing protein 3",Scube3,993,cell differentiation [GO:0030154]; positive regulation of smoothened signaling pathway [GO:0045880]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260],GO:0005509; GO:0005615; GO:0009986; GO:0030154; GO:0045880; GO:0051260; GO:0051291,,,cd00041;,PF12662;PF00431;PF12947;PF07645;PF07699;,cell surface [GO:0009986]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; cell differentiation [GO:0030154]; positive regulation of smoothened signaling pathway [GO:0045880]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]
Q9BY12,CHOYP_SCAPER.1.1|m.34551,0,0,0,0,0,0,0,0,0,S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291),SCAPER KIAA1454 ZNF291 MSTP063,1400,,GO:0003676; GO:0005634; GO:0005783; GO:0005829; GO:0008270,,,,PF16501;,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]
Q8R3L2,CHOYP_TCF25.1.1|m.28509,0,0,0,0,0,0,0,0,0,Transcription factor 25 (TCF-25) (Nuclear localized protein 1),Tcf25 D8Ertd325e Nulp1,676,"negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; transcription, DNA-templated [GO:0006351]",GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006351,,,,PF04910;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; transcription, DNA-templated [GO:0006351]"
Q689D1,CHOYP_TLR2.6.7|m.54975,0,0,0,0,0,0,0,0,3.00E-40,Toll-like receptor 2 (CD antigen CD282),TLR2,785,cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224],GO:0002224; GO:0002755; GO:0004872; GO:0004888; GO:0005794; GO:0006954; GO:0016021; GO:0030670; GO:0031226; GO:0034134; GO:0045087; GO:0045121; GO:0050707; GO:0050729; GO:0071726; GO:0071727,,,,PF13855;PF01463;PF01582;,Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; receptor activity [GO:0004872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224]
Q32N22,CHOYP_TRIADDRAFT_60787.1.1|m.6621,0,0,0,0,0,0,0,0,1.00E-15,TATA box-binding protein-associated factor RNA polymerase I subunit B (RNA polymerase I-specific TBP-associated factor 63 kDa) (TAFI63) (TATA box-binding protein-associated factor 1B) (TBP-associated factor 1B),taf1b,582,RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript [GO:0001189],GO:0001164; GO:0001187; GO:0001189; GO:0046872; GO:0070860,,,,PF11781;,"RNA polymerase I core factor complex [GO:0070860]; metal ion binding [GO:0046872]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; transcription factor activity, RNA polymerase I CORE element binding transcription factor recruiting [GO:0001187]; RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript [GO:0001189]"
P90666,CHOYP_TXND3.2.4|m.21415,42,0,0,0,0,0,0,0,0,Thioredoxin domain-containing protein 3 homolog (Intermediate chain 1) (NME/NM23 family member 8),NME8 IC1,837,cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228],GO:0004550; GO:0005623; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454,,,,PF00334;PF00085;,cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]
Q9VT65,CHOYP_contig_022851|m.26077,0,0,0,0,0,0,0,0,5.00E-71,Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2],CalpB CG8107,925,border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; sensory perception of pain [GO:0019233],GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540; GO:0019233,,,cd00214;cd00044;,PF01067;PF00648;,cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; sensory perception of pain [GO:0019233]
Q6GPV5,CHOYP_ARALYDRAFT_496711.1.1|m.58259,0,0,0,0,0,0,0,0,2.00E-15,E3 ubiquitin-protein ligase RNF181 (EC 2.3.2.27) (RING finger protein 181) (RING-type E3 ubiquitin transferase RNF181),rnf181,156,protein ubiquitination [GO:0016567],GO:0008270; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,PF13639;,transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
Q6TXF1,CHOYP_ARRD-6.1.1|m.9470,0.5,0,0,0,0,0,0,0,3.00E-39,Arrestin domain-containing protein 3 (Liver regeneration-related protein LRRG00048),Arrdc3,414,fat pad development [GO:0060613]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of multicellular organismal metabolic process [GO:0044252]; positive regulation of adrenergic receptor signaling pathway [GO:0071879]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; signal transduction [GO:0007165]; skin development [GO:0043588]; temperature homeostasis [GO:0001659],GO:0001659; GO:0005764; GO:0005769; GO:0005886; GO:0007165; GO:0031651; GO:0043588; GO:0044252; GO:0051443; GO:0060613; GO:0071879; GO:0090327,,,,PF02752;PF00339;,early endosome [GO:0005769]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; fat pad development [GO:0060613]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of multicellular organismal metabolic process [GO:0044252]; positive regulation of adrenergic receptor signaling pathway [GO:0071879]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; signal transduction [GO:0007165]; skin development [GO:0043588]; temperature homeostasis [GO:0001659]
Q5FVB0,CHOYP_ATXN10.1.1|m.33209,0,0,0,0,0,0,0,0,4.00E-45,Ataxin-10 (Spinocerebellar ataxia type 10 protein homolog),atxn10,485,,GO:0048471,,,,PF09759;,perinuclear region of cytoplasm [GO:0048471]
O14975,CHOYP_BRAFLDRAFT_102226.1.1|m.48829,0,0,0,0,0,0,0,0,1.00E-143,"Very long-chain acyl-CoA synthetase (VLACS) (VLCS) (EC 6.2.1.-) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 2) (THCA-CoA ligase) (Very long-chain-fatty-acid-CoA ligase)",SLC27A2 ACSVL1 FACVL1 FATP2 VLACS,620,bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; very long-chain fatty acid catabolic process [GO:0042760],GO:0001561; GO:0001676; GO:0004467; GO:0005102; GO:0005524; GO:0005739; GO:0005778; GO:0005779; GO:0005788; GO:0005789; GO:0005886; GO:0006635; GO:0006699; GO:0015245; GO:0019899; GO:0030176; GO:0031957; GO:0035579; GO:0042760; GO:0043312; GO:0044539; GO:0050197; GO:0070062; GO:0070251; GO:0097089; GO:0102391,,,,PF00501;PF13193;,endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; decanoate--CoA ligase activity [GO:0102391]; enzyme binding [GO:0019899]; fatty acid transporter activity [GO:0015245]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; receptor binding [GO:0005102]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; very long-chain fatty acid catabolic process [GO:0042760]
O43247,CHOYP_BRAFLDRAFT_117365.2.2|m.31681,5,0,0,0,0,0,0,0,1.00E-12,Testis-expressed protein 33,TEX33 C22orf33 EAN57,280,,,,,,PF15400;,
Q08DF7,CHOYP_BRAFLDRAFT_212438.1.1|m.29117,0,0,0,0,0,0,0,0,2.00E-132,"2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4)",PDE12,609,mRNA processing [GO:0006397],GO:0004535; GO:0005759; GO:0006397; GO:0046872,,,,PF03372;,mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]
Q80UM7,CHOYP_BRAFLDRAFT_247063.1.1|m.17671,0,0,0,0,0,0,0,0,0,Mannosyl-oligosaccharide glucosidase (EC 3.2.1.106) (Glucosidase 1) (Glycoprotein-processing glucosidase I),Mogs Gcs1,834,oligosaccharide metabolic process [GO:0009311],GO:0004573; GO:0005783; GO:0005789; GO:0009311; GO:0016020; GO:0016021; GO:0070062,PATHWAY: Glycan metabolism; N-glycan degradation.,,,PF03200;PF16923;,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311]
Q0IIB1,CHOYP_BRAFLDRAFT_260946.1.2|m.54464,3,0,0,0,0,0,0,0,0.00000004,Phytanoyl-CoA dioxygenase domain-containing protein 1 (EC 1.-.-.-),PHYHD1,291,,GO:0046872; GO:0051213,,,,PF05721;,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]
Q6GPV5,CHOYP_BRAFLDRAFT_285971.1.1|m.18286,0,0,0,0,0,0,0,0,4.00E-41,E3 ubiquitin-protein ligase RNF181 (EC 2.3.2.27) (RING finger protein 181) (RING-type E3 ubiquitin transferase RNF181),rnf181,156,protein ubiquitination [GO:0016567],GO:0008270; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,PF13639;,transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
O14975,CHOYP_BRAFLDRAFT_68867.1.1|m.4095,0,0,0,0,0,0,0,0,3.00E-137,"Very long-chain acyl-CoA synthetase (VLACS) (VLCS) (EC 6.2.1.-) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 2) (THCA-CoA ligase) (Very long-chain-fatty-acid-CoA ligase)",SLC27A2 ACSVL1 FACVL1 FATP2 VLACS,620,bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; very long-chain fatty acid catabolic process [GO:0042760],GO:0001561; GO:0001676; GO:0004467; GO:0005102; GO:0005524; GO:0005739; GO:0005778; GO:0005779; GO:0005788; GO:0005789; GO:0005886; GO:0006635; GO:0006699; GO:0015245; GO:0019899; GO:0030176; GO:0031957; GO:0035579; GO:0042760; GO:0043312; GO:0044539; GO:0050197; GO:0070062; GO:0070251; GO:0097089; GO:0102391,,,,PF00501;PF13193;,endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; decanoate--CoA ligase activity [GO:0102391]; enzyme binding [GO:0019899]; fatty acid transporter activity [GO:0015245]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; receptor binding [GO:0005102]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; very long-chain fatty acid catabolic process [GO:0042760]
Q2NL17,CHOYP_CLPT1.1.1|m.50172,0.5,0,0,0,0,0,0,0,0,Cleft lip and palate transmembrane protein 1 homolog,CLPTM1,670,cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],GO:0005887; GO:0007275; GO:0030154,,,,PF05602;,integral component of plasma membrane [GO:0005887]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]
P56101,CHOYP_DNJC5.1.1|m.52453,0,0,0,0,0,0,0,0,8.00E-55,DnaJ homolog subfamily C member 5 (CCCS1) (Cysteine string protein) (CSP),dnajc5,195,,GO:0016020,,,cd06257;,PF00226;,membrane [GO:0016020]
Q9D773,CHOYP_ISCW_ISCW005878.1.1|m.39374,0,0,0,0,0,0,0,0,8.00E-51,"39S ribosomal protein L2, mitochondrial (L2mt) (MRP-L2)",Mrpl2,306,mitochondrial translation [GO:0032543]; translation [GO:0006412],GO:0003723; GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0032543,,,,PF00181;PF03947;,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]
P10076,CHOYP_LOC100013817.1.1|m.34914,0,0,0,0,0,0,0,0,2.00E-57,Zinc finger protein 26 (Zfp-26) (Protein mKR3),Zfp26 Kiaa4196 Mkr3 Zfp-26,861,"regulation of transcription, DNA-templated [GO:0006355]",GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872,,,cd07765;,PF01352;PF00096;PF13912;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]"
P49715,CHOYP_LOC100204711.1.1|m.21838,0,0,0,0,0,0,0,0,1.00E-18,CCAAT/enhancer-binding protein alpha (C/EBP alpha),CEBPA CEBP,358,"brown fat cell differentiation [GO:0050873]; cell maturation [GO:0048469]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol metabolic process [GO:0008203]; cytokine-mediated signaling pathway [GO:0019221]; embryonic placenta development [GO:0001892]; fat cell differentiation [GO:0045444]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; granulocyte differentiation [GO:0030851]; inner ear development [GO:0048839]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; lung development [GO:0030324]; macrophage differentiation [GO:0030225]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription from RNA polymerase III promoter [GO:0045945]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; transcription, DNA-templated [GO:0006351]; transcription from RNA polymerase II promoter [GO:0006366]; transcription from RNA polymerase I promoter [GO:0006360]; urea cycle [GO:0000050]; viral process [GO:0016032]; white fat cell differentiation [GO:0050872]",GO:0000050; GO:0000122; GO:0000978; GO:0001013; GO:0001077; GO:0001228; GO:0001889; GO:0001892; GO:0003677; GO:0003700; GO:0003705; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006091; GO:0006351; GO:0006360; GO:0006366; GO:0007005; GO:0007219; GO:0008134; GO:0008203; GO:0008285; GO:0016032; GO:0019221; GO:0019900; GO:0030099; GO:0030225; GO:0030324; GO:0030851; GO:0032436; GO:0042593; GO:0042803; GO:0043231; GO:0044212; GO:0045444; GO:0045600; GO:0045669; GO:0045736; GO:0045892; GO:0045944; GO:0045945; GO:0048469; GO:0048839; GO:0050872; GO:0050873; GO:0055088; GO:0071285; GO:0071356; GO:0071407; GO:0090575,,,,PF07716;,"intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; kinase binding [GO:0019900]; protein homodimerization activity [GO:0042803]; RNA polymerase I regulatory region DNA binding [GO:0001013]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding [GO:0003705]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding [GO:0001228]; brown fat cell differentiation [GO:0050873]; cell maturation [GO:0048469]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol metabolic process [GO:0008203]; cytokine-mediated signaling pathway [GO:0019221]; embryonic placenta development [GO:0001892]; fat cell differentiation [GO:0045444]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; granulocyte differentiation [GO:0030851]; inner ear development [GO:0048839]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; lung development [GO:0030324]; macrophage differentiation [GO:0030225]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase III promoter [GO:0045945]; transcription from RNA polymerase I promoter [GO:0006360]; transcription from RNA polymerase II promoter [GO:0006366]; transcription, DNA-templated [GO:0006351]; urea cycle [GO:0000050]; viral process [GO:0016032]; white fat cell differentiation [GO:0050872]"
P52917,CHOYP_LOC100368955.1.1|m.48500,0,0,0,0,0,0,0,0,4.00E-100,Vacuolar protein sorting-associated protein 4 (DOA4-independent degradation protein 6) (Protein END13) (Vacuolar protein-targeting protein 10),VPS4 CSC1 DID6 END13 GRD13 VPL4 VPT10 YPR173C P9705.10,437,intralumenal vesicle formation [GO:0070676]; late endosome to vacuole transport [GO:0045324]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; protein homooligomerization [GO:0051260]; protein retention in Golgi apparatus [GO:0045053]; protein transport [GO:0015031]; sterol metabolic process [GO:0016125]; vacuole organization [GO:0007033],GO:0005524; GO:0005634; GO:0005768; GO:0005771; GO:0007033; GO:0015031; GO:0016020; GO:0016125; GO:0016236; GO:0016887; GO:0032511; GO:0042802; GO:0042803; GO:0045053; GO:0045324; GO:0051260; GO:0070676; GO:1990621,,,,PF00004;PF04212;PF09336;,endosome [GO:0005768]; ESCRT IV complex [GO:1990621]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; intralumenal vesicle formation [GO:0070676]; late endosome to vacuole transport [GO:0045324]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; protein homooligomerization [GO:0051260]; protein retention in Golgi apparatus [GO:0045053]; protein transport [GO:0015031]; sterol metabolic process [GO:0016125]; vacuole organization [GO:0007033]
Q54BA2,CHOYP_LOC100374274.2.3|m.27036,0,0,0,0,0,0,0,0,9.00E-15,"Ankyrin repeat, bromo and BTB domain-containing protein DDB_G0293800",DDB_G0293800,806,,,,,,PF12796;PF17035;PF00439;PF00651;,
Q8WY91,CHOYP_LOC100376482.1.7|m.7553,0,0,0,0,0,0,0,0,0.00000001,THAP domain-containing protein 4,THAP4 CGI-36 PP238,577,,GO:0003677; GO:0046872,,,cd07828;,PF08768;PF05485;,DNA binding [GO:0003677]; metal ion binding [GO:0046872]
A2AX52,CHOYP_LOC100486063.6.9|m.44250,0,0,0,0,0,0,0,0,3.00E-90,Collagen alpha-4(VI) chain,Col6a4 Dvwa,2309,cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208],GO:0005576; GO:0005578; GO:0005581; GO:0007155; GO:0043234; GO:0070208,,,,PF01391;PF00092;,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; protein complex [GO:0043234]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]
P70610,CHOYP_LOC100549486.1.1|m.54965,0.5,0,0,0,0,0,0,0,1.00E-137,Double C2-like domain-containing protein beta (Doc2-beta),Doc2b,412,calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104],GO:0005509; GO:0005544; GO:0005737; GO:0005886; GO:0006887; GO:0008104; GO:0019905; GO:0030276; GO:0031340; GO:0032024; GO:0045956; GO:0048791; GO:0070382; GO:0098793,,,,PF00168;,cytoplasm [GO:0005737]; exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104]
O70244,CHOYP_LOC100705265.3.3|m.40296,0,0,0,0,0,0,0,0,0,Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),Cubn Ifcr,3623,cholesterol metabolic process [GO:0008203]; cobalamin transport [GO:0015889]; hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766],GO:0001701; GO:0004872; GO:0005509; GO:0005765; GO:0005905; GO:0006766; GO:0006898; GO:0007584; GO:0008203; GO:0010008; GO:0015235; GO:0015889; GO:0016020; GO:0020028; GO:0030135; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0042802; GO:0043202; GO:0043234; GO:0070207,,,cd00041;,PF00431;PF00008;PF12947;PF07645;,brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; protein complex [GO:0043234]; calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; cobalamin transporter activity [GO:0015235]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; receptor activity [GO:0004872]; cholesterol metabolic process [GO:0008203]; cobalamin transport [GO:0015889]; hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]
P08011,CHOYP_MGST1.1.1|m.21583,0,0,0,0,0,0,0,0,1.00E-39,Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I),Mgst1 Gst12,155,cellular response to lipid hydroperoxide [GO:0071449]; glutathione metabolic process [GO:0006749]; Leydig cell differentiation [GO:0033327]; protein homotrimerization [GO:0070207]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to organonitrogen compound [GO:0010243],GO:0004364; GO:0004602; GO:0005634; GO:0005739; GO:0005741; GO:0005743; GO:0005778; GO:0005783; GO:0005789; GO:0006749; GO:0010243; GO:0016021; GO:0032496; GO:0033327; GO:0042493; GO:0042802; GO:0042803; GO:0043295; GO:0045177; GO:0070207; GO:0071449,,,,PF01124;,apical part of cell [GO:0045177]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular response to lipid hydroperoxide [GO:0071449]; glutathione metabolic process [GO:0006749]; Leydig cell differentiation [GO:0033327]; protein homotrimerization [GO:0070207]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to organonitrogen compound [GO:0010243]
Q0VD31,CHOYP_NAEGRDRAFT_47557.1.1|m.11283,1.5,0,0,0,0,0,0,0,2.00E-10,F-box/LRR-repeat protein 4 (F-box and leucine-rich repeat protein 4),FBXL4,621,,GO:0005634; GO:0005758,,,,PF00646;,mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]
Q6AXS0,CHOYP_NCKX6.1.1|m.52502,0,0,0,0,0,0,0,0,2.00E-158,"Sodium/potassium/calcium exchanger 6, mitochondrial (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)",Slc8b1 Nckx6 Nclx Slc24a6,585,glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transport [GO:0006851]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; response to stimulus [GO:0050896],GO:0005432; GO:0005739; GO:0005743; GO:0006851; GO:0030061; GO:0032592; GO:0042383; GO:0042593; GO:0042802; GO:0042803; GO:0050796; GO:0050896; GO:0051480; GO:0051560,,,,PF01699;,integral component of mitochondrial membrane [GO:0032592]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; sarcolemma [GO:0042383]; calcium:sodium antiporter activity [GO:0005432]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transport [GO:0006851]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; response to stimulus [GO:0050896]
P0DJG4,CHOYP_NEMVEDRAFT_V1G160170.1.1|m.66042,3.5,0,0,0,0,0,0,0,4.00E-27,Testicular haploid expressed gene protein-like (Theg spermatid-like protein),THEGL,465,,,,,,PF14912;,
O00461,CHOYP_TVAG_168130.1.2|m.10205,4,0,0,0,0,0,0,0,7.00E-11,"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)",GOLIM4 GIMPC GOLPH4 GPP130,696,transport [GO:0006810],GO:0000139; GO:0005794; GO:0005796; GO:0005801; GO:0006810; GO:0010008; GO:0016020; GO:0016021; GO:0030133; GO:0030139; GO:0032580,,,,,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]; transport [GO:0006810]
Q9Z0L8,CHOYP_ZGC_171566.1.1|m.22181,0.5,0,0,0,0,0,0,0,5.00E-85,Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (FGPH) (Folylpolyglutamate hydrolase) (GH) (Gamma-Glu-x carboxypeptidase),Ggh,317,glutamine metabolic process [GO:0006541]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043],GO:0005615; GO:0005634; GO:0005764; GO:0005829; GO:0006541; GO:0010043; GO:0032868; GO:0034722; GO:0042470; GO:0042493; GO:0045471; GO:0070062,,,,PF07722;,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleus [GO:0005634]; gamma-glutamyl-peptidase activity [GO:0034722]; glutamine metabolic process [GO:0006541]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]
Q03650,CHOYP_contig_041717|m.47768,0,0,0,0,0,0,0,0,0.000000002,"Cysteine-rich, acidic integral membrane protein",CRAM,945,endocytosis [GO:0006897],GO:0005886; GO:0006897; GO:0016021; GO:0020016,,,,PF07016;,ciliary pocket [GO:0020016]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]
Q5RF36,CHOYP_BRAFLDRAFT_118961.1.1|m.8363,0.5,0,0,0,0,0,0,0,0,Cytosolic Fe-S cluster assembly factor NARFL (Iron-only hydrogenase-like protein 1) (IOP1) (Nuclear prelamin A recognition factor-like protein),NARFL,476,iron-sulfur cluster assembly [GO:0016226],GO:0016226; GO:0046872; GO:0051539; GO:0097361,,,,PF02906;PF02256;,"CIA complex [GO:0097361]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"
Q8IZS6,CHOYP_BRAFLDRAFT_126379.1.3|m.5102,1,0,0,0,0,0,0,0,4.00E-13,Tctex1 domain-containing protein 3 (T-complex testis-specific protein 3) (T-complex-associated testis-expressed protein 3) (Tcte-3),TCTE3 TCTEX1D3,198,transport [GO:0006810],GO:0003774; GO:0005737; GO:0005874; GO:0006810; GO:0016020; GO:0030286,,,,PF03645;,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; motor activity [GO:0003774]; transport [GO:0006810]
Q03601,CHOYP_BRAFLDRAFT_88223.3.22|m.20538,0,0,0,0,0,0,0,0,0.000003,RING finger protein nhl-1,nhl-1 F54G8.4,974,protein ubiquitination [GO:0016567],GO:0004842; GO:0008270; GO:0016567,,,,PF01436;PF00097;,ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
P70031,CHOYP_CCKAR.4.6|m.43964,0,0,0,0,0,0,0,0,6.00E-87,Cholecystokinin receptor (CCK-XLR),cckar,453,,GO:0004930; GO:0005886; GO:0016021,,,,PF00001;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G-protein coupled receptor activity [GO:0004930]
Q8TD84,CHOYP_CNTN5.4.5|m.44639,0,0,0,0,0,0,0,0,0.000000002,Down syndrome cell adhesion molecule-like protein 1 (Down syndrome cell adhesion molecule 2),DSCAML1 DSCAM2 KIAA1132,2053,axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],GO:0001709; GO:0005615; GO:0005886; GO:0007156; GO:0007409; GO:0007417; GO:0007420; GO:0009953; GO:0009986; GO:0016021; GO:0030054; GO:0042803; GO:0045202; GO:0048704,,,cd00063;,PF00041;PF07679;,cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
Q7T1K4,CHOYP_ER.1.2|m.14189,1.5,0,0,0,0,0,0,0,1.00E-42,Androgen receptor (bfAR) (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4),ar nr3c4,777,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003700; GO:0004882; GO:0005496; GO:0005497; GO:0005634; GO:0005737; GO:0006351; GO:0006355; GO:0008270; GO:0043565; GO:0050681,,,,PF02166;PF00104;PF00105;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; androgen binding [GO:0005497]; androgen receptor activity [GO:0004882]; androgen receptor binding [GO:0050681]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q9M1W7,CHOYP_KLH26.1.2|m.8792,3,0,0,0,0,0,0,0,9.00E-11,F-box/kelch-repeat protein SKIP30 (SKP1-interacting partner 30),SKIP30 At3g63220 F16M2.70,352,protein ubiquitination [GO:0016567],GO:0016567,PATHWAY: Protein modification; protein ubiquitination.,,,PF01344;,protein ubiquitination [GO:0016567]
Q20930,CHOYP_LOAG_00377.2.4|m.54574,0,0,0,0,0,0,0,0,1.00E-31,ADAM family mig-17 (EC 3.4.24.-) (A disintegrin and metalloproteinase mig-17) (Abnormal cell migration protein 17),mig-17 F57B7.4,509,gonad morphogenesis [GO:0035262]; regulation of cell migration [GO:0030334],GO:0004222; GO:0005604; GO:0005615; GO:0030334; GO:0035262; GO:0046872,,,cd04267;,PF01421;,basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; gonad morphogenesis [GO:0035262]; regulation of cell migration [GO:0030334]
Q69ZM6,CHOYP_LOC100372921.2.2|m.56247,1,0,0,0,0,0,0,0,2.00E-91,Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog),Stk36 Kiaa1278,1316,brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of sequence-specific DNA binding transcription factor activity [GO:0051090],GO:0003351; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007228; GO:0007420; GO:0008134; GO:0009791; GO:0045880; GO:0046872; GO:0051090; GO:0060271,,,,PF00069;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of sequence-specific DNA binding transcription factor activity [GO:0051090]
Q99758,CHOYP_LOC100373083.1.2|m.19986,0,0,0,0,0,0,0,0,0,ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3),ABCA3 ABC3,1704,cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]; transport [GO:0006810],GO:0005215; GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006810; GO:0006869; GO:0016020; GO:0016021; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233,,,,PF00005;,"alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]; transport [GO:0006810]"
Q27274,CHOYP_LOC100634688.1.6|m.20228,0,0,0,0,0,0,0,0,3.00E-114,60 kDa SS-A/Ro ribonucleoprotein homolog,rop-1 C12D8.11,643,,GO:0003723; GO:0005737; GO:0030529; GO:0046872,,,,PF05731;,cytoplasm [GO:0005737]; intracellular ribonucleoprotein complex [GO:0030529]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]
Q9UHB7,CHOYP_LOC100723342.1.1|m.58414,0,0,0,0,0,0,0,0,2.00E-30,AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein),AFF4 AF5Q31 MCEF HSPC092,1163,spermatid development [GO:0007286]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription from RNA polymerase II promoter [GO:0006366],GO:0001650; GO:0003700; GO:0005634; GO:0005654; GO:0006366; GO:0006368; GO:0007286; GO:0008023; GO:0035327,,,,PF05110;,"fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; spermatid development [GO:0007286]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription from RNA polymerase II promoter [GO:0006366]"
A8K0R7,CHOYP_LOC100900174.1.1|m.14983,0,0,0,0,0,0,0,0,7.00E-15,Zinc finger protein 839 (Renal carcinoma antigen NY-REN-50),ZNF839 C14orf131,811,,GO:0046872,,,,PF15961;,metal ion binding [GO:0046872]
P38650,CHOYP_LOC577805.3.4|m.46026,0.5,0,0,0,0,0,0,0,1.00E-39,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) (MAP 1C)",Dync1h1 Dhc1 Dnch1 Dnchc1 Dnec1 Dyhc Map1c,4644,microtubule-based movement [GO:0007018]; transport [GO:0006810],GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0006810; GO:0007018; GO:0016887; GO:0030286,,,,PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; transport [GO:0006810]
Q52KK4,CHOYP_NAF1.1.1|m.13716,0,0,0,0,0,0,0,0,3.00E-44,H/ACA ribonucleoprotein complex non-core subunit NAF1,Naf1,457,pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364],GO:0001522; GO:0003723; GO:0005634; GO:0005732; GO:0005737; GO:0006364; GO:0042254,,,,PF04410;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]; RNA binding [GO:0003723]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]
Q96GD3,CHOYP_SCMH1.1.1|m.1166,0.5,0,0,0,0,0,0,0,1.00E-160,Polycomb protein SCMH1 (Sex comb on midleg homolog 1),SCMH1,660,"anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006338; GO:0006351; GO:0007283; GO:0009653; GO:0009952; GO:0010369; GO:0016458; GO:0045892,,,,PF02820;PF17208;PF00536;PF12140;,"chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]"
Q9NVU7,CHOYP_SDA1.1.1|m.12704,0,0,0,0,0,0,0,0,0,Protein SDA1 homolog (Nucleolar protein 130) (SDA1 domain-containing protein 1) (hSDA),SDAD1 NUC130,687,actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055],GO:0000055; GO:0005634; GO:0005730; GO:0030036; GO:0042273,,,,PF08158;PF05285;,nucleolus [GO:0005730]; nucleus [GO:0005634]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]
Q8IV38,CHOYP_AFUA_1G01020.7.50|m.19296,1,0,0,0,0,0,0,0,0.000009,Ankyrin repeat and MYND domain-containing protein 2,ANKMY2,441,regulation of smoothened signaling pathway [GO:0008589],GO:0005929; GO:0008589; GO:0046872,,,,PF12796;PF01753;,cilium [GO:0005929]; metal ion binding [GO:0046872]; regulation of smoothened signaling pathway [GO:0008589]
O60678,CHOYP_ANM3.1.1|m.376,0,0,0,0,0,0,0,0,0,Protein arginine N-methyltransferase 3 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3),PRMT3 HRMT1L3,531,negative regulation of protein ubiquitination [GO:0031397]; protein methylation [GO:0006479],GO:0005737; GO:0005829; GO:0005840; GO:0006479; GO:0008168; GO:0016274; GO:0031397; GO:0046872,,,,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribosome [GO:0005840]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; protein-arginine N-methyltransferase activity [GO:0016274]; negative regulation of protein ubiquitination [GO:0031397]; protein methylation [GO:0006479]
O54905,CHOYP_B3GN5.2.4|m.35685,0,0,0,0,0,0,0,0,7.00E-49,"Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-II)",B3galt2,422,oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486],GO:0000139; GO:0006486; GO:0008499; GO:0009312; GO:0016021; GO:0047275,PATHWAY: Protein modification; protein glycosylation.,,,PF01762;,"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]"
A4IF63,CHOYP_BRAFLDRAFT_273508.4.4|m.61165,0,0,0,0,0,0,0,0,0.0000004,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,744,regulation of neuron apoptotic process [GO:0043523],GO:0004842; GO:0005737; GO:0008270; GO:0043523,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
A4IF63,CHOYP_BRAFLDRAFT_63298.6.6|m.60187,0,0,0,0,0,0,0,0,0.000000001,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,744,regulation of neuron apoptotic process [GO:0043523],GO:0004842; GO:0005737; GO:0008270; GO:0043523,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
S4R2P9,CHOYP_BRAFLDRAFT_78683.1.4|m.29747,0,0,0,0,0,0,0,0,6.00E-140,Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3),Slc8a3 Ncx3,928,calcium ion export from cell [GO:1990034]; calcium ion import into cell [GO:1990035]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537],GO:0002244; GO:0005432; GO:0005741; GO:0005789; GO:0005874; GO:0005887; GO:0006851; GO:0006874; GO:0007154; GO:0007612; GO:0007613; GO:0014819; GO:0015368; GO:0016528; GO:0021537; GO:0030001; GO:0030054; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043197; GO:0043204; GO:0046872; GO:0048471; GO:0048709; GO:0051560; GO:0060291; GO:0060402; GO:0070588; GO:0071320; GO:0071456; GO:0099580; GO:1990034; GO:1990035,,,,PF03160;PF01699;PF16494;,cell junction [GO:0030054]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:cation antiporter activity [GO:0015368]; calcium:sodium antiporter activity [GO:0005432]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export from cell [GO:1990034]; calcium ion import into cell [GO:1990035]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]
P02676,CHOYP_BRAFLDRAFT_86061.10.13|m.52540,0,0,0,0,0,0,0,0,4.00E-45,Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain],FGB,468,adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; platelet activation [GO:0030168]; protein polymerization [GO:0051258]; signal transduction [GO:0007165],GO:0001948; GO:0002250; GO:0005577; GO:0007165; GO:0030168; GO:0045087; GO:0051258,,,cd00087;,PF08702;PF00147;,fibrinogen complex [GO:0005577]; glycoprotein binding [GO:0001948]; adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; platelet activation [GO:0030168]; protein polymerization [GO:0051258]; signal transduction [GO:0007165]
O70496,CHOYP_CLCN7.3.3|m.51894,0,0,0,0,0,0,0,0,0,H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7),Clcn7 Clc7,803,chloride transmembrane transport [GO:1902476]; response to pH [GO:0009268],GO:0005247; GO:0005524; GO:0005765; GO:0009268; GO:0015297; GO:0016020; GO:0016021; GO:0031410; GO:1902476,,,,PF00571;PF00654;,cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; response to pH [GO:0009268]
Q69QQ6,CHOYP_HS90A.2.3|m.21992,0,0,0,0,0,0,0,0,0,Heat shock protein 81-2 (HSP81-2) (Heat shock protein 90),HSP81-2 HSP90 Os09g0482100 LOC_Os09g30418 P0463D04.32,699,protein folding [GO:0006457]; response to stress [GO:0006950],GO:0005524; GO:0005737; GO:0006457; GO:0006950,,,,PF02518;PF00183;,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein folding [GO:0006457]; response to stress [GO:0006950]
O13671,CHOYP_IPO11.1.1|m.10815,0,0,0,0,0,0,0,0,5.00E-10,Importin-alpha re-exporter (Cellular apoptosis susceptibility protein homolog),kap109 pi080 SPBC30B4.05,967,nucleocytoplasmic transport [GO:0006913]; protein targeting [GO:0006605],GO:0005525; GO:0005635; GO:0005643; GO:0005737; GO:0006605; GO:0006913; GO:0031965; GO:0034399,,,,PF03378;PF08506;PF03810;,cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; GTP binding [GO:0005525]; nucleocytoplasmic transport [GO:0006913]; protein targeting [GO:0006605]
O70400,CHOYP_ISCW_ISCW000210.2.4|m.14990,0,0,0,0,0,0,0,0,1.00E-10,PDZ and LIM domain protein 1 (C-terminal LIM domain protein 1) (Elfin) (LIM domain protein CLP-36),Pdlim1 Clim1,327,"regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]",GO:0001666; GO:0003713; GO:0005667; GO:0005737; GO:0005856; GO:0005913; GO:0005925; GO:0006355; GO:0008270; GO:0098641,,,,PF15936;PF00412;PF00595;,"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; transcription factor complex [GO:0005667]; cadherin binding involved in cell-cell adhesion [GO:0098641]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]"
Q62762,CHOYP_KC1G3.1.2|m.18974,0,0,0,0,0,0,0,0,0,Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1),Csnk1g2 Ck1g2,415,endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; Wnt signaling pathway [GO:0016055],GO:0000287; GO:0001948; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006897; GO:0008360; GO:0016020; GO:0016055; GO:0018105; GO:0042277; GO:0046777; GO:0051219,,,,PF12605;PF00069;,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; glycoprotein binding [GO:0001948]; magnesium ion binding [GO:0000287]; peptide binding [GO:0042277]; phosphoprotein binding [GO:0051219]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; Wnt signaling pathway [GO:0016055]
Q5RJI4,CHOYP_LOC100184284.2.2|m.21644,1,0,0,0,0,0,0,0,2.00E-31,"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)",Pkdcc Sgk493 Vlk,492,bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; palate development [GO:0060021]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; skeletal system development [GO:0001501],GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021,,,,PF12260;,extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; palate development [GO:0060021]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; skeletal system development [GO:0001501]
Q3T0W7,CHOYP_LOC100369330.1.1|m.48177,0,0,0,0,0,0,0,0,1.00E-41,Ubiquitin-like protein ATG12 (Autophagy-related protein 12) (APG12-like),ATG12,140,autophagosome assembly [GO:0000045]; C-terminal protein lipidation [GO:0006501]; innate immune response [GO:0045087]; mitophagy [GO:0000422]; nucleophagy [GO:0044804],GO:0000045; GO:0000422; GO:0006501; GO:0019776; GO:0034045; GO:0034274; GO:0044804; GO:0045087,,,cd01612;,PF04110;,Atg12-Atg5-Atg16 complex [GO:0034274]; pre-autophagosomal structure membrane [GO:0034045]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; C-terminal protein lipidation [GO:0006501]; innate immune response [GO:0045087]; mitophagy [GO:0000422]; nucleophagy [GO:0044804]
A4IF63,CHOYP_LOC100375551.2.2|m.63719,0.5,0,0,0,0,0,0,0,0.000000003,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,744,regulation of neuron apoptotic process [GO:0043523],GO:0004842; GO:0005737; GO:0008270; GO:0043523,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
Q3U2J5,CHOYP_LOC100892187.1.1|m.12761,0,0,0,0,0,0,0,0,8.00E-87,Calmodulin-lysine N-methyltransferase (CLNMT) (CaM KMT) (EC 2.1.1.60),Camkmt Clnmt,323,mitochondrion organization [GO:0007005]; peptidyl-lysine methylation [GO:0018022],GO:0005634; GO:0005794; GO:0007005; GO:0018022; GO:0018025,,,,PF10294;,Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; calmodulin-lysine N-methyltransferase activity [GO:0018025]; mitochondrion organization [GO:0007005]; peptidyl-lysine methylation [GO:0018022]
Q9UA35,CHOYP_LOC574602.1.1|m.44079,0.5,0,0,0,0,0,0,0,1.00E-132,Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT),SLC28A3 CNT3,683,,GO:0005337; GO:0005887,,,,PF07670;PF07662;PF01773;,integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]
Q27991,CHOYP_LOC585963.1.2|m.36775,0.5,0,0,0,0,0,0,0,2.00E-35,"Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB)",MYH10,1976,"actin filament-based movement [GO:0030048]; adult heart development [GO:0007512]; aorta development [GO:0035904]; axon guidance [GO:0007411]; cardiac myofibril assembly [GO:0055003]; cardiac septum development [GO:0003279]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; cerebellar Purkinje cell layer development [GO:0021680]; coronary vasculature development [GO:0060976]; exocytosis [GO:0006887]; fourth ventricle development [GO:0021592]; in utero embryonic development [GO:0001701]; lateral ventricle development [GO:0021670]; mitotic cytokinesis [GO:0000281]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; plasma membrane repair [GO:0001778]; regulation of cell shape [GO:0008360]; retina development in camera-type eye [GO:0060041]; substrate-dependent cell migration, cell extension [GO:0006930]; third ventricle development [GO:0021678]; ventricular cardiac muscle cell development [GO:0055015]",GO:0000146; GO:0000281; GO:0001701; GO:0001725; GO:0001764; GO:0001778; GO:0003279; GO:0005524; GO:0005634; GO:0005819; GO:0005886; GO:0005903; GO:0005938; GO:0006887; GO:0006930; GO:0007097; GO:0007155; GO:0007411; GO:0007512; GO:0008283; GO:0008360; GO:0016460; GO:0021592; GO:0021670; GO:0021678; GO:0021680; GO:0030027; GO:0030048; GO:0030424; GO:0030426; GO:0030496; GO:0030898; GO:0031594; GO:0032154; GO:0035904; GO:0043025; GO:0043197; GO:0043531; GO:0050885; GO:0055003; GO:0055015; GO:0060041; GO:0060976; GO:0070062; GO:0097513,,,,PF00612;PF00063;PF02736;PF01576;,"axon [GO:0030424]; brush border [GO:0005903]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; stress fiber [GO:0001725]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; actin filament-based movement [GO:0030048]; adult heart development [GO:0007512]; aorta development [GO:0035904]; axon guidance [GO:0007411]; cardiac myofibril assembly [GO:0055003]; cardiac septum development [GO:0003279]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; cerebellar Purkinje cell layer development [GO:0021680]; coronary vasculature development [GO:0060976]; exocytosis [GO:0006887]; fourth ventricle development [GO:0021592]; in utero embryonic development [GO:0001701]; lateral ventricle development [GO:0021670]; mitotic cytokinesis [GO:0000281]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; plasma membrane repair [GO:0001778]; regulation of cell shape [GO:0008360]; retina development in camera-type eye [GO:0060041]; substrate-dependent cell migration, cell extension [GO:0006930]; third ventricle development [GO:0021678]; ventricular cardiac muscle cell development [GO:0055015]"
Q9ULI1,CHOYP_LOC763845.1.1|m.35345,0,0,0,0,0,0,0,0,3.00E-69,NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239),NWD2 KIAA1239,1742,,,,,,PF13271;,
Q6PDZ2,CHOYP_NEMVEDRAFT_V1G241267.1.1|m.7467,0,0,0,0,0,0,0,0,5.00E-17,TATA box-binding protein-associated factor RNA polymerase I subunit C (RNA polymerase I-specific TBP-associated factor 95 kDa) (TAFI95) (TATA box-binding protein-associated factor 1C) (TBP-associated factor 1C) (Transcription initiation factor SL1/TIF-IB subunit C),Taf1c,836,chromatin silencing at rDNA [GO:0000183]; transcription from RNA polymerase I promoter [GO:0006360]; transcription initiation from RNA polymerase I promoter [GO:0006361],GO:0000120; GO:0000183; GO:0001164; GO:0001650; GO:0005654; GO:0005730; GO:0006360; GO:0006361,,,,,fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I transcription factor complex [GO:0000120]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; chromatin silencing at rDNA [GO:0000183]; transcription from RNA polymerase I promoter [GO:0006360]; transcription initiation from RNA polymerase I promoter [GO:0006361]
P74148,CHOYP_NEMVEDRAFT_V1G242153.1.4|m.7718,0,0,0,0,0,0,0,0,7.00E-11,Universal stress protein Sll1388 (USP Sll1388),sll1388,154,response to stress [GO:0006950],GO:0006950,,,,PF00582;,response to stress [GO:0006950]
P55040,CHOYP_AGAP_AGAP007681.1.1|m.36727,0,0,0,0,0,0,0,0,4.00E-27,GTP-binding protein GEM (GTP-binding mitogen-induced T-cell protein) (RAS-like protein KIR),GEM KIR,296,cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic nuclear division [GO:0007067]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264],GO:0000287; GO:0003924; GO:0005525; GO:0005634; GO:0006955; GO:0007067; GO:0007165; GO:0007166; GO:0007264; GO:0009898; GO:0019003; GO:0030496; GO:0051233; GO:0051276; GO:0051310; GO:0072686,,,,PF00071;,cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic nuclear division [GO:0007067]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]
Q9P0W8,CHOYP_BRAFLDRAFT_65681.1.1|m.445,0.5,0,0,0,0,0,0,0,5.00E-23,Spermatogenesis-associated protein 7 (HSD-3.1) (Spermatogenesis-associated protein HSD3),SPATA7 HSD3,599,photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601],GO:0005654; GO:0005739; GO:0005829; GO:0005930; GO:0007601; GO:0015630; GO:0032391; GO:0036064; GO:0045494; GO:0050896; GO:1903546; GO:1903621,,,,PF15244;,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
Q80X72,CHOYP_BRAFLDRAFT_89744.1.1|m.29497,0,0,0,0,0,0,0,0,3.00E-12,Leucine-rich repeat-containing protein 15,Lrrc15,579,cytokine-mediated signaling pathway [GO:0019221]; negative regulation of establishment of protein localization to plasma membrane [GO:0090005]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813],GO:0001968; GO:0004860; GO:0005518; GO:0005737; GO:0006469; GO:0016021; GO:0019221; GO:0030335; GO:0043236; GO:0046426; GO:0046813; GO:0070062; GO:0090005,,,,PF13855;,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; protein kinase inhibitor activity [GO:0004860]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of establishment of protein localization to plasma membrane [GO:0090005]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]
P15989,CHOYP_CO6A3.3.5|m.39796,0,0,0,0,0,0,0,0,2.00E-104,Collagen alpha-3(VI) chain,COL6A3,3137,cell adhesion [GO:0007155],GO:0004867; GO:0005578; GO:0005581; GO:0007155,,,cd00063;,PF01391;PF00014;PF00092;,collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
Q8CC21,CHOYP_LOC100122208.1.1|m.58545,0,0,0,0,0,0,0,0,3.00E-29,"Tetratricopeptide repeat protein 19, mitochondrial (TPR repeat protein 19)",Ttc19,365,mitochondrial respiratory chain complex III assembly [GO:0034551],GO:0005739; GO:0005743; GO:0034551,,,,PF13374;,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex III assembly [GO:0034551]
P28285,CHOYP_LOC100145215.1.1|m.6904,0,0,0,0,0,0,0,0,6.00E-28,5-hydroxytryptamine receptor 2A (5-HT receptor 2A) (Serotonin receptor 2A),5-HT1A 5HT-R2A CG16720,834,"adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; anesthesia-resistant memory [GO:0007615]; inter-male aggressive behavior [GO:0002121]; male courtship behavior [GO:0008049]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin receptor signaling pathway [GO:0007210]",GO:0001586; GO:0002121; GO:0004993; GO:0005886; GO:0007198; GO:0007208; GO:0007210; GO:0007615; GO:0008049; GO:0008227; GO:0016021; GO:0030594; GO:0045187,,,,PF00001;,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G-protein coupled amine receptor activity [GO:0008227]; G-protein coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; anesthesia-resistant memory [GO:0007615]; inter-male aggressive behavior [GO:0002121]; male courtship behavior [GO:0008049]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin receptor signaling pathway [GO:0007210]"
Q8K2C9,CHOYP_LOC100376136.1.1|m.4906,0,0,0,0,0,0,0,0,4.00E-78,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Butyrate-induced protein 1) (B-ind1) (Protein-tyrosine phosphatase-like A domain-containing protein 1),Hacd3 Ptplad1,362,fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; very long-chain fatty acid biosynthetic process [GO:0042761],GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0005925; GO:0007249; GO:0007254; GO:0007266; GO:0016021; GO:0018812; GO:0019899; GO:0030497; GO:0031965; GO:0042761; GO:0045070; GO:0046726; GO:0102344; GO:0102345,PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000250|UniProtKB:Q9P035}.,,,PF04387;,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; very long-chain fatty acid biosynthetic process [GO:0042761]
Q6NT55,CHOYP_LOC100379072.1.1|m.43496,0,0,0,0,0,0,0,0,1.00E-128,Cytochrome P450 4F22 (EC 1.14.14.-),CYP4F22,531,icosanoid metabolic process [GO:0006690],GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0031090,,,,PF00067;,"endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690]"
Q3SYU1,CHOYP_LOC101076180.1.1|m.41749,0,0,0,0,0,0,0,0,0,Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor),NOC2L NIR,746,"apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleolus to nucleoplasm transport [GO:0032066]; ribosomal large subunit biogenesis [GO:0042273]; transcription, DNA-templated [GO:0006351]",GO:0000122; GO:0002903; GO:0003714; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006351; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0032066; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243,,,,PF03715;,"cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleolus to nucleoplasm transport [GO:0032066]; ribosomal large subunit biogenesis [GO:0042273]; transcription, DNA-templated [GO:0006351]"
Q9HAC7,CHOYP_LOC101160363.1.1|m.194,0,0,0,0,0,0,0,0,6.00E-172,Succinate--hydroxymethylglutarate CoA-transferase (EC 2.8.3.13) (Dermal papilla-derived protein 13) (SuccinylCoA:glutarate-CoA transferase),SUGCT C7orf10 DERP13,445,,GO:0005739; GO:0047369,,,,PF02515;,mitochondrion [GO:0005739]; succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369]
O08550,CHOYP_MLL.1.1|m.33426,0,0,0,0,0,0,0,0,6.00E-121,Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 4 homolog) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7),Kmt2b Mll2 Trx2 Wbp7,2713,"gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone lysine methylation [GO:0034968]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0001541; GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0007613; GO:0008270; GO:0009994; GO:0016458; GO:0030728; GO:0034968; GO:0035097; GO:0042800; GO:0051568; GO:0051569; GO:0080182,,,,PF05965;PF05964;PF00628;PF00856;PF02008;,"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]; gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone lysine methylation [GO:0034968]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
P81718,CHOYP_PTPRB.3.4|m.52977,0,0,0,0,0,0,0,0,2.00E-49,Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Protein-tyrosine phosphatase SHP-1),Ptpn6 Ptph6,613,cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; protein dephosphorylation [GO:0006470]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to wounding [GO:0009611],GO:0004725; GO:0005001; GO:0005634; GO:0005737; GO:0006470; GO:0008283; GO:0009611; GO:0030154; GO:0046703; GO:0070372,,,,PF00017;PF00102;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; natural killer cell lectin-like receptor binding [GO:0046703]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; protein dephosphorylation [GO:0006470]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to wounding [GO:0009611]
P81718,CHOYP_PTPRT.1.45|m.2628,0,0,0,0,0,0,0,0,1.00E-49,Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Protein-tyrosine phosphatase SHP-1),Ptpn6 Ptph6,613,cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; protein dephosphorylation [GO:0006470]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to wounding [GO:0009611],GO:0004725; GO:0005001; GO:0005634; GO:0005737; GO:0006470; GO:0008283; GO:0009611; GO:0030154; GO:0046703; GO:0070372,,,,PF00017;PF00102;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; natural killer cell lectin-like receptor binding [GO:0046703]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; protein dephosphorylation [GO:0006470]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to wounding [GO:0009611]
P43006,CHOYP_TBB4B.3.7|m.22777,0,0,0,0,0,0,0,0,3.00E-179,Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2),Slc1a2 Eaat2 Glt1,572,adult behavior [GO:0030534]; anion transmembrane transport [GO:0098656]; cellular response to extracellular stimulus [GO:0031668]; D-aspartate import [GO:0070779]; L-glutamate import [GO:0051938]; L-glutamate transmembrane transport [GO:0089711]; L-glutamate transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; positive regulation of glucose import [GO:0046326]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632],GO:0005313; GO:0005886; GO:0005887; GO:0007399; GO:0007632; GO:0008509; GO:0009416; GO:0009611; GO:0009986; GO:0010259; GO:0015501; GO:0015813; GO:0021537; GO:0030424; GO:0030534; GO:0030673; GO:0031668; GO:0035264; GO:0042493; GO:0043200; GO:0046326; GO:0051938; GO:0070779; GO:0089711; GO:0098656,,,,PF00375;,axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; glutamate:sodium symporter activity [GO:0015501]; L-glutamate transmembrane transporter activity [GO:0005313]; adult behavior [GO:0030534]; anion transmembrane transport [GO:0098656]; cellular response to extracellular stimulus [GO:0031668]; D-aspartate import [GO:0070779]; L-glutamate import [GO:0051938]; L-glutamate transmembrane transport [GO:0089711]; L-glutamate transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; positive regulation of glucose import [GO:0046326]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632]
Q2QLG0,CHOYP_AFUA_1G01020.33.50|m.43179,0,0,0,0,0,0,0,0,5.00E-15,"Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein)",ASZ1 GASZ,477,cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],GO:0007140; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071546,,,,PF00023;PF12796;PF07647;,pi-body [GO:0071546]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]
Q75J93,CHOYP_BRAFLDRAFT_125403.1.1|m.30476,1.5,0,0,0,0,0,0,0,1.00E-125,Circularly permutated Ras protein 1 (DdiCPRas1),cpras1 DDB_G0277381,842,ER to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; small GTPase mediated signal transduction [GO:0007264],GO:0005525; GO:0006886; GO:0006888; GO:0007264; GO:0008270; GO:0030127,,,,PF00071;,COPII vesicle coat [GO:0030127]; GTP binding [GO:0005525]; zinc ion binding [GO:0008270]; ER to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; small GTPase mediated signal transduction [GO:0007264]
O35309,CHOYP_BRAFLDRAFT_208436.29.32|m.61623,0,0,0,0,0,0,0,0,0.000001,N-myc-interactor (Nmi) (N-myc and STAT interactor),Nmi,314,interferon-gamma-mediated signaling pathway [GO:0060333]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha biosynthetic process [GO:0045355]; negative regulation of interferon-beta biosynthetic process [GO:0045358]; negative regulation of type I interferon production [GO:0032480]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; transcription from RNA polymerase II promoter [GO:0006366],GO:0000166; GO:0003712; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0032480; GO:0042802; GO:0045355; GO:0045358; GO:0045824; GO:0060333; GO:1902524,,,,PF07334;PF07292;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; transcription cofactor activity [GO:0003712]; interferon-gamma-mediated signaling pathway [GO:0060333]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha biosynthetic process [GO:0045355]; negative regulation of interferon-beta biosynthetic process [GO:0045358]; negative regulation of type I interferon production [GO:0032480]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; transcription from RNA polymerase II promoter [GO:0006366]
Q9NXB0,CHOYP_BRAFLDRAFT_279949.1.1|m.54415,1,0,0,0,0,0,0,0,4.00E-138,Meckel syndrome type 1 protein,MKS1,559,"branching morphogenesis of an epithelial tube [GO:0048754]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]",GO:0001843; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007368; GO:0010669; GO:0016020; GO:0036038; GO:0036064; GO:0042733; GO:0044458; GO:0048706; GO:0048754; GO:0060122; GO:0060271; GO:0060322; GO:0060828; GO:0061009; GO:0097711; GO:1901620; GO:1905515; GO:1990403; GO:2000095,,,,PF07162;,"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; branching morphogenesis of an epithelial tube [GO:0048754]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]"
Q4R9E0,CHOYP_BRAFLDRAFT_63652.1.1|m.8021,0,0,0,0,0,0,0,0,8.00E-29,Tectonic-3,TCTN3 TECT3 QtsA-10216,608,apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224],GO:0006915; GO:0007224; GO:0016021; GO:0060271,,,,PF07773;,integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224]
Q86GV3,CHOYP_GCY.2.4|m.33243,0,0,0,0,0,0,0,0,0,Receptor-type guanylate cyclase gcy-28 (EC 4.6.1.2) (GCY-X1),gcy-28 T01A4.1,1276,cGMP biosynthetic process [GO:0006182]; chemotaxis [GO:0006935]; intracellular signal transduction [GO:0035556]; olfactory behavior [GO:0042048]; sensory perception of chemical stimulus [GO:0007606]; sensory processing [GO:0050893]; signal transduction [GO:0007165],GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006935; GO:0007165; GO:0007606; GO:0008074; GO:0016021; GO:0030424; GO:0030425; GO:0035556; GO:0042048; GO:0043005; GO:0043204; GO:0044297; GO:0046872; GO:0050893,,,,PF01094;PF00211;PF07714;,"axon [GO:0030424]; cell body [GO:0044297]; dendrite [GO:0030425]; guanylate cyclase complex, soluble [GO:0008074]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; chemotaxis [GO:0006935]; intracellular signal transduction [GO:0035556]; olfactory behavior [GO:0042048]; sensory perception of chemical stimulus [GO:0007606]; sensory processing [GO:0050893]; signal transduction [GO:0007165]"
P59014,CHOYP_GEPH.2.2|m.56703,0,0,0,0,0,0,0,0,5.00E-15,Molybdenum cofactor biosynthesis bifunctional protein [Includes: Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C); Molybdenum cofactor biosynthesis protein B],moaCB CT1330,312,Mo-molybdopterin cofactor biosynthetic process [GO:0006777],GO:0006777; GO:0061799,PATHWAY: Cofactor biosynthesis; molybdopterin biosynthesis. {ECO:0000250|UniProtKB:P0A738}.,,cd01420;cd00886;,PF01967;PF00994;,cyclic pyranopterin monophosphate synthase activity [GO:0061799]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]
Q91766,CHOYP_LOC100023660.1.1|m.30865,0,0,0,0,0,0,0,0,0,Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1),hnf4a hnf4 nr2a1,464,"transcription, DNA-templated [GO:0006351]",GO:0003700; GO:0003707; GO:0005634; GO:0006351; GO:0008270; GO:0043565,,,,PF00104;PF00105;,"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]; transcription, DNA-templated [GO:0006351]"
P71359,CHOYP_LOC100370129.1.4|m.6950,0,0,0,0,0,0,0,0,5.00E-41,ATP-dependent DNA helicase RecQ (EC 3.6.4.12),recQ HI_0728,619,DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432],GO:0003677; GO:0005524; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0009378; GO:0009432; GO:0043140,,,,PF00270;PF00271;PF00570;PF16124;PF09382;,chromosome [GO:0005694]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]
Q8BVV7,CHOYP_LOC100372020.1.1|m.59998,0,0,0,0,0,0,0,0,6.00E-67,Centrosomal protein of 95 kDa (Cep95) (Coiled-coil domain-containing protein 45),Cep95 Ccdc45,827,,GO:0000922; GO:0005737; GO:0005813,,,,,centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]
Q9R1M5,CHOYP_LOC100372392.1.8|m.6461,0,0,0,0,0,0,0,0,6.00E-14,"NACHT, LRR and PYD domains-containing protein 5 (Maternal antigen that embryos require) (Mater protein) (Ooplasm-specific protein 1) (OP1)",Nlrp5 Mater Nalp5,1163,animal organ morphogenesis [GO:0009887]; cellular protein complex assembly [GO:0043623]; cellular protein localization [GO:0034613]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; in utero embryonic development [GO:0001701]; neuron death [GO:0070997]; regulation of protein stability [GO:0031647]; regulation of RNA stability [GO:0043487],GO:0001701; GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005938; GO:0007566; GO:0009566; GO:0009887; GO:0031647; GO:0034613; GO:0043234; GO:0043487; GO:0043623; GO:0045179; GO:0070997,,,,PF13516;,apical cortex [GO:0045179]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein complex [GO:0043234]; ATP binding [GO:0005524]; animal organ morphogenesis [GO:0009887]; cellular protein complex assembly [GO:0043623]; cellular protein localization [GO:0034613]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; in utero embryonic development [GO:0001701]; neuron death [GO:0070997]; regulation of protein stability [GO:0031647]; regulation of RNA stability [GO:0043487]
Q9UKK3,CHOYP_LOC100373327.1.13|m.13252,0,0,0,0,0,0,0,0,0,Poly [ADP-ribose] polymerase 4 (PARP-4) (EC 2.4.2.30) (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (PARP-related/IalphaI-related H5/proline-rich) (PH5P) (Vault poly(ADP-ribose) polymerase) (VPARP),PARP4 ADPRTL1 KIAA0177 PARPL,1724,cell death [GO:0008219]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; response to drug [GO:0042493]; transport [GO:0006810],GO:0003677; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005876; GO:0006281; GO:0006464; GO:0006471; GO:0006810; GO:0006954; GO:0006974; GO:0008219; GO:0016020; GO:0019899; GO:0030529; GO:0042493; GO:0070062,,,cd00027;,PF00533;PF00644;PF08487;PF00092;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular ribonucleoprotein complex [GO:0030529]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell death [GO:0008219]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; response to drug [GO:0042493]; transport [GO:0006810]
Q8C761,CHOYP_LOC100373809.1.2|m.35126,1.5,0,0,0,0,0,0,0,1.00E-144,WD repeat-containing protein 60,Wdr60,999,cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704],GO:0000242; GO:0000922; GO:0005615; GO:0005868; GO:0005929; GO:0031021; GO:0048704; GO:0060271; GO:0070062; GO:0097546,,,,PF00400;,ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; interphase microtubule organizing center [GO:0031021]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]
O43903,CHOYP_LOC100485604.1.1|m.45268,0,0,0,0,0,0,0,0,1.00E-59,Growth arrest-specific protein 2 (GAS-2),GAS2,313,apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; regulation of cell shape [GO:0008360],GO:0005829; GO:0005884; GO:0006915; GO:0007050; GO:0008360; GO:0016020,,,cd00014;,PF00307;PF02187;,actin filament [GO:0005884]; cytosol [GO:0005829]; membrane [GO:0016020]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; regulation of cell shape [GO:0008360]
P92555,CHOYP_LOC100490320.2.2|m.36450,0,0,0,0,0,0,0,0,0.000003,Uncharacterized mitochondrial protein AtMg01250 (ORF102),AtMg01250; At2g07697,122,,GO:0005739,,,,PF00078;,mitochondrion [GO:0005739]
Q17QJ5,CHOYP_LOC100645644.1.1|m.55634,0,0,0,0,0,0,0,0,4.00E-89,Tetraspanin-5 (Tspan-5),TSPAN5,268,cell surface receptor signaling pathway [GO:0007166]; establishment of protein localization to plasma membrane [GO:0090002]; positive regulation of Notch signaling pathway [GO:0045747]; protein maturation [GO:0051604],GO:0005887; GO:0007166; GO:0045747; GO:0051604; GO:0090002,,,,PF00335;,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]; establishment of protein localization to plasma membrane [GO:0090002]; positive regulation of Notch signaling pathway [GO:0045747]; protein maturation [GO:0051604]
Q76I76,CHOYP_LOC100651687.1.1|m.39884,0,0,0,0,0,0,0,0,9.00E-133,Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L),SSH2 KIAA1725 SSH2L,1423,actin cytoskeleton organization [GO:0030036]; protein dephosphorylation [GO:0006470]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of lamellipodium assembly [GO:0010591],GO:0003677; GO:0003779; GO:0004721; GO:0004725; GO:0005615; GO:0005737; GO:0005856; GO:0006470; GO:0008064; GO:0008138; GO:0010591; GO:0030036; GO:0050770,,,cd00127;,PF08766;PF00782;,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; actin binding [GO:0003779]; DNA binding [GO:0003677]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; protein dephosphorylation [GO:0006470]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of lamellipodium assembly [GO:0010591]
O34309,CHOYP_LOC100890479.1.3|m.8193,0,0,0,0,0,0,0,0,8.00E-49,"Putative phosphoenolpyruvate synthase (Putative PEP synthase) (Pyruvate, water dikinase)",pps BSU18830,866,,GO:0005524; GO:0016301,,,,PF00391;PF01326;,ATP binding [GO:0005524]; kinase activity [GO:0016301]
Q9VA73,CHOYP_LOC100901947.1.1|m.7834,1,0,0,0,0,0,0,0,0,Calcium-binding mitochondrial carrier protein Aralar1,aralar1 CG2139,695,aspartate transport [GO:0015810]; L-glutamate transmembrane transport [GO:0089711]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060],GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0005811; GO:0006839; GO:0015183; GO:0015810; GO:0016021; GO:0022857; GO:0042060; GO:0043490; GO:0089711,,,,PF13833;PF00153;,integral component of membrane [GO:0016021]; lipid particle [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transport [GO:0015810]; L-glutamate transmembrane transport [GO:0089711]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]
P08004,CHOYP_LOC100907845.2.3|m.23111,0,0,0,0,0,0,0,0,3.00E-19,Chitin synthase 1 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase 1),CHS1 YNL192W N1404,1131,barrier septum site selection [GO:0000918]; cell separation after cytokinesis [GO:0000920]; cell wall chitin biosynthetic process [GO:0006038]; fungal-type cell wall organization [GO:0031505],GO:0000918; GO:0000920; GO:0004100; GO:0005886; GO:0006038; GO:0016021; GO:0030428; GO:0031505; GO:0045009,,,,PF01644;PF08407;,cell septum [GO:0030428]; chitosome [GO:0045009]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; barrier septum site selection [GO:0000918]; cell separation after cytokinesis [GO:0000920]; cell wall chitin biosynthetic process [GO:0006038]; fungal-type cell wall organization [GO:0031505]
Q16513,CHOYP_LOC582022.1.1|m.31,0,0,0,0,0,0,0,0,0,Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2),PKN2 PRK2 PRKCL2,984,"apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]",GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006351; GO:0006355; GO:0006468; GO:0006915; GO:0007049; GO:0007155; GO:0007165; GO:0010631; GO:0016020; GO:0016301; GO:0018105; GO:0030027; GO:0030496; GO:0032154; GO:0032467; GO:0035556; GO:0042826; GO:0043234; GO:0043296; GO:0043297; GO:0045070; GO:0045296; GO:0045931; GO:0048471; GO:0051301; GO:0070063; GO:2000145,,,,PF02185;PF00069;PF00433;,"apical junction complex [GO:0043296]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex [GO:0043234]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]"
Q6ZS30,CHOYP_NBEL1.1.1|m.33217,0,0,0,0,0,0,0,0,0,Neurobeachin-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein),NBEAL1 ALS2CR16 ALS2CR17,2694,,,,,cd06071;,PF02138;PF15787;PF14844;PF00400;,
B7QDG3,CHOYP_NNRE.2.2|m.27199,0.5,0,0,0,0,0,0,0,5.00E-96,NAD(P)H-hydrate epimerase (EC 5.1.99.6) (NAD(P)HX epimerase),ISCW022186,275,,GO:0000166; GO:0005739; GO:0046872; GO:0052856; GO:0052857,,,,PF03853;,mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166]
Q641W3,CHOYP_NUFIP1.1.1|m.8979,0,0,0,0,0,0,0,0,1.00E-42,Nuclear fragile X mental retardation-interacting protein 1 (Nuclear FMRP-interacting protein 1),Nufip1,486,box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein oligomerization [GO:0051259],GO:0000492; GO:0001650; GO:0005634; GO:0005726; GO:0008023; GO:0016363; GO:0022626; GO:0030515; GO:0045944; GO:0046872; GO:0048786; GO:0051259; GO:0070761,,,,PF10453;,cytosolic ribosome [GO:0022626]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; transcription elongation factor complex [GO:0008023]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein oligomerization [GO:0051259]
Q64319,CHOYP_SLC3A1.1.1|m.14892,1,0,0,0,0,0,0,0,3.00E-85,"Neutral and basic amino acid transport protein rBAT (D2) (Solute carrier family 3 member 1) (b(0,+)-type amino acid transport protein) (NAA-TR)",Slc3a1 Nbat,683,amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],GO:0003824; GO:0005743; GO:0005774; GO:0005886; GO:0005887; GO:0005975; GO:0006865; GO:0031526; GO:0046982; GO:0070062,,,,PF00128;,brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975]
Q16932,CHOYP_STX.1.1|m.30392,0,0,0,0,0,0,0,0,1.00E-161,Syntaxin,,290,intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; neurotransmitter transport [GO:0006836]; regulation of exocytosis [GO:0017157]; vesicle-mediated transport [GO:0016192],GO:0005622; GO:0006836; GO:0006886; GO:0016021; GO:0016192; GO:0017157; GO:0061025,,,,PF05739;PF00804;,integral component of membrane [GO:0016021]; intracellular [GO:0005622]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; neurotransmitter transport [GO:0006836]; regulation of exocytosis [GO:0017157]; vesicle-mediated transport [GO:0016192]
Q9NZQ8,CHOYP_TRPM5.1.2|m.59669,0,0,0,0,0,0,0,0,6.00E-32,Transient receptor potential cation channel subfamily M member 5 (Long transient receptor potential channel 5) (LTrpC-5) (LTrpC5) (MLSN1- and TRP-related gene 1 protein),TRPM5 LTRPC5 MTR1,1165,calcium ion transmembrane transport [GO:0070588]; sensory perception of taste [GO:0050909],GO:0005216; GO:0005227; GO:0005244; GO:0005267; GO:0005272; GO:0005886; GO:0016021; GO:0030425; GO:0043025; GO:0050909; GO:0070588,,,,PF00520;,dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; ion channel activity [GO:0005216]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; calcium ion transmembrane transport [GO:0070588]; sensory perception of taste [GO:0050909]
Q9VAC5,CHOYP_AAEL_AAEL003910.1.1|m.36530,0,0,0,0,0,0,0,0,6.00E-143,ADAM 17-like protease (EC 3.4.24.-),Tace CG7908,732,membrane protein ectodomain proteolysis [GO:0006509],GO:0004222; GO:0006509; GO:0016021; GO:0046872,,,cd04270;,PF16698;PF00200;PF01562;,integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; membrane protein ectodomain proteolysis [GO:0006509]
Q8L970,CHOYP_BRAFLDRAFT_67911.1.1|m.4174,0,0,0,0,0,0,0,0,1.00E-16,Probable prolyl 4-hydroxylase 7 (AtP4H7) (EC 1.14.11.2),P4H7 At3g28480 MFJ20.17,316,,GO:0004656; GO:0005506; GO:0005789; GO:0016021; GO:0031418,,,,PF13640;PF01549;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]
Q7Z5J8,CHOYP_BRAFLDRAFT_75707.1.1|m.8533,0,0,0,0,0,0,0,0,0,Ankyrin and armadillo repeat-containing protein,ANKAR,1434,,GO:0005634; GO:0005737; GO:0016021,,,,PF12796;PF00514;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]
O88450,CHOYP_BRAFLDRAFT_75725.1.1|m.9603,0,0,0,0,0,0,0,0,2.00E-67,Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator) (NUDR) (Suppressin),Deaf1 Spn,565,"embryonic skeletal system development [GO:0048706]; neural tube closure [GO:0001843]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of multicellular organismal development [GO:2000026]; transcription, DNA-templated [GO:0006351]",GO:0001843; GO:0003677; GO:0003700; GO:0005576; GO:0005634; GO:0006351; GO:0033599; GO:0045944; GO:0046872; GO:0048706; GO:2000026,,,,PF01342;PF01753;,"extracellular region [GO:0005576]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; embryonic skeletal system development [GO:0048706]; neural tube closure [GO:0001843]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of multicellular organismal development [GO:2000026]; transcription, DNA-templated [GO:0006351]"
P08053,CHOYP_CALM.32.50|m.48894,2,0,0,0,0,0,0,0,2.00E-34,Myosin regulatory light chain (Calcium-binding light chain),,147,,GO:0005509; GO:0016459,,,cd00051;,PF00036;PF13499;,myosin complex [GO:0016459]; calcium ion binding [GO:0005509]
P24862,CHOYP_CCNB.2.2|m.16937,0,0,0,0,0,0,0,0,1.00E-175,G2/mitotic-specific cyclin-B,,408,cell division [GO:0051301]; mitotic nuclear division [GO:0007067],GO:0005634; GO:0007067; GO:0051301,,,,PF02984;PF00134;,nucleus [GO:0005634]; cell division [GO:0051301]; mitotic nuclear division [GO:0007067]
Q3TT38,CHOYP_CF106.1.1|m.14354,0,0,0,0,0,0,0,0,1.00E-85,Uncharacterized protein C6orf106 homolog,D17Wsu92e,291,macroautophagy [GO:0016236],GO:0000407; GO:0005776; GO:0016236; GO:0043130,,,cd14947;,PF16158;,autophagosome [GO:0005776]; pre-autophagosomal structure [GO:0000407]; ubiquitin binding [GO:0043130]; macroautophagy [GO:0016236]
Q9GV77,CHOYP_FREM2.1.1|m.31430,0,0,0,0,0,0,0,0,0,Extracellular matrix protein 3 (FREM2 homolog),ECM3,3103,cell communication [GO:0007154]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275],GO:0005509; GO:0005886; GO:0007154; GO:0007156; GO:0007275; GO:0016021,,,,PF03160;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell communication [GO:0007154]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]
O77245,CHOYP_LOC100161053.1.1|m.6306,0,0,0,0,0,0,0,0,3.00E-84,Nuclear hormone receptor E75 (Nuclear receptor subfamily 1 group D member 3),E75 NR1D3,606,"transcription, DNA-templated [GO:0006351]",GO:0003700; GO:0003707; GO:0005634; GO:0006351; GO:0008270; GO:0043565,,,,PF00104;PF00105;,"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]; transcription, DNA-templated [GO:0006351]"
Q26474,CHOYP_LOC100168017.1.1|m.40316,0,0,0,0,0,0,0,0,2.00E-32,Lachesin,LAC,349,cell adhesion [GO:0007155]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004714; GO:0005886; GO:0007155; GO:0007169; GO:0031225,,,,PF07679;,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell adhesion [GO:0007155]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
Q9P0M2,CHOYP_LOC100176099.1.1|m.40368,1,0,0,0,0,0,0,0,1.00E-17,A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma),AKAP7 AKAP18,348,protein localization [GO:0008104]; regulation of protein kinase A signaling [GO:0010738],GO:0000166; GO:0005634; GO:0005829; GO:0008104; GO:0010738; GO:0034237; GO:0051018,,,,PF10469;PF10470;,cytosol [GO:0005829]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein localization [GO:0008104]; regulation of protein kinase A signaling [GO:0010738]
P23919,CHOYP_LOC100369259.1.1|m.7509,0,0,0,0,0,0,0,0,1.00E-73,Thymidylate kinase (EC 2.7.4.9) (dTMP kinase),DTYMK CDC8 TMPK TYMK,212,cell cycle [GO:0007049]; cell proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; myoblast differentiation [GO:0045445]; nucleobase-containing small molecule interconversion [GO:0015949]; response to cadmium ion [GO:0046686]; response to estrogen [GO:0043627],GO:0004798; GO:0005524; GO:0005737; GO:0005758; GO:0005759; GO:0005829; GO:0006227; GO:0006233; GO:0006235; GO:0007049; GO:0008283; GO:0009041; GO:0015949; GO:0043627; GO:0045445; GO:0046686; GO:0050145; GO:0071363,PATHWAY: Pyrimidine metabolism; dTTP biosynthesis.,,,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; nucleoside phosphate kinase activity [GO:0050145]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]; cell cycle [GO:0007049]; cell proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; myoblast differentiation [GO:0045445]; nucleobase-containing small molecule interconversion [GO:0015949]; response to cadmium ion [GO:0046686]; response to estrogen [GO:0043627]
Q6PFY8,CHOYP_LOC100369333.14.32|m.32582,0,0,0,0,0,0,0,0,6.00E-15,Tripartite motif-containing protein 45,Trim45,580,bone development [GO:0060348],GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348,,,,PF00630;PF00643;PF13445;,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
Q9W735,CHOYP_LOC100374504.1.2|m.27883,0,0,0,0,0,0,0,0,3.00E-101,Prominin-1-A (Prominin-like protein 1),prom1a proml1,826,,GO:0005783; GO:0005793; GO:0005886; GO:0016021; GO:0016324; GO:0031528,,,,PF05478;,apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]
Q96DM1,CHOYP_LOC100498109.3.3|m.55841,0.5,0,0,0,0,0,0,0,2.00E-41,PiggyBac transposable element-derived protein 4,PGBD4,585,,,,,,PF13843;PF13842;,
A6BM72,CHOYP_LOC100555755.1.1|m.58711,0,0,0,0,0,0,0,0,3.00E-51,Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11),MEGF11 KIAA1781 UNQ1949/PRO4432,1044,homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],GO:0010842; GO:0016021; GO:0016323; GO:0034109,,,,PF12661;PF00053;,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]
Q9D9M5,CHOYP_LOC100559885.1.1|m.50207,0,0,0,0,0,0,0,0,7.00E-57,Pyridoxal phosphate phosphatase PHOSPHO2 (EC 3.1.3.74),Phospho2,241,,GO:0016791; GO:0033883; GO:0046872,,,,PF06888;,metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pyridoxal phosphatase activity [GO:0033883]
Q5URB8,CHOYP_LOC589750.3.5|m.42967,0.5,0,0,0,0,0,0,0,5.00E-21,Putative ankyrin repeat protein R841,MIMI_R841,601,,,,,,PF00023;PF12796;,
Q9V439,CHOYP_LOC659964.1.1|m.25995,1,0,0,0,0,0,0,0,1.00E-56,Mediator of RNA polymerase II transcription subunit 22 (Mediator complex subunit 22) (dMED24),MED22 Med24 CG3034,143,"mitotic nuclear division [GO:0007067]; negative regulation of neuroblast proliferation [GO:0007406]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; transcription, DNA-templated [GO:0006351]",GO:0000785; GO:0001104; GO:0005634; GO:0005730; GO:0006351; GO:0006357; GO:0007067; GO:0007406; GO:0016592; GO:1902064,,,,PF06179;,"chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II transcription cofactor activity [GO:0001104]; mitotic nuclear division [GO:0007067]; negative regulation of neuroblast proliferation [GO:0007406]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; transcription, DNA-templated [GO:0006351]"
Q9P0M2,CHOYP_LOC754150.1.1|m.29730,0.5,0,0,0,0,0,0,0,2.00E-19,A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma),AKAP7 AKAP18,348,protein localization [GO:0008104]; regulation of protein kinase A signaling [GO:0010738],GO:0000166; GO:0005634; GO:0005829; GO:0008104; GO:0010738; GO:0034237; GO:0051018,,,,PF10469;PF10470;,cytosol [GO:0005829]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein localization [GO:0008104]; regulation of protein kinase A signaling [GO:0010738]
Q6DJF8,CHOYP_MET23.1.1|m.14359,0,0,0,0,0,0,0,0,2.00E-84,Methyltransferase-like protein 23 (EC 2.1.1.-),mettl23,234,,GO:0005737; GO:0008168; GO:0016021,,,,PF10294;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; methyltransferase activity [GO:0008168]
Q54F07,CHOYP_METK1.1.2|m.59870,0,0,0,0,0,0,0,0,8.00E-170,S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (Methionine adenosyltransferase) (MAT),metK DDB_G0291179,384,methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],GO:0004478; GO:0005524; GO:0005829; GO:0006555; GO:0006556; GO:0006730; GO:0045335; GO:0046872; GO:0048269,PATHWAY: Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. {ECO:0000250|UniProtKB:Q00266}.,,,PF02773;PF02772;PF00438;,cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]
Q99836,CHOYP_MYD88.5.7|m.41603,0,0,0,0,0,0,0,0,7.00E-68,Myeloid differentiation primary response protein MyD88,MYD88,296,3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I interferon production [GO:0032481]; regulation of inflammatory response [GO:0050727]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224],GO:0002224; GO:0002755; GO:0005123; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0006954; GO:0007165; GO:0007166; GO:0010008; GO:0032481; GO:0032740; GO:0032747; GO:0032755; GO:0034162; GO:0042802; GO:0043066; GO:0043123; GO:0043621; GO:0045087; GO:0050727; GO:0050830; GO:0051092; GO:0070555; GO:0070935; GO:0070976; GO:0071260,,,cd08312;,PF00531;PF01582;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; TIR domain binding [GO:0070976]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I interferon production [GO:0032481]; regulation of inflammatory response [GO:0050727]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]
Q9Y2M2,CHOYP_NEMVEDRAFT_V1G100491.1.1|m.7381,0,0,0,0,0,0,0,0,4.00E-59,Protein SSUH2 homolog (Protein ssu-2 homolog),SSUH2 C3orf32 FLS485,353,,GO:0005737,,,,,cytoplasm [GO:0005737]
Q9VBP3,CHOYP_PARP14.19.22|m.59129,0,0,0,0,0,0,0,0,9.00E-11,Tankyrase (dTNKS) (EC 2.4.2.30) (Poly [ADP-ribose] polymerase),Tnks tankyrase CG4719,1181,chaeta development [GO:0022416]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; regulation of proteasome assembly [GO:0090364]; spindle assembly [GO:0051225]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055],GO:0003950; GO:0006471; GO:0016055; GO:0022416; GO:0032212; GO:0035220; GO:0046872; GO:0051225; GO:0090364; GO:0097110,,,,PF00023;PF12796;PF00644;PF07647;,metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; scaffold protein binding [GO:0097110]; chaeta development [GO:0022416]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; regulation of proteasome assembly [GO:0090364]; spindle assembly [GO:0051225]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]
Q5E9W3,CHOYP_PYRD.1.1|m.47593,0,0,0,0,0,0,0,0,4.00E-149,"Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase)",DHODH,395,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205],GO:0004152; GO:0005743; GO:0006207; GO:0016021; GO:0044205,PATHWAY: Pyrimidine metabolism; UMP biosynthesis via de novo pathway; orotate from (S)-dihydroorotate (quinone route): step 1/1.,,cd04738;,PF01180;,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; dihydroorotate dehydrogenase activity [GO:0004152]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]
P90702,CHOYP_RL44.1.2|m.28788,0,0,0,0,0,0,0,0,2.00E-27,60S ribosomal protein L44,rpl-44,105,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412,,,,PF00935;,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
Q9H9A7,CHOYP_RMI1.1.1|m.17246,0,0,0,0,0,0,0,0,2.00E-56,RecQ-mediated genome instability protein 1 (BLM-associated protein of 75 kDa) (BLAP75) (FAAP75),RMI1 C9orf76,625,DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; glucose homeostasis [GO:0042593]; multicellular organism growth [GO:0035264]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to glucose [GO:0009749]; strand displacement [GO:0000732],GO:0000166; GO:0000731; GO:0000732; GO:0002023; GO:0005654; GO:0006260; GO:0009749; GO:0016604; GO:0035264; GO:0042593; GO:1901796,,,,PF16099;PF08585;,nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; glucose homeostasis [GO:0042593]; multicellular organism growth [GO:0035264]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to glucose [GO:0009749]; strand displacement [GO:0000732]
O34383,CHOYP_SC6A5.5.7|m.49357,0,0,0,0,0,0,0,0,3.00E-13,Uncharacterized sodium-dependent transporter YocR,yocR BSU19340,445,,GO:0005328; GO:0005886; GO:0016021,,,,PF00209;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]
Q5M823,CHOYP_TAD2A.1.1|m.27478,0,0,0,0,0,0,0,0,7.00E-58,NudC domain-containing protein 2,Nudcd2,157,developmental process [GO:0032502]; protein folding [GO:0006457],GO:0000777; GO:0000922; GO:0005737; GO:0005815; GO:0005829; GO:0006457; GO:0032502; GO:0051082; GO:0070062,,,,PF04969;,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; unfolded protein binding [GO:0051082]; developmental process [GO:0032502]; protein folding [GO:0006457]
Q1JPJ2,CHOYP_TRIADDRAFT_64367.1.1|m.42126,0.5,0,0,0,0,0,0,0,1.00E-161,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",XPNPEP1,623,bradykinin catabolic process [GO:0010815],GO:0005829; GO:0010815; GO:0030145; GO:0070006; GO:0070062,,,cd01085;,PF01321;PF00557;PF16188;,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; bradykinin catabolic process [GO:0010815]
None,CHOYP_contig_020442|m.23651,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100175021.11.11|m.63958,3.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004029|m.4597,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100502592.1.1|m.27996,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_65361.2.3|m.48007,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024730|m.28114,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_032690|m.37333,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_118709.3.4|m.52468,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_007858|m.9121,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC584740.2.2|m.34290,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TYRO1.5.6|m.44175,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_005830|m.6680,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PROF.2.2|m.41295,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEG10.47.91|m.45614,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AFUA_1G01020.42.50|m.61399,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_118365.1.1|m.44334,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G203842.1.1|m.60815,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS8.2.14|m.14441,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MUC5B.1.1|m.15734,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100368311.1.2|m.26733,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043680|m.50456,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_035697|m.40446,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_018098|m.21196,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.12.15|m.49134,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_HAAF.11.13|m.44366,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_046854|m.55054,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042766|m.49278,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_128887.2.2|m.46965,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_035470|m.40228,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003319|m.3735,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043301|m.50018,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024156|m.27442,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ADAR.2.3|m.45677,5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026383|m.30057,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_120041.1.1|m.6386,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_001360|m.1426,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_053146|m.63745,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G164392.3.3|m.59979,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC594151.1.2|m.7270,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EEF1A.1.3|m.18896,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026389|m.30064,2.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_60200.1.3|m.22201,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_012849|m.14773,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003695|m.4176,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039097|m.44266,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ACE.4.4|m.17563,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC590756.3.6|m.40372,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100697793.5.6|m.62286,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_055335|m.66005,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023639|m.26898,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100186936.1.2|m.12235,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048930|m.58050,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100890844.1.2|m.46790,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100375342.3.3|m.40363,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,K1M1_SHEEP,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SMP_078690.4.5|m.41580,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100373653.2.3|m.43046,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_010674|m.12365,3.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LRP1B.1.2|m.7346,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_012366|m.14229,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050515|m.60136,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIADDRAFT_61712.1.1|m.38683,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_246510.1.1|m.27433,8.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC411194.1.1|m.8502,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SCP.6.12|m.50694,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BDHB.1.1|m.9128,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_033147|m.37856,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AFUA_1G01020.24.50|m.32940,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_013837|m.15768,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050319|m.59838,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025014|m.28472,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DPSE_GA28241.1.1|m.18767,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEG10.22.91|m.28727,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RL39.2.2|m.64898,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_FUT2.5.5|m.63708,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_67258.12.18|m.47677,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_044225|m.51129,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100373146.1.2|m.13310,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G199564.4.6|m.54685,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_018118|m.21239,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_IAP2.4.5|m.56879,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004652|m.5338,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_84207.2.2|m.36438,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042815|m.49366,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014529|m.16671,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_120990.10.18|m.51025,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_022826|m.26063,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014339|m.16407,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042066|m.48310,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100199505.2.2|m.25542,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_029139|m.33073,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_030819|m.35130,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEGF6A.1.2|m.17795,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_006775|m.7711,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC578656.9.15|m.53454,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_052844|m.63401,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100368071.1.1|m.6755,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_90820.1.1|m.9279,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023301|m.26512,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_046883|m.55107,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_006664|m.7577,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEG10.50.91|m.46730,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100377009.9.10|m.60552,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_021736|m.24962,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_051254|m.61184,5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_032534|m.37120,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_030528|m.34754,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026140|m.29796,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008740|m.10166,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008114|m.9394,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100488715.1.1|m.61241,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_235412.1.2|m.52493,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PHUM_PHUM377430.1.2|m.29459,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.8.15|m.27207,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_INT2.1.1|m.52909,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050773|m.60479,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ATRP.1.1|m.22451,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374741.20.83|m.20589,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002989|m.3291,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_033346|m.38026,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003356|m.3782,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.11.15|m.43498,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ODPX.1.1|m.29098,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_018444|m.21618,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_009817|m.11438,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_006293|m.7131,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ISCW_ISCW008596.1.2|m.8803,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC578656.2.15|m.11315,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050158|m.59641,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100375194.5.7|m.46447,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043041|m.49677,2,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC594379.1.1|m.55370,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_119209.1.1|m.4850,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_161161.1.1|m.39447,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_125265.2.4|m.18968,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100370236.1.3|m.7766,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DMOJ_GI17052.1.1|m.4566,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_118281.2.4|m.23718,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_282752.2.2|m.17526,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002305|m.2519,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_087500.3.4|m.52917,2.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_010233|m.11921,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024498|m.27853,3.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101058182.1.1|m.57909,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039595|m.44817,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101165968.6.7|m.55758,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_005913|m.6764,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_019189|m.22478,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002691|m.2966,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_IMG5_109580.1.1|m.27791,7,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101067432.1.1|m.16927,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025411|m.28960,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_UNC-89.2.2|m.64371,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_88566.1.11|m.2935,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ACTA.1.2|m.13068,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023311|m.26521,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_INF2.3.5|m.13728,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MYSP.2.9|m.1763,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048420|m.57335,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050842|m.60581,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374741.65.83|m.53330,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_KCNC4.3.5|m.49537,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008016|m.9273,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_005908|m.6759,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100370844.1.2|m.30341,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AGAP_AGAP004367.1.1|m.17195,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_055225|m.65857,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ISCW_ISCW019177.4.4|m.63940,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041025|m.46710,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023259|m.26467,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100210520.1.1|m.22500,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_87336.4.9|m.23926,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100543236.1.2|m.20322,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100379079.4.5|m.23435,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_124260.1.1|m.8355,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003069|m.3372,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_012819|m.14744,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100370504.1.2|m.17506,7.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041706|m.47739,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042130|m.48414,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024665|m.28048,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_GIGA5.4.4|m.39598,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MPPA.2.2|m.18273,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CALMB.1.1|m.41570,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024605|m.27976,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_87294.6.6|m.64622,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G233709.6.13|m.49823,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050044|m.59512,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_013486|m.15438,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRI46.2.3|m.61659,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AUHM.1.2|m.28847,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042295|m.48677,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_051254|m.61185,4,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DPSE_GA17556.1.1|m.110,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100119236.1.1|m.22785,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002762|m.3056,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.15.15|m.63175,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_117283.2.2|m.37544,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_001413|m.1466,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SMC.3.5|m.51502,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_79377.21.30|m.53309,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EGFR.2.3|m.61781,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LACBIDRAFT_295117.3.10|m.29879,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_POP7.1.2|m.28402,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100639574.1.1|m.40201,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_027678|m.31381,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MYSTI_04398.1.1|m.27734,3,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_051433|m.61487,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIM2.13.59|m.25214,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_006220|m.7061,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_045193|m.52491,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_WHITE.1.1|m.38819,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_016762|m.19724,4,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EDI_002780.1.1|m.31041,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_020370|m.23576,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004751|m.5446,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RT06.1.1|m.1899,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026644|m.30335,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_017672|m.20677,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_87864.1.1|m.23722,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008837|m.10279,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048122|m.56947,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LR16A.3.3|m.59539,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS27L.3.4|m.33064,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEG10.84.91|m.63832,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PKH_082300.1.1|m.29388,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RL23A.6.6|m.63333,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100634688.5.6|m.51871,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DYAK_GE21870.1.1|m.28467,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025959|m.29617,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS2.7.10|m.39920,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIB2.1.1|m.226,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ACINU.1.1|m.9352,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_119491.1.1|m.58761,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_278918.4.5|m.39356,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PCYB_062570.1.1|m.58917,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIM3.37.58|m.39048,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100175021.7.11|m.58378,2,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_87283.1.1|m.46768,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100872674.2.2|m.28811,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_029942|m.33992,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100372845.1.3|m.7734,2.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_108792.2.5|m.31493,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023675|m.26925,2.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_022855|m.26082,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_016375|m.19279,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100636931.6.8|m.48882,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100708199.3.6|m.23799,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TBB4.1.1|m.40048,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC373275.4.7|m.47552,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025862|m.29523,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025058|m.28495,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031987|m.36469,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014324|m.16389,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AGAP_AGAP011396.1.1|m.1458,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100378999.1.1|m.36850,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100375204.2.2|m.21491,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIM2.42.59|m.43682,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_055303|m.65981,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.5.15|m.18769,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002597|m.2856,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.8.15|m.27209,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CASP7.21.23|m.63852,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G201445.4.5|m.54666,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC579946.14.24|m.49258,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIM2.16.59|m.31979,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040238|m.45605,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100376767.1.1|m.49887,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100898095.9.19|m.32685,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_049771|m.59128,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100369333.22.32|m.39414,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_70742.1.1|m.8525,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CHD5.1.2|m.18513,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NAEGRDRAFT_71860.1.1|m.2556,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RN213.10.13|m.56907,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G198667.12.15|m.51327,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_129914.1.3|m.8213,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_206799.1.23|m.3242,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DNAJC4.2.2|m.19500,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100202812.1.1|m.31203,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_80496.8.10|m.49028,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS9.3.13|m.30475,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031271|m.35690,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042249|m.48611,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CDC42.11.11|m.60002,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004338|m.4955,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_046706|m.54827,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042272|m.48643,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_022951|m.26161,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_93247.1.1|m.7558,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PGCB.2.2|m.43444,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_234854.2.2|m.58013,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_000422|m.391,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AAEL_AAEL009219.4.4|m.49371,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_034213|m.38895,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008261|m.9575,10,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIM2.47.59|m.53277,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RL13.4.4|m.53596,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SI_CH211-197G15.7.1.3|m.4409,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026676|m.30376,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041380|m.47215,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SAFB2.1.3|m.11138,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC578897.1.1|m.11932,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PAES_2382.1.1|m.53692,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374819.2.7|m.48237,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025311|m.28826,3,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS2.8.10|m.48098,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_032666|m.37309,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023888|m.27197,3,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003783|m.4287,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_035123|m.39896,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374981.1.16|m.21258,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040388|m.45791,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_028143|m.32002,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_053627|m.64220,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008509|m.9905,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SCP.5.12|m.49390,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101065647.2.2|m.10863,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TB11.01.6740.1.1|m.42560,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC756958.1.2|m.17672,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_038408|m.43447,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EEF2.1.2|m.44023,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023172|m.26349,3,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_018978|m.22243,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031210|m.35616,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008923|m.10388,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ANM12.1.1|m.53881,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100213495.2.2|m.51531,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025861|m.29521,2.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CASP7.2.23|m.5415,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_57788.6.10|m.45495,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_291510.8.9|m.51135,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026679|m.30379,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_027899|m.31627,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_027342|m.31071,2,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PRG4.1.2|m.7441,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G241446.1.2|m.22601,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_049102|m.58220,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,ALBU_BOVIN,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_STRN-MLCK.2.3|m.9348,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_037956|m.42826,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026106|m.29754,8.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025391|m.28934,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043845|m.50665,4.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_90706.2.2|m.29119,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DERE_GG18317.1.1|m.44730,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008030|m.9291,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048134|m.56964,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_VOLCADRAFT_88866.1.1|m.15255,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_055359|m.66029,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100493179.5.15|m.32003,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_019562|m.22860,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_038817|m.43926,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041293|m.47088,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_038126|m.43051,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_80496.1.10|m.12618,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_58035.2.2|m.65815,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_038062|m.42970,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024739|m.28119,7.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_131039.7.9|m.55824,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_045851|m.53508,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002407|m.2657,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G197314.1.2|m.61421,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_67258.17.18|m.57125,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CTXA.1.2|m.31637,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TTHERM_00599920.1.1|m.38926,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048603|m.57625,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_098350.1.1|m.14015,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014863|m.17135,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_052658|m.63135,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_037727|m.42549,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_038765|m.43871,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031244|m.35665,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_399490.1.3|m.7885,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_021455|m.24647,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_009306|m.10820,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100376214.9.11|m.53354,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014469|m.16593,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026398|m.30077,3,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_054223|m.64734,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIM5.1.2|m.60878,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_020411|m.23625,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040978|m.46621,5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SMP_148730.1.1|m.58317,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_204923.2.2|m.63877,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_013163|m.15116,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014215|m.16209,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_021870|m.25105,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043488|m.50266,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SACS.4.17|m.32398,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEGF6.1.59|m.1169,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100889159.1.3|m.11532,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G214844.29.34|m.57719,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_028566|m.32498,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048626|m.57669,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_73101.3.4|m.32464,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_105672.2.2|m.52359,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC590568.2.4|m.38593,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEGF6.28.59|m.37722,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CED1.26.29|m.53629,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PSTA_4372.1.1|m.39115,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CED1.9.29|m.29470,4,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_027327|m.31055,2,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_030794|m.35106,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_OSHV1_GP010.1.2|m.28853,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_009887|m.11524,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040238|m.45604,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100373888.8.9|m.60548,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AGRIN.4.5|m.27580,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_015918|m.18639,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PY04960.1.1|m.26352,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DHC6.1.1|m.22887,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_HAAF.3.13|m.8849,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_047828|m.56501,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_016010|m.18750,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100372473.1.5|m.7845,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100638431.10.10|m.59513,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIADDRAFT_32712.2.4|m.28430,2,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042449|m.48875,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEGF6.15.59|m.24311,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050483|m.60085,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_YL086.1.1|m.33481,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031003|m.35364,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025192|m.28699,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_044678|m.51771,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CHL1.2.2|m.65829,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024046|m.27342,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_INVS.2.6|m.8331,2,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_122381.3.4|m.23140,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042362|m.48774,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RAC1.2.3|m.23406,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043909|m.50738,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101067075.1.2|m.30552,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DPSE_GA28568.4.9|m.21893,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004461|m.5117,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_71629.1.1|m.65970,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023655|m.26913,13,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100634184.2.3|m.15892,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100891466.2.10|m.9752,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_99603.1.1|m.4456,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_2AAA.1.1|m.13307,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100164822.1.1|m.47189,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100892516.1.1|m.38152,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101158638.1.2|m.5931,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_010487|m.12180,3,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_020507|m.23691,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ACT.5.27|m.15585,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040513|m.45971,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_282105.2.2|m.59782,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEG10.56.91|m.47515,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031630|m.36105,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_027379|m.31113,4.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.1.15|m.2270,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100749806.3.3|m.54541,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_053912|m.64506,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023474|m.26716,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100934353.1.1|m.11772,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEGF6.35.59|m.42904,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RN213.7.13|m.45976,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100533220.2.2|m.13990,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_051794|m.62013,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
